GO Term,Description,P-value,FDR q-value,Enrichment,N,B,n,b,GenesGO:0030198,extracellular matrix organization,7.66E-10,8.54E-06,2.65,8230,270,586,51,"[FMOD  -  fibromodulin, ELN  -  elastin, COL14A1  -  collagen, type xiv, alpha 1, CD151  -  cd151 molecule (raph blood group), LGALS3  -  lectin, galactoside-binding, soluble, 3, FBLN1  -  fibulin 1, CTSK  -  cathepsin k, BGN  -  biglycan, FOXC1  -  forkhead box c1, CTSD  -  cathepsin d, P4HB  -  prolyl 4-hydroxylase, beta polypeptide, SOX9  -  sry (sex determining region y)-box 9, FOXF2  -  forkhead box f2, DDR1  -  discoidin domain receptor tyrosine kinase 1, MMP11  -  matrix metallopeptidase 11 (stromelysin 3), FURIN  -  furin (paired basic amino acid cleaving enzyme), BMP1  -  bone morphogenetic protein 1, VCAM1  -  vascular cell adhesion molecule 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, APP  -  amyloid beta (a4) precursor protein, PLEC  -  plectin, SERPINF2  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 2, BMP4  -  bone morphogenetic protein 4, TNFRSF11B  -  tumor necrosis factor receptor superfamily, member 11b, PDGFA  -  platelet-derived growth factor alpha polypeptide, ITGA5  -  integrin, alpha 5 (fibronectin receptor, alpha polypeptide), ACTN1  -  actinin, alpha 1, ITGA7  -  integrin, alpha 7, RECK  -  reversion-inducing-cysteine-rich protein with kazal motifs, MFAP5  -  microfibrillar associated protein 5, PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, ITGA3  -  integrin, alpha 3 (antigen cd49c, alpha 3 subunit of vla-3 receptor), ITGB5  -  integrin, beta 5, FBLN5  -  fibulin 5, LUM  -  lumican, NID2  -  nidogen 2 (osteonidogen), COL8A1  -  collagen, type viii, alpha 1, TGFB1  -  transforming growth factor, beta 1, COL4A5  -  collagen, type iv, alpha 5, DAG1  -  dystroglycan 1 (dystrophin-associated glycoprotein 1), MFAP4  -  microfibrillar-associated protein 4, DMD  -  dystrophin, LAMA5  -  laminin, alpha 5, EFEMP1  -  egf containing fibulin-like extracellular matrix protein 1, PRKCA  -  protein kinase c, alpha, LAMA4  -  laminin, alpha 4, COL11A1  -  collagen, type xi, alpha 1, GAS6  -  growth arrest-specific 6, ITGA6  -  integrin, alpha 6, FBLN2  -  fibulin 2, LAMB1  -  laminin, beta 1]"GO:0043062,extracellular structure organization,7.66E-10,4.27E-06,2.65,8230,270,586,51,"[FMOD  -  fibromodulin, ELN  -  elastin, COL14A1  -  collagen, type xiv, alpha 1, CD151  -  cd151 molecule (raph blood group), LGALS3  -  lectin, galactoside-binding, soluble, 3, FBLN1  -  fibulin 1, CTSK  -  cathepsin k, BGN  -  biglycan, FOXC1  -  forkhead box c1, CTSD  -  cathepsin d, P4HB  -  prolyl 4-hydroxylase, beta polypeptide, SOX9  -  sry (sex determining region y)-box 9, FOXF2  -  forkhead box f2, DDR1  -  discoidin domain receptor tyrosine kinase 1, MMP11  -  matrix metallopeptidase 11 (stromelysin 3), FURIN  -  furin (paired basic amino acid cleaving enzyme), BMP1  -  bone morphogenetic protein 1, VCAM1  -  vascular cell adhesion molecule 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, APP  -  amyloid beta (a4) precursor protein, PLEC  -  plectin, SERPINF2  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 2, BMP4  -  bone morphogenetic protein 4, TNFRSF11B  -  tumor necrosis factor receptor superfamily, member 11b, PDGFA  -  platelet-derived growth factor alpha polypeptide, ITGA5  -  integrin, alpha 5 (fibronectin receptor, alpha polypeptide), ACTN1  -  actinin, alpha 1, ITGA7  -  integrin, alpha 7, RECK  -  reversion-inducing-cysteine-rich protein with kazal motifs, MFAP5  -  microfibrillar associated protein 5, PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, ITGA3  -  integrin, alpha 3 (antigen cd49c, alpha 3 subunit of vla-3 receptor), ITGB5  -  integrin, beta 5, FBLN5  -  fibulin 5, LUM  -  lumican, NID2  -  nidogen 2 (osteonidogen), COL8A1  -  collagen, type viii, alpha 1, TGFB1  -  transforming growth factor, beta 1, COL4A5  -  collagen, type iv, alpha 5, DAG1  -  dystroglycan 1 (dystrophin-associated glycoprotein 1), MFAP4  -  microfibrillar-associated protein 4, DMD  -  dystrophin, LAMA5  -  laminin, alpha 5, EFEMP1  -  egf containing fibulin-like extracellular matrix protein 1, PRKCA  -  protein kinase c, alpha, LAMA4  -  laminin, alpha 4, COL11A1  -  collagen, type xi, alpha 1, GAS6  -  growth arrest-specific 6, ITGA6  -  integrin, alpha 6, FBLN2  -  fibulin 2, LAMB1  -  laminin, beta 1]"GO:0060548,negative regulation of cell death,4.19E-08,1.56E-04,1.75,8230,554,892,105,"[BNIP3  -  bcl2/adenovirus e1b 19kda interacting protein 3, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, BNIP2  -  bcl2/adenovirus e1b 19kda interacting protein 2, NCK1  -  nck adaptor protein 1, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), PAX7  -  paired box 7, HTRA2  -  htra serine peptidase 2, CD59  -  cd59 molecule, complement regulatory protein, PSMA1  -  proteasome (prosome, macropain) subunit, alpha type, 1, HRAS  -  harvey rat sarcoma viral oncogene homolog, FOXO1  -  forkhead box o1, ASIC2  -  acid-sensing (proton-gated) ion channel 2, FOXC1  -  forkhead box c1, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, CRLF1  -  cytokine receptor-like factor 1, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, PDCD10  -  programmed cell death 10, SOX9  -  sry (sex determining region y)-box 9, PSMB9  -  proteasome (prosome, macropain) subunit, beta type, 9, SOX4  -  sry (sex determining region y)-box 4, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, NACA  -  nascent polypeptide-associated complex alpha subunit, PSMB4  -  proteasome (prosome, macropain) subunit, beta type, 4, APOE  -  apolipoprotein e, SOD2  -  superoxide dismutase 2, mitochondrial, SOD1  -  superoxide dismutase 1, soluble, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, IL6ST  -  interleukin 6 signal transducer (gp130, oncostatin m receptor), BMP4  -  bone morphogenetic protein 4, AQP1  -  aquaporin 1 (colton blood group), ITGA5  -  integrin, alpha 5 (fibronectin receptor, alpha polypeptide), PSMD11  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 11, PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), MDK  -  midkine (neurite growth-promoting factor 2), CFL1  -  cofilin 1 (non-muscle), MECP2  -  methyl cpg binding protein 2 (rett syndrome), ADAR  -  adenosine deaminase, rna-specific, PDPK1  -  3-phosphoinositide dependent protein kinase-1, FGF2  -  fibroblast growth factor 2 (basic), EGFR  -  epidermal growth factor receptor, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, FGF4  -  fibroblast growth factor 4, ADA  -  adenosine deaminase, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, MED1  -  mediator complex subunit 1, CEBPB  -  ccaat/enhancer binding protein (c/ebp), beta, AMIGO2  -  adhesion molecule with ig-like domain 2, KRT18  -  keratin 18, ROCK1  -  rho-associated, coiled-coil containing protein kinase 1, DAPK1  -  death-associated protein kinase 1, MAPK8IP1  -  mitogen-activated protein kinase 8 interacting protein 1, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), EDNRA  -  endothelin receptor type a, TRAF2  -  tnf receptor-associated factor 2, HDAC1  -  histone deacetylase 1, TPT1  -  tumor protein, translationally-controlled 1, IRAK1  -  interleukin-1 receptor-associated kinase 1, IFIT3  -  interferon-induced protein with tetratricopeptide repeats 3, TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), AGT  -  angiotensinogen (serpin peptidase inhibitor, clade a, member 8), GPI  -  glucose-6-phosphate isomerase, UNG  -  uracil-dna glycosylase, CAST  -  calpastatin, CTSH  -  cathepsin h, ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, NGF  -  nerve growth factor (beta polypeptide), NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, WNT5A  -  wingless-type mmtv integration site family, member 5a, TSC22D3  -  tsc22 domain family, member 3, TEK  -  tek tyrosine kinase, endothelial, MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), SHH  -  sonic hedgehog, BAG1  -  bcl2-associated athanogene, JUN  -  jun proto-oncogene, GPX1  -  glutathione peroxidase 1, STAT3  -  signal transducer and activator of transcription 3 (acute-phase response factor), PRNP  -  prion protein, CRYAB  -  crystallin, alpha b, ARNT2  -  aryl-hydrocarbon receptor nuclear translocator 2, CCNG1  -  cyclin g1, ATF5  -  activating transcription factor 5, NFE2L2  -  nuclear factor (erythroid-derived 2)-like 2, JAK2  -  janus kinase 2, TYRO3  -  tyro3 protein tyrosine kinase, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, SFRP1  -  secreted frizzled-related protein 1, IGF1R  -  insulin-like growth factor 1 receptor, MAPK7  -  mitogen-activated protein kinase 7, SERPINB9  -  serpin peptidase inhibitor, clade b (ovalbumin), member 9, CAT  -  catalase, FADD  -  fas (tnfrsf6)-associated via death domain, BCL6  -  b-cell cll/lymphoma 6, KRIT1  -  krit1, ankyrin repeat containing, CFDP1  -  craniofacial development protein 1, PRKCG  -  protein kinase c, gamma, SLC25A4  -  solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4, SMAD3  -  smad family member 3, PRKCA  -  protein kinase c, alpha, SMAD6  -  smad family member 6, GSK3B  -  glycogen synthase kinase 3 beta, CBS  -  cystathionine-beta-synthase, GAS6  -  growth arrest-specific 6, ITSN1  -  intersectin 1 (sh3 domain protein), GAS1  -  growth arrest-specific 1]"GO:0043069,negative regulation of programmed cell death,1.10E-07,3.07E-04,1.75,8230,528,892,100,"[BNIP3  -  bcl2/adenovirus e1b 19kda interacting protein 3, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, BNIP2  -  bcl2/adenovirus e1b 19kda interacting protein 2, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), PAX7  -  paired box 7, CD59  -  cd59 molecule, complement regulatory protein, PSMA1  -  proteasome (prosome, macropain) subunit, alpha type, 1, HRAS  -  harvey rat sarcoma viral oncogene homolog, FOXO1  -  forkhead box o1, ASIC2  -  acid-sensing (proton-gated) ion channel 2, FOXC1  -  forkhead box c1, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, CRLF1  -  cytokine receptor-like factor 1, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, PDCD10  -  programmed cell death 10, SOX9  -  sry (sex determining region y)-box 9, PSMB9  -  proteasome (prosome, macropain) subunit, beta type, 9, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, NACA  -  nascent polypeptide-associated complex alpha subunit, PSMB4  -  proteasome (prosome, macropain) subunit, beta type, 4, APOE  -  apolipoprotein e, SOD2  -  superoxide dismutase 2, mitochondrial, SOD1  -  superoxide dismutase 1, soluble, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, IL6ST  -  interleukin 6 signal transducer (gp130, oncostatin m receptor), BMP4  -  bone morphogenetic protein 4, AQP1  -  aquaporin 1 (colton blood group), ITGA5  -  integrin, alpha 5 (fibronectin receptor, alpha polypeptide), PSMD11  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 11, PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), MDK  -  midkine (neurite growth-promoting factor 2), CFL1  -  cofilin 1 (non-muscle), MECP2  -  methyl cpg binding protein 2 (rett syndrome), ADAR  -  adenosine deaminase, rna-specific, PDPK1  -  3-phosphoinositide dependent protein kinase-1, EGFR  -  epidermal growth factor receptor, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, FGF4  -  fibroblast growth factor 4, ADA  -  adenosine deaminase, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, MED1  -  mediator complex subunit 1, CEBPB  -  ccaat/enhancer binding protein (c/ebp), beta, AMIGO2  -  adhesion molecule with ig-like domain 2, KRT18  -  keratin 18, ROCK1  -  rho-associated, coiled-coil containing protein kinase 1, DAPK1  -  death-associated protein kinase 1, MAPK8IP1  -  mitogen-activated protein kinase 8 interacting protein 1, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), EDNRA  -  endothelin receptor type a, TRAF2  -  tnf receptor-associated factor 2, HDAC1  -  histone deacetylase 1, TPT1  -  tumor protein, translationally-controlled 1, IRAK1  -  interleukin-1 receptor-associated kinase 1, IFIT3  -  interferon-induced protein with tetratricopeptide repeats 3, TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), AGT  -  angiotensinogen (serpin peptidase inhibitor, clade a, member 8), GPI  -  glucose-6-phosphate isomerase, UNG  -  uracil-dna glycosylase, CAST  -  calpastatin, CTSH  -  cathepsin h, ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, NGF  -  nerve growth factor (beta polypeptide), NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, WNT5A  -  wingless-type mmtv integration site family, member 5a, TSC22D3  -  tsc22 domain family, member 3, TEK  -  tek tyrosine kinase, endothelial, MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), SHH  -  sonic hedgehog, BAG1  -  bcl2-associated athanogene, JUN  -  jun proto-oncogene, GPX1  -  glutathione peroxidase 1, PRNP  -  prion protein, CRYAB  -  crystallin, alpha b, ARNT2  -  aryl-hydrocarbon receptor nuclear translocator 2, CCNG1  -  cyclin g1, ATF5  -  activating transcription factor 5, NFE2L2  -  nuclear factor (erythroid-derived 2)-like 2, JAK2  -  janus kinase 2, TYRO3  -  tyro3 protein tyrosine kinase, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, SFRP1  -  secreted frizzled-related protein 1, IGF1R  -  insulin-like growth factor 1 receptor, MAPK7  -  mitogen-activated protein kinase 7, SERPINB9  -  serpin peptidase inhibitor, clade b (ovalbumin), member 9, CAT  -  catalase, FADD  -  fas (tnfrsf6)-associated via death domain, BCL6  -  b-cell cll/lymphoma 6, KRIT1  -  krit1, ankyrin repeat containing, CFDP1  -  craniofacial development protein 1, PRKCG  -  protein kinase c, gamma, SLC25A4  -  solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4, SMAD3  -  smad family member 3, PRKCA  -  protein kinase c, alpha, GSK3B  -  glycogen synthase kinase 3 beta, SMAD6  -  smad family member 6, CBS  -  cystathionine-beta-synthase, GAS6  -  growth arrest-specific 6, ITSN1  -  intersectin 1 (sh3 domain protein), GAS1  -  growth arrest-specific 1]"GO:0043066,negative regulation of apoptotic process,1.13E-07,2.52E-04,1.75,8230,522,892,99,"[BNIP3  -  bcl2/adenovirus e1b 19kda interacting protein 3, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, BNIP2  -  bcl2/adenovirus e1b 19kda interacting protein 2, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), PAX7  -  paired box 7, CD59  -  cd59 molecule, complement regulatory protein, PSMA1  -  proteasome (prosome, macropain) subunit, alpha type, 1, HRAS  -  harvey rat sarcoma viral oncogene homolog, FOXO1  -  forkhead box o1, ASIC2  -  acid-sensing (proton-gated) ion channel 2, FOXC1  -  forkhead box c1, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, CRLF1  -  cytokine receptor-like factor 1, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, SOX9  -  sry (sex determining region y)-box 9, PDCD10  -  programmed cell death 10, PSMB9  -  proteasome (prosome, macropain) subunit, beta type, 9, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, NACA  -  nascent polypeptide-associated complex alpha subunit, PSMB4  -  proteasome (prosome, macropain) subunit, beta type, 4, APOE  -  apolipoprotein e, SOD2  -  superoxide dismutase 2, mitochondrial, SOD1  -  superoxide dismutase 1, soluble, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, IL6ST  -  interleukin 6 signal transducer (gp130, oncostatin m receptor), BMP4  -  bone morphogenetic protein 4, AQP1  -  aquaporin 1 (colton blood group), ITGA5  -  integrin, alpha 5 (fibronectin receptor, alpha polypeptide), PSMD11  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 11, PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), MDK  -  midkine (neurite growth-promoting factor 2), CFL1  -  cofilin 1 (non-muscle), MECP2  -  methyl cpg binding protein 2 (rett syndrome), ADAR  -  adenosine deaminase, rna-specific, PDPK1  -  3-phosphoinositide dependent protein kinase-1, EGFR  -  epidermal growth factor receptor, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, FGF4  -  fibroblast growth factor 4, ADA  -  adenosine deaminase, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, MED1  -  mediator complex subunit 1, CEBPB  -  ccaat/enhancer binding protein (c/ebp), beta, AMIGO2  -  adhesion molecule with ig-like domain 2, KRT18  -  keratin 18, ROCK1  -  rho-associated, coiled-coil containing protein kinase 1, DAPK1  -  death-associated protein kinase 1, MAPK8IP1  -  mitogen-activated protein kinase 8 interacting protein 1, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), EDNRA  -  endothelin receptor type a, TRAF2  -  tnf receptor-associated factor 2, HDAC1  -  histone deacetylase 1, TPT1  -  tumor protein, translationally-controlled 1, IRAK1  -  interleukin-1 receptor-associated kinase 1, IFIT3  -  interferon-induced protein with tetratricopeptide repeats 3, TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), AGT  -  angiotensinogen (serpin peptidase inhibitor, clade a, member 8), GPI  -  glucose-6-phosphate isomerase, UNG  -  uracil-dna glycosylase, CAST  -  calpastatin, CTSH  -  cathepsin h, ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, NGF  -  nerve growth factor (beta polypeptide), NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, WNT5A  -  wingless-type mmtv integration site family, member 5a, TSC22D3  -  tsc22 domain family, member 3, TEK  -  tek tyrosine kinase, endothelial, MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), SHH  -  sonic hedgehog, BAG1  -  bcl2-associated athanogene, JUN  -  jun proto-oncogene, GPX1  -  glutathione peroxidase 1, PRNP  -  prion protein, CRYAB  -  crystallin, alpha b, ARNT2  -  aryl-hydrocarbon receptor nuclear translocator 2, CCNG1  -  cyclin g1, ATF5  -  activating transcription factor 5, NFE2L2  -  nuclear factor (erythroid-derived 2)-like 2, JAK2  -  janus kinase 2, TYRO3  -  tyro3 protein tyrosine kinase, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, SFRP1  -  secreted frizzled-related protein 1, IGF1R  -  insulin-like growth factor 1 receptor, MAPK7  -  mitogen-activated protein kinase 7, SERPINB9  -  serpin peptidase inhibitor, clade b (ovalbumin), member 9, CAT  -  catalase, FADD  -  fas (tnfrsf6)-associated via death domain, BCL6  -  b-cell cll/lymphoma 6, KRIT1  -  krit1, ankyrin repeat containing, CFDP1  -  craniofacial development protein 1, PRKCG  -  protein kinase c, gamma, SMAD3  -  smad family member 3, PRKCA  -  protein kinase c, alpha, GSK3B  -  glycogen synthase kinase 3 beta, SMAD6  -  smad family member 6, CBS  -  cystathionine-beta-synthase, GAS6  -  growth arrest-specific 6, ITSN1  -  intersectin 1 (sh3 domain protein), GAS1  -  growth arrest-specific 1]"GO:0006950,response to stress,6.09E-07,1.13E-03,1.32,8230,1769,998,283,"[TRIM27  -  tripartite motif containing 27, BNIP3  -  bcl2/adenovirus e1b 19kda interacting protein 3, RFC4  -  replication factor c (activator 1) 4, 37kda, HSF2  -  heat shock transcription factor 2, RFC2  -  replication factor c (activator 1) 2, 40kda, NCK1  -  nck adaptor protein 1, REV3L  -  rev3-like, polymerase (dna directed), zeta, catalytic subunit, SERPINA3  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 3, HNRNPA0  -  heterogeneous nuclear ribonucleoprotein a0, TSC22D4  -  tsc22 domain family, member 4, ABCA1  -  atp-binding cassette, sub-family a (abc1), member 1, TICAM1  -  toll-like receptor adaptor molecule 1, SPN  -  sialophorin, EPAS1  -  endothelial pas domain protein 1, TRPM2  -  transient receptor potential cation channel, subfamily m, member 2, LGALS3  -  lectin, galactoside-binding, soluble, 3, ATF6  -  activating transcription factor 6, GCH1  -  gtp cyclohydrolase 1, HRAS  -  harvey rat sarcoma viral oncogene homolog, NBN  -  nibrin, MYO10  -  myosin x, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, CFB  -  complement factor b, SOX4  -  sry (sex determining region y)-box 4, EIF2S1  -  eukaryotic translation initiation factor 2, subunit 1 alpha, 35kda, BID  -  bh3 interacting domain death agonist, PLSCR1  -  phospholipid scramblase 1, WIPF2  -  was/wasl interacting protein family, member 2, MYLK  -  myosin light chain kinase, GJA1  -  gap junction protein, alpha 1, 43kda, SOD2  -  superoxide dismutase 2, mitochondrial, SOD1  -  superoxide dismutase 1, soluble, CREB1  -  camp responsive element binding protein 1, LMNA  -  lamin a/c, SERPINF2  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 2, ICAM1  -  intercellular adhesion molecule 1, C9  -  complement component 9, GADD45B  -  growth arrest and dna-damage-inducible, beta, HUWE1  -  hect, uba and wwe domain containing 1, e3 ubiquitin protein ligase, ADAR  -  adenosine deaminase, rna-specific, EGFR  -  epidermal growth factor receptor, ADA  -  adenosine deaminase, POLR1C  -  polymerase (rna) i polypeptide c, 30kda, EIF2B4  -  eukaryotic translation initiation factor 2b, subunit 4 delta, 67kda, PTGES  -  prostaglandin e synthase, PON2  -  paraoxonase 2, ARPC2  -  actin related protein 2/3 complex, subunit 2, 34kda, ADD1  -  adducin 1 (alpha), GNB1  -  guanine nucleotide binding protein (g protein), beta polypeptide 1, SERPING1  -  serpin peptidase inhibitor, clade g (c1 inhibitor), member 1, ADH5  -  alcohol dehydrogenase 5 (class iii), chi polypeptide, HSPE1  -  heat shock 10kda protein 1 (chaperonin 10), C1R  -  complement component 1, r subcomponent, C1S  -  complement component 1, s subcomponent, LY96  -  lymphocyte antigen 96, PARP1  -  poly (adp-ribose) polymerase 1, C4A  -  complement component 4a (rodgers blood group), EDNRA  -  endothelin receptor type a, TAOK3  -  tao kinase 3, FZR1  -  fizzy/cell division cycle 20 related 1 (drosophila), ADM  -  adrenomedullin, TRAF2  -  tnf receptor-associated factor 2, HSPA4  -  heat shock 70kda protein 4, POLR2B  -  polymerase (rna) ii (dna directed) polypeptide b, 140kda, TRAP1  -  tnf receptor-associated protein 1, PARP4  -  poly (adp-ribose) polymerase family, member 4, CAPZA2  -  capping protein (actin filament) muscle z-line, alpha 2, AKR1C3  -  aldo-keto reductase family 1, member c3, CAPZA1  -  capping protein (actin filament) muscle z-line, alpha 1, PRKACB  -  protein kinase, camp-dependent, catalytic, beta, HLA-E  -  major histocompatibility complex, class i, e, AGT  -  angiotensinogen (serpin peptidase inhibitor, clade a, member 8), TANK  -  traf family member-associated nfkb activator, UNG  -  uracil-dna glycosylase, PPP5C  -  protein phosphatase 5, catalytic subunit, RPA3  -  replication protein a3, 14kda, RPA2  -  replication protein a2, 32kda, TAB2  -  tgf-beta activated kinase 1/map3k7 binding protein 2, CTSL  -  cathepsin l, CTSK  -  cathepsin k, PPP2R5B  -  protein phosphatase 2, regulatory subunit b', beta, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, ACD  -  adrenocortical dysplasia homolog (mouse), AHR  -  aryl hydrocarbon receptor, CREB3L1  -  camp responsive element binding protein 3-like 1, CFH  -  complement factor h, HSPB6  -  heat shock protein, alpha-crystallin-related, b6, VCAM1  -  vascular cell adhesion molecule 1, F2R  -  coagulation factor ii (thrombin) receptor, VDAC1  -  voltage-dependent anion channel 1, CRIP1  -  cysteine-rich protein 1 (intestinal), MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), CRKL  -  v-crk avian sarcoma virus ct10 oncogene homolog-like, FOSL1  -  fos-like antigen 1, JUN  -  jun proto-oncogene, CRY1  -  cryptochrome 1 (photolyase-like), STAT2  -  signal transducer and activator of transcription 2, 113kda, UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, STAT1  -  signal transducer and activator of transcription 1, 91kda, PROS1  -  protein s (alpha), STAT3  -  signal transducer and activator of transcription 3 (acute-phase response factor), PRNP  -  prion protein, ARNT2  -  aryl-hydrocarbon receptor nuclear translocator 2, CRYAB  -  crystallin, alpha b, ALDOC  -  aldolase c, fructose-bisphosphate, CCNG1  -  cyclin g1, SSRP1  -  structure specific recognition protein 1, TNFSF4  -  tumor necrosis factor (ligand) superfamily, member 4, CD14  -  cd14 molecule, OXSR1  -  oxidative stress responsive 1, JAK2  -  janus kinase 2, NDRG1  -  n-myc downstream regulated 1, TUBB4B  -  tubulin, beta 4b class ivb, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, MAP2K1  -  mitogen-activated protein kinase kinase 1, UBXN4  -  ubx domain protein 4, MAP2K3  -  mitogen-activated protein kinase kinase 3, MAPK10  -  mitogen-activated protein kinase 10, MAPK7  -  mitogen-activated protein kinase 7, SRPK2  -  srsf protein kinase 2, SLC23A2  -  solute carrier family 23 (ascorbic acid transporter), member 2, UCHL1  -  ubiquitin carboxyl-terminal esterase l1 (ubiquitin thiolesterase), TNFRSF14  -  tumor necrosis factor receptor superfamily, member 14, MAPK3  -  mitogen-activated protein kinase 3, CAT  -  catalase, ASIC3  -  acid-sensing (proton-gated) ion channel 3, TRIM21  -  tripartite motif containing 21, FADD  -  fas (tnfrsf6)-associated via death domain, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, NREP  -  neuronal regeneration related protein, GBP1  -  guanylate binding protein 1, interferon-inducible, RBM14  -  rna binding motif protein 14, PRKCG  -  protein kinase c, gamma, GAP43  -  growth associated protein 43, PRKCA  -  protein kinase c, alpha, CCS  -  copper chaperone for superoxide dismutase, CBS  -  cystathionine-beta-synthase, PRKAR1B  -  protein kinase, camp-dependent, regulatory, type i, beta, NUPR1  -  nuclear protein, transcriptional regulator, 1, GAS6  -  growth arrest-specific 6, MPG  -  n-methylpurine-dna glycosylase, APEX1  -  apex nuclease (multifunctional dna repair enzyme) 1, GSTM2  -  glutathione s-transferase mu 2 (muscle), GSTM1  -  glutathione s-transferase mu 1, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), INHBA  -  inhibin, beta a, DDB1  -  damage-specific dna binding protein 1, 127kda, GAB2  -  grb2-associated binding protein 2, HTRA2  -  htra serine peptidase 2, CD59  -  cd59 molecule, complement regulatory protein, PSEN2  -  presenilin 2 (alzheimer disease 4), GTF2H1  -  general transcription factor iih, polypeptide 1, 62kda, PSMA1  -  proteasome (prosome, macropain) subunit, alpha type, 1, FOXO1  -  forkhead box o1, MSH6  -  muts homolog 6 (e. coli), CD97  -  cd97 molecule, MMP2  -  matrix metallopeptidase 2 (gelatinase a, 72kda gelatinase, 72kda type iv collagenase), CDC14B  -  cell division cycle 14b, IL4R  -  interleukin 4 receptor, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, UBE2L6  -  ubiquitin-conjugating enzyme e2l 6, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, P4HB  -  prolyl 4-hydroxylase, beta polypeptide, PSMB9  -  proteasome (prosome, macropain) subunit, beta type, 9, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, PSMB7  -  proteasome (prosome, macropain) subunit, beta type, 7, PSMB4  -  proteasome (prosome, macropain) subunit, beta type, 4, PDPN  -  podoplanin, TDG  -  thymine-dna glycosylase, TXNIP  -  thioredoxin interacting protein, SDC2  -  syndecan 2, APOE  -  apolipoprotein e, APP  -  amyloid beta (a4) precursor protein, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, NUAK1  -  nuak family, snf1-like kinase, 1, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, CXCL6  -  chemokine (c-x-c motif) ligand 6, IL32  -  interleukin 32, AQP1  -  aquaporin 1 (colton blood group), DGKZ  -  diacylglycerol kinase, zeta, PDGFA  -  platelet-derived growth factor alpha polypeptide, PSMD11  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 11, PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), MCM7  -  minichromosome maintenance complex component 7, FGFR1  -  fibroblast growth factor receptor 1, MDK  -  midkine (neurite growth-promoting factor 2), ROR2  -  receptor tyrosine kinase-like orphan receptor 2, FGF5  -  fibroblast growth factor 5, PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, CFL1  -  cofilin 1 (non-muscle), FGF7  -  fibroblast growth factor 7, BCLAF1  -  bcl2-associated transcription factor 1, MECP2  -  methyl cpg binding protein 2 (rett syndrome), RHOB  -  ras homolog family member b, MEF2A  -  myocyte enhancer factor 2a, PDPK1  -  3-phosphoinositide dependent protein kinase-1, FGF2  -  fibroblast growth factor 2 (basic), FGF4  -  fibroblast growth factor 4, MKNK1  -  map kinase interacting serine/threonine kinase 1, PDK3  -  pyruvate dehydrogenase kinase, isozyme 3, PSIP1  -  pc4 and sfrs1 interacting protein 1, GTF2H5  -  general transcription factor iih, polypeptide 5, TAP1  -  transporter 1, atp-binding cassette, sub-family b (mdr/tap), CEBPB  -  ccaat/enhancer binding protein (c/ebp), beta, TBX2  -  t-box 2, ASS1  -  argininosuccinate synthase 1, PTPN1  -  protein tyrosine phosphatase, non-receptor type 1, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, RUVBL1  -  ruvb-like 1 (e. coli), ARL6IP5  -  adp-ribosylation-like factor 6 interacting protein 5, CRCP  -  cgrp receptor component, IRAK1  -  interleukin-1 receptor-associated kinase 1, RAD1  -  rad1 homolog (s. pombe), IFIT1  -  interferon-induced protein with tetratricopeptide repeats 1, IFIT3  -  interferon-induced protein with tetratricopeptide repeats 3, IFI16  -  interferon, gamma-inducible protein 16, HIST2H2BE  -  histone cluster 2, h2be, PTX3  -  pentraxin 3, long, XPC  -  xeroderma pigmentosum, complementation group c, SMC3  -  structural maintenance of chromosomes 3, PDLIM1  -  pdz and lim domain 1, ATP1B1  -  atpase, na+/k+ transporting, beta 1 polypeptide, PXN  -  paxillin, NMI  -  n-myc (and stat) interactor, DPYSL3  -  dihydropyrimidinase-like 3, FOXN3  -  forkhead box n3, SLC12A2  -  solute carrier family 12 (sodium/potassium/chloride transporter), member 2, MICA  -  mhc class i polypeptide-related sequence a, ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, HDAC4  -  histone deacetylase 4, NFX1  -  nuclear transcription factor, x-box binding 1, NGF  -  nerve growth factor (beta polypeptide), NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, MATN2  -  matrilin 2, SLC2A1  -  solute carrier family 2 (facilitated glucose transporter), member 1, WNT5A  -  wingless-type mmtv integration site family, member 5a, RAD23B  -  rad23 homolog b (s. cerevisiae), TNFAIP6  -  tumor necrosis factor, alpha-induced protein 6, TSC22D3  -  tsc22 domain family, member 3, ASH2L  -  ash2 (absent, small, or homeotic)-like (drosophila), TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, TEK  -  tek tyrosine kinase, endothelial, DDIT4  -  dna-damage-inducible transcript 4, RBPJ  -  recombination signal binding protein for immunoglobulin kappa j region, RAD51D  -  rad51 paralog d, GPX1  -  glutathione peroxidase 1, DYRK2  -  dual-specificity tyrosine-(y)-phosphorylation regulated kinase 2, PLAU  -  plasminogen activator, urokinase, NFE2L2  -  nuclear factor (erythroid-derived 2)-like 2, PLAT  -  plasminogen activator, tissue, ISG15  -  isg15 ubiquitin-like modifier, GPX7  -  glutathione peroxidase 7, CLU  -  clusterin, ATR  -  ataxia telangiectasia and rad3 related, TPP1  -  tripeptidyl peptidase i, SFRP1  -  secreted frizzled-related protein 1, SMARCA5  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5, MGLL  -  monoglyceride lipase, BDKRB2  -  bradykinin receptor b2, SMAD1  -  smad family member 1, TGFB1  -  transforming growth factor, beta 1, TGFB1I1  -  transforming growth factor beta 1 induced transcript 1, IGFBP1  -  insulin-like growth factor binding protein 1, TDP2  -  tyrosyl-dna phosphodiesterase 2, BCL6  -  b-cell cll/lymphoma 6, TSPYL2  -  tspy-like 2, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), TGFBR3  -  transforming growth factor, beta receptor iii, RPS6KA4  -  ribosomal protein s6 kinase, 90kda, polypeptide 4, CUL4B  -  cullin 4b, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, FOS  -  fbj murine osteosarcoma viral oncogene homolog, YES1  -  v-yes-1 yamaguchi sarcoma viral oncogene homolog 1, CXCL1  -  chemokine (c-x-c motif) ligand 1 (melanoma growth stimulating activity, alpha), SGK1  -  serum/glucocorticoid regulated kinase 1, FNTB  -  farnesyltransferase, caax box, beta, POLD3  -  polymerase (dna-directed), delta 3, accessory subunit, SMAD3  -  smad family member 3, SMAD6  -  smad family member 6, CCND1  -  cyclin d1, GSK3B  -  glycogen synthase kinase 3 beta]"GO:0080134,regulation of response to stress,1.12E-06,1.79E-03,1.64,8230,684,794,108,"[APEX1  -  apex nuclease (multifunctional dna repair enzyme) 1, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), MID1  -  midline 1 (opitz/bbb syndrome), TICAM1  -  toll-like receptor adaptor molecule 1, SPN  -  sialophorin, CD59  -  cd59 molecule, complement regulatory protein, HRAS  -  harvey rat sarcoma viral oncogene homolog, FOXO1  -  forkhead box o1, TRAF4  -  tnf receptor-associated factor 4, PIAS1  -  protein inhibitor of activated stat, 1, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, CFB  -  complement factor b, P4HB  -  prolyl 4-hydroxylase, beta polypeptide, NDEL1  -  nude neurodevelopment protein 1-like 1, IL1R1  -  interleukin 1 receptor, type i, ARF1  -  adp-ribosylation factor 1, PLSCR1  -  phospholipid scramblase 1, PSMB4  -  proteasome (prosome, macropain) subunit, beta type, 4, PDPN  -  podoplanin, PLAUR  -  plasminogen activator, urokinase receptor, GJA1  -  gap junction protein, alpha 1, 43kda, MYLK  -  myosin light chain kinase, APOE  -  apolipoprotein e, SOD2  -  superoxide dismutase 2, mitochondrial, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, NUAK1  -  nuak family, snf1-like kinase, 1, SERPINF2  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 2, IL6ST  -  interleukin 6 signal transducer (gp130, oncostatin m receptor), PDGFA  -  platelet-derived growth factor alpha polypeptide, C9  -  complement component 9, GADD45B  -  growth arrest and dna-damage-inducible, beta, PPM1B  -  protein phosphatase, mg2+/mn2+ dependent, 1b, PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, MEF2A  -  myocyte enhancer factor 2a, FGF2  -  fibroblast growth factor 2 (basic), EGFR  -  epidermal growth factor receptor, FBLN5  -  fibulin 5, FZD7  -  frizzled family receptor 7, ADA  -  adenosine deaminase, MED1  -  mediator complex subunit 1, CNR1  -  cannabinoid receptor 1 (brain), SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, ZYX  -  zyxin, SERPING1  -  serpin peptidase inhibitor, clade g (c1 inhibitor), member 1, CDKN2D  -  cyclin-dependent kinase inhibitor 2d (p19, inhibits cdk4), LY96  -  lymphocyte antigen 96, MAPK8IP1  -  mitogen-activated protein kinase 8 interacting protein 1, PTPN1  -  protein tyrosine phosphatase, non-receptor type 1, ARL6IP5  -  adp-ribosylation-like factor 6 interacting protein 5, CDC37  -  cell division cycle 37, C4A  -  complement component 4a (rodgers blood group), TRAF2  -  tnf receptor-associated factor 2, LARP1  -  la ribonucleoprotein domain family, member 1, TPT1  -  tumor protein, translationally-controlled 1, IRAK1  -  interleukin-1 receptor-associated kinase 1, IFIT1  -  interferon-induced protein with tetratricopeptide repeats 1, AP1G1  -  adaptor-related protein complex 1, gamma 1 subunit, IFI16  -  interferon, gamma-inducible protein 16, AGT  -  angiotensinogen (serpin peptidase inhibitor, clade a, member 8), PVR  -  poliovirus receptor, IFNGR1  -  interferon gamma receptor 1, PVRL2  -  poliovirus receptor-related 2 (herpesvirus entry mediator b), MAP4K4  -  mitogen-activated protein kinase kinase kinase kinase 4, TAB2  -  tgf-beta activated kinase 1/map3k7 binding protein 2, CTSL  -  cathepsin l, CTSK  -  cathepsin k, NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, WNT5A  -  wingless-type mmtv integration site family, member 5a, DVL3  -  dishevelled segment polarity protein 3, CFH  -  complement factor h, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, TEK  -  tek tyrosine kinase, endothelial, JUN  -  jun proto-oncogene, STAT2  -  signal transducer and activator of transcription 2, 113kda, UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, STAT1  -  signal transducer and activator of transcription 1, 91kda, GPX1  -  glutathione peroxidase 1, PROS1  -  protein s (alpha), NFE2L2  -  nuclear factor (erythroid-derived 2)-like 2, PLAT  -  plasminogen activator, tissue, TNFSF4  -  tumor necrosis factor (ligand) superfamily, member 4, CD14  -  cd14 molecule, JAK2  -  janus kinase 2, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, TYRO3  -  tyro3 protein tyrosine kinase, CLU  -  clusterin, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, ATR  -  ataxia telangiectasia and rad3 related, MAP2K1  -  mitogen-activated protein kinase kinase 1, MAP2K3  -  mitogen-activated protein kinase kinase 3, MAPK10  -  mitogen-activated protein kinase 10, IGBP1  -  immunoglobulin (cd79a) binding protein 1, BDKRB2  -  bradykinin receptor b2, MGLL  -  monoglyceride lipase, IGF1R  -  insulin-like growth factor 1 receptor, MAPK7  -  mitogen-activated protein kinase 7, SERPINE2  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 2, TGFB1  -  transforming growth factor, beta 1, MAPK3  -  mitogen-activated protein kinase 3, PRKG1  -  protein kinase, cgmp-dependent, type i, FADD  -  fas (tnfrsf6)-associated via death domain, BCL6  -  b-cell cll/lymphoma 6, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), FOS  -  fbj murine osteosarcoma viral oncogene homolog, PRKCA  -  protein kinase c, alpha, SMAD3  -  smad family member 3, CBS  -  cystathionine-beta-synthase, NR1D2  -  nuclear receptor subfamily 1, group d, member 2]"GO:0048523,negative regulation of cellular process,1.21E-06,1.69E-03,1.29,8230,2265,832,296,"[MAD2L1BP  -  mad2l1 binding protein, YAF2  -  yy1 associated factor 2, BNIP3  -  bcl2/adenovirus e1b 19kda interacting protein 3, NDN  -  necdin, melanoma antigen (mage) family member, BNIP2  -  bcl2/adenovirus e1b 19kda interacting protein 2, NCK1  -  nck adaptor protein 1, TSC22D4  -  tsc22 domain family, member 4, ABCA1  -  atp-binding cassette, sub-family a (abc1), member 1, SPN  -  sialophorin, NCOR2  -  nuclear receptor corepressor 2, IQGAP1  -  iq motif containing gtpase activating protein 1, HRAS  -  harvey rat sarcoma viral oncogene homolog, NBN  -  nibrin, NUBP1  -  nucleotide binding protein 1, ENO1  -  enolase 1, (alpha), NBL1  -  neuroblastoma 1, dan family bmp antagonist, ASIC2  -  acid-sensing (proton-gated) ion channel 2, SOX9  -  sry (sex determining region y)-box 9, SOX4  -  sry (sex determining region y)-box 4, NAB1  -  ngfi-a binding protein 1 (egr1 binding protein 1), PLSCR1  -  phospholipid scramblase 1, NACA  -  nascent polypeptide-associated complex alpha subunit, RGS7  -  regulator of g-protein signaling 7, GJA1  -  gap junction protein, alpha 1, 43kda, SOD2  -  superoxide dismutase 2, mitochondrial, RGS3  -  regulator of g-protein signaling 3, BMPR1A  -  bone morphogenetic protein receptor, type ia, CREB1  -  camp responsive element binding protein 1, LMNA  -  lamin a/c, BMP4  -  bone morphogenetic protein 4, RGS16  -  regulator of g-protein signaling 16, SNTA1  -  syntrophin, alpha 1, ACTN1  -  actinin, alpha 1, GADD45B  -  growth arrest and dna-damage-inducible, beta, PPM1B  -  protein phosphatase, mg2+/mn2+ dependent, 1b, ADAR  -  adenosine deaminase, rna-specific, EGFR  -  epidermal growth factor receptor, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, SAMD4A  -  sterile alpha motif domain containing 4a, FZD7  -  frizzled family receptor 7, ADA  -  adenosine deaminase, MED1  -  mediator complex subunit 1, EIF2B4  -  eukaryotic translation initiation factor 2b, subunit 4 delta, 67kda, RNF2  -  ring finger protein 2, CNR1  -  cannabinoid receptor 1 (brain), EFNB2  -  ephrin-b2, PTGES  -  prostaglandin e synthase, KRT18  -  keratin 18, ROCK1  -  rho-associated, coiled-coil containing protein kinase 1, ADD1  -  adducin 1 (alpha), EIF4E2  -  eukaryotic translation initiation factor 4e family member 2, SMARCA2  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, MAPK8IP1  -  mitogen-activated protein kinase 8 interacting protein 1, PARP1  -  poly (adp-ribose) polymerase 1, LRPPRC  -  leucine-rich pentatricopeptide repeat containing, FZR1  -  fizzy/cell division cycle 20 related 1 (drosophila), ADM  -  adrenomedullin, TRAF2  -  tnf receptor-associated factor 2, FSTL3  -  follistatin-like 3 (secreted glycoprotein), MBD2  -  methyl-cpg binding domain protein 2, TRAP1  -  tnf receptor-associated protein 1, LAMB1  -  laminin, beta 1, TPT1  -  tumor protein, translationally-controlled 1, CAPZA2  -  capping protein (actin filament) muscle z-line, alpha 2, AKR1C3  -  aldo-keto reductase family 1, member c3, CAPZA1  -  capping protein (actin filament) muscle z-line, alpha 1, ACAA2  -  acetyl-coa acyltransferase 2, PDE5A  -  phosphodiesterase 5a, cgmp-specific, SIK1  -  salt-inducible kinase 1, AGT  -  angiotensinogen (serpin peptidase inhibitor, clade a, member 8), SPG20  -  spastic paraplegia 20 (troyer syndrome), UNG  -  uracil-dna glycosylase, FTH1  -  ferritin, heavy polypeptide 1, AIMP2  -  aminoacyl trna synthetase complex-interacting multifunctional protein 2, CAST  -  calpastatin, GPNMB  -  glycoprotein (transmembrane) nmb, LPXN  -  leupaxin, HMGXB4  -  hmg box domain containing 4, CTSH  -  cathepsin h, WWP2  -  ww domain containing e3 ubiquitin protein ligase 2, DDR1  -  discoidin domain receptor tyrosine kinase 1, AHR  -  aryl hydrocarbon receptor, SEMA4F  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4f, STK3  -  serine/threonine kinase 3, PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, EZH2  -  enhancer of zeste homolog 2 (drosophila), HIVEP1  -  human immunodeficiency virus type i enhancer binding protein 1, SNX13  -  sorting nexin 13, ERF  -  ets2 repressor factor, MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), ST13  -  suppression of tumorigenicity 13 (colon carcinoma) (hsp70 interacting protein), FOSL1  -  fos-like antigen 1, JUN  -  jun proto-oncogene, CRY1  -  cryptochrome 1 (photolyase-like), UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, STAT1  -  signal transducer and activator of transcription 1, 91kda, EED  -  embryonic ectoderm development, STAT3  -  signal transducer and activator of transcription 3 (acute-phase response factor), PRNP  -  prion protein, ARNT2  -  aryl-hydrocarbon receptor nuclear translocator 2, CRYAB  -  crystallin, alpha b, CCNG1  -  cyclin g1, TNFSF4  -  tumor necrosis factor (ligand) superfamily, member 4, FXR1  -  fragile x mental retardation, autosomal homolog 1, JAK2  -  janus kinase 2, DLC1  -  deleted in liver cancer 1, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, TYRO3  -  tyro3 protein tyrosine kinase, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, MAP2K1  -  mitogen-activated protein kinase kinase 1, CBLB  -  cbl proto-oncogene b, e3 ubiquitin protein ligase, MAPK7  -  mitogen-activated protein kinase 7, SRPK2  -  srsf protein kinase 2, UCHL1  -  ubiquitin carboxyl-terminal esterase l1 (ubiquitin thiolesterase), MVP  -  major vault protein, TNFRSF14  -  tumor necrosis factor receptor superfamily, member 14, UBTF  -  upstream binding transcription factor, rna polymerase i, CAT  -  catalase, CAV2  -  caveolin 2, PRKG1  -  protein kinase, cgmp-dependent, type i, TRIM21  -  tripartite motif containing 21, FADD  -  fas (tnfrsf6)-associated via death domain, COPS2  -  cop9 signalosome subunit 2, RYK  -  receptor-like tyrosine kinase, BAMBI  -  bmp and activin membrane-bound inhibitor, STAM  -  signal transducing adaptor molecule (sh3 domain and itam motif) 1, KRIT1  -  krit1, ankyrin repeat containing, CFDP1  -  craniofacial development protein 1, PRKCG  -  protein kinase c, gamma, SLC25A4  -  solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4, PRKCA  -  protein kinase c, alpha, CBS  -  cystathionine-beta-synthase, NR1D2  -  nuclear receptor subfamily 1, group d, member 2, NUPR1  -  nuclear protein, transcriptional regulator, 1, RRAS  -  related ras viral (r-ras) oncogene homolog, GAS6  -  growth arrest-specific 6, GAS1  -  growth arrest-specific 1, APEX1  -  apex nuclease (multifunctional dna repair enzyme) 1, FMR1  -  fragile x mental retardation 1, PAWR  -  prkc, apoptosis, wt1, regulator, GSN  -  gelsolin, CDH2  -  cadherin 2, type 1, n-cadherin (neuronal), MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), HEXIM1  -  hexamethylene bis-acetamide inducible 1, CDC34  -  cell division cycle 34, PAX7  -  paired box 7, PBX1  -  pre-b-cell leukemia homeobox 1, HTRA2  -  htra serine peptidase 2, CD59  -  cd59 molecule, complement regulatory protein, FOXO1  -  forkhead box o1, RGS5  -  regulator of g-protein signaling 5, MSH6  -  muts homolog 6 (e. coli), KMT2A  -  lysine (k)-specific methyltransferase 2a, SIN3B  -  sin3 transcription regulator family member b, PIAS1  -  protein inhibitor of activated stat, 1, IL4R  -  interleukin 4 receptor, FOXC1  -  forkhead box c1, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, CRLF1  -  cytokine receptor-like factor 1, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, DFNA5  -  deafness, autosomal dominant 5, PSMB9  -  proteasome (prosome, macropain) subunit, beta type, 9, PDCD10  -  programmed cell death 10, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, FOXF2  -  forkhead box f2, ARF1  -  adp-ribosylation factor 1, UBR2  -  ubiquitin protein ligase e3 component n-recognin 2, MMP11  -  matrix metallopeptidase 11 (stromelysin 3), FURIN  -  furin (paired basic amino acid cleaving enzyme), PSMB4  -  proteasome (prosome, macropain) subunit, beta type, 4, TDG  -  thymine-dna glycosylase, APOE  -  apolipoprotein e, APP  -  amyloid beta (a4) precursor protein, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, WWOX  -  ww domain containing oxidoreductase, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, IL6ST  -  interleukin 6 signal transducer (gp130, oncostatin m receptor), DGKZ  -  diacylglycerol kinase, zeta, ITGA5  -  integrin, alpha 5 (fibronectin receptor, alpha polypeptide), PDGFA  -  platelet-derived growth factor alpha polypeptide, PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), FGFR1  -  fibroblast growth factor receptor 1, MDK  -  midkine (neurite growth-promoting factor 2), PTBP1  -  polypyrimidine tract binding protein 1, ATXN1  -  ataxin 1, ROR2  -  receptor tyrosine kinase-like orphan receptor 2, ITGA3  -  integrin, alpha 3 (antigen cd49c, alpha 3 subunit of vla-3 receptor), PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, CFL1  -  cofilin 1 (non-muscle), MECP2  -  methyl cpg binding protein 2 (rett syndrome), RHOB  -  ras homolog family member b, MEF2A  -  myocyte enhancer factor 2a, PDPK1  -  3-phosphoinositide dependent protein kinase-1, FGF2  -  fibroblast growth factor 2 (basic), FGF4  -  fibroblast growth factor 4, PTGIR  -  prostaglandin i2 (prostacyclin) receptor (ip), ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, CEBPB  -  ccaat/enhancer binding protein (c/ebp), beta, AMIGO2  -  adhesion molecule with ig-like domain 2, INPPL1  -  inositol polyphosphate phosphatase-like 1, TBX2  -  t-box 2, NPR3  -  natriuretic peptide receptor c/guanylate cyclase c (atrionatriuretic peptide receptor c), CDKN1C  -  cyclin-dependent kinase inhibitor 1c (p57, kip2), DAG1  -  dystroglycan 1 (dystrophin-associated glycoprotein 1), TBCD  -  tubulin folding cofactor d, KAT8  -  k(lysine) acetyltransferase 8, ASPH  -  aspartate beta-hydroxylase, CDKN2D  -  cyclin-dependent kinase inhibitor 2d (p19, inhibits cdk4), SRGAP2  -  slit-robo rho gtpase activating protein 2, DAPK1  -  death-associated protein kinase 1, PTPN1  -  protein tyrosine phosphatase, non-receptor type 1, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), PPAP2B  -  phosphatidic acid phosphatase type 2b, CDH13  -  cadherin 13, h-cadherin (heart), EFEMP1  -  egf containing fibulin-like extracellular matrix protein 1, EIF3E  -  eukaryotic translation initiation factor 3, subunit e, HDAC1  -  histone deacetylase 1, ITGA6  -  integrin, alpha 6, PKIG  -  protein kinase (camp-dependent, catalytic) inhibitor gamma, SALL2  -  sal-like 2 (drosophila), IRAK1  -  interleukin-1 receptor-associated kinase 1, PURA  -  purine-rich element binding protein a, IFIT1  -  interferon-induced protein with tetratricopeptide repeats 1, IFIT3  -  interferon-induced protein with tetratricopeptide repeats 3, TIMP3  -  timp metallopeptidase inhibitor 3, IFI16  -  interferon, gamma-inducible protein 16, STRN3  -  striatin, calmodulin binding protein 3, SMC3  -  structural maintenance of chromosomes 3, TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), TLE2  -  transducin-like enhancer of split 2 (e(sp1) homolog, drosophila), ZHX2  -  zinc fingers and homeoboxes 2, TLE4  -  transducin-like enhancer of split 4 (e(sp1) homolog, drosophila), GPC1  -  glypican 1, GPI  -  glucose-6-phosphate isomerase, NOTCH3  -  notch 3, ZFHX3  -  zinc finger homeobox 3, ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, HDAC4  -  histone deacetylase 4, NFX1  -  nuclear transcription factor, x-box binding 1, ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, NGF  -  nerve growth factor (beta polypeptide), NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, NFIX  -  nuclear factor i/x (ccaat-binding transcription factor), WNT5A  -  wingless-type mmtv integration site family, member 5a, TSC22D3  -  tsc22 domain family, member 3, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, TEK  -  tek tyrosine kinase, endothelial, DDIT4  -  dna-damage-inducible transcript 4, SUZ12  -  suz12 polycomb repressive complex 2 subunit, RBPJ  -  recombination signal binding protein for immunoglobulin kappa j region, BAG1  -  bcl2-associated athanogene, SHH  -  sonic hedgehog, PABPC1  -  poly(a) binding protein, cytoplasmic 1, GPX1  -  glutathione peroxidase 1, TERF1  -  telomeric repeat binding factor (nima-interacting) 1, ATF5  -  activating transcription factor 5, NFE2L2  -  nuclear factor (erythroid-derived 2)-like 2, PLAT  -  plasminogen activator, tissue, PLAGL1  -  pleiomorphic adenoma gene-like 1, ISG15  -  isg15 ubiquitin-like modifier, RARRES3  -  retinoic acid receptor responder (tazarotene induced) 3, NR2F1  -  nuclear receptor subfamily 2, group f, member 1, NF2  -  neurofibromin 2 (merlin), CLU  -  clusterin, ATR  -  ataxia telangiectasia and rad3 related, TWF2  -  twinfilin actin-binding protein 2, IGBP1  -  immunoglobulin (cd79a) binding protein 1, SMARCA5  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5, BDKRB2  -  bradykinin receptor b2, MGLL  -  monoglyceride lipase, TGFBI  -  transforming growth factor, beta-induced, 68kda, IGF1R  -  insulin-like growth factor 1 receptor, SERPINE2  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 2, SERPINB9  -  serpin peptidase inhibitor, clade b (ovalbumin), member 9, TGFB1  -  transforming growth factor, beta 1, SMAD2  -  smad family member 2, TGFB1I1  -  transforming growth factor beta 1 induced transcript 1, BCL6  -  b-cell cll/lymphoma 6, TGIF1  -  tgfb-induced factor homeobox 1, TSPYL2  -  tspy-like 2, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), PHB2  -  prohibitin 2, RBBP4  -  retinoblastoma binding protein 4, TGFBR3  -  transforming growth factor, beta receptor iii, DMD  -  dystrophin, CXCL1  -  chemokine (c-x-c motif) ligand 1 (melanoma growth stimulating activity, alpha), FNTB  -  farnesyltransferase, caax box, beta, KAT6B  -  k(lysine) acetyltransferase 6b, NBAS  -  neuroblastoma amplified sequence, SMAD3  -  smad family member 3, SMAD6  -  smad family member 6, GSK3B  -  glycogen synthase kinase 3 beta, CCND1  -  cyclin d1, ITSN1  -  intersectin 1 (sh3 domain protein), MAF  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog]"GO:0006956,complement activation,1.84E-06,2.28E-03,12.56,8230,40,131,8,"[C9  -  complement component 9, C4A  -  complement component 4a (rodgers blood group), CFH  -  complement factor h, CFHR1  -  complement factor h-related 1, CFB  -  complement factor b, CLU  -  clusterin, C1R  -  complement component 1, r subcomponent, C1S  -  complement component 1, s subcomponent]"GO:0031347,regulation of defense response,2.19E-06,2.44E-03,1.86,8230,385,794,69,"[IFIT1  -  interferon-induced protein with tetratricopeptide repeats 1, IFI16  -  interferon, gamma-inducible protein 16, AP1G1  -  adaptor-related protein complex 1, gamma 1 subunit, TICAM1  -  toll-like receptor adaptor molecule 1, SPN  -  sialophorin, CD59  -  cd59 molecule, complement regulatory protein, AGT  -  angiotensinogen (serpin peptidase inhibitor, clade a, member 8), PVR  -  poliovirus receptor, IFNGR1  -  interferon gamma receptor 1, PVRL2  -  poliovirus receptor-related 2 (herpesvirus entry mediator b), TAB2  -  tgf-beta activated kinase 1/map3k7 binding protein 2, CTSL  -  cathepsin l, PIAS1  -  protein inhibitor of activated stat, 1, CTSK  -  cathepsin k, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, CFB  -  complement factor b, NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, IL1R1  -  interleukin 1 receptor, type i, ARF1  -  adp-ribosylation factor 1, WNT5A  -  wingless-type mmtv integration site family, member 5a, PLSCR1  -  phospholipid scramblase 1, PSMB4  -  proteasome (prosome, macropain) subunit, beta type, 4, GJA1  -  gap junction protein, alpha 1, 43kda, CFH  -  complement factor h, APOE  -  apolipoprotein e, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, IL6ST  -  interleukin 6 signal transducer (gp130, oncostatin m receptor), TEK  -  tek tyrosine kinase, endothelial, C9  -  complement component 9, STAT2  -  signal transducer and activator of transcription 2, 113kda, JUN  -  jun proto-oncogene, UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, STAT1  -  signal transducer and activator of transcription 1, 91kda, PROS1  -  protein s (alpha), PPM1B  -  protein phosphatase, mg2+/mn2+ dependent, 1b, GPX1  -  glutathione peroxidase 1, MEF2A  -  myocyte enhancer factor 2a, EGFR  -  epidermal growth factor receptor, TNFSF4  -  tumor necrosis factor (ligand) superfamily, member 4, CD14  -  cd14 molecule, JAK2  -  janus kinase 2, ADA  -  adenosine deaminase, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, TYRO3  -  tyro3 protein tyrosine kinase, MED1  -  mediator complex subunit 1, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, CNR1  -  cannabinoid receptor 1 (brain), SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, MAP2K1  -  mitogen-activated protein kinase kinase 1, MAP2K3  -  mitogen-activated protein kinase kinase 3, MAPK10  -  mitogen-activated protein kinase 10, MGLL  -  monoglyceride lipase, MAPK7  -  mitogen-activated protein kinase 7, TGFB1  -  transforming growth factor, beta 1, ZYX  -  zyxin, MAPK3  -  mitogen-activated protein kinase 3, SERPING1  -  serpin peptidase inhibitor, clade g (c1 inhibitor), member 1, FADD  -  fas (tnfrsf6)-associated via death domain, BCL6  -  b-cell cll/lymphoma 6, LY96  -  lymphocyte antigen 96, PTPN1  -  protein tyrosine phosphatase, non-receptor type 1, FOS  -  fbj murine osteosarcoma viral oncogene homolog, CDC37  -  cell division cycle 37, C4A  -  complement component 4a (rodgers blood group), PRKCA  -  protein kinase c, alpha, SMAD3  -  smad family member 3, NR1D2  -  nuclear receptor subfamily 1, group d, member 2, IRAK1  -  interleukin-1 receptor-associated kinase 1]"GO:0044712,single-organism catabolic process,2.36E-06,2.39E-03,1.62,8230,530,995,104,"[FMOD  -  fibromodulin, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, BCKDK  -  branched chain ketoacid dehydrogenase kinase, SEPT5  -  septin 5, BPGM  -  2,3-bisphosphoglycerate mutase, LDHB  -  lactate dehydrogenase b, RPIA  -  ribose 5-phosphate isomerase a, GCSH  -  glycine cleavage system protein h (aminomethyl carrier), GTF2H1  -  general transcription factor iih, polypeptide 1, 62kda, LDHA  -  lactate dehydrogenase a, GCH1  -  gtp cyclohydrolase 1, ENO2  -  enolase 2 (gamma, neuronal), HRAS  -  harvey rat sarcoma viral oncogene homolog, MSH6  -  muts homolog 6 (e. coli), ENO1  -  enolase 1, (alpha), MMP2  -  matrix metallopeptidase 2 (gelatinase a, 72kda gelatinase, 72kda type iv collagenase), RIT1  -  ras-like without caax 1, MMP1  -  matrix metallopeptidase 1 (interstitial collagenase), SMPD4  -  sphingomyelin phosphodiesterase 4, neutral membrane (neutral sphingomyelinase-3), BGN  -  biglycan, MYO10  -  myosin x, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, NT5C2  -  5'-nucleotidase, cytosolic ii, ARF1  -  adp-ribosylation factor 1, FURIN  -  furin (paired basic amino acid cleaving enzyme), MMP11  -  matrix metallopeptidase 11 (stromelysin 3), OGDH  -  oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide), SORD  -  sorbitol dehydrogenase, PLCB2  -  phospholipase c, beta 2, TDG  -  thymine-dna glycosylase, TST  -  thiosulfate sulfurtransferase (rhodanese), APOE  -  apolipoprotein e, BLVRB  -  biliverdin reductase b (flavin reductase (nadph)), GUSB  -  glucuronidase, beta, GLUL  -  glutamate-ammonia ligase, MYH10  -  myosin, heavy chain 10, non-muscle, RHOB  -  ras homolog family member b, FGF2  -  fibroblast growth factor 2 (basic), HADH  -  hydroxyacyl-coa dehydrogenase, ADA  -  adenosine deaminase, COL4A1  -  collagen, type iv, alpha 1, DDX17  -  dead (asp-glu-ala-asp) box helicase 17, RHOG  -  ras homolog family member g, COL8A1  -  collagen, type viii, alpha 1, COL9A2  -  collagen, type ix, alpha 2, PLA2G15  -  phospholipase a2, group xv, COL9A1  -  collagen, type ix, alpha 1, GNB1  -  guanine nucleotide binding protein (g protein), beta polypeptide 1, COL4A5  -  collagen, type iv, alpha 5, ADH5  -  alcohol dehydrogenase 5 (class iii), chi polypeptide, SMARCA2  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, HEXA  -  hexosaminidase a (alpha polypeptide), COL11A1  -  collagen, type xi, alpha 1, RAB7L1  -  rab7, member ras oncogene family-like 1, ECH1  -  enoyl coa hydratase 1, peroxisomal, AKR1C3  -  aldo-keto reductase family 1, member c3, PGK1  -  phosphoglycerate kinase 1, PRKACB  -  protein kinase, camp-dependent, catalytic, beta, PDE5A  -  phosphodiesterase 5a, cgmp-specific, TKT  -  transketolase, PGD  -  phosphogluconate dehydrogenase, SUPV3L1  -  suppressor of var1, 3-like 1 (s. cerevisiae), GPC1  -  glypican 1, RAB14  -  rab14, member ras oncogene family, PRELP  -  proline/arginine-rich end leucine-rich repeat protein, COL14A1  -  collagen, type xiv, alpha 1, GPI  -  glucose-6-phosphate isomerase, DPYSL3  -  dihydropyrimidinase-like 3, DPYSL2  -  dihydropyrimidinase-like 2, RPE  -  ribulose-5-phosphate-3-epimerase, ACAN  -  aggrecan, CTSL  -  cathepsin l, PEX6  -  peroxisomal biogenesis factor 6, CTSK  -  cathepsin k, CTSD  -  cathepsin d, RAB2A  -  rab2a, member ras oncogene family, PFKL  -  phosphofructokinase, liver, PFKP  -  phosphofructokinase, platelet, TNNT3  -  troponin t type 3 (skeletal, fast), ALDH2  -  aldehyde dehydrogenase 2 family (mitochondrial), RAB13  -  rab13, member ras oncogene family, DLD  -  dihydrolipoamide dehydrogenase, MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), RAB33A  -  rab33a, member ras oncogene family, RAB9A  -  rab9a, member ras oncogene family, GPX1  -  glutathione peroxidase 1, ALDOC  -  aldolase c, fructose-bisphosphate, LUM  -  lumican, RARRES3  -  retinoic acid receptor responder (tazarotene induced) 3, PKM  -  pyruvate kinase, muscle, SMARCA5  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5, MGLL  -  monoglyceride lipase, TGFB1  -  transforming growth factor, beta 1, DNM2  -  dynamin 2, ACOT7  -  acyl-coa thioesterase 7, CAT  -  catalase, PLCE1  -  phospholipase c, epsilon 1, PHYH  -  phytanoyl-coa 2-hydroxylase, RBBP4  -  retinoblastoma binding protein 4, CSPG4  -  chondroitin sulfate proteoglycan 4, VCAN  -  versican, CBS  -  cystathionine-beta-synthase, MPG  -  n-methylpurine-dna glycosylase]"GO:0035556,intracellular signal transduction,3.17E-06,2.94E-03,1.44,8230,1089,890,169,"[GSTM2  -  glutathione s-transferase mu 2 (muscle), BNIP3  -  bcl2/adenovirus e1b 19kda interacting protein 3, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, GSN  -  gelsolin, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), TICAM1  -  toll-like receptor adaptor molecule 1, GEM  -  gtp binding protein overexpressed in skeletal muscle, GAB2  -  grb2-associated binding protein 2, IQGAP1  -  iq motif containing gtpase activating protein 1, HTRA2  -  htra serine peptidase 2, PSMA1  -  proteasome (prosome, macropain) subunit, alpha type, 1, FARP2  -  ferm, rhogef and pleckstrin domain protein 2, FOXO1  -  forkhead box o1, HRAS  -  harvey rat sarcoma viral oncogene homolog, NBN  -  nibrin, MSH6  -  muts homolog 6 (e. coli), RIT1  -  ras-like without caax 1, CDC42EP4  -  cdc42 effector protein (rho gtpase binding) 4, MYO9B  -  myosin ixb, PIAS1  -  protein inhibitor of activated stat, 1, IL4R  -  interleukin 4 receptor, DOK5  -  docking protein 5, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, PSMB9  -  proteasome (prosome, macropain) subunit, beta type, 9, SOX9  -  sry (sex determining region y)-box 9, RAB22A  -  rab22a, member ras oncogene family, SOX4  -  sry (sex determining region y)-box 4, TNK2  -  tyrosine kinase, non-receptor, 2, PIKFYVE  -  phosphoinositide kinase, fyve finger containing, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, ARF1  -  adp-ribosylation factor 1, BID  -  bh3 interacting domain death agonist, PSMB4  -  proteasome (prosome, macropain) subunit, beta type, 4, RGS7  -  regulator of g-protein signaling 7, PLCB2  -  phospholipase c, beta 2, APOE  -  apolipoprotein e, SOD2  -  superoxide dismutase 2, mitochondrial, CREB1  -  camp responsive element binding protein 1, WWOX  -  ww domain containing oxidoreductase, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, DGKZ  -  diacylglycerol kinase, zeta, PDGFA  -  platelet-derived growth factor alpha polypeptide, PSMD11  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 11, PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), FGFR1  -  fibroblast growth factor receptor 1, STK38L  -  serine/threonine kinase 38 like, ROR2  -  receptor tyrosine kinase-like orphan receptor 2, FGF5  -  fibroblast growth factor 5, PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, FGF7  -  fibroblast growth factor 7, CFL1  -  cofilin 1 (non-muscle), RHOB  -  ras homolog family member b, FGF2  -  fibroblast growth factor 2 (basic), MEF2A  -  myocyte enhancer factor 2a, PDPK1  -  3-phosphoinositide dependent protein kinase-1, RHOC  -  ras homolog family member c, EGFR  -  epidermal growth factor receptor, FGF4  -  fibroblast growth factor 4, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, MKNK1  -  map kinase interacting serine/threonine kinase 1, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, MED1  -  mediator complex subunit 1, ARHGAP1  -  rho gtpase activating protein 1, AMOTL2  -  angiomotin like 2, RHOG  -  ras homolog family member g, SH3BP5  -  sh3-domain binding protein 5 (btk-associated), ROCK1  -  rho-associated, coiled-coil containing protein kinase 1, GNB1  -  guanine nucleotide binding protein (g protein), beta polypeptide 1, NPR3  -  natriuretic peptide receptor c/guanylate cyclase c (atrionatriuretic peptide receptor c), DGKA  -  diacylglycerol kinase, alpha 80kda, SRGAP2  -  slit-robo rho gtpase activating protein 2, ASPH  -  aspartate beta-hydroxylase, DAPK1  -  death-associated protein kinase 1, LY96  -  lymphocyte antigen 96, PTPN1  -  protein tyrosine phosphatase, non-receptor type 1, ARL6IP5  -  adp-ribosylation-like factor 6 interacting protein 5, EDNRA  -  endothelin receptor type a, TAOK3  -  tao kinase 3, ADM  -  adrenomedullin, CDH13  -  cadherin 13, h-cadherin (heart), EFS  -  embryonal fyn-associated substrate, RAB7L1  -  rab7, member ras oncogene family-like 1, WASF1  -  was protein family, member 1, IRAK1  -  interleukin-1 receptor-associated kinase 1, IFI16  -  interferon, gamma-inducible protein 16, SIK1  -  salt-inducible kinase 1, AGT  -  angiotensinogen (serpin peptidase inhibitor, clade a, member 8), RAB14  -  rab14, member ras oncogene family, TANK  -  traf family member-associated nfkb activator, TAB2  -  tgf-beta activated kinase 1/map3k7 binding protein 2, MAP4K4  -  mitogen-activated protein kinase kinase kinase kinase 4, HDAC4  -  histone deacetylase 4, CTSH  -  cathepsin h, NGF  -  nerve growth factor (beta polypeptide), RAB3B  -  rab3b, member ras oncogene family, RAB2A  -  rab2a, member ras oncogene family, NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, DVL3  -  dishevelled segment polarity protein 3, STK3  -  serine/threonine kinase 3, PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, ARHGAP29  -  rho gtpase activating protein 29, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, RAB13  -  rab13, member ras oncogene family, RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), TEK  -  tek tyrosine kinase, endothelial, CRIP1  -  cysteine-rich protein 1 (intestinal), MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), CRKL  -  v-crk avian sarcoma virus ct10 oncogene homolog-like, DDIT4  -  dna-damage-inducible transcript 4, RAB33A  -  rab33a, member ras oncogene family, RAN  -  ran, member ras oncogene family, RAB9A  -  rab9a, member ras oncogene family, STAT2  -  signal transducer and activator of transcription 2, 113kda, JUN  -  jun proto-oncogene, BAG1  -  bcl2-associated athanogene, STAT1  -  signal transducer and activator of transcription 1, 91kda, CTNNAL1  -  catenin (cadherin-associated protein), alpha-like 1, STAT4  -  signal transducer and activator of transcription 4, STAT3  -  signal transducer and activator of transcription 3 (acute-phase response factor), GPX1  -  glutathione peroxidase 1, CRYAB  -  crystallin, alpha b, DYRK2  -  dual-specificity tyrosine-(y)-phosphorylation regulated kinase 2, CD14  -  cd14 molecule, OXSR1  -  oxidative stress responsive 1, JAK2  -  janus kinase 2, NDRG1  -  n-myc downstream regulated 1, RRAS2  -  related ras viral (r-ras) oncogene homolog 2, DLC1  -  deleted in liver cancer 1, TYRO3  -  tyro3 protein tyrosine kinase, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, BCAR3  -  breast cancer anti-estrogen resistance 3, CLU  -  clusterin, MAP2K1  -  mitogen-activated protein kinase kinase 1, MAP2K3  -  mitogen-activated protein kinase kinase 3, TRIP10  -  thyroid hormone receptor interactor 10, MAPK10  -  mitogen-activated protein kinase 10, MAPK7  -  mitogen-activated protein kinase 7, CBLB  -  cbl proto-oncogene b, e3 ubiquitin protein ligase, IGF1R  -  insulin-like growth factor 1 receptor, SRPK2  -  srsf protein kinase 2, TGFB1  -  transforming growth factor, beta 1, SMAD2  -  smad family member 2, MAPK3  -  mitogen-activated protein kinase 3, OGT  -  o-linked n-acetylglucosamine (glcnac) transferase, PLCE1  -  phospholipase c, epsilon 1, RAB32  -  rab32, member ras oncogene family, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, BCL6  -  b-cell cll/lymphoma 6, TGFBR3  -  transforming growth factor, beta receptor iii, DMD  -  dystrophin, RPS6KA4  -  ribosomal protein s6 kinase, 90kda, polypeptide 4, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, FOS  -  fbj murine osteosarcoma viral oncogene homolog, KRIT1  -  krit1, ankyrin repeat containing, CXCL1  -  chemokine (c-x-c motif) ligand 1 (melanoma growth stimulating activity, alpha), DMPK  -  dystrophia myotonica-protein kinase, PRKCG  -  protein kinase c, gamma, CSPG4  -  chondroitin sulfate proteoglycan 4, SMAD3  -  smad family member 3, PRKCA  -  protein kinase c, alpha, SMAD6  -  smad family member 6, GSK3B  -  glycogen synthase kinase 3 beta, RRAD  -  ras-related associated with diabetes, GAS6  -  growth arrest-specific 6, RRAS  -  related ras viral (r-ras) oncogene homolog, NUPR1  -  nuclear protein, transcriptional regulator, 1, ITSN1  -  intersectin 1 (sh3 domain protein)]"GO:0048519,negative regulation of biological process,3.18E-06,2.73E-03,1.28,8230,2470,737,284,"[YAF2  -  yy1 associated factor 2, BNIP3  -  bcl2/adenovirus e1b 19kda interacting protein 3, NCBP2  -  nuclear cap binding protein subunit 2, 20kda, NDN  -  necdin, melanoma antigen (mage) family member, BNIP2  -  bcl2/adenovirus e1b 19kda interacting protein 2, NCK1  -  nck adaptor protein 1, TSC22D4  -  tsc22 domain family, member 4, ABCA1  -  atp-binding cassette, sub-family a (abc1), member 1, SPN  -  sialophorin, NCOR2  -  nuclear receptor corepressor 2, IQGAP1  -  iq motif containing gtpase activating protein 1, HRAS  -  harvey rat sarcoma viral oncogene homolog, NBN  -  nibrin, ENO1  -  enolase 1, (alpha), NBL1  -  neuroblastoma 1, dan family bmp antagonist, ASIC2  -  acid-sensing (proton-gated) ion channel 2, SOX9  -  sry (sex determining region y)-box 9, SOX4  -  sry (sex determining region y)-box 4, NAB1  -  ngfi-a binding protein 1 (egr1 binding protein 1), PLSCR1  -  phospholipid scramblase 1, RGS7  -  regulator of g-protein signaling 7, PLAUR  -  plasminogen activator, urokinase receptor, GJA1  -  gap junction protein, alpha 1, 43kda, SOD2  -  superoxide dismutase 2, mitochondrial, RGS3  -  regulator of g-protein signaling 3, BMPR1A  -  bone morphogenetic protein receptor, type ia, LMNA  -  lamin a/c, SERPINF2  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 2, BMP4  -  bone morphogenetic protein 4, RGS16  -  regulator of g-protein signaling 16, SNTA1  -  syntrophin, alpha 1, ACTN1  -  actinin, alpha 1, GADD45B  -  growth arrest and dna-damage-inducible, beta, LITAF  -  lipopolysaccharide-induced tnf factor, PPM1B  -  protein phosphatase, mg2+/mn2+ dependent, 1b, ADAR  -  adenosine deaminase, rna-specific, EGFR  -  epidermal growth factor receptor, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, SAMD4A  -  sterile alpha motif domain containing 4a, FZD7  -  frizzled family receptor 7, ADA  -  adenosine deaminase, MED1  -  mediator complex subunit 1, EIF2B4  -  eukaryotic translation initiation factor 2b, subunit 4 delta, 67kda, RNF2  -  ring finger protein 2, CNR1  -  cannabinoid receptor 1 (brain), EFNB2  -  ephrin-b2, PTGES  -  prostaglandin e synthase, KRT18  -  keratin 18, ROCK1  -  rho-associated, coiled-coil containing protein kinase 1, ADD1  -  adducin 1 (alpha), EIF4E2  -  eukaryotic translation initiation factor 4e family member 2, SERPING1  -  serpin peptidase inhibitor, clade g (c1 inhibitor), member 1, SMARCA2  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, MAPK8IP1  -  mitogen-activated protein kinase 8 interacting protein 1, PARP1  -  poly (adp-ribose) polymerase 1, LRPPRC  -  leucine-rich pentatricopeptide repeat containing, FZR1  -  fizzy/cell division cycle 20 related 1 (drosophila), ADM  -  adrenomedullin, TRAF2  -  tnf receptor-associated factor 2, MBD2  -  methyl-cpg binding domain protein 2, TRAP1  -  tnf receptor-associated protein 1, LAMB1  -  laminin, beta 1, TPT1  -  tumor protein, translationally-controlled 1, CAPZA2  -  capping protein (actin filament) muscle z-line, alpha 2, AKR1C3  -  aldo-keto reductase family 1, member c3, CAPZA1  -  capping protein (actin filament) muscle z-line, alpha 1, ACAA2  -  acetyl-coa acyltransferase 2, PDE5A  -  phosphodiesterase 5a, cgmp-specific, SIK1  -  salt-inducible kinase 1, AGT  -  angiotensinogen (serpin peptidase inhibitor, clade a, member 8), SPG20  -  spastic paraplegia 20 (troyer syndrome), UNG  -  uracil-dna glycosylase, AIMP2  -  aminoacyl trna synthetase complex-interacting multifunctional protein 2, CAST  -  calpastatin, GPNMB  -  glycoprotein (transmembrane) nmb, LPXN  -  leupaxin, HMGXB4  -  hmg box domain containing 4, CTSH  -  cathepsin h, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, WWP2  -  ww domain containing e3 ubiquitin protein ligase 2, DDR1  -  discoidin domain receptor tyrosine kinase 1, AHR  -  aryl hydrocarbon receptor, SEMA4F  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4f, STK3  -  serine/threonine kinase 3, PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, EZH2  -  enhancer of zeste homolog 2 (drosophila), HIVEP1  -  human immunodeficiency virus type i enhancer binding protein 1, SNX13  -  sorting nexin 13, ERF  -  ets2 repressor factor, MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), ST13  -  suppression of tumorigenicity 13 (colon carcinoma) (hsp70 interacting protein), FOSL1  -  fos-like antigen 1, JUN  -  jun proto-oncogene, CRY1  -  cryptochrome 1 (photolyase-like), UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, STAT1  -  signal transducer and activator of transcription 1, 91kda, EED  -  embryonic ectoderm development, PROS1  -  protein s (alpha), ARNT2  -  aryl-hydrocarbon receptor nuclear translocator 2, CRYAB  -  crystallin, alpha b, CCNG1  -  cyclin g1, FXR1  -  fragile x mental retardation, autosomal homolog 1, JAK2  -  janus kinase 2, DLC1  -  deleted in liver cancer 1, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, TYRO3  -  tyro3 protein tyrosine kinase, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, MAP2K1  -  mitogen-activated protein kinase kinase 1, SACS  -  spastic ataxia of charlevoix-saguenay (sacsin), CBLB  -  cbl proto-oncogene b, e3 ubiquitin protein ligase, MAPK7  -  mitogen-activated protein kinase 7, SRPK2  -  srsf protein kinase 2, UCHL1  -  ubiquitin carboxyl-terminal esterase l1 (ubiquitin thiolesterase), MVP  -  major vault protein, TNFRSF14  -  tumor necrosis factor receptor superfamily, member 14, UBTF  -  upstream binding transcription factor, rna polymerase i, CAT  -  catalase, CAV2  -  caveolin 2, PRKG1  -  protein kinase, cgmp-dependent, type i, TRIM21  -  tripartite motif containing 21, COPS2  -  cop9 signalosome subunit 2, BAMBI  -  bmp and activin membrane-bound inhibitor, STAM  -  signal transducing adaptor molecule (sh3 domain and itam motif) 1, KRIT1  -  krit1, ankyrin repeat containing, SLC25A4  -  solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4, NUP153  -  nucleoporin 153kda, PRKCA  -  protein kinase c, alpha, CBS  -  cystathionine-beta-synthase, NR1D2  -  nuclear receptor subfamily 1, group d, member 2, NUPR1  -  nuclear protein, transcriptional regulator, 1, RRAS  -  related ras viral (r-ras) oncogene homolog, GAS6  -  growth arrest-specific 6, GAS1  -  growth arrest-specific 1, APEX1  -  apex nuclease (multifunctional dna repair enzyme) 1, FMR1  -  fragile x mental retardation 1, PAWR  -  prkc, apoptosis, wt1, regulator, GSN  -  gelsolin, CDH2  -  cadherin 2, type 1, n-cadherin (neuronal), MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), HEXIM1  -  hexamethylene bis-acetamide inducible 1, CDC34  -  cell division cycle 34, PAX7  -  paired box 7, PBX1  -  pre-b-cell leukemia homeobox 1, FLNA  -  filamin a, alpha, FOXO1  -  forkhead box o1, RGS5  -  regulator of g-protein signaling 5, MSH6  -  muts homolog 6 (e. coli), KMT2A  -  lysine (k)-specific methyltransferase 2a, SIN3B  -  sin3 transcription regulator family member b, PIAS1  -  protein inhibitor of activated stat, 1, IL4R  -  interleukin 4 receptor, FOXC1  -  forkhead box c1, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, CRLF1  -  cytokine receptor-like factor 1, UBE2L6  -  ubiquitin-conjugating enzyme e2l 6, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, DFNA5  -  deafness, autosomal dominant 5, PDCD10  -  programmed cell death 10, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, LMO4  -  lim domain only 4, FOXF2  -  forkhead box f2, ARF1  -  adp-ribosylation factor 1, UBR2  -  ubiquitin protein ligase e3 component n-recognin 2, MMP11  -  matrix metallopeptidase 11 (stromelysin 3), FURIN  -  furin (paired basic amino acid cleaving enzyme), TDG  -  thymine-dna glycosylase, APOE  -  apolipoprotein e, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, APP  -  amyloid beta (a4) precursor protein, WWOX  -  ww domain containing oxidoreductase, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, IL6ST  -  interleukin 6 signal transducer (gp130, oncostatin m receptor), TNFRSF11B  -  tumor necrosis factor receptor superfamily, member 11b, DGKZ  -  diacylglycerol kinase, zeta, ITGA5  -  integrin, alpha 5 (fibronectin receptor, alpha polypeptide), PDGFA  -  platelet-derived growth factor alpha polypeptide, PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), FGFR1  -  fibroblast growth factor receptor 1, MDK  -  midkine (neurite growth-promoting factor 2), PTBP1  -  polypyrimidine tract binding protein 1, ATXN1  -  ataxin 1, ROR2  -  receptor tyrosine kinase-like orphan receptor 2, ITGA3  -  integrin, alpha 3 (antigen cd49c, alpha 3 subunit of vla-3 receptor), PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, MECP2  -  methyl cpg binding protein 2 (rett syndrome), RHOB  -  ras homolog family member b, PDPK1  -  3-phosphoinositide dependent protein kinase-1, FGF4  -  fibroblast growth factor 4, PTGIR  -  prostaglandin i2 (prostacyclin) receptor (ip), ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, AMIGO2  -  adhesion molecule with ig-like domain 2, INPPL1  -  inositol polyphosphate phosphatase-like 1, TBX2  -  t-box 2, NPR3  -  natriuretic peptide receptor c/guanylate cyclase c (atrionatriuretic peptide receptor c), CDKN1C  -  cyclin-dependent kinase inhibitor 1c (p57, kip2), DAG1  -  dystroglycan 1 (dystrophin-associated glycoprotein 1), TBCD  -  tubulin folding cofactor d, KAT8  -  k(lysine) acetyltransferase 8, CDKN2D  -  cyclin-dependent kinase inhibitor 2d (p19, inhibits cdk4), ASPH  -  aspartate beta-hydroxylase, SRGAP2  -  slit-robo rho gtpase activating protein 2, DAPK1  -  death-associated protein kinase 1, PTPN1  -  protein tyrosine phosphatase, non-receptor type 1, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), ARL6IP5  -  adp-ribosylation-like factor 6 interacting protein 5, PPAP2B  -  phosphatidic acid phosphatase type 2b, CDH13  -  cadherin 13, h-cadherin (heart), EFEMP1  -  egf containing fibulin-like extracellular matrix protein 1, EIF3E  -  eukaryotic translation initiation factor 3, subunit e, HDAC1  -  histone deacetylase 1, ITGA6  -  integrin, alpha 6, PKIG  -  protein kinase (camp-dependent, catalytic) inhibitor gamma, SALL2  -  sal-like 2 (drosophila), PURA  -  purine-rich element binding protein a, IFIT1  -  interferon-induced protein with tetratricopeptide repeats 1, IFIT3  -  interferon-induced protein with tetratricopeptide repeats 3, TIMP3  -  timp metallopeptidase inhibitor 3, IFI16  -  interferon, gamma-inducible protein 16, STRN3  -  striatin, calmodulin binding protein 3, SMC3  -  structural maintenance of chromosomes 3, TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), TLE2  -  transducin-like enhancer of split 2 (e(sp1) homolog, drosophila), ZHX2  -  zinc fingers and homeoboxes 2, GPC1  -  glypican 1, GPI  -  glucose-6-phosphate isomerase, NOTCH3  -  notch 3, ZFHX3  -  zinc finger homeobox 3, ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, HDAC4  -  histone deacetylase 4, NFX1  -  nuclear transcription factor, x-box binding 1, ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, NFIX  -  nuclear factor i/x (ccaat-binding transcription factor), WNT5A  -  wingless-type mmtv integration site family, member 5a, TSC22D3  -  tsc22 domain family, member 3, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, TEK  -  tek tyrosine kinase, endothelial, SUZ12  -  suz12 polycomb repressive complex 2 subunit, RBPJ  -  recombination signal binding protein for immunoglobulin kappa j region, BAG1  -  bcl2-associated athanogene, SHH  -  sonic hedgehog, GPX1  -  glutathione peroxidase 1, DYRK2  -  dual-specificity tyrosine-(y)-phosphorylation regulated kinase 2, ATF5  -  activating transcription factor 5, NFE2L2  -  nuclear factor (erythroid-derived 2)-like 2, PLAT  -  plasminogen activator, tissue, PLAGL1  -  pleiomorphic adenoma gene-like 1, ISG15  -  isg15 ubiquitin-like modifier, RARRES3  -  retinoic acid receptor responder (tazarotene induced) 3, NR2F1  -  nuclear receptor subfamily 2, group f, member 1, CLU  -  clusterin, ATR  -  ataxia telangiectasia and rad3 related, IGBP1  -  immunoglobulin (cd79a) binding protein 1, SMARCA5  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5, MGLL  -  monoglyceride lipase, BDKRB2  -  bradykinin receptor b2, IGF1R  -  insulin-like growth factor 1 receptor, SERPINE2  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 2, SERPINB9  -  serpin peptidase inhibitor, clade b (ovalbumin), member 9, TGFB1  -  transforming growth factor, beta 1, SMAD2  -  smad family member 2, TGFB1I1  -  transforming growth factor beta 1 induced transcript 1, BCL6  -  b-cell cll/lymphoma 6, TGIF1  -  tgfb-induced factor homeobox 1, TSPYL2  -  tspy-like 2, SND1  -  staphylococcal nuclease and tudor domain containing 1, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), PHB2  -  prohibitin 2, RBBP4  -  retinoblastoma binding protein 4, TGFBR3  -  transforming growth factor, beta receptor iii, DMD  -  dystrophin, CXCL1  -  chemokine (c-x-c motif) ligand 1 (melanoma growth stimulating activity, alpha), THBS2  -  thrombospondin 2, FNTB  -  farnesyltransferase, caax box, beta, KAT6B  -  k(lysine) acetyltransferase 6b, SMAD3  -  smad family member 3, NBAS  -  neuroblastoma amplified sequence, SMAD6  -  smad family member 6, CCND1  -  cyclin d1, GSK3B  -  glycogen synthase kinase 3 beta, ITSN1  -  intersectin 1 (sh3 domain protein), MAF  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog]"GO:0072376,protein activation cascade,3.77E-06,3.00E-03,9.58,8230,59,131,9,"[C9  -  complement component 9, C4A  -  complement component 4a (rodgers blood group), CFH  -  complement factor h, PRCP  -  prolylcarboxypeptidase (angiotensinase c), CFHR1  -  complement factor h-related 1, CFB  -  complement factor b, CLU  -  clusterin, C1R  -  complement component 1, r subcomponent, C1S  -  complement component 1, s subcomponent]"GO:0006796,phosphate-containing compound metabolic process,4.01E-06,2.98E-03,1.44,8230,1101,858,165,"[PAICS  -  phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, SSH1  -  slingshot protein phosphatase 1, BCKDK  -  branched chain ketoacid dehydrogenase kinase, SEPT5  -  septin 5, GTF2H1  -  general transcription factor iih, polypeptide 1, 62kda, GCH1  -  gtp cyclohydrolase 1, HRAS  -  harvey rat sarcoma viral oncogene homolog, MSH6  -  muts homolog 6 (e. coli), RIT1  -  ras-like without caax 1, CDC14B  -  cell division cycle 14b, MYO10  -  myosin x, SMPD4  -  sphingomyelin phosphodiesterase 4, neutral membrane (neutral sphingomyelinase-3), DOK5  -  docking protein 5, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, SOX9  -  sry (sex determining region y)-box 9, TNK2  -  tyrosine kinase, non-receptor, 2, PIKFYVE  -  phosphoinositide kinase, fyve finger containing, EIF2S1  -  eukaryotic translation initiation factor 2, subunit 1 alpha, 35kda, ARF1  -  adp-ribosylation factor 1, PLSCR1  -  phospholipid scramblase 1, OGDH  -  oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide), TDG  -  thymine-dna glycosylase, PLCB2  -  phospholipase c, beta 2, CAMK1  -  calcium/calmodulin-dependent protein kinase i, SYNJ1  -  synaptojanin 1, MYLK  -  myosin light chain kinase, COASY  -  coa synthase, LIMK2  -  lim domain kinase 2, LPPR4  -  lipid phosphate phosphatase-related protein type 4, APP  -  amyloid beta (a4) precursor protein, BMPR1A  -  bone morphogenetic protein receptor, type ia, CREB1  -  camp responsive element binding protein 1, BMP4  -  bone morphogenetic protein 4, AQP1  -  aquaporin 1 (colton blood group), DGKZ  -  diacylglycerol kinase, zeta, FGFR1  -  fibroblast growth factor receptor 1, STK38L  -  serine/threonine kinase 38 like, SH3YL1  -  sh3 domain containing, ysc84-like 1 (s. cerevisiae), DDR2  -  discoidin domain receptor tyrosine kinase 2, MYH10  -  myosin, heavy chain 10, non-muscle, ROR2  -  receptor tyrosine kinase-like orphan receptor 2, PPM1B  -  protein phosphatase, mg2+/mn2+ dependent, 1b, TBPL1  -  tbp-like 1, MAML1  -  mastermind-like 1 (drosophila), PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, CFL1  -  cofilin 1 (non-muscle), MECP2  -  methyl cpg binding protein 2 (rett syndrome), RHOB  -  ras homolog family member b, FGF2  -  fibroblast growth factor 2 (basic), MEF2A  -  myocyte enhancer factor 2a, PDPK1  -  3-phosphoinositide dependent protein kinase-1, EGFR  -  epidermal growth factor receptor, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, MKNK1  -  map kinase interacting serine/threonine kinase 1, ADA  -  adenosine deaminase, DDX17  -  dead (asp-glu-ala-asp) box helicase 17, MED1  -  mediator complex subunit 1, FDXR  -  ferredoxin reductase, RHOG  -  ras homolog family member g, ROCK1  -  rho-associated, coiled-coil containing protein kinase 1, INPPL1  -  inositol polyphosphate phosphatase-like 1, PLA2G15  -  phospholipase a2, group xv, GNB1  -  guanine nucleotide binding protein (g protein), beta polypeptide 1, SMARCA2  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, DAPK1  -  death-associated protein kinase 1, INPP5A  -  inositol polyphosphate-5-phosphatase, 40kda, MAPK8IP1  -  mitogen-activated protein kinase 8 interacting protein 1, PTPN1  -  protein tyrosine phosphatase, non-receptor type 1, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, ADM  -  adrenomedullin, PTPN13  -  protein tyrosine phosphatase, non-receptor type 13 (apo-1/cd95 (fas)-associated phosphatase), PPAP2B  -  phosphatidic acid phosphatase type 2b, EFEMP1  -  egf containing fibulin-like extracellular matrix protein 1, RAB7L1  -  rab7, member ras oncogene family-like 1, PTPRF  -  protein tyrosine phosphatase, receptor type, f, IRAK1  -  interleukin-1 receptor-associated kinase 1, ERC1  -  elks/rab6-interacting/cast family member 1, PGK1  -  phosphoglycerate kinase 1, NADK  -  nad kinase, RFK  -  riboflavin kinase, PDE5A  -  phosphodiesterase 5a, cgmp-specific, PPP4R1  -  protein phosphatase 4, regulatory subunit 1, TKT  -  transketolase, PGD  -  phosphogluconate dehydrogenase, CAMK2G  -  calcium/calmodulin-dependent protein kinase ii gamma, SIK1  -  salt-inducible kinase 1, CAMK2B  -  calcium/calmodulin-dependent protein kinase ii beta, NME4  -  nme/nm23 nucleoside diphosphate kinase 4, AGT  -  angiotensinogen (serpin peptidase inhibitor, clade a, member 8), RAB14  -  rab14, member ras oncogene family, GPI  -  glucose-6-phosphate isomerase, CTPS1  -  ctp synthase 1, PPP5C  -  protein phosphatase 5, catalytic subunit, RPE  -  ribulose-5-phosphate-3-epimerase, TAB2  -  tgf-beta activated kinase 1/map3k7 binding protein 2, MAP4K4  -  mitogen-activated protein kinase kinase kinase kinase 4, PITPNB  -  phosphatidylinositol transfer protein, beta, PEX6  -  peroxisomal biogenesis factor 6, AK2  -  adenylate kinase 2, CTSH  -  cathepsin h, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, RAB2A  -  rab2a, member ras oncogene family, SULT2B1  -  sulfotransferase family, cytosolic, 2b, member 1, ATP6V1B1  -  atpase, h+ transporting, lysosomal 56/58kda, v1 subunit b1, WNT5A  -  wingless-type mmtv integration site family, member 5a, DDR1  -  discoidin domain receptor tyrosine kinase 1, STK3  -  serine/threonine kinase 3, PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, PFKP  -  phosphofructokinase, platelet, TNNT3  -  troponin t type 3 (skeletal, fast), NEK7  -  nima-related kinase 7, IDH3B  -  isocitrate dehydrogenase 3 (nad+) beta, RAB13  -  rab13, member ras oncogene family, TEK  -  tek tyrosine kinase, endothelial, MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), CRKL  -  v-crk avian sarcoma virus ct10 oncogene homolog-like, RAB33A  -  rab33a, member ras oncogene family, RAB9A  -  rab9a, member ras oncogene family, PRPS1  -  phosphoribosyl pyrophosphate synthetase 1, JUN  -  jun proto-oncogene, STAT4  -  signal transducer and activator of transcription 4, STAT3  -  signal transducer and activator of transcription 3 (acute-phase response factor), GPX1  -  glutathione peroxidase 1, CRYAB  -  crystallin, alpha b, ALDOC  -  aldolase c, fructose-bisphosphate, DYRK2  -  dual-specificity tyrosine-(y)-phosphorylation regulated kinase 2, RARRES3  -  retinoic acid receptor responder (tazarotene induced) 3, OXSR1  -  oxidative stress responsive 1, JAK2  -  janus kinase 2, TYRO3  -  tyro3 protein tyrosine kinase, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, ATR  -  ataxia telangiectasia and rad3 related, MAP2K1  -  mitogen-activated protein kinase kinase 1, MAP2K3  -  mitogen-activated protein kinase kinase 3, MAPK10  -  mitogen-activated protein kinase 10, MGLL  -  monoglyceride lipase, SMARCA5  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5, MAPK7  -  mitogen-activated protein kinase 7, IGF1R  -  insulin-like growth factor 1 receptor, SRPK2  -  srsf protein kinase 2, TGFB1  -  transforming growth factor, beta 1, SMAD2  -  smad family member 2, DNM2  -  dynamin 2, MAPK3  -  mitogen-activated protein kinase 3, CAT  -  catalase, PLCE1  -  phospholipase c, epsilon 1, PRKG1  -  protein kinase, cgmp-dependent, type i, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, RYK  -  receptor-like tyrosine kinase, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), TGFBR3  -  transforming growth factor, beta receptor iii, RBBP4  -  retinoblastoma binding protein 4, RPS6KA4  -  ribosomal protein s6 kinase, 90kda, polypeptide 4, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, FOS  -  fbj murine osteosarcoma viral oncogene homolog, YES1  -  v-yes-1 yamaguchi sarcoma viral oncogene homolog 1, DMPK  -  dystrophia myotonica-protein kinase, PRKCG  -  protein kinase c, gamma, SGK1  -  serum/glucocorticoid regulated kinase 1, PRKCA  -  protein kinase c, alpha, GSK3B  -  glycogen synthase kinase 3 beta, GAS6  -  growth arrest-specific 6, MPG  -  n-methylpurine-dna glycosylase]"GO:0042127,regulation of cell proliferation,4.36E-06,3.04E-03,1.59,8230,991,576,110,"[NDN  -  necdin, melanoma antigen (mage) family member, PAWR  -  prkc, apoptosis, wt1, regulator, NCK1  -  nck adaptor protein 1, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), TICAM1  -  toll-like receptor adaptor molecule 1, PAX7  -  paired box 7, PBX1  -  pre-b-cell leukemia homeobox 1, GAB2  -  grb2-associated binding protein 2, HRAS  -  harvey rat sarcoma viral oncogene homolog, FOXO1  -  forkhead box o1, KMT2A  -  lysine (k)-specific methyltransferase 2a, CRLF1  -  cytokine receptor-like factor 1, DFNA5  -  deafness, autosomal dominant 5, PDCD10  -  programmed cell death 10, SOX9  -  sry (sex determining region y)-box 9, SOX4  -  sry (sex determining region y)-box 4, GJA1  -  gap junction protein, alpha 1, 43kda, SOD2  -  superoxide dismutase 2, mitochondrial, BMPR1A  -  bone morphogenetic protein receptor, type ia, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, NUAK1  -  nuak family, snf1-like kinase, 1, IL6ST  -  interleukin 6 signal transducer (gp130, oncostatin m receptor), SERPINF2  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 2, BMP4  -  bone morphogenetic protein 4, PDGFA  -  platelet-derived growth factor alpha polypeptide, FGFR1  -  fibroblast growth factor receptor 1, ROR2  -  receptor tyrosine kinase-like orphan receptor 2, PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, FGF7  -  fibroblast growth factor 7, MECP2  -  methyl cpg binding protein 2 (rett syndrome), EGFR  -  epidermal growth factor receptor, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, FGF4  -  fibroblast growth factor 4, FZD7  -  frizzled family receptor 7, PTGIR  -  prostaglandin i2 (prostacyclin) receptor (ip), ADA  -  adenosine deaminase, MED1  -  mediator complex subunit 1, EFNB2  -  ephrin-b2, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, EFNB1  -  ephrin-b1, PTGES  -  prostaglandin e synthase, RHOG  -  ras homolog family member g, INPPL1  -  inositol polyphosphate phosphatase-like 1, TBX2  -  t-box 2, CDKN1C  -  cyclin-dependent kinase inhibitor 1c (p57, kip2), CDKN2D  -  cyclin-dependent kinase inhibitor 2d (p19, inhibits cdk4), ASPH  -  aspartate beta-hydroxylase, SMARCA2  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, SAT1  -  spermidine/spermine n1-acetyltransferase 1, ADM  -  adrenomedullin, CDH13  -  cadherin 13, h-cadherin (heart), LAMA5  -  laminin, alpha 5, MBD2  -  methyl-cpg binding domain protein 2, HDAC1  -  histone deacetylase 1, LAMB1  -  laminin, beta 1, AKR1C3  -  aldo-keto reductase family 1, member c3, IFIT3  -  interferon-induced protein with tetratricopeptide repeats 3, PDE5A  -  phosphodiesterase 5a, cgmp-specific, AIMP2  -  aminoacyl trna synthetase complex-interacting multifunctional protein 2, NOTCH3  -  notch 3, GPNMB  -  glycoprotein (transmembrane) nmb, ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, HDAC4  -  histone deacetylase 4, CTSH  -  cathepsin h, VEGFC  -  vascular endothelial growth factor c, NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, WNT5A  -  wingless-type mmtv integration site family, member 5a, DDR1  -  discoidin domain receptor tyrosine kinase 1, AHR  -  aryl hydrocarbon receptor, VCAM1  -  vascular cell adhesion molecule 1, CRIP2  -  cysteine-rich protein 2, TEK  -  tek tyrosine kinase, endothelial, SUZ12  -  suz12 polycomb repressive complex 2 subunit, FOSL1  -  fos-like antigen 1, RBPJ  -  recombination signal binding protein for immunoglobulin kappa j region, JUN  -  jun proto-oncogene, SHH  -  sonic hedgehog, STAT1  -  signal transducer and activator of transcription 1, 91kda, ARNT2  -  aryl-hydrocarbon receptor nuclear translocator 2, RARRES3  -  retinoic acid receptor responder (tazarotene induced) 3, JAK2  -  janus kinase 2, DLC1  -  deleted in liver cancer 1, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, MAP2K1  -  mitogen-activated protein kinase kinase 1, ZMIZ1  -  zinc finger, miz-type containing 1, CBLB  -  cbl proto-oncogene b, e3 ubiquitin protein ligase, SERPINE2  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 2, IGF1R  -  insulin-like growth factor 1 receptor, IGF2  -  insulin-like growth factor 2 (somatomedin a), SRPK2  -  srsf protein kinase 2, TGFB1  -  transforming growth factor, beta 1, TGFB1I1  -  transforming growth factor beta 1 induced transcript 1, TNFRSF14  -  tumor necrosis factor receptor superfamily, member 14, CAV2  -  caveolin 2, TGIF1  -  tgfb-induced factor homeobox 1, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), BAMBI  -  bmp and activin membrane-bound inhibitor, TGFBR3  -  transforming growth factor, beta receptor iii, PHB2  -  prohibitin 2, RBBP4  -  retinoblastoma binding protein 4, KRIT1  -  krit1, ankyrin repeat containing, CXCL1  -  chemokine (c-x-c motif) ligand 1 (melanoma growth stimulating activity, alpha), FNTB  -  farnesyltransferase, caax box, beta, SGK1  -  serum/glucocorticoid regulated kinase 1, PRKCA  -  protein kinase c, alpha, SMAD6  -  smad family member 6, GAS6  -  growth arrest-specific 6, GAS1  -  growth arrest-specific 1]"GO:2000352,negative regulation of endothelial cell apoptotic process,4.54E-06,2.98E-03,15.77,8230,12,261,6,"[NFE2L2  -  nuclear factor (erythroid-derived 2)-like 2, TEK  -  tek tyrosine kinase, endothelial, KRIT1  -  krit1, ankyrin repeat containing, MAPK7  -  mitogen-activated protein kinase 7, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, GAS6  -  growth arrest-specific 6]"GO:0006959,humoral immune response,6.80E-06,4.21E-03,7.76,8230,81,131,10,"[C9  -  complement component 9, C4A  -  complement component 4a (rodgers blood group), CFH  -  complement factor h, CFHR1  -  complement factor h-related 1, RBPJ  -  recombination signal binding protein for immunoglobulin kappa j region, CFB  -  complement factor b, CLU  -  clusterin, GPI  -  glucose-6-phosphate isomerase, C1R  -  complement component 1, r subcomponent, C1S  -  complement component 1, s subcomponent]"GO:0009056,catabolic process,6.86E-06,4.02E-03,1.4,8230,1038,999,177,"[FMOD  -  fibromodulin, GSTM2  -  glutathione s-transferase mu 2 (muscle), APEX1  -  apex nuclease (multifunctional dna repair enzyme) 1, GSTM1  -  glutathione s-transferase mu 1, NCBP2  -  nuclear cap binding protein subunit 2, 20kda, BNIP3  -  bcl2/adenovirus e1b 19kda interacting protein 3, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, GSTM4  -  glutathione s-transferase mu 4, BCKDK  -  branched chain ketoacid dehydrogenase kinase, SEPT5  -  septin 5, CDC34  -  cell division cycle 34, BPGM  -  2,3-bisphosphoglycerate mutase, DDB1  -  damage-specific dna binding protein 1, 127kda, LDHB  -  lactate dehydrogenase b, MAP1LC3B  -  microtubule-associated protein 1 light chain 3 beta, RPIA  -  ribose 5-phosphate isomerase a, GCSH  -  glycine cleavage system protein h (aminomethyl carrier), GTF2H1  -  general transcription factor iih, polypeptide 1, 62kda, LDHA  -  lactate dehydrogenase a, PSMA1  -  proteasome (prosome, macropain) subunit, alpha type, 1, GCH1  -  gtp cyclohydrolase 1, ENO2  -  enolase 2 (gamma, neuronal), HRAS  -  harvey rat sarcoma viral oncogene homolog, ENO1  -  enolase 1, (alpha), MSH6  -  muts homolog 6 (e. coli), MMP2  -  matrix metallopeptidase 2 (gelatinase a, 72kda gelatinase, 72kda type iv collagenase), RIT1  -  ras-like without caax 1, MMP1  -  matrix metallopeptidase 1 (interstitial collagenase), EIF4A2  -  eukaryotic translation initiation factor 4a2, MYO10  -  myosin x, SMPD4  -  sphingomyelin phosphodiesterase 4, neutral membrane (neutral sphingomyelinase-3), BGN  -  biglycan, EIF4B  -  eukaryotic translation initiation factor 4b, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, NT5C2  -  5'-nucleotidase, cytosolic ii, UBE2L6  -  ubiquitin-conjugating enzyme e2l 6, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, PSMB9  -  proteasome (prosome, macropain) subunit, beta type, 9, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, PSMB7  -  proteasome (prosome, macropain) subunit, beta type, 7, UBR2  -  ubiquitin protein ligase e3 component n-recognin 2, ARF1  -  adp-ribosylation factor 1, MMP11  -  matrix metallopeptidase 11 (stromelysin 3), LSM2  -  lsm2 homolog, u6 small nuclear rna associated (s. cerevisiae), FURIN  -  furin (paired basic amino acid cleaving enzyme), PSMB4  -  proteasome (prosome, macropain) subunit, beta type, 4, OGDH  -  oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide), TDG  -  thymine-dna glycosylase, SORD  -  sorbitol dehydrogenase, PLCB2  -  phospholipase c, beta 2, SDC2  -  syndecan 2, TST  -  thiosulfate sulfurtransferase (rhodanese), APOE  -  apolipoprotein e, SOD1  -  superoxide dismutase 1, soluble, BLVRB  -  biliverdin reductase b (flavin reductase (nadph)), EIF4G1  -  eukaryotic translation initiation factor 4 gamma, 1, SMG7  -  smg7 nonsense mediated mrna decay factor, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, GUSB  -  glucuronidase, beta, PSMD11  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 11, GLUL  -  glutamate-ammonia ligase, PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), MYH10  -  myosin, heavy chain 10, non-muscle, USP9Y  -  ubiquitin specific peptidase 9, y-linked, RHOB  -  ras homolog family member b, FGF2  -  fibroblast growth factor 2 (basic), HADH  -  hydroxyacyl-coa dehydrogenase, COL4A1  -  collagen, type iv, alpha 1, ADA  -  adenosine deaminase, DDX17  -  dead (asp-glu-ala-asp) box helicase 17, RHOG  -  ras homolog family member g, COL8A1  -  collagen, type viii, alpha 1, PON2  -  paraoxonase 2, LAMP1  -  lysosomal-associated membrane protein 1, COL9A2  -  collagen, type ix, alpha 2, PLA2G15  -  phospholipase a2, group xv, COL9A1  -  collagen, type ix, alpha 1, GNB1  -  guanine nucleotide binding protein (g protein), beta polypeptide 1, COL4A5  -  collagen, type iv, alpha 5, ADH5  -  alcohol dehydrogenase 5 (class iii), chi polypeptide, SMARCA2  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, HEXA  -  hexosaminidase a (alpha polypeptide), SAT1  -  spermidine/spermine n1-acetyltransferase 1, RNF40  -  ring finger protein 40, e3 ubiquitin protein ligase, FZR1  -  fizzy/cell division cycle 20 related 1 (drosophila), TRAF2  -  tnf receptor-associated factor 2, COL11A1  -  collagen, type xi, alpha 1, EIF3E  -  eukaryotic translation initiation factor 3, subunit e, ECE1  -  endothelin converting enzyme 1, RAB7L1  -  rab7, member ras oncogene family-like 1, ECH1  -  enoyl coa hydratase 1, peroxisomal, AKR1C3  -  aldo-keto reductase family 1, member c3, PGK1  -  phosphoglycerate kinase 1, PRKACB  -  protein kinase, camp-dependent, catalytic, beta, RPL23A  -  ribosomal protein l23a, MAGOH  -  mago-nashi homolog, proliferation-associated (drosophila), IFI16  -  interferon, gamma-inducible protein 16, PDE5A  -  phosphodiesterase 5a, cgmp-specific, XPC  -  xeroderma pigmentosum, complementation group c, RPL18A  -  ribosomal protein l18a, TKT  -  transketolase, PGD  -  phosphogluconate dehydrogenase, RPL15  -  ribosomal protein l15, RPL13  -  ribosomal protein l13, RPL12  -  ribosomal protein l12, ZHX2  -  zinc fingers and homeoboxes 2, SUPV3L1  -  suppressor of var1, 3-like 1 (s. cerevisiae), GPC1  -  glypican 1, RAB14  -  rab14, member ras oncogene family, RPL5  -  ribosomal protein l5, PRELP  -  proline/arginine-rich end leucine-rich repeat protein, COL14A1  -  collagen, type xiv, alpha 1, GPI  -  glucose-6-phosphate isomerase, RPL4  -  ribosomal protein l4, DPYSL3  -  dihydropyrimidinase-like 3, DPYSL2  -  dihydropyrimidinase-like 2, RPA3  -  replication protein a3, 14kda, RPE  -  ribulose-5-phosphate-3-epimerase, ACAN  -  aggrecan, RPA2  -  replication protein a2, 32kda, CTSL  -  cathepsin l, PEX6  -  peroxisomal biogenesis factor 6, CTSK  -  cathepsin k, CTSH  -  cathepsin h, CTSD  -  cathepsin d, RAB2A  -  rab2a, member ras oncogene family, WWP2  -  ww domain containing e3 ubiquitin protein ligase 2, RAD23B  -  rad23 homolog b (s. cerevisiae), PFKL  -  phosphofructokinase, liver, PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, PFKP  -  phosphofructokinase, platelet, TNNT3  -  troponin t type 3 (skeletal, fast), ALDH2  -  aldehyde dehydrogenase 2 family (mitochondrial), RAB13  -  rab13, member ras oncogene family, DLD  -  dihydrolipoamide dehydrogenase, MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), RAB33A  -  rab33a, member ras oncogene family, RAB9A  -  rab9a, member ras oncogene family, UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, RPL14  -  ribosomal protein l14, UBE4A  -  ubiquitination factor e4a, GPX1  -  glutathione peroxidase 1, PABPC1  -  poly(a) binding protein, cytoplasmic 1, ALDOC  -  aldolase c, fructose-bisphosphate, NFE2L2  -  nuclear factor (erythroid-derived 2)-like 2, LUM  -  lumican, ISG15  -  isg15 ubiquitin-like modifier, RARRES3  -  retinoic acid receptor responder (tazarotene induced) 3, RPS13  -  ribosomal protein s13, CRYZ  -  crystallin, zeta (quinone reductase), PKM  -  pyruvate kinase, muscle, TPP1  -  tripeptidyl peptidase i, MGLL  -  monoglyceride lipase, SMARCA5  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5, PABPC4  -  poly(a) binding protein, cytoplasmic 4 (inducible form), TGFB1  -  transforming growth factor, beta 1, UCHL1  -  ubiquitin carboxyl-terminal esterase l1 (ubiquitin thiolesterase), TGFB1I1  -  transforming growth factor beta 1 induced transcript 1, DNM2  -  dynamin 2, ACOT7  -  acyl-coa thioesterase 7, CAT  -  catalase, PLCE1  -  phospholipase c, epsilon 1, PHYH  -  phytanoyl-coa 2-hydroxylase, RBBP4  -  retinoblastoma binding protein 4, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, CUL4B  -  cullin 4b, UBE2G2  -  ubiquitin-conjugating enzyme e2g 2, RPL23  -  ribosomal protein l23, CSPG4  -  chondroitin sulfate proteoglycan 4, NBAS  -  neuroblastoma amplified sequence, ARIH1  -  ariadne homolog, ubiquitin-conjugating enzyme e2 binding protein, 1 (drosophila), VCAN  -  versican, CBS  -  cystathionine-beta-synthase, MPG  -  n-methylpurine-dna glycosylase, FBXL2  -  f-box and leucine-rich repeat protein 2]"GO:0006793,phosphorus metabolic process,8.08E-06,4.50E-03,1.42,8230,1113,858,165,"[PAICS  -  phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, SSH1  -  slingshot protein phosphatase 1, BCKDK  -  branched chain ketoacid dehydrogenase kinase, SEPT5  -  septin 5, GTF2H1  -  general transcription factor iih, polypeptide 1, 62kda, GCH1  -  gtp cyclohydrolase 1, HRAS  -  harvey rat sarcoma viral oncogene homolog, MSH6  -  muts homolog 6 (e. coli), RIT1  -  ras-like without caax 1, CDC14B  -  cell division cycle 14b, MYO10  -  myosin x, SMPD4  -  sphingomyelin phosphodiesterase 4, neutral membrane (neutral sphingomyelinase-3), DOK5  -  docking protein 5, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, SOX9  -  sry (sex determining region y)-box 9, TNK2  -  tyrosine kinase, non-receptor, 2, PIKFYVE  -  phosphoinositide kinase, fyve finger containing, EIF2S1  -  eukaryotic translation initiation factor 2, subunit 1 alpha, 35kda, ARF1  -  adp-ribosylation factor 1, PLSCR1  -  phospholipid scramblase 1, OGDH  -  oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide), TDG  -  thymine-dna glycosylase, PLCB2  -  phospholipase c, beta 2, CAMK1  -  calcium/calmodulin-dependent protein kinase i, SYNJ1  -  synaptojanin 1, MYLK  -  myosin light chain kinase, COASY  -  coa synthase, LIMK2  -  lim domain kinase 2, LPPR4  -  lipid phosphate phosphatase-related protein type 4, APP  -  amyloid beta (a4) precursor protein, BMPR1A  -  bone morphogenetic protein receptor, type ia, CREB1  -  camp responsive element binding protein 1, BMP4  -  bone morphogenetic protein 4, AQP1  -  aquaporin 1 (colton blood group), DGKZ  -  diacylglycerol kinase, zeta, FGFR1  -  fibroblast growth factor receptor 1, STK38L  -  serine/threonine kinase 38 like, SH3YL1  -  sh3 domain containing, ysc84-like 1 (s. cerevisiae), DDR2  -  discoidin domain receptor tyrosine kinase 2, MYH10  -  myosin, heavy chain 10, non-muscle, ROR2  -  receptor tyrosine kinase-like orphan receptor 2, PPM1B  -  protein phosphatase, mg2+/mn2+ dependent, 1b, TBPL1  -  tbp-like 1, MAML1  -  mastermind-like 1 (drosophila), PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, CFL1  -  cofilin 1 (non-muscle), MECP2  -  methyl cpg binding protein 2 (rett syndrome), RHOB  -  ras homolog family member b, FGF2  -  fibroblast growth factor 2 (basic), MEF2A  -  myocyte enhancer factor 2a, PDPK1  -  3-phosphoinositide dependent protein kinase-1, EGFR  -  epidermal growth factor receptor, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, MKNK1  -  map kinase interacting serine/threonine kinase 1, ADA  -  adenosine deaminase, DDX17  -  dead (asp-glu-ala-asp) box helicase 17, MED1  -  mediator complex subunit 1, FDXR  -  ferredoxin reductase, RHOG  -  ras homolog family member g, ROCK1  -  rho-associated, coiled-coil containing protein kinase 1, INPPL1  -  inositol polyphosphate phosphatase-like 1, PLA2G15  -  phospholipase a2, group xv, GNB1  -  guanine nucleotide binding protein (g protein), beta polypeptide 1, SMARCA2  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, DAPK1  -  death-associated protein kinase 1, INPP5A  -  inositol polyphosphate-5-phosphatase, 40kda, MAPK8IP1  -  mitogen-activated protein kinase 8 interacting protein 1, PTPN1  -  protein tyrosine phosphatase, non-receptor type 1, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, ADM  -  adrenomedullin, PTPN13  -  protein tyrosine phosphatase, non-receptor type 13 (apo-1/cd95 (fas)-associated phosphatase), PPAP2B  -  phosphatidic acid phosphatase type 2b, EFEMP1  -  egf containing fibulin-like extracellular matrix protein 1, RAB7L1  -  rab7, member ras oncogene family-like 1, PTPRF  -  protein tyrosine phosphatase, receptor type, f, IRAK1  -  interleukin-1 receptor-associated kinase 1, ERC1  -  elks/rab6-interacting/cast family member 1, PGK1  -  phosphoglycerate kinase 1, NADK  -  nad kinase, RFK  -  riboflavin kinase, PDE5A  -  phosphodiesterase 5a, cgmp-specific, PPP4R1  -  protein phosphatase 4, regulatory subunit 1, TKT  -  transketolase, PGD  -  phosphogluconate dehydrogenase, CAMK2G  -  calcium/calmodulin-dependent protein kinase ii gamma, SIK1  -  salt-inducible kinase 1, CAMK2B  -  calcium/calmodulin-dependent protein kinase ii beta, NME4  -  nme/nm23 nucleoside diphosphate kinase 4, AGT  -  angiotensinogen (serpin peptidase inhibitor, clade a, member 8), RAB14  -  rab14, member ras oncogene family, GPI  -  glucose-6-phosphate isomerase, CTPS1  -  ctp synthase 1, PPP5C  -  protein phosphatase 5, catalytic subunit, RPE  -  ribulose-5-phosphate-3-epimerase, TAB2  -  tgf-beta activated kinase 1/map3k7 binding protein 2, MAP4K4  -  mitogen-activated protein kinase kinase kinase kinase 4, PITPNB  -  phosphatidylinositol transfer protein, beta, PEX6  -  peroxisomal biogenesis factor 6, AK2  -  adenylate kinase 2, CTSH  -  cathepsin h, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, RAB2A  -  rab2a, member ras oncogene family, SULT2B1  -  sulfotransferase family, cytosolic, 2b, member 1, ATP6V1B1  -  atpase, h+ transporting, lysosomal 56/58kda, v1 subunit b1, WNT5A  -  wingless-type mmtv integration site family, member 5a, DDR1  -  discoidin domain receptor tyrosine kinase 1, STK3  -  serine/threonine kinase 3, PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, PFKP  -  phosphofructokinase, platelet, TNNT3  -  troponin t type 3 (skeletal, fast), NEK7  -  nima-related kinase 7, IDH3B  -  isocitrate dehydrogenase 3 (nad+) beta, RAB13  -  rab13, member ras oncogene family, TEK  -  tek tyrosine kinase, endothelial, MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), CRKL  -  v-crk avian sarcoma virus ct10 oncogene homolog-like, RAB33A  -  rab33a, member ras oncogene family, RAB9A  -  rab9a, member ras oncogene family, PRPS1  -  phosphoribosyl pyrophosphate synthetase 1, JUN  -  jun proto-oncogene, STAT4  -  signal transducer and activator of transcription 4, STAT3  -  signal transducer and activator of transcription 3 (acute-phase response factor), GPX1  -  glutathione peroxidase 1, CRYAB  -  crystallin, alpha b, ALDOC  -  aldolase c, fructose-bisphosphate, DYRK2  -  dual-specificity tyrosine-(y)-phosphorylation regulated kinase 2, RARRES3  -  retinoic acid receptor responder (tazarotene induced) 3, OXSR1  -  oxidative stress responsive 1, JAK2  -  janus kinase 2, TYRO3  -  tyro3 protein tyrosine kinase, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, ATR  -  ataxia telangiectasia and rad3 related, MAP2K1  -  mitogen-activated protein kinase kinase 1, MAP2K3  -  mitogen-activated protein kinase kinase 3, MAPK10  -  mitogen-activated protein kinase 10, MGLL  -  monoglyceride lipase, SMARCA5  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5, MAPK7  -  mitogen-activated protein kinase 7, IGF1R  -  insulin-like growth factor 1 receptor, SRPK2  -  srsf protein kinase 2, TGFB1  -  transforming growth factor, beta 1, DNM2  -  dynamin 2, SMAD2  -  smad family member 2, MAPK3  -  mitogen-activated protein kinase 3, CAT  -  catalase, PLCE1  -  phospholipase c, epsilon 1, PRKG1  -  protein kinase, cgmp-dependent, type i, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, RYK  -  receptor-like tyrosine kinase, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), TGFBR3  -  transforming growth factor, beta receptor iii, RBBP4  -  retinoblastoma binding protein 4, RPS6KA4  -  ribosomal protein s6 kinase, 90kda, polypeptide 4, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, FOS  -  fbj murine osteosarcoma viral oncogene homolog, YES1  -  v-yes-1 yamaguchi sarcoma viral oncogene homolog 1, DMPK  -  dystrophia myotonica-protein kinase, PRKCG  -  protein kinase c, gamma, SGK1  -  serum/glucocorticoid regulated kinase 1, PRKCA  -  protein kinase c, alpha, GSK3B  -  glycogen synthase kinase 3 beta, GAS6  -  growth arrest-specific 6, MPG  -  n-methylpurine-dna glycosylase]"GO:0050896,response to stimulus,9.43E-06,5.00E-03,1.16,8230,4070,906,519,"[SH3BP1  -  sh3-domain binding protein 1, SERPINA3  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 3, HNRNPA0  -  heterogeneous nuclear ribonucleoprotein a0, ABCA1  -  atp-binding cassette, sub-family a (abc1), member 1, GEM  -  gtp binding protein overexpressed in skeletal muscle, SPN  -  sialophorin, NCOR2  -  nuclear receptor corepressor 2, RNF14  -  ring finger protein 14, LDHA  -  lactate dehydrogenase a, LGALS3  -  lectin, galactoside-binding, soluble, 3, GCH1  -  gtp cyclohydrolase 1, TRAF4  -  tnf receptor-associated factor 4, CDC42EP4  -  cdc42 effector protein (rho gtpase binding) 4, ASIC2  -  acid-sensing (proton-gated) ion channel 2, SMPD4  -  sphingomyelin phosphodiesterase 4, neutral membrane (neutral sphingomyelinase-3), CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, SOX9  -  sry (sex determining region y)-box 9, ACR  -  acrosin, PLP2  -  proteolipid protein 2 (colonic epithelium-enriched), SOX4  -  sry (sex determining region y)-box 4, PLSCR1  -  phospholipid scramblase 1, PLCB2  -  phospholipase c, beta 2, PLAUR  -  plasminogen activator, urokinase receptor, GJA1  -  gap junction protein, alpha 1, 43kda, SOD2  -  superoxide dismutase 2, mitochondrial, SOD1  -  superoxide dismutase 1, soluble, CREB1  -  camp responsive element binding protein 1, LMNA  -  lamin a/c, SERPINF2  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 2, KRT19  -  keratin 19, LITAF  -  lipopolysaccharide-induced tnf factor, PPM1B  -  protein phosphatase, mg2+/mn2+ dependent, 1b, ADAR  -  adenosine deaminase, rna-specific, FZD7  -  frizzled family receptor 7, COL4A1  -  collagen, type iv, alpha 1, ADA  -  adenosine deaminase, POLR1C  -  polymerase (rna) i polypeptide c, 30kda, MED1  -  mediator complex subunit 1, CNR1  -  cannabinoid receptor 1 (brain), KRT14  -  keratin 14, PTGES  -  prostaglandin e synthase, AMOTL2  -  angiomotin like 2, KRT18  -  keratin 18, SH3BP5  -  sh3-domain binding protein 5 (btk-associated), PLIN2  -  perilipin 2, ADD1  -  adducin 1 (alpha), EIF4E2  -  eukaryotic translation initiation factor 4e family member 2, GNB1  -  guanine nucleotide binding protein (g protein), beta polypeptide 1, ADH5  -  alcohol dehydrogenase 5 (class iii), chi polypeptide, LY96  -  lymphocyte antigen 96, PARP1  -  poly (adp-ribose) polymerase 1, TAOK3  -  tao kinase 3, FZR1  -  fizzy/cell division cycle 20 related 1 (drosophila), ADM  -  adrenomedullin, LAMA5  -  laminin, alpha 5, COL11A1  -  collagen, type xi, alpha 1, POLR2B  -  polymerase (rna) ii (dna directed) polypeptide b, 140kda, PARP4  -  poly (adp-ribose) polymerase family, member 4, SYT1  -  synaptotagmin i, NUPL2  -  nucleoporin like 2, HOMER3  -  homer homolog 3 (drosophila), AGT  -  angiotensinogen (serpin peptidase inhibitor, clade a, member 8), PRCP  -  prolylcarboxypeptidase (angiotensinase c), SUPT5H  -  suppressor of ty 5 homolog (s. cerevisiae), FTH1  -  ferritin, heavy polypeptide 1, CTPS1  -  ctp synthase 1, PPP5C  -  protein phosphatase 5, catalytic subunit, KCNMB1  -  potassium large conductance calcium-activated channel, subfamily m, beta member 1, MAP4K4  -  mitogen-activated protein kinase kinase kinase kinase 4, LPXN  -  leupaxin, CTSL  -  cathepsin l, AK2  -  adenylate kinase 2, CTSK  -  cathepsin k, CTSH  -  cathepsin h, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, PPP2R5E  -  protein phosphatase 2, regulatory subunit b', epsilon isoform, AHR  -  aryl hydrocarbon receptor, STK3  -  serine/threonine kinase 3, PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, ARHGAP29  -  rho gtpase activating protein 29, CRIP1  -  cysteine-rich protein 1 (intestinal), CRKL  -  v-crk avian sarcoma virus ct10 oncogene homolog-like, RAB33A  -  rab33a, member ras oncogene family, FOSL1  -  fos-like antigen 1, RASSF7  -  ras association (ralgds/af-6) domain family (n-terminal) member 7, RAB9A  -  rab9a, member ras oncogene family, CRY1  -  cryptochrome 1 (photolyase-like), JUN  -  jun proto-oncogene, STAT2  -  signal transducer and activator of transcription 2, 113kda, STAT1  -  signal transducer and activator of transcription 1, 91kda, STAT4  -  signal transducer and activator of transcription 4, SLIT2  -  slit homolog 2 (drosophila), PROS1  -  protein s (alpha), STAT3  -  signal transducer and activator of transcription 3 (acute-phase response factor), PRNP  -  prion protein, CRYAB  -  crystallin, alpha b, ALDOC  -  aldolase c, fructose-bisphosphate, KAL1  -  kallmann syndrome 1 sequence, SSRP1  -  structure specific recognition protein 1, JAK2  -  janus kinase 2, MAP2K1  -  mitogen-activated protein kinase kinase 1, MAP2K3  -  mitogen-activated protein kinase kinase 3, TRIP10  -  thyroid hormone receptor interactor 10, MAPK10  -  mitogen-activated protein kinase 10, MAPK7  -  mitogen-activated protein kinase 7, SRPK2  -  srsf protein kinase 2, MAPK3  -  mitogen-activated protein kinase 3, ASIC3  -  acid-sensing (proton-gated) ion channel 3, RAB32  -  rab32, member ras oncogene family, PLCE1  -  phospholipase c, epsilon 1, PRKG1  -  protein kinase, cgmp-dependent, type i, TRIM21  -  tripartite motif containing 21, AMPH  -  amphiphysin, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, COPS2  -  cop9 signalosome subunit 2, GBP2  -  guanylate binding protein 2, interferon-inducible, NREP  -  neuronal regeneration related protein, GBP1  -  guanylate binding protein 1, interferon-inducible, BAMBI  -  bmp and activin membrane-bound inhibitor, STAM  -  signal transducing adaptor molecule (sh3 domain and itam motif) 1, PRKCG  -  protein kinase c, gamma, SLC25A6  -  solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6, GAP43  -  growth associated protein 43, CSPG4  -  chondroitin sulfate proteoglycan 4, PRKCA  -  protein kinase c, alpha, ARIH1  -  ariadne homolog, ubiquitin-conjugating enzyme e2 binding protein, 1 (drosophila), GAS6  -  growth arrest-specific 6, GAS1  -  growth arrest-specific 1, GSTM2  -  glutathione s-transferase mu 2 (muscle), APEX1  -  apex nuclease (multifunctional dna repair enzyme) 1, GSTM1  -  glutathione s-transferase mu 1, SECTM1  -  secreted and transmembrane 1, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, PAWR  -  prkc, apoptosis, wt1, regulator, GSN  -  gelsolin, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), DDB1  -  damage-specific dna binding protein 1, 127kda, GTF2H1  -  general transcription factor iih, polypeptide 1, 62kda, SEMA3F  -  sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3f, MSH6  -  muts homolog 6 (e. coli), UBE2L6  -  ubiquitin-conjugating enzyme e2l 6, P4HB  -  prolyl 4-hydroxylase, beta polypeptide, RAB22A  -  rab22a, member ras oncogene family, STK17B  -  serine/threonine kinase 17b, ARF1  -  adp-ribosylation factor 1, FURIN  -  furin (paired basic amino acid cleaving enzyme), SDC2  -  syndecan 2, APOE  -  apolipoprotein e, APP  -  amyloid beta (a4) precursor protein, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, WWOX  -  ww domain containing oxidoreductase, IL32  -  interleukin 32, AQP1  -  aquaporin 1 (colton blood group), PDGFA  -  platelet-derived growth factor alpha polypeptide, MCM7  -  minichromosome maintenance complex component 7, MDK  -  midkine (neurite growth-promoting factor 2), ATXN1  -  ataxin 1, PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, RHOB  -  ras homolog family member b, MECP2  -  methyl cpg binding protein 2 (rett syndrome), RHOC  -  ras homolog family member c, MEF2A  -  myocyte enhancer factor 2a, PDPK1  -  3-phosphoinositide dependent protein kinase-1, PSIP1  -  pc4 and sfrs1 interacting protein 1, PDK3  -  pyruvate dehydrogenase kinase, isozyme 3, DAP3  -  death associated protein 3, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, ARHGAP1  -  rho gtpase activating protein 1, RHOG  -  ras homolog family member g, ZYX  -  zyxin, DGKA  -  diacylglycerol kinase, alpha 80kda, DAG1  -  dystroglycan 1 (dystrophin-associated glycoprotein 1), ASS1  -  argininosuccinate synthase 1, ASPH  -  aspartate beta-hydroxylase, DAPK1  -  death-associated protein kinase 1, TIPARP  -  tcdd-inducible poly(adp-ribose) polymerase, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, HEXA  -  hexosaminidase a (alpha polypeptide), ZFAND5  -  zinc finger, an1-type domain 5, HDAC1  -  histone deacetylase 1, PKIG  -  protein kinase (camp-dependent, catalytic) inhibitor gamma, EPN2  -  epsin 2, XPC  -  xeroderma pigmentosum, complementation group c, CDK14  -  cyclin-dependent kinase 14, SMC3  -  structural maintenance of chromosomes 3, PDLIM1  -  pdz and lim domain 1, ATP1B1  -  atpase, na+/k+ transporting, beta 1 polypeptide, GPC1  -  glypican 1, RAB14  -  rab14, member ras oncogene family, GPI  -  glucose-6-phosphate isomerase, DPYSL2  -  dihydropyrimidinase-like 2, SLC12A2  -  solute carrier family 12 (sodium/potassium/chloride transporter), member 2, UNC119  -  unc-119 homolog (c. elegans), MATN2  -  matrilin 2, SLC2A1  -  solute carrier family 2 (facilitated glucose transporter), member 1, ATP6V1B1  -  atpase, h+ transporting, lysosomal 56/58kda, v1 subunit b1, WNT5A  -  wingless-type mmtv integration site family, member 5a, DVL3  -  dishevelled segment polarity protein 3, ATP6V0C  -  atpase, h+ transporting, lysosomal 16kda, v0 subunit c, GULP1  -  gulp, engulfment adaptor ptb domain containing 1, TSC22D3  -  tsc22 domain family, member 3, ASH2L  -  ash2 (absent, small, or homeotic)-like (drosophila), LTB  -  lymphotoxin beta (tnf superfamily, member 3), SHH  -  sonic hedgehog, BAG1  -  bcl2-associated athanogene, GPX1  -  glutathione peroxidase 1, DLX5  -  distal-less homeobox 5, ST6GAL1  -  st6 beta-galactosamide alpha-2,6-sialyltranferase 1, PLAU  -  plasminogen activator, urokinase, PLAT  -  plasminogen activator, tissue, LUM  -  lumican, GPX7  -  glutathione peroxidase 7, RRAS2  -  related ras viral (r-ras) oncogene homolog 2, ATR  -  ataxia telangiectasia and rad3 related, BCAM  -  basal cell adhesion molecule (lutheran blood group), TWF2  -  twinfilin actin-binding protein 2, SFRP1  -  secreted frizzled-related protein 1, MPZL1  -  myelin protein zero-like 1, MGLL  -  monoglyceride lipase, BDKRB2  -  bradykinin receptor b2, SERPINE2  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 2, SERPINB9  -  serpin peptidase inhibitor, clade b (ovalbumin), member 9, DNM2  -  dynamin 2, SMAD2  -  smad family member 2, TDP2  -  tyrosyl-dna phosphodiesterase 2, BCL6  -  b-cell cll/lymphoma 6, NR3C1  -  nuclear receptor subfamily 3, group c, member 1 (glucocorticoid receptor), RPS6KA4  -  ribosomal protein s6 kinase, 90kda, polypeptide 4, DMD  -  dystrophin, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, YES1  -  v-yes-1 yamaguchi sarcoma viral oncogene homolog 1, CXCL1  -  chemokine (c-x-c motif) ligand 1 (melanoma growth stimulating activity, alpha), DMPK  -  dystrophia myotonica-protein kinase, SCG5  -  secretogranin v (7b2 protein), SGK1  -  serum/glucocorticoid regulated kinase 1, SMAD3  -  smad family member 3, GSK3B  -  glycogen synthase kinase 3 beta, CCND1  -  cyclin d1, SMAD6  -  smad family member 6, PIGR  -  polymeric immunoglobulin receptor, ITSN1  -  intersectin 1 (sh3 domain protein), SH3GL1  -  sh3-domain grb2-like 1, BNIP3  -  bcl2/adenovirus e1b 19kda interacting protein 3, HSF2  -  heat shock transcription factor 2, NDN  -  necdin, melanoma antigen (mage) family member, RFC2  -  replication factor c (activator 1) 2, 40kda, NCK1  -  nck adaptor protein 1, REV3L  -  rev3-like, polymerase (dna directed), zeta, catalytic subunit, TSC22D4  -  tsc22 domain family, member 4, TICAM1  -  toll-like receptor adaptor molecule 1, IQGAP1  -  iq motif containing gtpase activating protein 1, EPAS1  -  endothelial pas domain protein 1, TRPM2  -  transient receptor potential cation channel, subfamily m, member 2, HABP4  -  hyaluronan binding protein 4, ATF6  -  activating transcription factor 6, HRAS  -  harvey rat sarcoma viral oncogene homolog, NBN  -  nibrin, ENO1  -  enolase 1, (alpha), KLF5  -  kruppel-like factor 5 (intestinal), RIT1  -  ras-like without caax 1, MYO9B  -  myosin ixb, EIF4A2  -  eukaryotic translation initiation factor 4a2, RRAGB  -  ras-related gtp binding b, MYO10  -  myosin x, EIF4B  -  eukaryotic translation initiation factor 4b, CFB  -  complement factor b, PPP1R12B  -  protein phosphatase 1, regulatory subunit 12b, TNK2  -  tyrosine kinase, non-receptor, 2, PIKFYVE  -  phosphoinositide kinase, fyve finger containing, BLMH  -  bleomycin hydrolase, EIF2S1  -  eukaryotic translation initiation factor 2, subunit 1 alpha, 35kda, BID  -  bh3 interacting domain death agonist, RGS7  -  regulator of g-protein signaling 7, MYLK  -  myosin light chain kinase, BMPR1A  -  bone morphogenetic protein receptor, type ia, EIF4G1  -  eukaryotic translation initiation factor 4 gamma, 1, BMP4  -  bone morphogenetic protein 4, ZNF259  -  zinc finger protein 259, ICAM1  -  intercellular adhesion molecule 1, C9  -  complement component 9, STK38L  -  serine/threonine kinase 38 like, GADD45B  -  growth arrest and dna-damage-inducible, beta, EEF1A2  -  eukaryotic translation elongation factor 1 alpha 2, EGFR  -  epidermal growth factor receptor, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, HTR7  -  5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled, EIF2B4  -  eukaryotic translation initiation factor 2b, subunit 4 delta, 67kda, EFNB2  -  ephrin-b2, EFNB1  -  ephrin-b1, ROCK1  -  rho-associated, coiled-coil containing protein kinase 1, ARPC2  -  actin related protein 2/3 complex, subunit 2, 34kda, SERPING1  -  serpin peptidase inhibitor, clade g (c1 inhibitor), member 1, CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, C1R  -  complement component 1, r subcomponent, C1S  -  complement component 1, s subcomponent, EDNRA  -  endothelin receptor type a, C4A  -  complement component 4a (rodgers blood group), TRAF2  -  tnf receptor-associated factor 2, FSTL3  -  follistatin-like 3 (secreted glycoprotein), MBD2  -  methyl-cpg binding domain protein 2, HSPA4  -  heat shock 70kda protein 4, EFS  -  embryonal fyn-associated substrate, RAB7L1  -  rab7, member ras oncogene family-like 1, OPTN  -  optineurin, TRAP1  -  tnf receptor-associated protein 1, WASF1  -  was protein family, member 1, TPT1  -  tumor protein, translationally-controlled 1, CAPZA2  -  capping protein (actin filament) muscle z-line, alpha 2, AKR1C3  -  aldo-keto reductase family 1, member c3, CAPZA1  -  capping protein (actin filament) muscle z-line, alpha 1, PDE5A  -  phosphodiesterase 5a, cgmp-specific, OSTF1  -  osteoclast stimulating factor 1, PPP4R1  -  protein phosphatase 4, regulatory subunit 1, CAMK2G  -  calcium/calmodulin-dependent protein kinase ii gamma, SIK1  -  salt-inducible kinase 1, CAMK2B  -  calcium/calmodulin-dependent protein kinase ii beta, EIF4G3  -  eukaryotic translation initiation factor 4 gamma, 3, TANK  -  traf family member-associated nfkb activator, UNG  -  uracil-dna glycosylase, RPA3  -  replication protein a3, 14kda, TAB2  -  tgf-beta activated kinase 1/map3k7 binding protein 2, HMGXB4  -  hmg box domain containing 4, CAP1  -  cap, adenylate cyclase-associated protein 1 (yeast), VEGFC  -  vascular endothelial growth factor c, PLXND1  -  plexin d1, HLA-DMB  -  major histocompatibility complex, class ii, dm beta, HLA-DMA  -  major histocompatibility complex, class ii, dm alpha, DDR1  -  discoidin domain receptor tyrosine kinase 1, CREB3L1  -  camp responsive element binding protein 3-like 1, CFH  -  complement factor h, HSPB6  -  heat shock protein, alpha-crystallin-related, b6, CFHR1  -  complement factor h-related 1, VCAM1  -  vascular cell adhesion molecule 1, VDAC1  -  voltage-dependent anion channel 1, TRADD  -  tnfrsf1a-associated via death domain, MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, CTNNAL1  -  catenin (cadherin-associated protein), alpha-like 1, ARNT2  -  aryl-hydrocarbon receptor nuclear translocator 2, CCNG1  -  cyclin g1, TNFSF4  -  tumor necrosis factor (ligand) superfamily, member 4, CD14  -  cd14 molecule, OXSR1  -  oxidative stress responsive 1, NDRG1  -  n-myc downstream regulated 1, DLC1  -  deleted in liver cancer 1, TYRO3  -  tyro3 protein tyrosine kinase, TUBB4B  -  tubulin, beta 4b class ivb, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, TNFSF9  -  tumor necrosis factor (ligand) superfamily, member 9, UBXN4  -  ubx domain protein 4, TXNRD1  -  thioredoxin reductase 1, CBLB  -  cbl proto-oncogene b, e3 ubiquitin protein ligase, SLC23A2  -  solute carrier family 23 (ascorbic acid transporter), member 2, UCHL1  -  ubiquitin carboxyl-terminal esterase l1 (ubiquitin thiolesterase), MVP  -  major vault protein, TNFRSF14  -  tumor necrosis factor receptor superfamily, member 14, CAT  -  catalase, FADD  -  fas (tnfrsf6)-associated via death domain, RYK  -  receptor-like tyrosine kinase, KRIT1  -  krit1, ankyrin repeat containing, RBM14  -  rna binding motif protein 14, NUP153  -  nucleoporin 153kda, CBS  -  cystathionine-beta-synthase, RRAD  -  ras-related associated with diabetes, NR1D2  -  nuclear receptor subfamily 1, group d, member 2, NUPR1  -  nuclear protein, transcriptional regulator, 1, RRAS  -  related ras viral (r-ras) oncogene homolog, MPG  -  n-methylpurine-dna glycosylase, SSH1  -  slingshot protein phosphatase 1, TCF12  -  transcription factor 12, CDC34  -  cell division cycle 34, GAB2  -  grb2-associated binding protein 2, HTRA2  -  htra serine peptidase 2, FLNA  -  filamin a, alpha, FLNB  -  filamin b, beta, CD59  -  cd59 molecule, complement regulatory protein, PSEN2  -  presenilin 2 (alzheimer disease 4), ARC  -  activity-regulated cytoskeleton-associated protein, PSMA1  -  proteasome (prosome, macropain) subunit, alpha type, 1, FARP2  -  ferm, rhogef and pleckstrin domain protein 2, FOXO1  -  forkhead box o1, RGS5  -  regulator of g-protein signaling 5, CD97  -  cd97 molecule, CDC14B  -  cell division cycle 14b, PIAS1  -  protein inhibitor of activated stat, 1, IL4R  -  interleukin 4 receptor, FOXC1  -  forkhead box c1, DOK5  -  docking protein 5, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, PSMB9  -  proteasome (prosome, macropain) subunit, beta type, 9, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, IL1R1  -  interleukin 1 receptor, type i, UBR2  -  ubiquitin protein ligase e3 component n-recognin 2, PSMB4  -  proteasome (prosome, macropain) subunit, beta type, 4, PDPN  -  podoplanin, CAMK1  -  calcium/calmodulin-dependent protein kinase i, TDG  -  thymine-dna glycosylase, COPS3  -  cop9 signalosome subunit 3, NUAK1  -  nuak family, snf1-like kinase, 1, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, IL6ST  -  interleukin 6 signal transducer (gp130, oncostatin m receptor), DGKZ  -  diacylglycerol kinase, zeta, TNFRSF11B  -  tumor necrosis factor receptor superfamily, member 11b, ITGA5  -  integrin, alpha 5 (fibronectin receptor, alpha polypeptide), PSMD11  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 11, PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), ITGA7  -  integrin, alpha 7, FGFR1  -  fibroblast growth factor receptor 1, GNG12  -  guanine nucleotide binding protein (g protein), gamma 12, DDR2  -  discoidin domain receptor tyrosine kinase 2, ROR2  -  receptor tyrosine kinase-like orphan receptor 2, PTGDS  -  prostaglandin d2 synthase 21kda (brain), MAML1  -  mastermind-like 1 (drosophila), FGF5  -  fibroblast growth factor 5, ITGA3  -  integrin, alpha 3 (antigen cd49c, alpha 3 subunit of vla-3 receptor), FGF7  -  fibroblast growth factor 7, CFL1  -  cofilin 1 (non-muscle), ITGA2B  -  integrin, alpha 2b (platelet glycoprotein iib of iib/iiia complex, antigen cd41), PTGER1  -  prostaglandin e receptor 1 (subtype ep1), 42kda, BCLAF1  -  bcl2-associated transcription factor 1, SEMA3C  -  sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3c, ITGB5  -  integrin, beta 5, FGF2  -  fibroblast growth factor 2 (basic), FGF4  -  fibroblast growth factor 4, MKNK1  -  map kinase interacting serine/threonine kinase 1, GTF2H5  -  general transcription factor iih, polypeptide 5, PTGIR  -  prostaglandin i2 (prostacyclin) receptor (ip), TAP1  -  transporter 1, atp-binding cassette, sub-family b (mdr/tap), CEBPB  -  ccaat/enhancer binding protein (c/ebp), beta, INPPL1  -  inositol polyphosphate phosphatase-like 1, PTN  -  pleiotrophin, TBX2  -  t-box 2, NPR3  -  natriuretic peptide receptor c/guanylate cyclase c (atrionatriuretic peptide receptor c), FCGRT  -  fc fragment of igg, receptor, transporter, alpha, SRGAP2  -  slit-robo rho gtpase activating protein 2, CDKN2D  -  cyclin-dependent kinase inhibitor 2d (p19, inhibits cdk4), PTPN1  -  protein tyrosine phosphatase, non-receptor type 1, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), RUVBL1  -  ruvb-like 1 (e. coli), ARL6IP5  -  adp-ribosylation-like factor 6 interacting protein 5, PPAP2B  -  phosphatidic acid phosphatase type 2b, EFEMP1  -  egf containing fibulin-like extracellular matrix protein 1, CDH13  -  cadherin 13, h-cadherin (heart), ITGA6  -  integrin, alpha 6, CRCP  -  cgrp receptor component, IRAK1  -  interleukin-1 receptor-associated kinase 1, PTPRF  -  protein tyrosine phosphatase, receptor type, f, RAD1  -  rad1 homolog (s. pombe), CHRND  -  cholinergic receptor, nicotinic, delta (muscle), IFIT1  -  interferon-induced protein with tetratricopeptide repeats 1, IFIT3  -  interferon-induced protein with tetratricopeptide repeats 3, TIMP3  -  timp metallopeptidase inhibitor 3, CHRNB1  -  cholinergic receptor, nicotinic, beta 1 (muscle), IFI16  -  interferon, gamma-inducible protein 16, HIST2H2BE  -  histone cluster 2, h2be, IFI27  -  interferon, alpha-inducible protein 27, IFI35  -  interferon-induced protein 35, PTX3  -  pentraxin 3, long, SLC7A8  -  solute carrier family 7 (amino acid transporter light chain, l system), member 8, STRN3  -  striatin, calmodulin binding protein 3, TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), TLE2  -  transducin-like enhancer of split 2 (e(sp1) homolog, drosophila), TLE4  -  transducin-like enhancer of split 4 (e(sp1) homolog, drosophila), NOVA1  -  neuro-oncological ventral antigen 1, IFNGR1  -  interferon gamma receptor 1, NOTCH3  -  notch 3, PVRL2  -  poliovirus receptor-related 2 (herpesvirus entry mediator b), ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, HDAC4  -  histone deacetylase 4, ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, NFX1  -  nuclear transcription factor, x-box binding 1, NGF  -  nerve growth factor (beta polypeptide), RAB3B  -  rab3b, member ras oncogene family, RAB2A  -  rab2a, member ras oncogene family, NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, RAD23B  -  rad23 homolog b (s. cerevisiae), TNFAIP6  -  tumor necrosis factor, alpha-induced protein 6, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, CGB  -  chorionic gonadotropin, beta polypeptide, CTSC  -  cathepsin c, RAB13  -  rab13, member ras oncogene family, RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), TEK  -  tek tyrosine kinase, endothelial, DDIT4  -  dna-damage-inducible transcript 4, RAN  -  ran, member ras oncogene family, RBPJ  -  recombination signal binding protein for immunoglobulin kappa j region, RAD51D  -  rad51 paralog d, TERF1  -  telomeric repeat binding factor (nima-interacting) 1, DYRK2  -  dual-specificity tyrosine-(y)-phosphorylation regulated kinase 2, NFE2L2  -  nuclear factor (erythroid-derived 2)-like 2, ISG15  -  isg15 ubiquitin-like modifier, FEZ1  -  fasciculation and elongation protein zeta 1 (zygin i), NR2F1  -  nuclear receptor subfamily 2, group f, member 1, BCAR3  -  breast cancer anti-estrogen resistance 3, CLU  -  clusterin, TPP1  -  tripeptidyl peptidase i, IK  -  ik cytokine, down-regulator of hla ii, IGBP1  -  immunoglobulin (cd79a) binding protein 1, SMARCA5  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5, TGFBI  -  transforming growth factor, beta-induced, 68kda, IGF1R  -  insulin-like growth factor 1 receptor, IGF2  -  insulin-like growth factor 2 (somatomedin a), TGFB1  -  transforming growth factor, beta 1, OGT  -  o-linked n-acetylglucosamine (glcnac) transferase, TGFB1I1  -  transforming growth factor beta 1 induced transcript 1, IGFBP1  -  insulin-like growth factor binding protein 1, TGIF1  -  tgfb-induced factor homeobox 1, TSPYL2  -  tspy-like 2, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), TGFBR3  -  transforming growth factor, beta receptor iii, CUL4B  -  cullin 4b, FOS  -  fbj murine osteosarcoma viral oncogene homolog, CABIN1  -  calcineurin binding protein 1, FNTB  -  farnesyltransferase, caax box, beta, POLD3  -  polymerase (dna-directed), delta 3, accessory subunit, RBP1  -  retinol binding protein 1, cellular]"GO:0042221,response to chemical,9.85E-06,4.99E-03,1.27,8230,1915,988,293,"[BNIP3  -  bcl2/adenovirus e1b 19kda interacting protein 3, NDN  -  necdin, melanoma antigen (mage) family member, HNRNPA0  -  heterogeneous nuclear ribonucleoprotein a0, ABCA1  -  atp-binding cassette, sub-family a (abc1), member 1, TICAM1  -  toll-like receptor adaptor molecule 1, SPN  -  sialophorin, NCOR2  -  nuclear receptor corepressor 2, IQGAP1  -  iq motif containing gtpase activating protein 1, EPAS1  -  endothelial pas domain protein 1, RNF14  -  ring finger protein 14, TRPM2  -  transient receptor potential cation channel, subfamily m, member 2, LGALS3  -  lectin, galactoside-binding, soluble, 3, ATF6  -  activating transcription factor 6, GCH1  -  gtp cyclohydrolase 1, HRAS  -  harvey rat sarcoma viral oncogene homolog, KLF5  -  kruppel-like factor 5 (intestinal), RIT1  -  ras-like without caax 1, ASIC2  -  acid-sensing (proton-gated) ion channel 2, MYO9B  -  myosin ixb, RRAGB  -  ras-related gtp binding b, SMPD4  -  sphingomyelin phosphodiesterase 4, neutral membrane (neutral sphingomyelinase-3), EIF4A2  -  eukaryotic translation initiation factor 4a2, EIF4B  -  eukaryotic translation initiation factor 4b, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, SOX9  -  sry (sex determining region y)-box 9, ACR  -  acrosin, PLP2  -  proteolipid protein 2 (colonic epithelium-enriched), SOX4  -  sry (sex determining region y)-box 4, HPN  -  hepsin, BLMH  -  bleomycin hydrolase, EIF2S1  -  eukaryotic translation initiation factor 2, subunit 1 alpha, 35kda, BID  -  bh3 interacting domain death agonist, PLSCR1  -  phospholipid scramblase 1, PLAUR  -  plasminogen activator, urokinase receptor, GHR  -  growth hormone receptor, GJA1  -  gap junction protein, alpha 1, 43kda, SOD2  -  superoxide dismutase 2, mitochondrial, SOD1  -  superoxide dismutase 1, soluble, BMPR1A  -  bone morphogenetic protein receptor, type ia, EIF4G1  -  eukaryotic translation initiation factor 4 gamma, 1, CREB1  -  camp responsive element binding protein 1, LMNA  -  lamin a/c, SERPINF2  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 2, BMP4  -  bone morphogenetic protein 4, KRT19  -  keratin 19, ICAM1  -  intercellular adhesion molecule 1, GLUL  -  glutamate-ammonia ligase, LITAF  -  lipopolysaccharide-induced tnf factor, PPM1B  -  protein phosphatase, mg2+/mn2+ dependent, 1b, EEF1A2  -  eukaryotic translation elongation factor 1 alpha 2, ADAR  -  adenosine deaminase, rna-specific, EGFR  -  epidermal growth factor receptor, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, FZD7  -  frizzled family receptor 7, ADA  -  adenosine deaminase, COL4A1  -  collagen, type iv, alpha 1, MED1  -  mediator complex subunit 1, EIF2B4  -  eukaryotic translation initiation factor 2b, subunit 4 delta, 67kda, CNR1  -  cannabinoid receptor 1 (brain), KRT14  -  keratin 14, PTGES  -  prostaglandin e synthase, KRT18  -  keratin 18, PLIN2  -  perilipin 2, ADD1  -  adducin 1 (alpha), EIF4E2  -  eukaryotic translation initiation factor 4e family member 2, GNB1  -  guanine nucleotide binding protein (g protein), beta polypeptide 1, ADH5  -  alcohol dehydrogenase 5 (class iii), chi polypeptide, HSPE1  -  heat shock 10kda protein 1 (chaperonin 10), CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, LY96  -  lymphocyte antigen 96, RRAGD  -  ras-related gtp binding d, PARP1  -  poly (adp-ribose) polymerase 1, EDNRA  -  endothelin receptor type a, ADM  -  adrenomedullin, TRAF2  -  tnf receptor-associated factor 2, FSTL3  -  follistatin-like 3 (secreted glycoprotein), HSPA4  -  heat shock 70kda protein 4, PARP4  -  poly (adp-ribose) polymerase family, member 4, AKR1C3  -  aldo-keto reductase family 1, member c3, PRKACB  -  protein kinase, camp-dependent, catalytic, beta, HLA-E  -  major histocompatibility complex, class i, e, CAMK2G  -  calcium/calmodulin-dependent protein kinase ii gamma, SYT1  -  synaptotagmin i, CAMK2B  -  calcium/calmodulin-dependent protein kinase ii beta, NUPL2  -  nucleoporin like 2, SUPT5H  -  suppressor of ty 5 homolog (s. cerevisiae), EIF4G3  -  eukaryotic translation initiation factor 4 gamma, 3, CTPS1  -  ctp synthase 1, PPP5C  -  protein phosphatase 5, catalytic subunit, KCNMB1  -  potassium large conductance calcium-activated channel, subfamily m, beta member 1, AK2  -  adenylate kinase 2, CTSL  -  cathepsin l, PPP2R5B  -  protein phosphatase 2, regulatory subunit b', beta, CTSH  -  cathepsin h, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, VEGFC  -  vascular endothelial growth factor c, AHR  -  aryl hydrocarbon receptor, CREB3L1  -  camp responsive element binding protein 3-like 1, PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, VCAM1  -  vascular cell adhesion molecule 1, F2R  -  coagulation factor ii (thrombin) receptor, CRIP1  -  cysteine-rich protein 1 (intestinal), TRADD  -  tnfrsf1a-associated via death domain, CRKL  -  v-crk avian sarcoma virus ct10 oncogene homolog-like, FOSL1  -  fos-like antigen 1, JUN  -  jun proto-oncogene, STAT2  -  signal transducer and activator of transcription 2, 113kda, UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, STAT1  -  signal transducer and activator of transcription 1, 91kda, STAT4  -  signal transducer and activator of transcription 4, SLIT2  -  slit homolog 2 (drosophila), STAT3  -  signal transducer and activator of transcription 3 (acute-phase response factor), PRNP  -  prion protein, ARNT2  -  aryl-hydrocarbon receptor nuclear translocator 2, CRYAB  -  crystallin, alpha b, ALDOC  -  aldolase c, fructose-bisphosphate, KAL1  -  kallmann syndrome 1 sequence, CCNG1  -  cyclin g1, TNFSF4  -  tumor necrosis factor (ligand) superfamily, member 4, CD14  -  cd14 molecule, JAK2  -  janus kinase 2, NDRG1  -  n-myc downstream regulated 1, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, MAP2K1  -  mitogen-activated protein kinase kinase 1, UBXN4  -  ubx domain protein 4, MAPK7  -  mitogen-activated protein kinase 7, TNFRSF14  -  tumor necrosis factor receptor superfamily, member 14, MAPK3  -  mitogen-activated protein kinase 3, CAT  -  catalase, ASIC3  -  acid-sensing (proton-gated) ion channel 3, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, RYK  -  receptor-like tyrosine kinase, GBP2  -  guanylate binding protein 2, interferon-inducible, GBP1  -  guanylate binding protein 1, interferon-inducible, BAMBI  -  bmp and activin membrane-bound inhibitor, RBM14  -  rna binding motif protein 14, PRKCG  -  protein kinase c, gamma, NUP153  -  nucleoporin 153kda, PRKCA  -  protein kinase c, alpha, CCS  -  copper chaperone for superoxide dismutase, CBS  -  cystathionine-beta-synthase, PRKAR1B  -  protein kinase, camp-dependent, regulatory, type i, beta, ARIH1  -  ariadne homolog, ubiquitin-conjugating enzyme e2 binding protein, 1 (drosophila), NUPR1  -  nuclear protein, transcriptional regulator, 1, GAS6  -  growth arrest-specific 6, GAS1  -  growth arrest-specific 1, GSTM2  -  glutathione s-transferase mu 2 (muscle), APEX1  -  apex nuclease (multifunctional dna repair enzyme) 1, GSTM1  -  glutathione s-transferase mu 1, SSH1  -  slingshot protein phosphatase 1, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, GSN  -  gelsolin, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), CDC34  -  cell division cycle 34, INHBA  -  inhibin, beta a, HTRA2  -  htra serine peptidase 2, FLNB  -  filamin b, beta, PSEN2  -  presenilin 2 (alzheimer disease 4), FOXO1  -  forkhead box o1, MMP2  -  matrix metallopeptidase 2 (gelatinase a, 72kda gelatinase, 72kda type iv collagenase), PIAS1  -  protein inhibitor of activated stat, 1, IL4R  -  interleukin 4 receptor, UBE2L6  -  ubiquitin-conjugating enzyme e2l 6, P4HB  -  prolyl 4-hydroxylase, beta polypeptide, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, IL1R1  -  interleukin 1 receptor, type i, UBR2  -  ubiquitin protein ligase e3 component n-recognin 2, FURIN  -  furin (paired basic amino acid cleaving enzyme), TXNIP  -  thioredoxin interacting protein, SDC2  -  syndecan 2, POM121  -  pom121 transmembrane nucleoporin, APOE  -  apolipoprotein e, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, WWOX  -  ww domain containing oxidoreductase, CXCL6  -  chemokine (c-x-c motif) ligand 6, IL6ST  -  interleukin 6 signal transducer (gp130, oncostatin m receptor), AQP1  -  aquaporin 1 (colton blood group), TNFRSF11B  -  tumor necrosis factor receptor superfamily, member 11b, ADIPOR2  -  adiponectin receptor 2, PDGFA  -  platelet-derived growth factor alpha polypeptide, MCM7  -  minichromosome maintenance complex component 7, FGFR1  -  fibroblast growth factor receptor 1, MDK  -  midkine (neurite growth-promoting factor 2), GNG12  -  guanine nucleotide binding protein (g protein), gamma 12, PTGDS  -  prostaglandin d2 synthase 21kda (brain), FGF5  -  fibroblast growth factor 5, ITGA3  -  integrin, alpha 3 (antigen cd49c, alpha 3 subunit of vla-3 receptor), PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, PTGER1  -  prostaglandin e receptor 1 (subtype ep1), 42kda, CFL1  -  cofilin 1 (non-muscle), FGF7  -  fibroblast growth factor 7, SEMA3C  -  sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3c, RHOB  -  ras homolog family member b, MEF2A  -  myocyte enhancer factor 2a, PDPK1  -  3-phosphoinositide dependent protein kinase-1, FGF2  -  fibroblast growth factor 2 (basic), NUP98  -  nucleoporin 98kda, FGF4  -  fibroblast growth factor 4, MKNK1  -  map kinase interacting serine/threonine kinase 1, PDK3  -  pyruvate dehydrogenase kinase, isozyme 3, PTGIR  -  prostaglandin i2 (prostacyclin) receptor (ip), ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, CEBPB  -  ccaat/enhancer binding protein (c/ebp), beta, RHOG  -  ras homolog family member g, INPPL1  -  inositol polyphosphate phosphatase-like 1, DAG1  -  dystroglycan 1 (dystrophin-associated glycoprotein 1), ASS1  -  argininosuccinate synthase 1, CDKN2D  -  cyclin-dependent kinase inhibitor 2d (p19, inhibits cdk4), ASPH  -  aspartate beta-hydroxylase, DAPK1  -  death-associated protein kinase 1, PTPN1  -  protein tyrosine phosphatase, non-receptor type 1, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), ARL6IP5  -  adp-ribosylation-like factor 6 interacting protein 5, HDAC1  -  histone deacetylase 1, ITGA6  -  integrin, alpha 6, IRAK1  -  interleukin-1 receptor-associated kinase 1, IFIT1  -  interferon-induced protein with tetratricopeptide repeats 1, IFIT3  -  interferon-induced protein with tetratricopeptide repeats 3, TIMP3  -  timp metallopeptidase inhibitor 3, CHRNB1  -  cholinergic receptor, nicotinic, beta 1 (muscle), IFI27  -  interferon, alpha-inducible protein 27, IFI35  -  interferon-induced protein 35, STRN3  -  striatin, calmodulin binding protein 3, XPC  -  xeroderma pigmentosum, complementation group c, SLC7A8  -  solute carrier family 7 (amino acid transporter light chain, l system), member 8, RAB14  -  rab14, member ras oncogene family, PXN  -  paxillin, DPYSL3  -  dihydropyrimidinase-like 3, DPYSL2  -  dihydropyrimidinase-like 2, IFNGR1  -  interferon gamma receptor 1, ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, HDAC4  -  histone deacetylase 4, ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, NGF  -  nerve growth factor (beta polypeptide), NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, ATP6V1B1  -  atpase, h+ transporting, lysosomal 56/58kda, v1 subunit b1, WNT5A  -  wingless-type mmtv integration site family, member 5a, ATP6V0C  -  atpase, h+ transporting, lysosomal 16kda, v0 subunit c, DVL3  -  dishevelled segment polarity protein 3, PFKL  -  phosphofructokinase, liver, ASH2L  -  ash2 (absent, small, or homeotic)-like (drosophila), TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, CTSC  -  cathepsin c, RAB13  -  rab13, member ras oncogene family, RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), TEK  -  tek tyrosine kinase, endothelial, DDIT4  -  dna-damage-inducible transcript 4, SHH  -  sonic hedgehog, GPX1  -  glutathione peroxidase 1, DLX5  -  distal-less homeobox 5, TERF1  -  telomeric repeat binding factor (nima-interacting) 1, PLAU  -  plasminogen activator, urokinase, NFE2L2  -  nuclear factor (erythroid-derived 2)-like 2, PLAT  -  plasminogen activator, tissue, LUM  -  lumican, ISG15  -  isg15 ubiquitin-like modifier, FEZ1  -  fasciculation and elongation protein zeta 1 (zygin i), BCAR3  -  breast cancer anti-estrogen resistance 3, CLU  -  clusterin, ATR  -  ataxia telangiectasia and rad3 related, TPP1  -  tripeptidyl peptidase i, TWF2  -  twinfilin actin-binding protein 2, IGBP1  -  immunoglobulin (cd79a) binding protein 1, SFRP1  -  secreted frizzled-related protein 1, IGF1R  -  insulin-like growth factor 1 receptor, IGF2  -  insulin-like growth factor 2 (somatomedin a), SMAD1  -  smad family member 1, SERPINB9  -  serpin peptidase inhibitor, clade b (ovalbumin), member 9, TGFB1  -  transforming growth factor, beta 1, SMAD2  -  smad family member 2, OGT  -  o-linked n-acetylglucosamine (glcnac) transferase, IGFBP1  -  insulin-like growth factor binding protein 1, TGIF1  -  tgfb-induced factor homeobox 1, TSPYL2  -  tspy-like 2, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), TGFBR3  -  transforming growth factor, beta receptor iii, RPS6KA4  -  ribosomal protein s6 kinase, 90kda, polypeptide 4, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, FOSL2  -  fos-like antigen 2, FOSB  -  fbj murine osteosarcoma viral oncogene homolog b, FOS  -  fbj murine osteosarcoma viral oncogene homolog, CXCL1  -  chemokine (c-x-c motif) ligand 1 (melanoma growth stimulating activity, alpha), THBD  -  thrombomodulin, FNTB  -  farnesyltransferase, caax box, beta, SMAD3  -  smad family member 3, SMAD6  -  smad family member 6, GSK3B  -  glycogen synthase kinase 3 beta, CCND1  -  cyclin d1, PIGR  -  polymeric immunoglobulin receptor, ITSN1  -  intersectin 1 (sh3 domain protein)]"GO:0051246,regulation of protein metabolic process,1.03E-05,4.97E-03,1.37,8230,1289,892,192,"[NCBP2  -  nuclear cap binding protein subunit 2, 20kda, FMR1  -  fragile x mental retardation 1, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, SSH1  -  slingshot protein phosphatase 1, NCK1  -  nck adaptor protein 1, SERPINA3  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 3, PAWR  -  prkc, apoptosis, wt1, regulator, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), HEXIM1  -  hexamethylene bis-acetamide inducible 1, TICAM1  -  toll-like receptor adaptor molecule 1, PAX7  -  paired box 7, SPN  -  sialophorin, IQGAP1  -  iq motif containing gtpase activating protein 1, FLNA  -  filamin a, alpha, CD59  -  cd59 molecule, complement regulatory protein, GTF2H1  -  general transcription factor iih, polypeptide 1, 62kda, PSMA1  -  proteasome (prosome, macropain) subunit, alpha type, 1, ATF6  -  activating transcription factor 6, HRAS  -  harvey rat sarcoma viral oncogene homolog, NBN  -  nibrin, KMT2A  -  lysine (k)-specific methyltransferase 2a, TRAF4  -  tnf receptor-associated factor 4, CDC14B  -  cell division cycle 14b, PIAS1  -  protein inhibitor of activated stat, 1, EIF4A2  -  eukaryotic translation initiation factor 4a2, EIF4B  -  eukaryotic translation initiation factor 4b, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, CRLF1  -  cytokine receptor-like factor 1, CFB  -  complement factor b, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, SOX9  -  sry (sex determining region y)-box 9, PDCD10  -  programmed cell death 10, PSMB9  -  proteasome (prosome, macropain) subunit, beta type, 9, SOX4  -  sry (sex determining region y)-box 4, TNK2  -  tyrosine kinase, non-receptor, 2, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, EIF2S1  -  eukaryotic translation initiation factor 2, subunit 1 alpha, 35kda, FURIN  -  furin (paired basic amino acid cleaving enzyme), PSMB4  -  proteasome (prosome, macropain) subunit, beta type, 4, CAMK1  -  calcium/calmodulin-dependent protein kinase i, PLAUR  -  plasminogen activator, urokinase receptor, GJA1  -  gap junction protein, alpha 1, 43kda, APOE  -  apolipoprotein e, SOD1  -  superoxide dismutase 1, soluble, RGS3  -  regulator of g-protein signaling 3, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, APP  -  amyloid beta (a4) precursor protein, BMPR1A  -  bone morphogenetic protein receptor, type ia, EIF4G1  -  eukaryotic translation initiation factor 4 gamma, 1, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, LMNA  -  lamin a/c, SNX1  -  sorting nexin 1, SERPINF2  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 2, IL6ST  -  interleukin 6 signal transducer (gp130, oncostatin m receptor), BMP4  -  bone morphogenetic protein 4, SNTA1  -  syntrophin, alpha 1, PDGFA  -  platelet-derived growth factor alpha polypeptide, ITGA5  -  integrin, alpha 5 (fibronectin receptor, alpha polypeptide), ICAM1  -  intercellular adhesion molecule 1, PSMD11  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 11, C9  -  complement component 9, PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), FGFR1  -  fibroblast growth factor receptor 1, GADD45B  -  growth arrest and dna-damage-inducible, beta, DDR2  -  discoidin domain receptor tyrosine kinase 2, FGF7  -  fibroblast growth factor 7, MECP2  -  methyl cpg binding protein 2 (rett syndrome), ADAR  -  adenosine deaminase, rna-specific, FGF2  -  fibroblast growth factor 2 (basic), PDPK1  -  3-phosphoinositide dependent protein kinase-1, EGFR  -  epidermal growth factor receptor, FGF4  -  fibroblast growth factor 4, SAMD4A  -  sterile alpha motif domain containing 4a, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, MKNK1  -  map kinase interacting serine/threonine kinase 1, EIF2B4  -  eukaryotic translation initiation factor 2b, subunit 4 delta, 67kda, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, CEBPB  -  ccaat/enhancer binding protein (c/ebp), beta, ADD1  -  adducin 1 (alpha), EIF4E2  -  eukaryotic translation initiation factor 4e family member 2, SERPING1  -  serpin peptidase inhibitor, clade g (c1 inhibitor), member 1, CDKN1C  -  cyclin-dependent kinase inhibitor 1c (p57, kip2), CDKN2D  -  cyclin-dependent kinase inhibitor 2d (p19, inhibits cdk4), ASPH  -  aspartate beta-hydroxylase, DAPK1  -  death-associated protein kinase 1, MAPK8IP1  -  mitogen-activated protein kinase 8 interacting protein 1, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), LRPPRC  -  leucine-rich pentatricopeptide repeat containing, EDNRA  -  endothelin receptor type a, CDC37  -  cell division cycle 37, C4A  -  complement component 4a (rodgers blood group), TAOK3  -  tao kinase 3, FZR1  -  fizzy/cell division cycle 20 related 1 (drosophila), TRAF2  -  tnf receptor-associated factor 2, PPAP2B  -  phosphatidic acid phosphatase type 2b, EIF3E  -  eukaryotic translation initiation factor 3, subunit e, PKIG  -  protein kinase (camp-dependent, catalytic) inhibitor gamma, IRAK1  -  interleukin-1 receptor-associated kinase 1, QKI  -  qki, kh domain containing, rna binding, TIMP3  -  timp metallopeptidase inhibitor 3, MAGOH  -  mago-nashi homolog, proliferation-associated (drosophila), PDE5A  -  phosphodiesterase 5a, cgmp-specific, EIF3C  -  eukaryotic translation initiation factor 3, subunit c, EIF3D  -  eukaryotic translation initiation factor 3, subunit d, AGT  -  angiotensinogen (serpin peptidase inhibitor, clade a, member 8), EIF4G3  -  eukaryotic translation initiation factor 4 gamma, 3, AIMP2  -  aminoacyl trna synthetase complex-interacting multifunctional protein 2, TAB2  -  tgf-beta activated kinase 1/map3k7 binding protein 2, HDAC4  -  histone deacetylase 4, VEGFC  -  vascular endothelial growth factor c, EIF3M  -  eukaryotic translation initiation factor 3, subunit m, NGF  -  nerve growth factor (beta polypeptide), NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, WNT5A  -  wingless-type mmtv integration site family, member 5a, DVL3  -  dishevelled segment polarity protein 3, STK3  -  serine/threonine kinase 3, RAD23B  -  rad23 homolog b (s. cerevisiae), PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, CFH  -  complement factor h, EZH2  -  enhancer of zeste homolog 2 (drosophila), ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, TEK  -  tek tyrosine kinase, endothelial, CRKL  -  v-crk avian sarcoma virus ct10 oncogene homolog-like, ST13  -  suppression of tumorigenicity 13 (colon carcinoma) (hsp70 interacting protein), DDIT4  -  dna-damage-inducible transcript 4, RBPMS  -  rna binding protein with multiple splicing, LTB  -  lymphotoxin beta (tnf superfamily, member 3), GGA3  -  golgi-associated, gamma adaptin ear containing, arf binding protein 3, UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, SHH  -  sonic hedgehog, JUN  -  jun proto-oncogene, KIAA1199  -  kiaa1199, EED  -  embryonic ectoderm development, SLIT2  -  slit homolog 2 (drosophila), PABPC1  -  poly(a) binding protein, cytoplasmic 1, GPX1  -  glutathione peroxidase 1, PROS1  -  protein s (alpha), PRNP  -  prion protein, CCNG1  -  cyclin g1, PLAT  -  plasminogen activator, tissue, FXR1  -  fragile x mental retardation, autosomal homolog 1, ISG15  -  isg15 ubiquitin-like modifier, JAK2  -  janus kinase 2, DLC1  -  deleted in liver cancer 1, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, NF2  -  neurofibromin 2 (merlin), CLU  -  clusterin, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, MAP2K1  -  mitogen-activated protein kinase kinase 1, TPP1  -  tripeptidyl peptidase i, MAP2K3  -  mitogen-activated protein kinase kinase 3, MAPK10  -  mitogen-activated protein kinase 10, IGBP1  -  immunoglobulin (cd79a) binding protein 1, SFRP1  -  secreted frizzled-related protein 1, BDKRB2  -  bradykinin receptor b2, IGF1R  -  insulin-like growth factor 1 receptor, SERPINE2  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 2, MAPK7  -  mitogen-activated protein kinase 7, CBLB  -  cbl proto-oncogene b, e3 ubiquitin protein ligase, IGF2  -  insulin-like growth factor 2 (somatomedin a), TGFB1  -  transforming growth factor, beta 1, UCHL1  -  ubiquitin carboxyl-terminal esterase l1 (ubiquitin thiolesterase), SERPINB9  -  serpin peptidase inhibitor, clade b (ovalbumin), member 9, MVP  -  major vault protein, OGT  -  o-linked n-acetylglucosamine (glcnac) transferase, MAPK3  -  mitogen-activated protein kinase 3, TNFRSF14  -  tumor necrosis factor receptor superfamily, member 14, IGFBP1  -  insulin-like growth factor binding protein 1, GNB2L1  -  guanine nucleotide binding protein (g protein), beta polypeptide 2-like 1, PLCE1  -  phospholipase c, epsilon 1, TRIM21  -  tripartite motif containing 21, SERPINB6  -  serpin peptidase inhibitor, clade b (ovalbumin), member 6, FADD  -  fas (tnfrsf6)-associated via death domain, TSPYL2  -  tspy-like 2, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), RPS6KA4  -  ribosomal protein s6 kinase, 90kda, polypeptide 4, DMD  -  dystrophin, CUL4B  -  cullin 4b, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, PRKCG  -  protein kinase c, gamma, CCND2  -  cyclin d2, CSPG4  -  chondroitin sulfate proteoglycan 4, SMAD3  -  smad family member 3, PRKCA  -  protein kinase c, alpha, SMAD6  -  smad family member 6, GSK3B  -  glycogen synthase kinase 3 beta, CCND1  -  cyclin d1, CBS  -  cystathionine-beta-synthase, GAS6  -  growth arrest-specific 6, NUPR1  -  nuclear protein, transcriptional regulator, 1, GAS1  -  growth arrest-specific 1]"GO:2000351,regulation of endothelial cell apoptotic process,1.17E-05,5.44E-03,11.04,8230,20,261,7,"[NFE2L2  -  nuclear factor (erythroid-derived 2)-like 2, TEK  -  tek tyrosine kinase, endothelial, AKR1C3  -  aldo-keto reductase family 1, member c3, KRIT1  -  krit1, ankyrin repeat containing, MAPK7  -  mitogen-activated protein kinase 7, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, GAS6  -  growth arrest-specific 6]"GO:0048583,regulation of response to stimulus,1.42E-05,6.31E-03,1.35,8230,2003,604,198,"[BNIP3  -  bcl2/adenovirus e1b 19kda interacting protein 3, NCK1  -  nck adaptor protein 1, ABCA1  -  atp-binding cassette, sub-family a (abc1), member 1, TICAM1  -  toll-like receptor adaptor molecule 1, RNF14  -  ring finger protein 14, HRAS  -  harvey rat sarcoma viral oncogene homolog, TRAF4  -  tnf receptor-associated factor 4, NBL1  -  neuroblastoma 1, dan family bmp antagonist, RRAGB  -  ras-related gtp binding b, CFB  -  complement factor b, SOX9  -  sry (sex determining region y)-box 9, SOX4  -  sry (sex determining region y)-box 4, NDEL1  -  nude neurodevelopment protein 1-like 1, PLSCR1  -  phospholipid scramblase 1, RGS7  -  regulator of g-protein signaling 7, GJA1  -  gap junction protein, alpha 1, 43kda, MYLK  -  myosin light chain kinase, SOD2  -  superoxide dismutase 2, mitochondrial, RGS3  -  regulator of g-protein signaling 3, BMPR1A  -  bone morphogenetic protein receptor, type ia, SERPINF2  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 2, LMNA  -  lamin a/c, RGS16  -  regulator of g-protein signaling 16, BMP4  -  bone morphogenetic protein 4, C9  -  complement component 9, LITAF  -  lipopolysaccharide-induced tnf factor, PPM1B  -  protein phosphatase, mg2+/mn2+ dependent, 1b, EGFR  -  epidermal growth factor receptor, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, FZD7  -  frizzled family receptor 7, ADA  -  adenosine deaminase, MED1  -  mediator complex subunit 1, CNR1  -  cannabinoid receptor 1 (brain), EFNB2  -  ephrin-b2, ARPC2  -  actin related protein 2/3 complex, subunit 2, 34kda, SERPING1  -  serpin peptidase inhibitor, clade g (c1 inhibitor), member 1, C1R  -  complement component 1, r subcomponent, LY96  -  lymphocyte antigen 96, C1S  -  complement component 1, s subcomponent, PARP1  -  poly (adp-ribose) polymerase 1, C4A  -  complement component 4a (rodgers blood group), TRAF2  -  tnf receptor-associated factor 2, MBD2  -  methyl-cpg binding domain protein 2, AKR1C3  -  aldo-keto reductase family 1, member c3, ACAA2  -  acetyl-coa acyltransferase 2, AP1G1  -  adaptor-related protein complex 1, gamma 1 subunit, PDE5A  -  phosphodiesterase 5a, cgmp-specific, CAMK2G  -  calcium/calmodulin-dependent protein kinase ii gamma, SPG20  -  spastic paraplegia 20 (troyer syndrome), COL14A1  -  collagen, type xiv, alpha 1, PPP5C  -  protein phosphatase 5, catalytic subunit, TAB2  -  tgf-beta activated kinase 1/map3k7 binding protein 2, LPXN  -  leupaxin, CTSK  -  cathepsin k, CTSH  -  cathepsin h, HMGXB4  -  hmg box domain containing 4, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, VEGFC  -  vascular endothelial growth factor c, PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, CFH  -  complement factor h, CFHR1  -  complement factor h-related 1, EZH2  -  enhancer of zeste homolog 2 (drosophila), VCAM1  -  vascular cell adhesion molecule 1, ARHGAP29  -  rho gtpase activating protein 29, RBPMS  -  rna binding protein with multiple splicing, STAT2  -  signal transducer and activator of transcription 2, 113kda, UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, JUN  -  jun proto-oncogene, STAT1  -  signal transducer and activator of transcription 1, 91kda, PROS1  -  protein s (alpha), GBF1  -  golgi brefeldin a resistant guanine nucleotide exchange factor 1, CD14  -  cd14 molecule, JAK2  -  janus kinase 2, DLC1  -  deleted in liver cancer 1, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, TYRO3  -  tyro3 protein tyrosine kinase, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, MAP2K1  -  mitogen-activated protein kinase kinase 1, MAP2K3  -  mitogen-activated protein kinase kinase 3, CBLB  -  cbl proto-oncogene b, e3 ubiquitin protein ligase, MAPK7  -  mitogen-activated protein kinase 7, UCHL1  -  ubiquitin carboxyl-terminal esterase l1 (ubiquitin thiolesterase), TNFRSF14  -  tumor necrosis factor receptor superfamily, member 14, CAT  -  catalase, CAV2  -  caveolin 2, PRKG1  -  protein kinase, cgmp-dependent, type i, BAMBI  -  bmp and activin membrane-bound inhibitor, NREP  -  neuronal regeneration related protein, STAM  -  signal transducing adaptor molecule (sh3 domain and itam motif) 1, CSPG4  -  chondroitin sulfate proteoglycan 4, PRKCA  -  protein kinase c, alpha, GAS6  -  growth arrest-specific 6, NR1D2  -  nuclear receptor subfamily 1, group d, member 2, GAS1  -  growth arrest-specific 1, APEX1  -  apex nuclease (multifunctional dna repair enzyme) 1, PAWR  -  prkc, apoptosis, wt1, regulator, CDH2  -  cadherin 2, type 1, n-cadherin (neuronal), MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), MID1  -  midline 1 (opitz/bbb syndrome), CDC34  -  cell division cycle 34, GAB2  -  grb2-associated binding protein 2, FLNA  -  filamin a, alpha, FOXO1  -  forkhead box o1, RGS5  -  regulator of g-protein signaling 5, KMT2A  -  lysine (k)-specific methyltransferase 2a, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, CRLF1  -  cytokine receptor-like factor 1, DFNA5  -  deafness, autosomal dominant 5, P4HB  -  prolyl 4-hydroxylase, beta polypeptide, PDCD10  -  programmed cell death 10, IL1R1  -  interleukin 1 receptor, type i, UBR2  -  ubiquitin protein ligase e3 component n-recognin 2, FURIN  -  furin (paired basic amino acid cleaving enzyme), PDPN  -  podoplanin, APOE  -  apolipoprotein e, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, APP  -  amyloid beta (a4) precursor protein, NUAK1  -  nuak family, snf1-like kinase, 1, CD200  -  cd200 molecule, WWOX  -  ww domain containing oxidoreductase, IL6ST  -  interleukin 6 signal transducer (gp130, oncostatin m receptor), DGKZ  -  diacylglycerol kinase, zeta, PDGFA  -  platelet-derived growth factor alpha polypeptide, ITGA5  -  integrin, alpha 5 (fibronectin receptor, alpha polypeptide), FGFR1  -  fibroblast growth factor receptor 1, MDK  -  midkine (neurite growth-promoting factor 2), ATXN1  -  ataxin 1, ROR2  -  receptor tyrosine kinase-like orphan receptor 2, PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, FGF7  -  fibroblast growth factor 7, RHOB  -  ras homolog family member b, PDPK1  -  3-phosphoinositide dependent protein kinase-1, FBLN5  -  fibulin 5, FGF4  -  fibroblast growth factor 4, PTGIR  -  prostaglandin i2 (prostacyclin) receptor (ip), DDX17  -  dead (asp-glu-ala-asp) box helicase 17, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, ARHGAP1  -  rho gtpase activating protein 1, RHOG  -  ras homolog family member g, ZYX  -  zyxin, DAG1  -  dystroglycan 1 (dystrophin-associated glycoprotein 1), CDKN1C  -  cyclin-dependent kinase inhibitor 1c (p57, kip2), CDKN2D  -  cyclin-dependent kinase inhibitor 2d (p19, inhibits cdk4), ASPH  -  aspartate beta-hydroxylase, SRGAP2  -  slit-robo rho gtpase activating protein 2, DAPK1  -  death-associated protein kinase 1, PTPN1  -  protein tyrosine phosphatase, non-receptor type 1, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), ARL6IP5  -  adp-ribosylation-like factor 6 interacting protein 5, CDC37  -  cell division cycle 37, PPAP2B  -  phosphatidic acid phosphatase type 2b, CDH13  -  cadherin 13, h-cadherin (heart), HDAC1  -  histone deacetylase 1, ITGA6  -  integrin, alpha 6, IFIT1  -  interferon-induced protein with tetratricopeptide repeats 1, STRN3  -  striatin, calmodulin binding protein 3, CDK14  -  cyclin-dependent kinase 14, TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), GPC1  -  glypican 1, IFNGR1  -  interferon gamma receptor 1, PVRL2  -  poliovirus receptor-related 2 (herpesvirus entry mediator b), ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, WNT5A  -  wingless-type mmtv integration site family, member 5a, DVL3  -  dishevelled segment polarity protein 3, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, TEK  -  tek tyrosine kinase, endothelial, RBPJ  -  recombination signal binding protein for immunoglobulin kappa j region, SHH  -  sonic hedgehog, GPX1  -  glutathione peroxidase 1, NFE2L2  -  nuclear factor (erythroid-derived 2)-like 2, PLAT  -  plasminogen activator, tissue, CLU  -  clusterin, ATR  -  ataxia telangiectasia and rad3 related, IGBP1  -  immunoglobulin (cd79a) binding protein 1, MGLL  -  monoglyceride lipase, BDKRB2  -  bradykinin receptor b2, SERPINE2  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 2, IGF1R  -  insulin-like growth factor 1 receptor, IGF2  -  insulin-like growth factor 2 (somatomedin a), TGFB1  -  transforming growth factor, beta 1, TGFB1I1  -  transforming growth factor beta 1 induced transcript 1, OGT  -  o-linked n-acetylglucosamine (glcnac) transferase, TGIF1  -  tgfb-induced factor homeobox 1, TSPYL2  -  tspy-like 2, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), PHB2  -  prohibitin 2, TGFBR3  -  transforming growth factor, beta receptor iii, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, DMD  -  dystrophin, YES1  -  v-yes-1 yamaguchi sarcoma viral oncogene homolog 1, FNTB  -  farnesyltransferase, caax box, beta, GSK3B  -  glycogen synthase kinase 3 beta, SMAD6  -  smad family member 6, PIGR  -  polymeric immunoglobulin receptor, SH3BGR  -  sh3 domain binding glutamic acid-rich protein, ITSN1  -  intersectin 1 (sh3 domain protein)]"GO:0044238,primary metabolic process,1.53E-05,6.57E-03,1.14,8230,4253,996,587,"[WTAP  -  wilms tumor 1 associated protein, HNRNPA0  -  heterogeneous nuclear ribonucleoprotein a0, ABCA1  -  atp-binding cassette, sub-family a (abc1), member 1, SEPT5  -  septin 5, LDHB  -  lactate dehydrogenase b, NCOR2  -  nuclear receptor corepressor 2, SPG7  -  spastic paraplegia 7 (pure and complicated autosomal recessive), RNF14  -  ring finger protein 14, GCSH  -  glycine cleavage system protein h (aminomethyl carrier), LDHA  -  lactate dehydrogenase a, LGALS3  -  lectin, galactoside-binding, soluble, 3, GCH1  -  gtp cyclohydrolase 1, BLOC1S1  -  biogenesis of lysosomal organelles complex-1, subunit 1, LOXL1  -  lysyl oxidase-like 1, SMPD4  -  sphingomyelin phosphodiesterase 4, neutral membrane (neutral sphingomyelinase-3), CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, SOX9  -  sry (sex determining region y)-box 9, ACR  -  acrosin, LSM2  -  lsm2 homolog, u6 small nuclear rna associated (s. cerevisiae), PLSCR1  -  phospholipid scramblase 1, PLTP  -  phospholipid transfer protein, SORD  -  sorbitol dehydrogenase, PLCB2  -  phospholipase c, beta 2, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, GHR  -  growth hormone receptor, PLAUR  -  plasminogen activator, urokinase receptor, SOD2  -  superoxide dismutase 2, mitochondrial, SOD1  -  superoxide dismutase 1, soluble, SUB1  -  sub1 homolog (s. cerevisiae), CREB1  -  camp responsive element binding protein 1, LMNA  -  lamin a/c, GLUL  -  glutamate-ammonia ligase, SNRPE  -  small nuclear ribonucleoprotein polypeptide e, CTSA  -  cathepsin a, PPIA  -  peptidylprolyl isomerase a (cyclophilin a), LITAF  -  lipopolysaccharide-induced tnf factor, PPM1B  -  protein phosphatase, mg2+/mn2+ dependent, 1b, TBPL1  -  tbp-like 1, USP9Y  -  ubiquitin specific peptidase 9, y-linked, ADAR  -  adenosine deaminase, rna-specific, SNAPC1  -  small nuclear rna activating complex, polypeptide 1, 43kda, ADA  -  adenosine deaminase, POLR1C  -  polymerase (rna) i polypeptide c, 30kda, BAG2  -  bcl2-associated athanogene 2, MED1  -  mediator complex subunit 1, PTGES  -  prostaglandin e synthase, PLIN2  -  perilipin 2, HLTF  -  helicase-like transcription factor, CHST15  -  carbohydrate (n-acetylgalactosamine 4-sulfate 6-o) sulfotransferase 15, PLA2G15  -  phospholipase a2, group xv, ADD1  -  adducin 1 (alpha), GNB1  -  guanine nucleotide binding protein (g protein), beta polypeptide 1, ADH5  -  alcohol dehydrogenase 5 (class iii), chi polypeptide, SMARCA2  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, MAPK8IP1  -  mitogen-activated protein kinase 8 interacting protein 1, PARP1  -  poly (adp-ribose) polymerase 1, TAOK3  -  tao kinase 3, FZR1  -  fizzy/cell division cycle 20 related 1 (drosophila), ADM  -  adrenomedullin, COL11A1  -  collagen, type xi, alpha 1, POLR2B  -  polymerase (rna) ii (dna directed) polypeptide b, 140kda, PARP4  -  poly (adp-ribose) polymerase family, member 4, QKI  -  qki, kh domain containing, rna binding, AEBP1  -  ae binding protein 1, PRKACB  -  protein kinase, camp-dependent, catalytic, beta, ASCC2  -  activating signal cointegrator 1 complex subunit 2, CSTF3  -  cleavage stimulation factor, 3' pre-rna, subunit 3, 77kda, NUPL2  -  nucleoporin like 2, SUPV3L1  -  suppressor of var1, 3-like 1 (s. cerevisiae), AGT  -  angiotensinogen (serpin peptidase inhibitor, clade a, member 8), PRCP  -  prolylcarboxypeptidase (angiotensinase c), SUPT5H  -  suppressor of ty 5 homolog (s. cerevisiae), PRELP  -  proline/arginine-rich end leucine-rich repeat protein, CTPS1  -  ctp synthase 1, AIMP2  -  aminoacyl trna synthetase complex-interacting multifunctional protein 2, PPP5C  -  protein phosphatase 5, catalytic subunit, AGA  -  aspartylglucosaminidase, MAP4K4  -  mitogen-activated protein kinase kinase kinase kinase 4, ACAN  -  aggrecan, LPXN  -  leupaxin, PITPNB  -  phosphatidylinositol transfer protein, beta, CTSL  -  cathepsin l, AK2  -  adenylate kinase 2, SEP15  -  15 kda selenoprotein, CTSK  -  cathepsin k, CTSH  -  cathepsin h, PPP2R5B  -  protein phosphatase 2, regulatory subunit b', beta, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, CTSD  -  cathepsin d, SULT2B1  -  sulfotransferase family, cytosolic, 2b, member 1, NUDT21  -  nudix (nucleoside diphosphate linked moiety x)-type motif 21, WWP2  -  ww domain containing e3 ubiquitin protein ligase 2, AHR  -  aryl hydrocarbon receptor, STK3  -  serine/threonine kinase 3, CYB5A  -  cytochrome b5 type a (microsomal), PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, SNRNP40  -  small nuclear ribonucleoprotein 40kda (u5), ALDH2  -  aldehyde dehydrogenase 2 family (mitochondrial), NEK7  -  nima-related kinase 7, ST13  -  suppression of tumorigenicity 13 (colon carcinoma) (hsp70 interacting protein), RBPMS  -  rna binding protein with multiple splicing, RAB33A  -  rab33a, member ras oncogene family, FOSL1  -  fos-like antigen 1, RAB9A  -  rab9a, member ras oncogene family, PRPS1  -  phosphoribosyl pyrophosphate synthetase 1, STAT2  -  signal transducer and activator of transcription 2, 113kda, CRY1  -  cryptochrome 1 (photolyase-like), STAT1  -  signal transducer and activator of transcription 1, 91kda, UBE4A  -  ubiquitination factor e4a, STAT4  -  signal transducer and activator of transcription 4, PROS1  -  protein s (alpha), CRYAB  -  crystallin, alpha b, ALDOC  -  aldolase c, fructose-bisphosphate, ADRM1  -  adhesion regulating molecule 1, SSRP1  -  structure specific recognition protein 1, JAK2  -  janus kinase 2, MAPK10  -  mitogen-activated protein kinase 10, MAPK7  -  mitogen-activated protein kinase 7, SRPK2  -  srsf protein kinase 2, MAPK3  -  mitogen-activated protein kinase 3, TRIM21  -  tripartite motif containing 21, PLCE1  -  phospholipase c, epsilon 1, PRKG1  -  protein kinase, cgmp-dependent, type i, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, COPS2  -  cop9 signalosome subunit 2, GBE1  -  glucan (1,4-alpha-), branching enzyme 1, RPL23  -  ribosomal protein l23, PRKCG  -  protein kinase c, gamma, SLC25A6  -  solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6, CSPG4  -  chondroitin sulfate proteoglycan 4, PRKCA  -  protein kinase c, alpha, VCAN  -  versican, ARIH1  -  ariadne homolog, ubiquitin-conjugating enzyme e2 binding protein, 1 (drosophila), PRKAR1B  -  protein kinase, camp-dependent, regulatory, type i, beta, GAS6  -  growth arrest-specific 6, FBXL2  -  f-box and leucine-rich repeat protein 2, APEX1  -  apex nuclease (multifunctional dna repair enzyme) 1, GSTM2  -  glutathione s-transferase mu 2 (muscle), GSTM1  -  glutathione s-transferase mu 1, SRSF11  -  serine/arginine-rich splicing factor 11, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, LUC7L3  -  luc7-like 3 (s. cerevisiae), GSTM4  -  glutathione s-transferase mu 4, PAWR  -  prkc, apoptosis, wt1, regulator, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), SREK1  -  splicing regulatory glutamine/lysine-rich protein 1, DDB1  -  damage-specific dna binding protein 1, 127kda, PBX1  -  pre-b-cell leukemia homeobox 1, PC  -  pyruvate carboxylase, GTF2H1  -  general transcription factor iih, polypeptide 1, 62kda, MSH6  -  muts homolog 6 (e. coli), KMT2A  -  lysine (k)-specific methyltransferase 2a, MMP2  -  matrix metallopeptidase 2 (gelatinase a, 72kda gelatinase, 72kda type iv collagenase), GTF3C2  -  general transcription factor iiic, polypeptide 2, beta 110kda, MMP1  -  matrix metallopeptidase 1 (interstitial collagenase), UBE2L6  -  ubiquitin-conjugating enzyme e2l 6, GTF2I  -  general transcription factor iii, P4HB  -  prolyl 4-hydroxylase, beta polypeptide, CYB5R1  -  cytochrome b5 reductase 1, STK17B  -  serine/threonine kinase 17b, ARF1  -  adp-ribosylation factor 1, GTF3C1  -  general transcription factor iiic, polypeptide 1, alpha 220kda, MMP11  -  matrix metallopeptidase 11 (stromelysin 3), FURIN  -  furin (paired basic amino acid cleaving enzyme), SDC2  -  syndecan 2, GYS1  -  glycogen synthase 1 (muscle), NOLC1  -  nucleolar and coiled-body phosphoprotein 1, ZNF473  -  zinc finger protein 473, APOE  -  apolipoprotein e, APP  -  amyloid beta (a4) precursor protein, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, WWOX  -  ww domain containing oxidoreductase, GUSB  -  glucuronidase, beta, AQP1  -  aquaporin 1 (colton blood group), DHX15  -  deah (asp-glu-ala-his) box helicase 15, ADIPOR2  -  adiponectin receptor 2, MCM7  -  minichromosome maintenance complex component 7, TUBA1A  -  tubulin, alpha 1a, ATXN1  -  ataxin 1, WBP4  -  ww domain binding protein 4, PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, RHOB  -  ras homolog family member b, MECP2  -  methyl cpg binding protein 2 (rett syndrome), MEF2A  -  myocyte enhancer factor 2a, PDPK1  -  3-phosphoinositide dependent protein kinase-1, PSIP1  -  pc4 and sfrs1 interacting protein 1, PDK3  -  pyruvate dehydrogenase kinase, isozyme 3, MEF2D  -  myocyte enhancer factor 2d, HADH  -  hydroxyacyl-coa dehydrogenase, RHOG  -  ras homolog family member g, PTP4A3  -  protein tyrosine phosphatase type iva, member 3, PCOLCE  -  procollagen c-endopeptidase enhancer, MEP1A  -  meprin a, alpha (paba peptide hydrolase), SCAF11  -  sr-related ctd-associated factor 11, DAG1  -  dystroglycan 1 (dystrophin-associated glycoprotein 1), KAT8  -  k(lysine) acetyltransferase 8, ASS1  -  argininosuccinate synthase 1, ASPH  -  aspartate beta-hydroxylase, DAPK1  -  death-associated protein kinase 1, TIPARP  -  tcdd-inducible poly(adp-ribose) polymerase, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, HEXA  -  hexosaminidase a (alpha polypeptide), HDAC1  -  histone deacetylase 1, SALL2  -  sal-like 2 (drosophila), KAT7  -  k(lysine) acetyltransferase 7, PGK1  -  phosphoglycerate kinase 1, MAGOH  -  mago-nashi homolog, proliferation-associated (drosophila), RFK  -  riboflavin kinase, XPC  -  xeroderma pigmentosum, complementation group c, PGD  -  phosphogluconate dehydrogenase, SMC3  -  structural maintenance of chromosomes 3, BAHD1  -  bromo adjacent homology domain containing 1, ZHX2  -  zinc fingers and homeoboxes 2, GPC1  -  glypican 1, ABLIM3  -  actin binding lim protein family, member 3, RAB14  -  rab14, member ras oncogene family, NMI  -  n-myc (and stat) interactor, GPI  -  glucose-6-phosphate isomerase, DPYSL3  -  dihydropyrimidinase-like 3, DPYSL2  -  dihydropyrimidinase-like 2, MLXIP  -  mlx interacting protein, MAN2B1  -  mannosidase, alpha, class 2b, member 1, ZFHX3  -  zinc finger homeobox 3, PEX6  -  peroxisomal biogenesis factor 6, SLC2A1  -  solute carrier family 2 (facilitated glucose transporter), member 1, ATP6V1B1  -  atpase, h+ transporting, lysosomal 56/58kda, v1 subunit b1, WNT5A  -  wingless-type mmtv integration site family, member 5a, PFKL  -  phosphofructokinase, liver, SLC2A3  -  solute carrier family 2 (facilitated glucose transporter), member 3, PFKP  -  phosphofructokinase, platelet, ASH2L  -  ash2 (absent, small, or homeotic)-like (drosophila), PFDN1  -  prefoldin subunit 1, PFDN4  -  prefoldin subunit 4, DLD  -  dihydrolipoamide dehydrogenase, SHH  -  sonic hedgehog, BAG1  -  bcl2-associated athanogene, RPL14  -  ribosomal protein l14, GPX1  -  glutathione peroxidase 1, ST6GAL1  -  st6 beta-galactosamide alpha-2,6-sialyltranferase 1, ATF5  -  activating transcription factor 5, PLAU  -  plasminogen activator, urokinase, PLAT  -  plasminogen activator, tissue, LUM  -  lumican, PLAGL1  -  pleiomorphic adenoma gene-like 1, ST3GAL4  -  st3 beta-galactoside alpha-2,3-sialyltransferase 4, UBA3  -  ubiquitin-like modifier activating enzyme 3, ATR  -  ataxia telangiectasia and rad3 related, PKM  -  pyruvate kinase, muscle, MGLL  -  monoglyceride lipase, SRSF1  -  serine/arginine-rich splicing factor 1, SMAD1  -  smad family member 1, DNM2  -  dynamin 2, SMAD2  -  smad family member 2, ACOT7  -  acyl-coa thioesterase 7, TDP2  -  tyrosyl-dna phosphodiesterase 2, BCL6  -  b-cell cll/lymphoma 6, TRA2B  -  transformer 2 beta homolog (drosophila), PHYH  -  phytanoyl-coa 2-hydroxylase, PHB2  -  prohibitin 2, NR3C1  -  nuclear receptor subfamily 3, group c, member 1 (glucocorticoid receptor), RPS6KA4  -  ribosomal protein s6 kinase, 90kda, polypeptide 4, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, YES1  -  v-yes-1 yamaguchi sarcoma viral oncogene homolog 1, DMPK  -  dystrophia myotonica-protein kinase, SCG5  -  secretogranin v (7b2 protein), SGK1  -  serum/glucocorticoid regulated kinase 1, NBAS  -  neuroblastoma amplified sequence, SMAD3  -  smad family member 3, CCND1  -  cyclin d1, GSK3B  -  glycogen synthase kinase 3 beta, SMAD6  -  smad family member 6, P4HA2  -  prolyl 4-hydroxylase, alpha polypeptide ii, MAF  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog, TRIM27  -  tripartite motif containing 27, YAF2  -  yy1 associated factor 2, NCBP2  -  nuclear cap binding protein subunit 2, 20kda, BNIP3  -  bcl2/adenovirus e1b 19kda interacting protein 3, RFC4  -  replication factor c (activator 1) 4, 37kda, HSF2  -  heat shock transcription factor 2, NDN  -  necdin, melanoma antigen (mage) family member, RFC2  -  replication factor c (activator 1) 2, 40kda, REV3L  -  rev3-like, polymerase (dna directed), zeta, catalytic subunit, SACM1L  -  sac1 suppressor of actin mutations 1-like (yeast), TRAK1  -  trafficking protein, kinesin binding 1, ELF4  -  e74-like factor 4 (ets domain transcription factor), BCKDK  -  branched chain ketoacid dehydrogenase kinase, TSC22D4  -  tsc22 domain family, member 4, BPGM  -  2,3-bisphosphoglycerate mutase, RPIA  -  ribose 5-phosphate isomerase a, EPAS1  -  endothelial pas domain protein 1, ATP6AP2  -  atpase, h+ transporting, lysosomal accessory protein 2, NASP  -  nuclear autoantigenic sperm protein (histone-binding), HABP4  -  hyaluronan binding protein 4, ATF6  -  activating transcription factor 6, ENO2  -  enolase 2 (gamma, neuronal), HRAS  -  harvey rat sarcoma viral oncogene homolog, NBN  -  nibrin, ENO1  -  enolase 1, (alpha), KLF5  -  kruppel-like factor 5 (intestinal), RELB  -  v-rel avian reticuloendotheliosis viral oncogene homolog b, RIT1  -  ras-like without caax 1, TUBA4A  -  tubulin, alpha 4a, EIF4A2  -  eukaryotic translation initiation factor 4a2, BGN  -  biglycan, MYO10  -  myosin x, EIF4B  -  eukaryotic translation initiation factor 4b, NT5C2  -  5'-nucleotidase, cytosolic ii, CFB  -  complement factor b, TNK2  -  tyrosine kinase, non-receptor, 2, BLMH  -  bleomycin hydrolase, PIKFYVE  -  phosphoinositide kinase, fyve finger containing, HPN  -  hepsin, EIF2S1  -  eukaryotic translation initiation factor 2, subunit 1 alpha, 35kda, NAB1  -  ngfi-a binding protein 1 (egr1 binding protein 1), BID  -  bh3 interacting domain death agonist, NACA  -  nascent polypeptide-associated complex alpha subunit, PRMT3  -  protein arginine methyltransferase 3, BMP1  -  bone morphogenetic protein 1, SYNJ1  -  synaptojanin 1, TST  -  thiosulfate sulfurtransferase (rhodanese), MYLK  -  myosin light chain kinase, BMPR1A  -  bone morphogenetic protein receptor, type ia, EIF4G1  -  eukaryotic translation initiation factor 4 gamma, 1, BMP4  -  bone morphogenetic protein 4, C9  -  complement component 9, STK38L  -  serine/threonine kinase 38 like, SH3YL1  -  sh3 domain containing, ysc84-like 1 (s. cerevisiae), MYH10  -  myosin, heavy chain 10, non-muscle, SNUPN  -  snurportin 1, EGFR  -  epidermal growth factor receptor, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, PQBP1  -  polyglutamine binding protein 1, EIF2B4  -  eukaryotic translation initiation factor 2b, subunit 4 delta, 67kda, RNF2  -  ring finger protein 2, HNRNPR  -  heterogeneous nuclear ribonucleoprotein r, PDZRN3  -  pdz domain containing ring finger 3, ROCK1  -  rho-associated, coiled-coil containing protein kinase 1, ZHX3  -  zinc fingers and homeoboxes 3, SERPING1  -  serpin peptidase inhibitor, clade g (c1 inhibitor), member 1, CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, HSPE1  -  heat shock 10kda protein 1 (chaperonin 10), C1R  -  complement component 1, r subcomponent, C1S  -  complement component 1, s subcomponent, RRP1B  -  ribosomal rna processing 1b, SWAP70  -  swap switching b-cell complex 70kda subunit, LRPPRC  -  leucine-rich pentatricopeptide repeat containing, C4A  -  complement component 4a (rodgers blood group), TRAF2  -  tnf receptor-associated factor 2, FSTL3  -  follistatin-like 3 (secreted glycoprotein), MBD2  -  methyl-cpg binding domain protein 2, ECE1  -  endothelin converting enzyme 1, RAB7L1  -  rab7, member ras oncogene family-like 1, ECH1  -  enoyl coa hydratase 1, peroxisomal, TRAP1  -  tnf receptor-associated protein 1, ERC1  -  elks/rab6-interacting/cast family member 1, AKR1C3  -  aldo-keto reductase family 1, member c3, NADK  -  nad kinase, RPL23A  -  ribosomal protein l23a, ACAA2  -  acetyl-coa acyltransferase 2, PDE5A  -  phosphodiesterase 5a, cgmp-specific, RPL18A  -  ribosomal protein l18a, PPP4R1  -  protein phosphatase 4, regulatory subunit 1, CAMK2G  -  calcium/calmodulin-dependent protein kinase ii gamma, RPL15  -  ribosomal protein l15, SIK1  -  salt-inducible kinase 1, RPL13  -  ribosomal protein l13, CAMK2B  -  calcium/calmodulin-dependent protein kinase ii beta, RPL12  -  ribosomal protein l12, EMG1  -  emg1 n1-specific pseudouridine methyltransferase, EIF3C  -  eukaryotic translation initiation factor 3, subunit c, EIF3D  -  eukaryotic translation initiation factor 3, subunit d, RPL5  -  ribosomal protein l5, CASP7  -  caspase 7, apoptosis-related cysteine peptidase, CASP4  -  caspase 4, apoptosis-related cysteine peptidase, UNG  -  uracil-dna glycosylase, RPL4  -  ribosomal protein l4, RPA3  -  replication protein a3, 14kda, EIF3I  -  eukaryotic translation initiation factor 3, subunit i, RPE  -  ribulose-5-phosphate-3-epimerase, RPA2  -  replication protein a2, 32kda, HIVEP2  -  human immunodeficiency virus type i enhancer binding protein 2, ACD  -  adrenocortical dysplasia homolog (mouse), HLA-DMA  -  major histocompatibility complex, class ii, dm alpha, DDR1  -  discoidin domain receptor tyrosine kinase 1, B4GALT3  -  udp-gal:betaglcnac beta 1,4- galactosyltransferase, polypeptide 3, CFH  -  complement factor h, PTRF  -  polymerase i and transcript release factor, CFHR1  -  complement factor h-related 1, EZH2  -  enhancer of zeste homolog 2 (drosophila), F2R  -  coagulation factor ii (thrombin) receptor, HIVEP1  -  human immunodeficiency virus type i enhancer binding protein 1, B3GALT4  -  udp-gal:betaglcnac beta 1,3-galactosyltransferase, polypeptide 4, ERF  -  ets2 repressor factor, TRADD  -  tnfrsf1a-associated via death domain, MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), MYCBP  -  myc binding protein, CTSF  -  cathepsin f, HOXB2  -  homeobox b2, ADAM19  -  adam metallopeptidase domain 19, UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, EED  -  embryonic ectoderm development, ARNT2  -  aryl-hydrocarbon receptor nuclear translocator 2, HMG20B  -  high mobility group 20b, HNRNPU  -  heterogeneous nuclear ribonucleoprotein u (scaffold attachment factor a), TNFSF4  -  tumor necrosis factor (ligand) superfamily, member 4, OXSR1  -  oxidative stress responsive 1, DLC1  -  deleted in liver cancer 1, RPS13  -  ribosomal protein s13, TYRO3  -  tyro3 protein tyrosine kinase, TUBB4B  -  tubulin, beta 4b class ivb, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, MRPS18B  -  mitochondrial ribosomal protein s18b, TUBB4A  -  tubulin, beta 4a class iva, ZMIZ1  -  zinc finger, miz-type containing 1, SACS  -  spastic ataxia of charlevoix-saguenay (sacsin), TXNRD1  -  thioredoxin reductase 1, PABPC4  -  poly(a) binding protein, cytoplasmic 4 (inducible form), SLC23A2  -  solute carrier family 23 (ascorbic acid transporter), member 2, UCHL1  -  ubiquitin carboxyl-terminal esterase l1 (ubiquitin thiolesterase), MVP  -  major vault protein, UBTF  -  upstream binding transcription factor, rna polymerase i, HNRNPA1  -  heterogeneous nuclear ribonucleoprotein a1, GNB2L1  -  guanine nucleotide binding protein (g protein), beta polypeptide 2-like 1, CAT  -  catalase, FADD  -  fas (tnfrsf6)-associated via death domain, RYK  -  receptor-like tyrosine kinase, SLC35A2  -  solute carrier family 35 (udp-galactose transporter), member a2, RUNX1T1  -  runt-related transcription factor 1; translocated to, 1 (cyclin d-related), UBE2G2  -  ubiquitin-conjugating enzyme e2g 2, RBM14  -  rna binding motif protein 14, NUP153  -  nucleoporin 153kda, CBS  -  cystathionine-beta-synthase, NR1D2  -  nuclear receptor subfamily 1, group d, member 2, NUPR1  -  nuclear protein, transcriptional regulator, 1, RRBP1  -  ribosome binding protein 1, MPG  -  n-methylpurine-dna glycosylase, FMOD  -  fibromodulin, PAICS  -  phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase, SSH1  -  slingshot protein phosphatase 1, ZNF638  -  zinc finger protein 638, PJA2  -  praja ring finger 2, e3 ubiquitin protein ligase, TCF12  -  transcription factor 12, HEXIM1  -  hexamethylene bis-acetamide inducible 1, CDC34  -  cell division cycle 34, INHBA  -  inhibin, beta a, HTRA2  -  htra serine peptidase 2, FLNA  -  filamin a, alpha, LMO3  -  lim domain only 3 (rhombotin-like 2), PSEN2  -  presenilin 2 (alzheimer disease 4), PSMA1  -  proteasome (prosome, macropain) subunit, alpha type, 1, FOXO1  -  forkhead box o1, CDC14B  -  cell division cycle 14b, SIN3B  -  sin3 transcription regulator family member b, PIAS1  -  protein inhibitor of activated stat, 1, FOXC1  -  forkhead box c1, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, PSMB9  -  proteasome (prosome, macropain) subunit, beta type, 9, PIR  -  pirin (iron-binding nuclear protein), PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, LMO4  -  lim domain only 4, PSMB7  -  proteasome (prosome, macropain) subunit, beta type, 7, FOXF2  -  forkhead box f2, UBR2  -  ubiquitin protein ligase e3 component n-recognin 2, PSMB4  -  proteasome (prosome, macropain) subunit, beta type, 4, CAND1  -  cullin-associated and neddylation-dissociated 1, PDPN  -  podoplanin, OGDH  -  oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide), CAMK1  -  calcium/calmodulin-dependent protein kinase i, TDG  -  thymine-dna glycosylase, TXNIP  -  thioredoxin interacting protein, COASY  -  coa synthase, POM121  -  pom121 transmembrane nucleoporin, COPS3  -  cop9 signalosome subunit 3, LPPR4  -  lipid phosphate phosphatase-related protein type 4, SMG7  -  smg7 nonsense mediated mrna decay factor, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, IL6ST  -  interleukin 6 signal transducer (gp130, oncostatin m receptor), DGKZ  -  diacylglycerol kinase, zeta, PSMD11  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 11, UBR4  -  ubiquitin protein ligase e3 component n-recognin 4, TAF11  -  taf11 rna polymerase ii, tata box binding protein (tbp)-associated factor, 28kda, PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), FGFR1  -  fibroblast growth factor receptor 1, PTBP1  -  polypyrimidine tract binding protein 1, DDR2  -  discoidin domain receptor tyrosine kinase 2, TOMM20  -  translocase of outer mitochondrial membrane 20 homolog (yeast), ROR2  -  receptor tyrosine kinase-like orphan receptor 2, PTGDS  -  prostaglandin d2 synthase 21kda (brain), MAML1  -  mastermind-like 1 (drosophila), CFL1  -  cofilin 1 (non-muscle), BCLAF1  -  bcl2-associated transcription factor 1, FGF2  -  fibroblast growth factor 2 (basic), NUP98  -  nucleoporin 98kda, MKNK1  -  map kinase interacting serine/threonine kinase 1, GTF2H5  -  general transcription factor iih, polypeptide 5, DDX17  -  dead (asp-glu-ala-asp) box helicase 17, FDXR  -  ferredoxin reductase, CEBPB  -  ccaat/enhancer binding protein (c/ebp), beta, CEBPD  -  ccaat/enhancer binding protein (c/ebp), delta, INPPL1  -  inositol polyphosphate phosphatase-like 1, TBX2  -  t-box 2, TBCD  -  tubulin folding cofactor d, CDKN2D  -  cyclin-dependent kinase inhibitor 2d (p19, inhibits cdk4), INPP5A  -  inositol polyphosphate-5-phosphatase, 40kda, PTPN1  -  protein tyrosine phosphatase, non-receptor type 1, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), RUVBL1  -  ruvb-like 1 (e. coli), RNF40  -  ring finger protein 40, e3 ubiquitin protein ligase, PPAP2B  -  phosphatidic acid phosphatase type 2b, PTPN13  -  protein tyrosine phosphatase, non-receptor type 13 (apo-1/cd95 (fas)-associated phosphatase), EFEMP1  -  egf containing fibulin-like extracellular matrix protein 1, EIF3E  -  eukaryotic translation initiation factor 3, subunit e, CRCP  -  cgrp receptor component, PTPRF  -  protein tyrosine phosphatase, receptor type, f, IRAK1  -  interleukin-1 receptor-associated kinase 1, RAD1  -  rad1 homolog (s. pombe), PURA  -  purine-rich element binding protein a, IFI16  -  interferon, gamma-inducible protein 16, IFI27  -  interferon, alpha-inducible protein 27, SLC7A8  -  solute carrier family 7 (amino acid transporter light chain, l system), member 8, TKT  -  transketolase, ZMYND11  -  zinc finger, mynd-type containing 11, TLE2  -  transducin-like enhancer of split 2 (e(sp1) homolog, drosophila), NME4  -  nme/nm23 nucleoside diphosphate kinase 4, AHCYL1  -  adenosylhomocysteinase-like 1, NOVA1  -  neuro-oncological ventral antigen 1, PXN  -  paxillin, FOXN3  -  forkhead box n3, NOTCH3  -  notch 3, NFYA  -  nuclear transcription factor y, alpha, HDAC4  -  histone deacetylase 4, CHD4  -  chromodomain helicase dna binding protein 4, ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, NFX1  -  nuclear transcription factor, x-box binding 1, RAB3B  -  rab3b, member ras oncogene family, NGF  -  nerve growth factor (beta polypeptide), RAB2A  -  rab2a, member ras oncogene family, TRAM1  -  translocation associated membrane protein 1, NFIX  -  nuclear factor i/x (ccaat-binding transcription factor), RAD23B  -  rad23 homolog b (s. cerevisiae), NHP2L1  -  nhp2 non-histone chromosome protein 2-like 1 (s. cerevisiae), CGB  -  chorionic gonadotropin, beta polypeptide, TNNT3  -  troponin t type 3 (skeletal, fast), IDH3B  -  isocitrate dehydrogenase 3 (nad+) beta, CTSC  -  cathepsin c, RAB13  -  rab13, member ras oncogene family, IDH2  -  isocitrate dehydrogenase 2 (nadp+), mitochondrial, TEK  -  tek tyrosine kinase, endothelial, SUZ12  -  suz12 polycomb repressive complex 2 subunit, RAN  -  ran, member ras oncogene family, RBPJ  -  recombination signal binding protein for immunoglobulin kappa j region, RAD51D  -  rad51 paralog d, PABPC1  -  poly(a) binding protein, cytoplasmic 1, TERF1  -  telomeric repeat binding factor (nima-interacting) 1, DYRK2  -  dual-specificity tyrosine-(y)-phosphorylation regulated kinase 2, NFE2L2  -  nuclear factor (erythroid-derived 2)-like 2, CLNS1A  -  chloride channel, nucleotide-sensitive, 1a, ISG15  -  isg15 ubiquitin-like modifier, RARRES3  -  retinoic acid receptor responder (tazarotene induced) 3, NR2F1  -  nuclear receptor subfamily 2, group f, member 1, CLU  -  clusterin, TPP1  -  tripeptidyl peptidase i, RBL2  -  retinoblastoma-like 2 (p130), SMARCA5  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5, RBMS1  -  rna binding motif, single stranded interacting protein 1, IGF1R  -  insulin-like growth factor 1 receptor, IGF2  -  insulin-like growth factor 2 (somatomedin a), TGFB1  -  transforming growth factor, beta 1, OGT  -  o-linked n-acetylglucosamine (glcnac) transferase, TGFB1I1  -  transforming growth factor beta 1 induced transcript 1, IGFBP1  -  insulin-like growth factor binding protein 1, TGIF1  -  tgfb-induced factor homeobox 1, TSPYL2  -  tspy-like 2, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), SND1  -  staphylococcal nuclease and tudor domain containing 1, TGFBR3  -  transforming growth factor, beta receptor iii, RBBP4  -  retinoblastoma binding protein 4, CUL4B  -  cullin 4b, FOSL2  -  fos-like antigen 2, FOSB  -  fbj murine osteosarcoma viral oncogene homolog b, FOS  -  fbj murine osteosarcoma viral oncogene homolog, FNTB  -  farnesyltransferase, caax box, beta, KAT6B  -  k(lysine) acetyltransferase 6b, POLD3  -  polymerase (dna-directed), delta 3, accessory subunit, CKB  -  creatine kinase, brain, RBP1  -  retinol binding protein 1, cellular]"GO:0034310,primary alcohol catabolic process,1.58E-05,6.53E-03,391.9,8230,3,14,2,"[AKR1C3  -  aldo-keto reductase family 1, member c3, ADH5  -  alcohol dehydrogenase 5 (class iii), chi polypeptide]"GO:0044710,single-organism metabolic process,1.81E-05,7.21E-03,1.27,8230,2123,854,280,"[RFC2  -  replication factor c (activator 1) 2, 40kda, REV3L  -  rev3-like, polymerase (dna directed), zeta, catalytic subunit, TRAK1  -  trafficking protein, kinesin binding 1, BCKDK  -  branched chain ketoacid dehydrogenase kinase, SEPT5  -  septin 5, ABCA1  -  atp-binding cassette, sub-family a (abc1), member 1, BPGM  -  2,3-bisphosphoglycerate mutase, NCOR2  -  nuclear receptor corepressor 2, IQGAP1  -  iq motif containing gtpase activating protein 1, GCSH  -  glycine cleavage system protein h (aminomethyl carrier), LDHA  -  lactate dehydrogenase a, GCH1  -  gtp cyclohydrolase 1, HRAS  -  harvey rat sarcoma viral oncogene homolog, ENO2  -  enolase 2 (gamma, neuronal), NBN  -  nibrin, NUBP1  -  nucleotide binding protein 1, ENO1  -  enolase 1, (alpha), BLOC1S1  -  biogenesis of lysosomal organelles complex-1, subunit 1, RIT1  -  ras-like without caax 1, MYO10  -  myosin x, BGN  -  biglycan, SMPD4  -  sphingomyelin phosphodiesterase 4, neutral membrane (neutral sphingomyelinase-3), CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, CFB  -  complement factor b, SOX9  -  sry (sex determining region y)-box 9, PIKFYVE  -  phosphoinositide kinase, fyve finger containing, PLSCR1  -  phospholipid scramblase 1, PLTP  -  phospholipid transfer protein, BMP1  -  bone morphogenetic protein 1, PLCB2  -  phospholipase c, beta 2, SORD  -  sorbitol dehydrogenase, SYNJ1  -  synaptojanin 1, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, SOD2  -  superoxide dismutase 2, mitochondrial, CREB1  -  camp responsive element binding protein 1, C9  -  complement component 9, CTSA  -  cathepsin a, SH3YL1  -  sh3 domain containing, ysc84-like 1 (s. cerevisiae), MYH10  -  myosin, heavy chain 10, non-muscle, TBPL1  -  tbp-like 1, EGFR  -  epidermal growth factor receptor, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, ADA  -  adenosine deaminase, COL4A1  -  collagen, type iv, alpha 1, MED1  -  mediator complex subunit 1, RNF2  -  ring finger protein 2, PTGES  -  prostaglandin e synthase, PLIN2  -  perilipin 2, COL8A1  -  collagen, type viii, alpha 1, CHST15  -  carbohydrate (n-acetylgalactosamine 4-sulfate 6-o) sulfotransferase 15, COL9A2  -  collagen, type ix, alpha 2, PLA2G15  -  phospholipase a2, group xv, GNB1  -  guanine nucleotide binding protein (g protein), beta polypeptide 1, SERPING1  -  serpin peptidase inhibitor, clade g (c1 inhibitor), member 1, COL4A5  -  collagen, type iv, alpha 5, ADH5  -  alcohol dehydrogenase 5 (class iii), chi polypeptide, CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, C1R  -  complement component 1, r subcomponent, SMARCA2  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, C1S  -  complement component 1, s subcomponent, PARP1  -  poly (adp-ribose) polymerase 1, SWAP70  -  swap switching b-cell complex 70kda subunit, C4A  -  complement component 4a (rodgers blood group), FZR1  -  fizzy/cell division cycle 20 related 1 (drosophila), ADM  -  adrenomedullin, COL11A1  -  collagen, type xi, alpha 1, RAB7L1  -  rab7, member ras oncogene family-like 1, POLR2B  -  polymerase (rna) ii (dna directed) polypeptide b, 140kda, ECH1  -  enoyl coa hydratase 1, peroxisomal, PARP4  -  poly (adp-ribose) polymerase family, member 4, AKR1C3  -  aldo-keto reductase family 1, member c3, QKI  -  qki, kh domain containing, rna binding, NADK  -  nad kinase, ACAA2  -  acetyl-coa acyltransferase 2, PDE5A  -  phosphodiesterase 5a, cgmp-specific, NUPL2  -  nucleoporin like 2, AGT  -  angiotensinogen (serpin peptidase inhibitor, clade a, member 8), PRCP  -  prolylcarboxypeptidase (angiotensinase c), PRELP  -  proline/arginine-rich end leucine-rich repeat protein, COL14A1  -  collagen, type xiv, alpha 1, UNG  -  uracil-dna glycosylase, CTPS1  -  ctp synthase 1, PPP5C  -  protein phosphatase 5, catalytic subunit, AIMP2  -  aminoacyl trna synthetase complex-interacting multifunctional protein 2, RPA3  -  replication protein a3, 14kda, RPE  -  ribulose-5-phosphate-3-epimerase, MAP4K4  -  mitogen-activated protein kinase kinase kinase kinase 4, ACAN  -  aggrecan, TAB2  -  tgf-beta activated kinase 1/map3k7 binding protein 2, AK2  -  adenylate kinase 2, PITPNB  -  phosphatidylinositol transfer protein, beta, CTSL  -  cathepsin l, CTSK  -  cathepsin k, CTSH  -  cathepsin h, CTSD  -  cathepsin d, EZR  -  ezrin, SULT2B1  -  sulfotransferase family, cytosolic, 2b, member 1, STK3  -  serine/threonine kinase 3, B4GALT3  -  udp-gal:betaglcnac beta 1,4- galactosyltransferase, polypeptide 3, CYB5A  -  cytochrome b5 type a (microsomal), CFH  -  complement factor h, PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, CFHR1  -  complement factor h-related 1, EZH2  -  enhancer of zeste homolog 2 (drosophila), VCAM1  -  vascular cell adhesion molecule 1, B3GALT4  -  udp-gal:betaglcnac beta 1,3-galactosyltransferase, polypeptide 4, ALDH2  -  aldehyde dehydrogenase 2 family (mitochondrial), MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), CRKL  -  v-crk avian sarcoma virus ct10 oncogene homolog-like, RAB33A  -  rab33a, member ras oncogene family, RAB9A  -  rab9a, member ras oncogene family, PRPS1  -  phosphoribosyl pyrophosphate synthetase 1, JUN  -  jun proto-oncogene, CRY1  -  cryptochrome 1 (photolyase-like), CRYAB  -  crystallin, alpha b, ALDOC  -  aldolase c, fructose-bisphosphate, SSRP1  -  structure specific recognition protein 1, TNFSF4  -  tumor necrosis factor (ligand) superfamily, member 4, OXSR1  -  oxidative stress responsive 1, JAK2  -  janus kinase 2, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, TYRO3  -  tyro3 protein tyrosine kinase, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, MAP2K1  -  mitogen-activated protein kinase kinase 1, MAP2K3  -  mitogen-activated protein kinase kinase 3, TXNRD1  -  thioredoxin reductase 1, MAPK10  -  mitogen-activated protein kinase 10, MAPK7  -  mitogen-activated protein kinase 7, SLC23A2  -  solute carrier family 23 (ascorbic acid transporter), member 2, MVP  -  major vault protein, MAPK3  -  mitogen-activated protein kinase 3, CAT  -  catalase, PLCE1  -  phospholipase c, epsilon 1, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, SLC35A2  -  solute carrier family 35 (udp-galactose transporter), member a2, GBE1  -  glucan (1,4-alpha-), branching enzyme 1, UBE2G2  -  ubiquitin-conjugating enzyme e2g 2, RBM14  -  rna binding motif protein 14, SLC25A4  -  solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4, CSPG4  -  chondroitin sulfate proteoglycan 4, NUP153  -  nucleoporin 153kda, PRKCA  -  protein kinase c, alpha, CBS  -  cystathionine-beta-synthase, VCAN  -  versican, MPG  -  n-methylpurine-dna glycosylase, APEX1  -  apex nuclease (multifunctional dna repair enzyme) 1, FMOD  -  fibromodulin, GSTM2  -  glutathione s-transferase mu 2 (muscle), GSTM1  -  glutathione s-transferase mu 1, PAICS  -  phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, GSTM4  -  glutathione s-transferase mu 4, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), DDB1  -  damage-specific dna binding protein 1, 127kda, PBX1  -  pre-b-cell leukemia homeobox 1, HTRA2  -  htra serine peptidase 2, PC  -  pyruvate carboxylase, GTF2H1  -  general transcription factor iih, polypeptide 1, 62kda, MSH6  -  muts homolog 6 (e. coli), KMT2A  -  lysine (k)-specific methyltransferase 2a, CDC14B  -  cell division cycle 14b, SIN3B  -  sin3 transcription regulator family member b, MMP1  -  matrix metallopeptidase 1 (interstitial collagenase), PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, DOK5  -  docking protein 5, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, P4HB  -  prolyl 4-hydroxylase, beta polypeptide, PSMB9  -  proteasome (prosome, macropain) subunit, beta type, 9, CYB5R1  -  cytochrome b5 reductase 1, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, ARF1  -  adp-ribosylation factor 1, UBR2  -  ubiquitin protein ligase e3 component n-recognin 2, MMP11  -  matrix metallopeptidase 11 (stromelysin 3), FURIN  -  furin (paired basic amino acid cleaving enzyme), PSMB4  -  proteasome (prosome, macropain) subunit, beta type, 4, OGDH  -  oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide), PDPN  -  podoplanin, TDG  -  thymine-dna glycosylase, SDC2  -  syndecan 2, GYS1  -  glycogen synthase 1 (muscle), COASY  -  coa synthase, APOE  -  apolipoprotein e, LPPR4  -  lipid phosphate phosphatase-related protein type 4, APP  -  amyloid beta (a4) precursor protein, WWOX  -  ww domain containing oxidoreductase, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, IL6ST  -  interleukin 6 signal transducer (gp130, oncostatin m receptor), AQP1  -  aquaporin 1 (colton blood group), DGKZ  -  diacylglycerol kinase, zeta, PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), FGFR1  -  fibroblast growth factor receptor 1, ROR2  -  receptor tyrosine kinase-like orphan receptor 2, PTGDS  -  prostaglandin d2 synthase 21kda (brain), PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, MECP2  -  methyl cpg binding protein 2 (rett syndrome), RHOB  -  ras homolog family member b, MEF2A  -  myocyte enhancer factor 2a, FGF2  -  fibroblast growth factor 2 (basic), GTF2H5  -  general transcription factor iih, polypeptide 5, HADH  -  hydroxyacyl-coa dehydrogenase, DDX17  -  dead (asp-glu-ala-asp) box helicase 17, FDXR  -  ferredoxin reductase, RHOG  -  ras homolog family member g, INPPL1  -  inositol polyphosphate phosphatase-like 1, KAT8  -  k(lysine) acetyltransferase 8, ASS1  -  argininosuccinate synthase 1, INPP5A  -  inositol polyphosphate-5-phosphatase, 40kda, TIPARP  -  tcdd-inducible poly(adp-ribose) polymerase, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), RUVBL1  -  ruvb-like 1 (e. coli), HEXA  -  hexosaminidase a (alpha polypeptide), SAT1  -  spermidine/spermine n1-acetyltransferase 1, RNF40  -  ring finger protein 40, e3 ubiquitin protein ligase, PPAP2B  -  phosphatidic acid phosphatase type 2b, HDAC1  -  histone deacetylase 1, KAT7  -  k(lysine) acetyltransferase 7, IRAK1  -  interleukin-1 receptor-associated kinase 1, RAD1  -  rad1 homolog (s. pombe), PGK1  -  phosphoglycerate kinase 1, RFK  -  riboflavin kinase, SLC7A8  -  solute carrier family 7 (amino acid transporter light chain, l system), member 8, TKT  -  transketolase, PGD  -  phosphogluconate dehydrogenase, SMC3  -  structural maintenance of chromosomes 3, SLC16A3  -  solute carrier family 16 (monocarboxylate transporter), member 3, NME4  -  nme/nm23 nucleoside diphosphate kinase 4, AHCYL1  -  adenosylhomocysteinase-like 1, GPC1  -  glypican 1, RAB14  -  rab14, member ras oncogene family, GPI  -  glucose-6-phosphate isomerase, DPYSL2  -  dihydropyrimidinase-like 2, MAN2B1  -  mannosidase, alpha, class 2b, member 1, NFYA  -  nuclear transcription factor y, alpha, PEX6  -  peroxisomal biogenesis factor 6, HDAC4  -  histone deacetylase 4, ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, RAB2A  -  rab2a, member ras oncogene family, SLC2A1  -  solute carrier family 2 (facilitated glucose transporter), member 1, ATP6V1B1  -  atpase, h+ transporting, lysosomal 56/58kda, v1 subunit b1, RAD23B  -  rad23 homolog b (s. cerevisiae), SLC2A3  -  solute carrier family 2 (facilitated glucose transporter), member 3, PFKP  -  phosphofructokinase, platelet, ASH2L  -  ash2 (absent, small, or homeotic)-like (drosophila), TNNT3  -  troponin t type 3 (skeletal, fast), IDH3B  -  isocitrate dehydrogenase 3 (nad+) beta, IDH2  -  isocitrate dehydrogenase 2 (nadp+), mitochondrial, RAB13  -  rab13, member ras oncogene family, DLD  -  dihydrolipoamide dehydrogenase, SUZ12  -  suz12 polycomb repressive complex 2 subunit, SHH  -  sonic hedgehog, GPX1  -  glutathione peroxidase 1, RAD51D  -  rad51 paralog d, TERF1  -  telomeric repeat binding factor (nima-interacting) 1, ST6GAL1  -  st6 beta-galactosamide alpha-2,6-sialyltranferase 1, LUM  -  lumican, RARRES3  -  retinoic acid receptor responder (tazarotene induced) 3, ST3GAL4  -  st3 beta-galactoside alpha-2,3-sialyltransferase 4, CLU  -  clusterin, ATR  -  ataxia telangiectasia and rad3 related, PKM  -  pyruvate kinase, muscle, TPP1  -  tripeptidyl peptidase i, SMARCA5  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5, MGLL  -  monoglyceride lipase, IGF2  -  insulin-like growth factor 2 (somatomedin a), TGFB1  -  transforming growth factor, beta 1, OGT  -  o-linked n-acetylglucosamine (glcnac) transferase, DNM2  -  dynamin 2, TDP2  -  tyrosyl-dna phosphodiesterase 2, NR3C1  -  nuclear receptor subfamily 3, group c, member 1 (glucocorticoid receptor), RBBP4  -  retinoblastoma binding protein 4, CUL4B  -  cullin 4b, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, FOS  -  fbj murine osteosarcoma viral oncogene homolog, KAT6B  -  k(lysine) acetyltransferase 6b, POLD3  -  polymerase (dna-directed), delta 3, accessory subunit, CKB  -  creatine kinase, brain, GSK3B  -  glycogen synthase kinase 3 beta, P4HA2  -  prolyl 4-hydroxylase, alpha polypeptide ii, RBP1  -  retinol binding protein 1, cellular]"GO:0008285,negative regulation of cell proliferation,2.87E-05,1.10E-02,1.85,8230,452,571,58,"[IFIT3  -  interferon-induced protein with tetratricopeptide repeats 3, NDN  -  necdin, melanoma antigen (mage) family member, PAWR  -  prkc, apoptosis, wt1, regulator, PDE5A  -  phosphodiesterase 5a, cgmp-specific, AIMP2  -  aminoacyl trna synthetase complex-interacting multifunctional protein 2, HRAS  -  harvey rat sarcoma viral oncogene homolog, KMT2A  -  lysine (k)-specific methyltransferase 2a, GPNMB  -  glycoprotein (transmembrane) nmb, ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, HDAC4  -  histone deacetylase 4, DFNA5  -  deafness, autosomal dominant 5, SOX9  -  sry (sex determining region y)-box 9, SOX4  -  sry (sex determining region y)-box 4, WNT5A  -  wingless-type mmtv integration site family, member 5a, DDR1  -  discoidin domain receptor tyrosine kinase 1, GJA1  -  gap junction protein, alpha 1, 43kda, SOD2  -  superoxide dismutase 2, mitochondrial, BMP4  -  bone morphogenetic protein 4, FOSL1  -  fos-like antigen 1, RBPJ  -  recombination signal binding protein for immunoglobulin kappa j region, SHH  -  sonic hedgehog, JUN  -  jun proto-oncogene, STAT1  -  signal transducer and activator of transcription 1, 91kda, ROR2  -  receptor tyrosine kinase-like orphan receptor 2, RARRES3  -  retinoic acid receptor responder (tazarotene induced) 3, JAK2  -  janus kinase 2, PTGIR  -  prostaglandin i2 (prostacyclin) receptor (ip), DLC1  -  deleted in liver cancer 1, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, MED1  -  mediator complex subunit 1, EFNB2  -  ephrin-b2, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, MAP2K1  -  mitogen-activated protein kinase kinase 1, PTGES  -  prostaglandin e synthase, INPPL1  -  inositol polyphosphate phosphatase-like 1, SERPINE2  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 2, CBLB  -  cbl proto-oncogene b, e3 ubiquitin protein ligase, TGFB1  -  transforming growth factor, beta 1, TGFB1I1  -  transforming growth factor beta 1 induced transcript 1, TNFRSF14  -  tumor necrosis factor receptor superfamily, member 14, CDKN1C  -  cyclin-dependent kinase inhibitor 1c (p57, kip2), CAV2  -  caveolin 2, TGIF1  -  tgfb-induced factor homeobox 1, ASPH  -  aspartate beta-hydroxylase, SMARCA2  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, CDKN2D  -  cyclin-dependent kinase inhibitor 2d (p19, inhibits cdk4), TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), TGFBR3  -  transforming growth factor, beta receptor iii, RBBP4  -  retinoblastoma binding protein 4, PHB2  -  prohibitin 2, KRIT1  -  krit1, ankyrin repeat containing, CXCL1  -  chemokine (c-x-c motif) ligand 1 (melanoma growth stimulating activity, alpha), FNTB  -  farnesyltransferase, caax box, beta, ADM  -  adrenomedullin, CDH13  -  cadherin 13, h-cadherin (heart), PRKCA  -  protein kinase c, alpha, SMAD6  -  smad family member 6, GAS1  -  growth arrest-specific 1]"GO:0071704,organic substance metabolic process,3.26E-05,1.21E-02,1.13,8230,4382,996,600,"[WTAP  -  wilms tumor 1 associated protein, HNRNPA0  -  heterogeneous nuclear ribonucleoprotein a0, ABCA1  -  atp-binding cassette, sub-family a (abc1), member 1, SEPT5  -  septin 5, LDHB  -  lactate dehydrogenase b, NCOR2  -  nuclear receptor corepressor 2, SPG7  -  spastic paraplegia 7 (pure and complicated autosomal recessive), RNF14  -  ring finger protein 14, GCSH  -  glycine cleavage system protein h (aminomethyl carrier), LDHA  -  lactate dehydrogenase a, LGALS3  -  lectin, galactoside-binding, soluble, 3, GCH1  -  gtp cyclohydrolase 1, BLOC1S1  -  biogenesis of lysosomal organelles complex-1, subunit 1, LOXL1  -  lysyl oxidase-like 1, SMPD4  -  sphingomyelin phosphodiesterase 4, neutral membrane (neutral sphingomyelinase-3), CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, SOX9  -  sry (sex determining region y)-box 9, ACR  -  acrosin, LSM2  -  lsm2 homolog, u6 small nuclear rna associated (s. cerevisiae), PLSCR1  -  phospholipid scramblase 1, PLTP  -  phospholipid transfer protein, SORD  -  sorbitol dehydrogenase, PLCB2  -  phospholipase c, beta 2, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, GHR  -  growth hormone receptor, PLAUR  -  plasminogen activator, urokinase receptor, SOD2  -  superoxide dismutase 2, mitochondrial, SOD1  -  superoxide dismutase 1, soluble, SUB1  -  sub1 homolog (s. cerevisiae), CREB1  -  camp responsive element binding protein 1, LMNA  -  lamin a/c, GLUL  -  glutamate-ammonia ligase, SNRPE  -  small nuclear ribonucleoprotein polypeptide e, CTSA  -  cathepsin a, PPIA  -  peptidylprolyl isomerase a (cyclophilin a), LITAF  -  lipopolysaccharide-induced tnf factor, PPM1B  -  protein phosphatase, mg2+/mn2+ dependent, 1b, TBPL1  -  tbp-like 1, USP9Y  -  ubiquitin specific peptidase 9, y-linked, ADAR  -  adenosine deaminase, rna-specific, SNAPC1  -  small nuclear rna activating complex, polypeptide 1, 43kda, COL4A1  -  collagen, type iv, alpha 1, ADA  -  adenosine deaminase, POLR1C  -  polymerase (rna) i polypeptide c, 30kda, BAG2  -  bcl2-associated athanogene 2, MED1  -  mediator complex subunit 1, PTGES  -  prostaglandin e synthase, COL8A1  -  collagen, type viii, alpha 1, PLIN2  -  perilipin 2, HLTF  -  helicase-like transcription factor, CHST15  -  carbohydrate (n-acetylgalactosamine 4-sulfate 6-o) sulfotransferase 15, COL9A2  -  collagen, type ix, alpha 2, PLA2G15  -  phospholipase a2, group xv, ADD1  -  adducin 1 (alpha), COL9A1  -  collagen, type ix, alpha 1, GNB1  -  guanine nucleotide binding protein (g protein), beta polypeptide 1, COL4A5  -  collagen, type iv, alpha 5, ADH5  -  alcohol dehydrogenase 5 (class iii), chi polypeptide, SMARCA2  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, MAPK8IP1  -  mitogen-activated protein kinase 8 interacting protein 1, PARP1  -  poly (adp-ribose) polymerase 1, TAOK3  -  tao kinase 3, FZR1  -  fizzy/cell division cycle 20 related 1 (drosophila), ADM  -  adrenomedullin, COL11A1  -  collagen, type xi, alpha 1, POLR2B  -  polymerase (rna) ii (dna directed) polypeptide b, 140kda, PARP4  -  poly (adp-ribose) polymerase family, member 4, QKI  -  qki, kh domain containing, rna binding, AEBP1  -  ae binding protein 1, PRKACB  -  protein kinase, camp-dependent, catalytic, beta, ASCC2  -  activating signal cointegrator 1 complex subunit 2, CSTF3  -  cleavage stimulation factor, 3' pre-rna, subunit 3, 77kda, NUPL2  -  nucleoporin like 2, SUPV3L1  -  suppressor of var1, 3-like 1 (s. cerevisiae), AGT  -  angiotensinogen (serpin peptidase inhibitor, clade a, member 8), PRCP  -  prolylcarboxypeptidase (angiotensinase c), SUPT5H  -  suppressor of ty 5 homolog (s. cerevisiae), PRELP  -  proline/arginine-rich end leucine-rich repeat protein, CTPS1  -  ctp synthase 1, AIMP2  -  aminoacyl trna synthetase complex-interacting multifunctional protein 2, PPP5C  -  protein phosphatase 5, catalytic subunit, AGA  -  aspartylglucosaminidase, MAP4K4  -  mitogen-activated protein kinase kinase kinase kinase 4, ACAN  -  aggrecan, LPXN  -  leupaxin, CTSL  -  cathepsin l, PITPNB  -  phosphatidylinositol transfer protein, beta, AK2  -  adenylate kinase 2, SEP15  -  15 kda selenoprotein, CTSK  -  cathepsin k, CTSH  -  cathepsin h, PPP2R5B  -  protein phosphatase 2, regulatory subunit b', beta, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, CTSD  -  cathepsin d, SULT2B1  -  sulfotransferase family, cytosolic, 2b, member 1, NUDT21  -  nudix (nucleoside diphosphate linked moiety x)-type motif 21, WWP2  -  ww domain containing e3 ubiquitin protein ligase 2, AHR  -  aryl hydrocarbon receptor, STK3  -  serine/threonine kinase 3, CYB5A  -  cytochrome b5 type a (microsomal), PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, SNRNP40  -  small nuclear ribonucleoprotein 40kda (u5), ALDH2  -  aldehyde dehydrogenase 2 family (mitochondrial), NEK7  -  nima-related kinase 7, ST13  -  suppression of tumorigenicity 13 (colon carcinoma) (hsp70 interacting protein), RBPMS  -  rna binding protein with multiple splicing, RAB33A  -  rab33a, member ras oncogene family, FOSL1  -  fos-like antigen 1, RAB9A  -  rab9a, member ras oncogene family, PRPS1  -  phosphoribosyl pyrophosphate synthetase 1, STAT2  -  signal transducer and activator of transcription 2, 113kda, CRY1  -  cryptochrome 1 (photolyase-like), STAT1  -  signal transducer and activator of transcription 1, 91kda, UBE4A  -  ubiquitination factor e4a, STAT4  -  signal transducer and activator of transcription 4, PROS1  -  protein s (alpha), CRYAB  -  crystallin, alpha b, ALDOC  -  aldolase c, fructose-bisphosphate, ADRM1  -  adhesion regulating molecule 1, SSRP1  -  structure specific recognition protein 1, JAK2  -  janus kinase 2, MAPK10  -  mitogen-activated protein kinase 10, MAPK7  -  mitogen-activated protein kinase 7, SRPK2  -  srsf protein kinase 2, MAPK3  -  mitogen-activated protein kinase 3, TRIM21  -  tripartite motif containing 21, PLCE1  -  phospholipase c, epsilon 1, PRKG1  -  protein kinase, cgmp-dependent, type i, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, COPS2  -  cop9 signalosome subunit 2, GBE1  -  glucan (1,4-alpha-), branching enzyme 1, RPL23  -  ribosomal protein l23, PRKCG  -  protein kinase c, gamma, SLC25A6  -  solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6, CSPG4  -  chondroitin sulfate proteoglycan 4, PRKCA  -  protein kinase c, alpha, VCAN  -  versican, ARIH1  -  ariadne homolog, ubiquitin-conjugating enzyme e2 binding protein, 1 (drosophila), PRKAR1B  -  protein kinase, camp-dependent, regulatory, type i, beta, GAS6  -  growth arrest-specific 6, FBXL2  -  f-box and leucine-rich repeat protein 2, APEX1  -  apex nuclease (multifunctional dna repair enzyme) 1, GSTM2  -  glutathione s-transferase mu 2 (muscle), GSTM1  -  glutathione s-transferase mu 1, SRSF11  -  serine/arginine-rich splicing factor 11, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, LUC7L3  -  luc7-like 3 (s. cerevisiae), GSTM4  -  glutathione s-transferase mu 4, PAWR  -  prkc, apoptosis, wt1, regulator, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), SREK1  -  splicing regulatory glutamine/lysine-rich protein 1, DDB1  -  damage-specific dna binding protein 1, 127kda, PBX1  -  pre-b-cell leukemia homeobox 1, PC  -  pyruvate carboxylase, GTF2H1  -  general transcription factor iih, polypeptide 1, 62kda, MSH6  -  muts homolog 6 (e. coli), KMT2A  -  lysine (k)-specific methyltransferase 2a, MMP2  -  matrix metallopeptidase 2 (gelatinase a, 72kda gelatinase, 72kda type iv collagenase), GTF3C2  -  general transcription factor iiic, polypeptide 2, beta 110kda, MMP1  -  matrix metallopeptidase 1 (interstitial collagenase), UBE2L6  -  ubiquitin-conjugating enzyme e2l 6, GTF2I  -  general transcription factor iii, P4HB  -  prolyl 4-hydroxylase, beta polypeptide, CYB5R1  -  cytochrome b5 reductase 1, STK17B  -  serine/threonine kinase 17b, ARF1  -  adp-ribosylation factor 1, GTF3C1  -  general transcription factor iiic, polypeptide 1, alpha 220kda, MMP11  -  matrix metallopeptidase 11 (stromelysin 3), FURIN  -  furin (paired basic amino acid cleaving enzyme), SDC2  -  syndecan 2, GYS1  -  glycogen synthase 1 (muscle), NOLC1  -  nucleolar and coiled-body phosphoprotein 1, ZNF473  -  zinc finger protein 473, APOE  -  apolipoprotein e, APP  -  amyloid beta (a4) precursor protein, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, WWOX  -  ww domain containing oxidoreductase, GUSB  -  glucuronidase, beta, AQP1  -  aquaporin 1 (colton blood group), DHX15  -  deah (asp-glu-ala-his) box helicase 15, ADIPOR2  -  adiponectin receptor 2, MCM7  -  minichromosome maintenance complex component 7, TUBA1A  -  tubulin, alpha 1a, ATXN1  -  ataxin 1, WBP4  -  ww domain binding protein 4, PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, RHOB  -  ras homolog family member b, MECP2  -  methyl cpg binding protein 2 (rett syndrome), MEF2A  -  myocyte enhancer factor 2a, PDPK1  -  3-phosphoinositide dependent protein kinase-1, PSIP1  -  pc4 and sfrs1 interacting protein 1, PDK3  -  pyruvate dehydrogenase kinase, isozyme 3, MEF2D  -  myocyte enhancer factor 2d, HADH  -  hydroxyacyl-coa dehydrogenase, RHOG  -  ras homolog family member g, PTP4A3  -  protein tyrosine phosphatase type iva, member 3, PCOLCE  -  procollagen c-endopeptidase enhancer, MEP1A  -  meprin a, alpha (paba peptide hydrolase), SCAF11  -  sr-related ctd-associated factor 11, DAG1  -  dystroglycan 1 (dystrophin-associated glycoprotein 1), KAT8  -  k(lysine) acetyltransferase 8, ASS1  -  argininosuccinate synthase 1, ASPH  -  aspartate beta-hydroxylase, DAPK1  -  death-associated protein kinase 1, TIPARP  -  tcdd-inducible poly(adp-ribose) polymerase, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, HEXA  -  hexosaminidase a (alpha polypeptide), SAT1  -  spermidine/spermine n1-acetyltransferase 1, HDAC1  -  histone deacetylase 1, SALL2  -  sal-like 2 (drosophila), KAT7  -  k(lysine) acetyltransferase 7, PGK1  -  phosphoglycerate kinase 1, MAGOH  -  mago-nashi homolog, proliferation-associated (drosophila), RFK  -  riboflavin kinase, XPC  -  xeroderma pigmentosum, complementation group c, PGD  -  phosphogluconate dehydrogenase, SMC3  -  structural maintenance of chromosomes 3, SLC16A3  -  solute carrier family 16 (monocarboxylate transporter), member 3, BAHD1  -  bromo adjacent homology domain containing 1, ZHX2  -  zinc fingers and homeoboxes 2, GPC1  -  glypican 1, ABLIM3  -  actin binding lim protein family, member 3, RAB14  -  rab14, member ras oncogene family, NMI  -  n-myc (and stat) interactor, GPI  -  glucose-6-phosphate isomerase, DPYSL3  -  dihydropyrimidinase-like 3, DPYSL2  -  dihydropyrimidinase-like 2, MLXIP  -  mlx interacting protein, MAN2B1  -  mannosidase, alpha, class 2b, member 1, ZFHX3  -  zinc finger homeobox 3, PEX6  -  peroxisomal biogenesis factor 6, SLC2A1  -  solute carrier family 2 (facilitated glucose transporter), member 1, ATP6V1B1  -  atpase, h+ transporting, lysosomal 56/58kda, v1 subunit b1, WNT5A  -  wingless-type mmtv integration site family, member 5a, PFKL  -  phosphofructokinase, liver, SLC2A3  -  solute carrier family 2 (facilitated glucose transporter), member 3, PFKP  -  phosphofructokinase, platelet, ASH2L  -  ash2 (absent, small, or homeotic)-like (drosophila), PFDN1  -  prefoldin subunit 1, PFDN4  -  prefoldin subunit 4, DLD  -  dihydrolipoamide dehydrogenase, LTB  -  lymphotoxin beta (tnf superfamily, member 3), SHH  -  sonic hedgehog, BAG1  -  bcl2-associated athanogene, RPL14  -  ribosomal protein l14, GPX1  -  glutathione peroxidase 1, ST6GAL1  -  st6 beta-galactosamide alpha-2,6-sialyltranferase 1, ATF5  -  activating transcription factor 5, PLAU  -  plasminogen activator, urokinase, PLAT  -  plasminogen activator, tissue, LUM  -  lumican, PLAGL1  -  pleiomorphic adenoma gene-like 1, ST3GAL4  -  st3 beta-galactoside alpha-2,3-sialyltransferase 4, UBA3  -  ubiquitin-like modifier activating enzyme 3, ATR  -  ataxia telangiectasia and rad3 related, PKM  -  pyruvate kinase, muscle, MGLL  -  monoglyceride lipase, SRSF1  -  serine/arginine-rich splicing factor 1, SMAD1  -  smad family member 1, DNM2  -  dynamin 2, SMAD2  -  smad family member 2, ACOT7  -  acyl-coa thioesterase 7, TDP2  -  tyrosyl-dna phosphodiesterase 2, BCL6  -  b-cell cll/lymphoma 6, TRA2B  -  transformer 2 beta homolog (drosophila), PHYH  -  phytanoyl-coa 2-hydroxylase, PHB2  -  prohibitin 2, NR3C1  -  nuclear receptor subfamily 3, group c, member 1 (glucocorticoid receptor), RPS6KA4  -  ribosomal protein s6 kinase, 90kda, polypeptide 4, DMD  -  dystrophin, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, YES1  -  v-yes-1 yamaguchi sarcoma viral oncogene homolog 1, DMPK  -  dystrophia myotonica-protein kinase, SCG5  -  secretogranin v (7b2 protein), SGK1  -  serum/glucocorticoid regulated kinase 1, NBAS  -  neuroblastoma amplified sequence, SMAD3  -  smad family member 3, CCND1  -  cyclin d1, GSK3B  -  glycogen synthase kinase 3 beta, SMAD6  -  smad family member 6, P4HA2  -  prolyl 4-hydroxylase, alpha polypeptide ii, MAF  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog, TRIM27  -  tripartite motif containing 27, YAF2  -  yy1 associated factor 2, NCBP2  -  nuclear cap binding protein subunit 2, 20kda, BNIP3  -  bcl2/adenovirus e1b 19kda interacting protein 3, RFC4  -  replication factor c (activator 1) 4, 37kda, HSF2  -  heat shock transcription factor 2, NDN  -  necdin, melanoma antigen (mage) family member, RFC2  -  replication factor c (activator 1) 2, 40kda, REV3L  -  rev3-like, polymerase (dna directed), zeta, catalytic subunit, SACM1L  -  sac1 suppressor of actin mutations 1-like (yeast), ELF4  -  e74-like factor 4 (ets domain transcription factor), TRAK1  -  trafficking protein, kinesin binding 1, BCKDK  -  branched chain ketoacid dehydrogenase kinase, TSC22D4  -  tsc22 domain family, member 4, BPGM  -  2,3-bisphosphoglycerate mutase, RPIA  -  ribose 5-phosphate isomerase a, EPAS1  -  endothelial pas domain protein 1, ATP6AP2  -  atpase, h+ transporting, lysosomal accessory protein 2, NASP  -  nuclear autoantigenic sperm protein (histone-binding), HABP4  -  hyaluronan binding protein 4, ATF6  -  activating transcription factor 6, ENO2  -  enolase 2 (gamma, neuronal), HRAS  -  harvey rat sarcoma viral oncogene homolog, NBN  -  nibrin, ENO1  -  enolase 1, (alpha), KLF5  -  kruppel-like factor 5 (intestinal), RELB  -  v-rel avian reticuloendotheliosis viral oncogene homolog b, RIT1  -  ras-like without caax 1, TUBA4A  -  tubulin, alpha 4a, EIF4A2  -  eukaryotic translation initiation factor 4a2, BGN  -  biglycan, MYO10  -  myosin x, EIF4B  -  eukaryotic translation initiation factor 4b, NT5C2  -  5'-nucleotidase, cytosolic ii, CFB  -  complement factor b, TNK2  -  tyrosine kinase, non-receptor, 2, BLMH  -  bleomycin hydrolase, PIKFYVE  -  phosphoinositide kinase, fyve finger containing, HPN  -  hepsin, EIF2S1  -  eukaryotic translation initiation factor 2, subunit 1 alpha, 35kda, NAB1  -  ngfi-a binding protein 1 (egr1 binding protein 1), BID  -  bh3 interacting domain death agonist, NACA  -  nascent polypeptide-associated complex alpha subunit, PRMT3  -  protein arginine methyltransferase 3, BMP1  -  bone morphogenetic protein 1, SYNJ1  -  synaptojanin 1, TST  -  thiosulfate sulfurtransferase (rhodanese), MYLK  -  myosin light chain kinase, BLVRB  -  biliverdin reductase b (flavin reductase (nadph)), BMPR1A  -  bone morphogenetic protein receptor, type ia, EIF4G1  -  eukaryotic translation initiation factor 4 gamma, 1, BMP4  -  bone morphogenetic protein 4, C9  -  complement component 9, STK38L  -  serine/threonine kinase 38 like, SH3YL1  -  sh3 domain containing, ysc84-like 1 (s. cerevisiae), MYH10  -  myosin, heavy chain 10, non-muscle, SNUPN  -  snurportin 1, EGFR  -  epidermal growth factor receptor, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, PQBP1  -  polyglutamine binding protein 1, EIF2B4  -  eukaryotic translation initiation factor 2b, subunit 4 delta, 67kda, RNF2  -  ring finger protein 2, HNRNPR  -  heterogeneous nuclear ribonucleoprotein r, PDZRN3  -  pdz domain containing ring finger 3, ROCK1  -  rho-associated, coiled-coil containing protein kinase 1, ZHX3  -  zinc fingers and homeoboxes 3, SERPING1  -  serpin peptidase inhibitor, clade g (c1 inhibitor), member 1, CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, HSPE1  -  heat shock 10kda protein 1 (chaperonin 10), C1R  -  complement component 1, r subcomponent, C1S  -  complement component 1, s subcomponent, RRP1B  -  ribosomal rna processing 1b, SWAP70  -  swap switching b-cell complex 70kda subunit, LRPPRC  -  leucine-rich pentatricopeptide repeat containing, C4A  -  complement component 4a (rodgers blood group), TRAF2  -  tnf receptor-associated factor 2, FSTL3  -  follistatin-like 3 (secreted glycoprotein), MBD2  -  methyl-cpg binding domain protein 2, ECE1  -  endothelin converting enzyme 1, RAB7L1  -  rab7, member ras oncogene family-like 1, ECH1  -  enoyl coa hydratase 1, peroxisomal, TRAP1  -  tnf receptor-associated protein 1, ERC1  -  elks/rab6-interacting/cast family member 1, AKR1C3  -  aldo-keto reductase family 1, member c3, NADK  -  nad kinase, RPL23A  -  ribosomal protein l23a, ACAA2  -  acetyl-coa acyltransferase 2, PDE5A  -  phosphodiesterase 5a, cgmp-specific, RPL18A  -  ribosomal protein l18a, PPP4R1  -  protein phosphatase 4, regulatory subunit 1, CAMK2G  -  calcium/calmodulin-dependent protein kinase ii gamma, RPL15  -  ribosomal protein l15, SIK1  -  salt-inducible kinase 1, RPL13  -  ribosomal protein l13, CAMK2B  -  calcium/calmodulin-dependent protein kinase ii beta, RPL12  -  ribosomal protein l12, EMG1  -  emg1 n1-specific pseudouridine methyltransferase, EIF3C  -  eukaryotic translation initiation factor 3, subunit c, EIF3D  -  eukaryotic translation initiation factor 3, subunit d, RPL5  -  ribosomal protein l5, CASP7  -  caspase 7, apoptosis-related cysteine peptidase, COL14A1  -  collagen, type xiv, alpha 1, CASP4  -  caspase 4, apoptosis-related cysteine peptidase, UNG  -  uracil-dna glycosylase, RPL4  -  ribosomal protein l4, RPA3  -  replication protein a3, 14kda, EIF3I  -  eukaryotic translation initiation factor 3, subunit i, RPE  -  ribulose-5-phosphate-3-epimerase, RPA2  -  replication protein a2, 32kda, HIVEP2  -  human immunodeficiency virus type i enhancer binding protein 2, EZR  -  ezrin, ACD  -  adrenocortical dysplasia homolog (mouse), HLA-DMA  -  major histocompatibility complex, class ii, dm alpha, DDR1  -  discoidin domain receptor tyrosine kinase 1, B4GALT3  -  udp-gal:betaglcnac beta 1,4- galactosyltransferase, polypeptide 3, CFH  -  complement factor h, PTRF  -  polymerase i and transcript release factor, CFHR1  -  complement factor h-related 1, EZH2  -  enhancer of zeste homolog 2 (drosophila), VCAM1  -  vascular cell adhesion molecule 1, F2R  -  coagulation factor ii (thrombin) receptor, HIVEP1  -  human immunodeficiency virus type i enhancer binding protein 1, B3GALT4  -  udp-gal:betaglcnac beta 1,3-galactosyltransferase, polypeptide 4, ERF  -  ets2 repressor factor, TRADD  -  tnfrsf1a-associated via death domain, MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), MYCBP  -  myc binding protein, CTSF  -  cathepsin f, HOXB2  -  homeobox b2, ADAM19  -  adam metallopeptidase domain 19, UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, EED  -  embryonic ectoderm development, ARNT2  -  aryl-hydrocarbon receptor nuclear translocator 2, HMG20B  -  high mobility group 20b, HNRNPU  -  heterogeneous nuclear ribonucleoprotein u (scaffold attachment factor a), TNFSF4  -  tumor necrosis factor (ligand) superfamily, member 4, OXSR1  -  oxidative stress responsive 1, RPS13  -  ribosomal protein s13, DLC1  -  deleted in liver cancer 1, TYRO3  -  tyro3 protein tyrosine kinase, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, TUBB4B  -  tubulin, beta 4b class ivb, MRPS18B  -  mitochondrial ribosomal protein s18b, TUBB4A  -  tubulin, beta 4a class iva, ZMIZ1  -  zinc finger, miz-type containing 1, SACS  -  spastic ataxia of charlevoix-saguenay (sacsin), TXNRD1  -  thioredoxin reductase 1, PABPC4  -  poly(a) binding protein, cytoplasmic 4 (inducible form), SLC23A2  -  solute carrier family 23 (ascorbic acid transporter), member 2, UCHL1  -  ubiquitin carboxyl-terminal esterase l1 (ubiquitin thiolesterase), MVP  -  major vault protein, UBTF  -  upstream binding transcription factor, rna polymerase i, HNRNPA1  -  heterogeneous nuclear ribonucleoprotein a1, GNB2L1  -  guanine nucleotide binding protein (g protein), beta polypeptide 2-like 1, CAT  -  catalase, FADD  -  fas (tnfrsf6)-associated via death domain, RYK  -  receptor-like tyrosine kinase, SLC35A2  -  solute carrier family 35 (udp-galactose transporter), member a2, RUNX1T1  -  runt-related transcription factor 1; translocated to, 1 (cyclin d-related), UBE2G2  -  ubiquitin-conjugating enzyme e2g 2, RBM14  -  rna binding motif protein 14, NUP153  -  nucleoporin 153kda, CBS  -  cystathionine-beta-synthase, NR1D2  -  nuclear receptor subfamily 1, group d, member 2, NUPR1  -  nuclear protein, transcriptional regulator, 1, RRBP1  -  ribosome binding protein 1, MPG  -  n-methylpurine-dna glycosylase, FMOD  -  fibromodulin, PAICS  -  phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase, SSH1  -  slingshot protein phosphatase 1, ZNF638  -  zinc finger protein 638, PJA2  -  praja ring finger 2, e3 ubiquitin protein ligase, TCF12  -  transcription factor 12, HEXIM1  -  hexamethylene bis-acetamide inducible 1, CDC34  -  cell division cycle 34, INHBA  -  inhibin, beta a, HTRA2  -  htra serine peptidase 2, FLNA  -  filamin a, alpha, LMO3  -  lim domain only 3 (rhombotin-like 2), PSEN2  -  presenilin 2 (alzheimer disease 4), PSMA1  -  proteasome (prosome, macropain) subunit, alpha type, 1, FOXO1  -  forkhead box o1, CDC14B  -  cell division cycle 14b, SIN3B  -  sin3 transcription regulator family member b, PIAS1  -  protein inhibitor of activated stat, 1, FOXC1  -  forkhead box c1, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, PSMB9  -  proteasome (prosome, macropain) subunit, beta type, 9, PIR  -  pirin (iron-binding nuclear protein), PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, LMO4  -  lim domain only 4, PSMB7  -  proteasome (prosome, macropain) subunit, beta type, 7, FOXF2  -  forkhead box f2, UBR2  -  ubiquitin protein ligase e3 component n-recognin 2, PSMB4  -  proteasome (prosome, macropain) subunit, beta type, 4, CAND1  -  cullin-associated and neddylation-dissociated 1, PDPN  -  podoplanin, OGDH  -  oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide), CAMK1  -  calcium/calmodulin-dependent protein kinase i, TDG  -  thymine-dna glycosylase, TXNIP  -  thioredoxin interacting protein, COASY  -  coa synthase, POM121  -  pom121 transmembrane nucleoporin, COPS3  -  cop9 signalosome subunit 3, LPPR4  -  lipid phosphate phosphatase-related protein type 4, SMG7  -  smg7 nonsense mediated mrna decay factor, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, IL6ST  -  interleukin 6 signal transducer (gp130, oncostatin m receptor), DGKZ  -  diacylglycerol kinase, zeta, PSMD11  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 11, UBR4  -  ubiquitin protein ligase e3 component n-recognin 4, TAF11  -  taf11 rna polymerase ii, tata box binding protein (tbp)-associated factor, 28kda, PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), FGFR1  -  fibroblast growth factor receptor 1, PTBP1  -  polypyrimidine tract binding protein 1, DDR2  -  discoidin domain receptor tyrosine kinase 2, TOMM20  -  translocase of outer mitochondrial membrane 20 homolog (yeast), ROR2  -  receptor tyrosine kinase-like orphan receptor 2, PTGDS  -  prostaglandin d2 synthase 21kda (brain), MAML1  -  mastermind-like 1 (drosophila), CFL1  -  cofilin 1 (non-muscle), BCLAF1  -  bcl2-associated transcription factor 1, FGF2  -  fibroblast growth factor 2 (basic), NUP98  -  nucleoporin 98kda, MKNK1  -  map kinase interacting serine/threonine kinase 1, GTF2H5  -  general transcription factor iih, polypeptide 5, DDX17  -  dead (asp-glu-ala-asp) box helicase 17, FDXR  -  ferredoxin reductase, CEBPB  -  ccaat/enhancer binding protein (c/ebp), beta, CEBPD  -  ccaat/enhancer binding protein (c/ebp), delta, INPPL1  -  inositol polyphosphate phosphatase-like 1, TBX2  -  t-box 2, TBCD  -  tubulin folding cofactor d, CDKN2D  -  cyclin-dependent kinase inhibitor 2d (p19, inhibits cdk4), INPP5A  -  inositol polyphosphate-5-phosphatase, 40kda, PTPN1  -  protein tyrosine phosphatase, non-receptor type 1, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), RUVBL1  -  ruvb-like 1 (e. coli), RNF40  -  ring finger protein 40, e3 ubiquitin protein ligase, PPAP2B  -  phosphatidic acid phosphatase type 2b, PTPN13  -  protein tyrosine phosphatase, non-receptor type 13 (apo-1/cd95 (fas)-associated phosphatase), EFEMP1  -  egf containing fibulin-like extracellular matrix protein 1, EIF3E  -  eukaryotic translation initiation factor 3, subunit e, CRCP  -  cgrp receptor component, PTPRF  -  protein tyrosine phosphatase, receptor type, f, IRAK1  -  interleukin-1 receptor-associated kinase 1, RAD1  -  rad1 homolog (s. pombe), PURA  -  purine-rich element binding protein a, IFI16  -  interferon, gamma-inducible protein 16, IFI27  -  interferon, alpha-inducible protein 27, SLC7A8  -  solute carrier family 7 (amino acid transporter light chain, l system), member 8, TKT  -  transketolase, ZMYND11  -  zinc finger, mynd-type containing 11, TLE2  -  transducin-like enhancer of split 2 (e(sp1) homolog, drosophila), NME4  -  nme/nm23 nucleoside diphosphate kinase 4, AHCYL1  -  adenosylhomocysteinase-like 1, NOVA1  -  neuro-oncological ventral antigen 1, PXN  -  paxillin, FOXN3  -  forkhead box n3, NOTCH3  -  notch 3, NFYA  -  nuclear transcription factor y, alpha, HDAC4  -  histone deacetylase 4, CHD4  -  chromodomain helicase dna binding protein 4, ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, NFX1  -  nuclear transcription factor, x-box binding 1, RAB3B  -  rab3b, member ras oncogene family, NGF  -  nerve growth factor (beta polypeptide), RAB2A  -  rab2a, member ras oncogene family, TRAM1  -  translocation associated membrane protein 1, NFIX  -  nuclear factor i/x (ccaat-binding transcription factor), RAD23B  -  rad23 homolog b (s. cerevisiae), NHP2L1  -  nhp2 non-histone chromosome protein 2-like 1 (s. cerevisiae), CGB  -  chorionic gonadotropin, beta polypeptide, TNNT3  -  troponin t type 3 (skeletal, fast), IDH3B  -  isocitrate dehydrogenase 3 (nad+) beta, CTSC  -  cathepsin c, RAB13  -  rab13, member ras oncogene family, IDH2  -  isocitrate dehydrogenase 2 (nadp+), mitochondrial, TEK  -  tek tyrosine kinase, endothelial, SUZ12  -  suz12 polycomb repressive complex 2 subunit, RAN  -  ran, member ras oncogene family, RBPJ  -  recombination signal binding protein for immunoglobulin kappa j region, RAD51D  -  rad51 paralog d, PABPC1  -  poly(a) binding protein, cytoplasmic 1, TERF1  -  telomeric repeat binding factor (nima-interacting) 1, DYRK2  -  dual-specificity tyrosine-(y)-phosphorylation regulated kinase 2, NFE2L2  -  nuclear factor (erythroid-derived 2)-like 2, CLNS1A  -  chloride channel, nucleotide-sensitive, 1a, ISG15  -  isg15 ubiquitin-like modifier, RARRES3  -  retinoic acid receptor responder (tazarotene induced) 3, NR2F1  -  nuclear receptor subfamily 2, group f, member 1, CLU  -  clusterin, TPP1  -  tripeptidyl peptidase i, RBL2  -  retinoblastoma-like 2 (p130), SMARCA5  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5, RBMS1  -  rna binding motif, single stranded interacting protein 1, IGF1R  -  insulin-like growth factor 1 receptor, IGF2  -  insulin-like growth factor 2 (somatomedin a), TGFB1  -  transforming growth factor, beta 1, OGT  -  o-linked n-acetylglucosamine (glcnac) transferase, TGFB1I1  -  transforming growth factor beta 1 induced transcript 1, IGFBP1  -  insulin-like growth factor binding protein 1, TGIF1  -  tgfb-induced factor homeobox 1, TSPYL2  -  tspy-like 2, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), SND1  -  staphylococcal nuclease and tudor domain containing 1, TGFBR3  -  transforming growth factor, beta receptor iii, RBBP4  -  retinoblastoma binding protein 4, CUL4B  -  cullin 4b, FOSL2  -  fos-like antigen 2, FOSB  -  fbj murine osteosarcoma viral oncogene homolog b, FOS  -  fbj murine osteosarcoma viral oncogene homolog, KAT6B  -  k(lysine) acetyltransferase 6b, FNTB  -  farnesyltransferase, caax box, beta, POLD3  -  polymerase (dna-directed), delta 3, accessory subunit, CKB  -  creatine kinase, brain, RBP1  -  retinol binding protein 1, cellular]"GO:0010033,response to organic substance,3.52E-05,1.26E-02,1.39,8230,1602,600,162,"[APEX1  -  apex nuclease (multifunctional dna repair enzyme) 1, NDN  -  necdin, melanoma antigen (mage) family member, SSH1  -  slingshot protein phosphatase 1, GSN  -  gelsolin, HNRNPA0  -  heterogeneous nuclear ribonucleoprotein a0, ABCA1  -  atp-binding cassette, sub-family a (abc1), member 1, TICAM1  -  toll-like receptor adaptor molecule 1, CDC34  -  cell division cycle 34, NCOR2  -  nuclear receptor corepressor 2, RNF14  -  ring finger protein 14, FLNB  -  filamin b, beta, ATF6  -  activating transcription factor 6, HRAS  -  harvey rat sarcoma viral oncogene homolog, FOXO1  -  forkhead box o1, RIT1  -  ras-like without caax 1, RRAGB  -  ras-related gtp binding b, EIF4A2  -  eukaryotic translation initiation factor 4a2, EIF4B  -  eukaryotic translation initiation factor 4b, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, UBE2L6  -  ubiquitin-conjugating enzyme e2l 6, SOX9  -  sry (sex determining region y)-box 9, ACR  -  acrosin, SOX4  -  sry (sex determining region y)-box 4, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, IL1R1  -  interleukin 1 receptor, type i, UBR2  -  ubiquitin protein ligase e3 component n-recognin 2, PLSCR1  -  phospholipid scramblase 1, FURIN  -  furin (paired basic amino acid cleaving enzyme), GJA1  -  gap junction protein, alpha 1, 43kda, APOE  -  apolipoprotein e, SOD2  -  superoxide dismutase 2, mitochondrial, BMPR1A  -  bone morphogenetic protein receptor, type ia, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, EIF4G1  -  eukaryotic translation initiation factor 4 gamma, 1, WWOX  -  ww domain containing oxidoreductase, LMNA  -  lamin a/c, IL6ST  -  interleukin 6 signal transducer (gp130, oncostatin m receptor), SERPINF2  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 2, BMP4  -  bone morphogenetic protein 4, TNFRSF11B  -  tumor necrosis factor receptor superfamily, member 11b, PDGFA  -  platelet-derived growth factor alpha polypeptide, KRT19  -  keratin 19, FGFR1  -  fibroblast growth factor receptor 1, MDK  -  midkine (neurite growth-promoting factor 2), LITAF  -  lipopolysaccharide-induced tnf factor, PPM1B  -  protein phosphatase, mg2+/mn2+ dependent, 1b, ITGA3  -  integrin, alpha 3 (antigen cd49c, alpha 3 subunit of vla-3 receptor), PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, PTGER1  -  prostaglandin e receptor 1 (subtype ep1), 42kda, FGF7  -  fibroblast growth factor 7, ADAR  -  adenosine deaminase, rna-specific, PDPK1  -  3-phosphoinositide dependent protein kinase-1, EGFR  -  epidermal growth factor receptor, FGF4  -  fibroblast growth factor 4, FZD7  -  frizzled family receptor 7, PTGIR  -  prostaglandin i2 (prostacyclin) receptor (ip), ADA  -  adenosine deaminase, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, MED1  -  mediator complex subunit 1, CNR1  -  cannabinoid receptor 1 (brain), SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, PTGES  -  prostaglandin e synthase, KRT18  -  keratin 18, PLIN2  -  perilipin 2, INPPL1  -  inositol polyphosphate phosphatase-like 1, EIF4E2  -  eukaryotic translation initiation factor 4e family member 2, DAG1  -  dystroglycan 1 (dystrophin-associated glycoprotein 1), ADH5  -  alcohol dehydrogenase 5 (class iii), chi polypeptide, CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, ASS1  -  argininosuccinate synthase 1, ASPH  -  aspartate beta-hydroxylase, CDKN2D  -  cyclin-dependent kinase inhibitor 2d (p19, inhibits cdk4), LY96  -  lymphocyte antigen 96, DAPK1  -  death-associated protein kinase 1, PTPN1  -  protein tyrosine phosphatase, non-receptor type 1, PARP1  -  poly (adp-ribose) polymerase 1, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), ADM  -  adrenomedullin, TRAF2  -  tnf receptor-associated factor 2, HSPA4  -  heat shock 70kda protein 4, HDAC1  -  histone deacetylase 1, ITGA6  -  integrin, alpha 6, AKR1C3  -  aldo-keto reductase family 1, member c3, IFIT1  -  interferon-induced protein with tetratricopeptide repeats 1, IFIT3  -  interferon-induced protein with tetratricopeptide repeats 3, TIMP3  -  timp metallopeptidase inhibitor 3, CHRNB1  -  cholinergic receptor, nicotinic, beta 1 (muscle), IFI27  -  interferon, alpha-inducible protein 27, IFI35  -  interferon-induced protein 35, STRN3  -  striatin, calmodulin binding protein 3, CAMK2G  -  calcium/calmodulin-dependent protein kinase ii gamma, NUPL2  -  nucleoporin like 2, RAB14  -  rab14, member ras oncogene family, EIF4G3  -  eukaryotic translation initiation factor 4 gamma, 3, PPP5C  -  protein phosphatase 5, catalytic subunit, DPYSL2  -  dihydropyrimidinase-like 2, IFNGR1  -  interferon gamma receptor 1, AK2  -  adenylate kinase 2, HDAC4  -  histone deacetylase 4, CTSH  -  cathepsin h, ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, ATP6V1B1  -  atpase, h+ transporting, lysosomal 56/58kda, v1 subunit b1, WNT5A  -  wingless-type mmtv integration site family, member 5a, CREB3L1  -  camp responsive element binding protein 3-like 1, PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, VCAM1  -  vascular cell adhesion molecule 1, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, RAB13  -  rab13, member ras oncogene family, RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), CRIP1  -  cysteine-rich protein 1 (intestinal), TEK  -  tek tyrosine kinase, endothelial, FOSL1  -  fos-like antigen 1, JUN  -  jun proto-oncogene, STAT2  -  signal transducer and activator of transcription 2, 113kda, UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, STAT1  -  signal transducer and activator of transcription 1, 91kda, STAT4  -  signal transducer and activator of transcription 4, GPX1  -  glutathione peroxidase 1, ARNT2  -  aryl-hydrocarbon receptor nuclear translocator 2, CRYAB  -  crystallin, alpha b, ALDOC  -  aldolase c, fructose-bisphosphate, CCNG1  -  cyclin g1, NFE2L2  -  nuclear factor (erythroid-derived 2)-like 2, PLAT  -  plasminogen activator, tissue, LUM  -  lumican, ISG15  -  isg15 ubiquitin-like modifier, CD14  -  cd14 molecule, JAK2  -  janus kinase 2, FEZ1  -  fasciculation and elongation protein zeta 1 (zygin i), RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, CLU  -  clusterin, MAP2K1  -  mitogen-activated protein kinase kinase 1, TPP1  -  tripeptidyl peptidase i, IGBP1  -  immunoglobulin (cd79a) binding protein 1, IGF1R  -  insulin-like growth factor 1 receptor, MAPK7  -  mitogen-activated protein kinase 7, IGF2  -  insulin-like growth factor 2 (somatomedin a), TGFB1  -  transforming growth factor, beta 1, SERPINB9  -  serpin peptidase inhibitor, clade b (ovalbumin), member 9, OGT  -  o-linked n-acetylglucosamine (glcnac) transferase, TNFRSF14  -  tumor necrosis factor receptor superfamily, member 14, CAT  -  catalase, TGIF1  -  tgfb-induced factor homeobox 1, TSPYL2  -  tspy-like 2, GBP1  -  guanylate binding protein 1, interferon-inducible, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), BAMBI  -  bmp and activin membrane-bound inhibitor, TGFBR3  -  transforming growth factor, beta receptor iii, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, RBM14  -  rna binding motif protein 14, FNTB  -  farnesyltransferase, caax box, beta, NUP153  -  nucleoporin 153kda, PRKCA  -  protein kinase c, alpha, SMAD6  -  smad family member 6, GSK3B  -  glycogen synthase kinase 3 beta, GAS6  -  growth arrest-specific 6, ITSN1  -  intersectin 1 (sh3 domain protein), GAS1  -  growth arrest-specific 1]"GO:0006007,glucose catabolic process,3.58E-05,1.25E-02,3.44,8230,39,981,16,"[PGK1  -  phosphoglycerate kinase 1, TKT  -  transketolase, PGD  -  phosphogluconate dehydrogenase, ALDOC  -  aldolase c, fructose-bisphosphate, BPGM  -  2,3-bisphosphoglycerate mutase, OGDH  -  oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide), LDHB  -  lactate dehydrogenase b, PFKL  -  phosphofructokinase, liver, RPIA  -  ribose 5-phosphate isomerase a, PFKP  -  phosphofructokinase, platelet, LDHA  -  lactate dehydrogenase a, GPI  -  glucose-6-phosphate isomerase, PKM  -  pyruvate kinase, muscle, ENO2  -  enolase 2 (gamma, neuronal), RPE  -  ribulose-5-phosphate-3-epimerase, ENO1  -  enolase 1, (alpha)]"GO:0006790,sulfur compound metabolic process,4.28E-05,1.44E-02,2.57,8230,89,935,26,"[GSTM2  -  glutathione s-transferase mu 2 (muscle), FMOD  -  fibromodulin, GSTM1  -  glutathione s-transferase mu 1, GSTM4  -  glutathione s-transferase mu 4, GPX1  -  glutathione peroxidase 1, EGFR  -  epidermal growth factor receptor, LUM  -  lumican, GPC1  -  glypican 1, ST3GAL4  -  st3 beta-galactoside alpha-2,3-sialyltransferase 4, PC  -  pyruvate carboxylase, PRELP  -  proline/arginine-rich end leucine-rich repeat protein, ACAN  -  aggrecan, BGN  -  biglycan, CHST15  -  carbohydrate (n-acetylgalactosamine 4-sulfate 6-o) sulfotransferase 15, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, SULT2B1  -  sulfotransferase family, cytosolic, 2b, member 1, B4GALT3  -  udp-gal:betaglcnac beta 1,4- galactosyltransferase, polypeptide 3, HEXA  -  hexosaminidase a (alpha polypeptide), SDC2  -  syndecan 2, GHR  -  growth hormone receptor, TST  -  thiosulfate sulfurtransferase (rhodanese), SOD2  -  superoxide dismutase 2, mitochondrial, SOD1  -  superoxide dismutase 1, soluble, CSPG4  -  chondroitin sulfate proteoglycan 4, CBS  -  cystathionine-beta-synthase, VCAN  -  versican]"GO:0044273,sulfur compound catabolic process,4.57E-05,1.50E-02,4.5,8230,22,915,11,"[FMOD  -  fibromodulin, HEXA  -  hexosaminidase a (alpha polypeptide), BGN  -  biglycan, LUM  -  lumican, TST  -  thiosulfate sulfurtransferase (rhodanese), GPC1  -  glypican 1, PRELP  -  proline/arginine-rich end leucine-rich repeat protein, CSPG4  -  chondroitin sulfate proteoglycan 4, VCAN  -  versican, CBS  -  cystathionine-beta-synthase, ACAN  -  aggrecan]"GO:0030155,regulation of cell adhesion,5.76E-05,1.83E-02,2.38,8230,241,431,30,"[TEK  -  tek tyrosine kinase, endothelial, GSN  -  gelsolin, ITGA3  -  integrin, alpha 3 (antigen cd49c, alpha 3 subunit of vla-3 receptor), FZD7  -  frizzled family receptor 7, JAK2  -  janus kinase 2, ADA  -  adenosine deaminase, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, MAP2K1  -  mitogen-activated protein kinase kinase 1, LPXN  -  leupaxin, COL8A1  -  collagen, type viii, alpha 1, ARPC2  -  actin related protein 2/3 complex, subunit 2, 34kda, MAPK7  -  mitogen-activated protein kinase 7, TGFB1  -  transforming growth factor, beta 1, SOX9  -  sry (sex determining region y)-box 9, PRKG1  -  protein kinase, cgmp-dependent, type i, TBCD  -  tubulin folding cofactor d, WNT5A  -  wingless-type mmtv integration site family, member 5a, DMD  -  dystrophin, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, LAMA5  -  laminin, alpha 5, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, CDH13  -  cadherin 13, h-cadherin (heart), LAMA4  -  laminin, alpha 4, PRKCA  -  protein kinase c, alpha, NUAK1  -  nuak family, snf1-like kinase, 1, GSK3B  -  glycogen synthase kinase 3 beta, SERPINF2  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 2, ITGA6  -  integrin, alpha 6, FBLN2  -  fibulin 2, LAMB1  -  laminin, beta 1]"GO:0044699,single-organism process,6.36E-05,1.97E-02,1.09,8230,5973,851,672,"[MAD2L1BP  -  mad2l1 binding protein, WTAP  -  wilms tumor 1 associated protein, SVEP1  -  sushi, von willebrand factor type a, egf and pentraxin domain containing 1, SERPINA3  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 3, ABLIM1  -  actin binding lim protein 1, ABCA1  -  atp-binding cassette, sub-family a (abc1), member 1, SEPT5  -  septin 5, GEM  -  gtp binding protein overexpressed in skeletal muscle, SPN  -  sialophorin, NCOR2  -  nuclear receptor corepressor 2, SPG7  -  spastic paraplegia 7 (pure and complicated autosomal recessive), GCSH  -  glycine cleavage system protein h (aminomethyl carrier), LDHA  -  lactate dehydrogenase a, LGALS3  -  lectin, galactoside-binding, soluble, 3, GCH1  -  gtp cyclohydrolase 1, TRAF4  -  tnf receptor-associated factor 4, BLOC1S1  -  biogenesis of lysosomal organelles complex-1, subunit 1, ASIC2  -  acid-sensing (proton-gated) ion channel 2, SMPD4  -  sphingomyelin phosphodiesterase 4, neutral membrane (neutral sphingomyelinase-3), CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, SOX9  -  sry (sex determining region y)-box 9, SOX4  -  sry (sex determining region y)-box 4, ACR  -  acrosin, PLP2  -  proteolipid protein 2 (colonic epithelium-enriched), PLSCR1  -  phospholipid scramblase 1, PLTP  -  phospholipid transfer protein, SORD  -  sorbitol dehydrogenase, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, PLAUR  -  plasminogen activator, urokinase receptor, GJA1  -  gap junction protein, alpha 1, 43kda, SOD2  -  superoxide dismutase 2, mitochondrial, LIMK2  -  lim domain kinase 2, PLEC  -  plectin, CREB1  -  camp responsive element binding protein 1, SNX1  -  sorting nexin 1, SERPINF2  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 2, LMNA  -  lamin a/c, SNTA1  -  syntrophin, alpha 1, KRT19  -  keratin 19, ACTN1  -  actinin, alpha 1, SNRPE  -  small nuclear ribonucleoprotein polypeptide e, CTSA  -  cathepsin a, PPIA  -  peptidylprolyl isomerase a (cyclophilin a), CNN1  -  calponin 1, basic, smooth muscle, LITAF  -  lipopolysaccharide-induced tnf factor, PPL  -  periplakin, TBPL1  -  tbp-like 1, ADAR  -  adenosine deaminase, rna-specific, FZD7  -  frizzled family receptor 7, COL4A1  -  collagen, type iv, alpha 1, ADA  -  adenosine deaminase, CNN3  -  calponin 3, acidic, MED1  -  mediator complex subunit 1, CNR1  -  cannabinoid receptor 1 (brain), KRT14  -  keratin 14, PTGES  -  prostaglandin e synthase, KRT16  -  keratin 16, KRT18  -  keratin 18, COL8A1  -  collagen, type viii, alpha 1, PLIN2  -  perilipin 2, LAMP1  -  lysosomal-associated membrane protein 1, CHST15  -  carbohydrate (n-acetylgalactosamine 4-sulfate 6-o) sulfotransferase 15, COL9A2  -  collagen, type ix, alpha 2, PLA2G15  -  phospholipase a2, group xv, ADD1  -  adducin 1 (alpha), LASP1  -  lim and sh3 protein 1, EIF4E2  -  eukaryotic translation initiation factor 4e family member 2, GNB1  -  guanine nucleotide binding protein (g protein), beta polypeptide 1, COL4A5  -  collagen, type iv, alpha 5, ADH5  -  alcohol dehydrogenase 5 (class iii), chi polypeptide, SMARCA2  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, PARP1  -  poly (adp-ribose) polymerase 1, FZR1  -  fizzy/cell division cycle 20 related 1 (drosophila), ADM  -  adrenomedullin, LAMA5  -  laminin, alpha 5, LAMA4  -  laminin, alpha 4, COL11A1  -  collagen, type xi, alpha 1, POLR2B  -  polymerase (rna) ii (dna directed) polypeptide b, 140kda, PARP4  -  poly (adp-ribose) polymerase family, member 4, LAMB1  -  laminin, beta 1, QKI  -  qki, kh domain containing, rna binding, AEBP1  -  ae binding protein 1, AP1G1  -  adaptor-related protein complex 1, gamma 1 subunit, SYT1  -  synaptotagmin i, NUPL2  -  nucleoporin like 2, HOMER3  -  homer homolog 3 (drosophila), PRCP  -  prolylcarboxypeptidase (angiotensinase c), AGT  -  angiotensinogen (serpin peptidase inhibitor, clade a, member 8), PRELP  -  proline/arginine-rich end leucine-rich repeat protein, FTH1  -  ferritin, heavy polypeptide 1, CTPS1  -  ctp synthase 1, AIMP2  -  aminoacyl trna synthetase complex-interacting multifunctional protein 2, PPP5C  -  protein phosphatase 5, catalytic subunit, KCNMB1  -  potassium large conductance calcium-activated channel, subfamily m, beta member 1, MAP4K4  -  mitogen-activated protein kinase kinase kinase kinase 4, ACAN  -  aggrecan, LPXN  -  leupaxin, PITPNB  -  phosphatidylinositol transfer protein, beta, CTSL  -  cathepsin l, AK2  -  adenylate kinase 2, CTSK  -  cathepsin k, CTSH  -  cathepsin h, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, CTSD  -  cathepsin d, SULT2B1  -  sulfotransferase family, cytosolic, 2b, member 1, AHR  -  aryl hydrocarbon receptor, STK3  -  serine/threonine kinase 3, CYB5A  -  cytochrome b5 type a (microsomal), PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, ALDH2  -  aldehyde dehydrogenase 2 family (mitochondrial), NEK7  -  nima-related kinase 7, CRIP2  -  cysteine-rich protein 2, CRIP1  -  cysteine-rich protein 1 (intestinal), CRKL  -  v-crk avian sarcoma virus ct10 oncogene homolog-like, RAB33A  -  rab33a, member ras oncogene family, FOSL1  -  fos-like antigen 1, RASSF7  -  ras association (ralgds/af-6) domain family (n-terminal) member 7, RAB9A  -  rab9a, member ras oncogene family, PRPS1  -  phosphoribosyl pyrophosphate synthetase 1, MFAP5  -  microfibrillar associated protein 5, CRY1  -  cryptochrome 1 (photolyase-like), JUN  -  jun proto-oncogene, STAT1  -  signal transducer and activator of transcription 1, 91kda, STAT4  -  signal transducer and activator of transcription 4, STAT3  -  signal transducer and activator of transcription 3 (acute-phase response factor), PROS1  -  protein s (alpha), PRNP  -  prion protein, CRYAB  -  crystallin, alpha b, ALDOC  -  aldolase c, fructose-bisphosphate, KAL1  -  kallmann syndrome 1 sequence, FXR1  -  fragile x mental retardation, autosomal homolog 1, SSRP1  -  structure specific recognition protein 1, JAK2  -  janus kinase 2, CRYZ  -  crystallin, zeta (quinone reductase), MAP2K1  -  mitogen-activated protein kinase kinase 1, MAP2K3  -  mitogen-activated protein kinase kinase 3, TRIP10  -  thyroid hormone receptor interactor 10, MAPK10  -  mitogen-activated protein kinase 10, MAPK7  -  mitogen-activated protein kinase 7, SRPK2  -  srsf protein kinase 2, MAPK3  -  mitogen-activated protein kinase 3, ASIC3  -  acid-sensing (proton-gated) ion channel 3, TRIM21  -  tripartite motif containing 21, PRKG1  -  protein kinase, cgmp-dependent, type i, PLCE1  -  phospholipase c, epsilon 1, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, AMPH  -  amphiphysin, COPS2  -  cop9 signalosome subunit 2, NREP  -  neuronal regeneration related protein, BAMBI  -  bmp and activin membrane-bound inhibitor, GBE1  -  glucan (1,4-alpha-), branching enzyme 1, STAM  -  signal transducing adaptor molecule (sh3 domain and itam motif) 1, RPL23  -  ribosomal protein l23, PRKCG  -  protein kinase c, gamma, CSPG4  -  chondroitin sulfate proteoglycan 4, SLC25A4  -  solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4, PRKCA  -  protein kinase c, alpha, VCAN  -  versican, GAS6  -  growth arrest-specific 6, GAS1  -  growth arrest-specific 1, CSRP2  -  cysteine and glycine-rich protein 2, TMEM123  -  transmembrane protein 123, APEX1  -  apex nuclease (multifunctional dna repair enzyme) 1, GSTM2  -  glutathione s-transferase mu 2 (muscle), GSTM1  -  glutathione s-transferase mu 1, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, PAWR  -  prkc, apoptosis, wt1, regulator, GSTM4  -  glutathione s-transferase mu 4, GSN  -  gelsolin, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), MID1  -  midline 1 (opitz/bbb syndrome), PAX7  -  paired box 7, DDB1  -  damage-specific dna binding protein 1, 127kda, PBX1  -  pre-b-cell leukemia homeobox 1, ANXA6  -  annexin a6, CYTH3  -  cytohesin 3, PC  -  pyruvate carboxylase, GTF2H1  -  general transcription factor iih, polypeptide 1, 62kda, PCDH1  -  protocadherin 1, DBP  -  d site of albumin promoter (albumin d-box) binding protein, MSH6  -  muts homolog 6 (e. coli), KMT2A  -  lysine (k)-specific methyltransferase 2a, MMP1  -  matrix metallopeptidase 1 (interstitial collagenase), PRAF2  -  pra1 domain family, member 2, P4HB  -  prolyl 4-hydroxylase, beta polypeptide, DFNA5  -  deafness, autosomal dominant 5, PDLIM7  -  pdz and lim domain 7 (enigma), PDCD10  -  programmed cell death 10, CYB5R1  -  cytochrome b5 reductase 1, ARF1  -  adp-ribosylation factor 1, FURIN  -  furin (paired basic amino acid cleaving enzyme), MMP11  -  matrix metallopeptidase 11 (stromelysin 3), SDC2  -  syndecan 2, GYS1  -  glycogen synthase 1 (muscle), NOLC1  -  nucleolar and coiled-body phosphoprotein 1, APOE  -  apolipoprotein e, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, APP  -  amyloid beta (a4) precursor protein, WWOX  -  ww domain containing oxidoreductase, IL32  -  interleukin 32, PDGFA  -  platelet-derived growth factor alpha polypeptide, CEP250  -  centrosomal protein 250kda, MDK  -  midkine (neurite growth-promoting factor 2), TUBA1A  -  tubulin, alpha 1a, ATXN1  -  ataxin 1, PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, RHOB  -  ras homolog family member b, MECP2  -  methyl cpg binding protein 2 (rett syndrome), PDPK1  -  3-phosphoinositide dependent protein kinase-1, RHOC  -  ras homolog family member c, MEF2A  -  myocyte enhancer factor 2a, MEA1  -  male-enhanced antigen 1, HADH  -  hydroxyacyl-coa dehydrogenase, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, AMIGO2  -  adhesion molecule with ig-like domain 2, RHOG  -  ras homolog family member g, GORASP2  -  golgi reassembly stacking protein 2, 55kda, MEOX2  -  mesenchyme homeobox 2, PCOLCE  -  procollagen c-endopeptidase enhancer, ZYX  -  zyxin, DGKA  -  diacylglycerol kinase, alpha 80kda, DAG1  -  dystroglycan 1 (dystrophin-associated glycoprotein 1), KAT8  -  k(lysine) acetyltransferase 8, ASS1  -  argininosuccinate synthase 1, ASPH  -  aspartate beta-hydroxylase, DAPK1  -  death-associated protein kinase 1, MFAP4  -  microfibrillar-associated protein 4, TIPARP  -  tcdd-inducible poly(adp-ribose) polymerase, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, HEXA  -  hexosaminidase a (alpha polypeptide), CDC37  -  cell division cycle 37, SAT1  -  spermidine/spermine n1-acetyltransferase 1, ZFAND5  -  zinc finger, an1-type domain 5, HDAC1  -  histone deacetylase 1, SALL2  -  sal-like 2 (drosophila), KAT7  -  k(lysine) acetyltransferase 7, PGK1  -  phosphoglycerate kinase 1, ATP2B1  -  atpase, ca++ transporting, plasma membrane 1, EPN2  -  epsin 2, RFK  -  riboflavin kinase, GOLGA2  -  golgin a2, CDK14  -  cyclin-dependent kinase 14, PGD  -  phosphogluconate dehydrogenase, SMC3  -  structural maintenance of chromosomes 3, SLC16A3  -  solute carrier family 16 (monocarboxylate transporter), member 3, ATP1B1  -  atpase, na+/k+ transporting, beta 1 polypeptide, ZHX2  -  zinc fingers and homeoboxes 2, INA  -  internexin neuronal intermediate filament protein, alpha, GPC1  -  glypican 1, RAB14  -  rab14, member ras oncogene family, MAP1A  -  microtubule-associated protein 1a, DZIP1  -  daz interacting zinc finger protein 1, GPI  -  glucose-6-phosphate isomerase, DPYSL2  -  dihydropyrimidinase-like 2, MAN2B1  -  mannosidase, alpha, class 2b, member 1, SLC12A2  -  solute carrier family 12 (sodium/potassium/chloride transporter), member 2, ZFHX3  -  zinc finger homeobox 3, PEX6  -  peroxisomal biogenesis factor 6, SLC1A1  -  solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system xag), member 1, UNC119  -  unc-119 homolog (c. elegans), WEE1  -  wee1 homolog (s. pombe), MATN2  -  matrilin 2, SLC2A1  -  solute carrier family 2 (facilitated glucose transporter), member 1, ATP6V1B1  -  atpase, h+ transporting, lysosomal 56/58kda, v1 subunit b1, WNT5A  -  wingless-type mmtv integration site family, member 5a, DVL3  -  dishevelled segment polarity protein 3, ATP6V0C  -  atpase, h+ transporting, lysosomal 16kda, v0 subunit c, GULP1  -  gulp, engulfment adaptor ptb domain containing 1, SLC2A3  -  solute carrier family 2 (facilitated glucose transporter), member 3, PFKP  -  phosphofructokinase, platelet, TSC22D3  -  tsc22 domain family, member 3, ASH2L  -  ash2 (absent, small, or homeotic)-like (drosophila), ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, PFDN1  -  prefoldin subunit 1, DLGAP4  -  discs, large (drosophila) homolog-associated protein 4, SMTN  -  smoothelin, DLD  -  dihydrolipoamide dehydrogenase, LTB  -  lymphotoxin beta (tnf superfamily, member 3), SHBG  -  sex hormone-binding globulin, SHH  -  sonic hedgehog, BAG1  -  bcl2-associated athanogene, RPL14  -  ribosomal protein l14, GPX1  -  glutathione peroxidase 1, DLX5  -  distal-less homeobox 5, ST6GAL1  -  st6 beta-galactosamide alpha-2,6-sialyltranferase 1, PLAU  -  plasminogen activator, urokinase, ATF5  -  activating transcription factor 5, PLAT  -  plasminogen activator, tissue, PLAGL1  -  pleiomorphic adenoma gene-like 1, LUM  -  lumican, ST3GAL4  -  st3 beta-galactoside alpha-2,3-sialyltransferase 4, UBA3  -  ubiquitin-like modifier activating enzyme 3, NID2  -  nidogen 2 (osteonidogen), ATR  -  ataxia telangiectasia and rad3 related, PKM  -  pyruvate kinase, muscle, BCAM  -  basal cell adhesion molecule (lutheran blood group), TWF2  -  twinfilin actin-binding protein 2, DYNC1H1  -  dynein, cytoplasmic 1, heavy chain 1, MPZL1  -  myelin protein zero-like 1, MGLL  -  monoglyceride lipase, BDKRB2  -  bradykinin receptor b2, SERPINE2  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 2, SRSF1  -  serine/arginine-rich splicing factor 1, DNM2  -  dynamin 2, SMAD2  -  smad family member 2, TDP2  -  tyrosyl-dna phosphodiesterase 2, BCL6  -  b-cell cll/lymphoma 6, PHB2  -  prohibitin 2, NR3C1  -  nuclear receptor subfamily 3, group c, member 1 (glucocorticoid receptor), PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, DMD  -  dystrophin, YES1  -  v-yes-1 yamaguchi sarcoma viral oncogene homolog 1, CXCL1  -  chemokine (c-x-c motif) ligand 1 (melanoma growth stimulating activity, alpha), DMPK  -  dystrophia myotonica-protein kinase, SGK1  -  serum/glucocorticoid regulated kinase 1, SMAD3  -  smad family member 3, CCND1  -  cyclin d1, COPE  -  coatomer protein complex, subunit epsilon, GSK3B  -  glycogen synthase kinase 3 beta, SMAD6  -  smad family member 6, PIGR  -  polymeric immunoglobulin receptor, P4HA2  -  prolyl 4-hydroxylase, alpha polypeptide ii, ITSN1  -  intersectin 1 (sh3 domain protein), DNASE1  -  deoxyribonuclease i, MAF  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog, NCBP2  -  nuclear cap binding protein subunit 2, 20kda, BNIP3  -  bcl2/adenovirus e1b 19kda interacting protein 3, RFC2  -  replication factor c (activator 1) 2, 40kda, HSF2  -  heat shock transcription factor 2, NDN  -  necdin, melanoma antigen (mage) family member, BNIP2  -  bcl2/adenovirus e1b 19kda interacting protein 2, REV3L  -  rev3-like, polymerase (dna directed), zeta, catalytic subunit, NCK1  -  nck adaptor protein 1, TRAK1  -  trafficking protein, kinesin binding 1, ELF4  -  e74-like factor 4 (ets domain transcription factor), BCKDK  -  branched chain ketoacid dehydrogenase kinase, ELN  -  elastin, TICAM1  -  toll-like receptor adaptor molecule 1, BPGM  -  2,3-bisphosphoglycerate mutase, IQGAP1  -  iq motif containing gtpase activating protein 1, EPAS1  -  endothelial pas domain protein 1, TRPM2  -  transient receptor potential cation channel, subfamily m, member 2, ENO2  -  enolase 2 (gamma, neuronal), HRAS  -  harvey rat sarcoma viral oncogene homolog, NBN  -  nibrin, ENO1  -  enolase 1, (alpha), NUBP1  -  nucleotide binding protein 1, NBL1  -  neuroblastoma 1, dan family bmp antagonist, RIT1  -  ras-like without caax 1, MYO9B  -  myosin ixb, TUBA4A  -  tubulin, alpha 4a, BGN  -  biglycan, MYO10  -  myosin x, CFB  -  complement factor b, PPP1R12B  -  protein phosphatase 1, regulatory subunit 12b, PIKFYVE  -  phosphoinositide kinase, fyve finger containing, NDEL1  -  nude neurodevelopment protein 1-like 1, NAB1  -  ngfi-a binding protein 1 (egr1 binding protein 1), BID  -  bh3 interacting domain death agonist, NACA  -  nascent polypeptide-associated complex alpha subunit, BMP1  -  bone morphogenetic protein 1, SYNJ1  -  synaptojanin 1, MYLK  -  myosin light chain kinase, BMPR1A  -  bone morphogenetic protein receptor, type ia, EIF4G1  -  eukaryotic translation initiation factor 4 gamma, 1, RGS16  -  regulator of g-protein signaling 16, BMP4  -  bone morphogenetic protein 4, C9  -  complement component 9, TPM2  -  tropomyosin 2 (beta), SH3YL1  -  sh3 domain containing, ysc84-like 1 (s. cerevisiae), GADD45B  -  growth arrest and dna-damage-inducible, beta, DAAM1  -  dishevelled associated activator of morphogenesis 1, MYH10  -  myosin, heavy chain 10, non-muscle, SNUPN  -  snurportin 1, EGFR  -  epidermal growth factor receptor, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, HTR7  -  5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled, EIF2B4  -  eukaryotic translation initiation factor 2b, subunit 4 delta, 67kda, RNF2  -  ring finger protein 2, EFNB2  -  ephrin-b2, EFNB1  -  ephrin-b1, PDZRN3  -  pdz domain containing ring finger 3, ROCK1  -  rho-associated, coiled-coil containing protein kinase 1, ARPC2  -  actin related protein 2/3 complex, subunit 2, 34kda, SERPING1  -  serpin peptidase inhibitor, clade g (c1 inhibitor), member 1, SGCE  -  sarcoglycan, epsilon, CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, C1R  -  complement component 1, r subcomponent, C1S  -  complement component 1, s subcomponent, SWAP70  -  swap switching b-cell complex 70kda subunit, LRPPRC  -  leucine-rich pentatricopeptide repeat containing, C4A  -  complement component 4a (rodgers blood group), TRAF2  -  tnf receptor-associated factor 2, FSTL3  -  follistatin-like 3 (secreted glycoprotein), STAG1  -  stromal antigen 1, HSPA4  -  heat shock 70kda protein 4, EFS  -  embryonal fyn-associated substrate, ECE1  -  endothelin converting enzyme 1, RAB7L1  -  rab7, member ras oncogene family-like 1, OPTN  -  optineurin, ECH1  -  enoyl coa hydratase 1, peroxisomal, TPT1  -  tumor protein, translationally-controlled 1, CAPZA2  -  capping protein (actin filament) muscle z-line, alpha 2, ERC1  -  elks/rab6-interacting/cast family member 1, AKR1C3  -  aldo-keto reductase family 1, member c3, CAPZA1  -  capping protein (actin filament) muscle z-line, alpha 1, NADK  -  nad kinase, RPL23A  -  ribosomal protein l23a, ACAA2  -  acetyl-coa acyltransferase 2, PDE5A  -  phosphodiesterase 5a, cgmp-specific, OSTF1  -  osteoclast stimulating factor 1, RPL15  -  ribosomal protein l15, CAMK2G  -  calcium/calmodulin-dependent protein kinase ii gamma, SIK1  -  salt-inducible kinase 1, RPL12  -  ribosomal protein l12, CAMK2B  -  calcium/calmodulin-dependent protein kinase ii beta, SPG20  -  spastic paraplegia 20 (troyer syndrome), RPL5  -  ribosomal protein l5, COL14A1  -  collagen, type xiv, alpha 1, CASP4  -  caspase 4, apoptosis-related cysteine peptidase, NFASC  -  neurofascin, UNG  -  uracil-dna glycosylase, RPL4  -  ribosomal protein l4, RPA3  -  replication protein a3, 14kda, RPE  -  ribulose-5-phosphate-3-epimerase, MTCP1  -  mature t-cell proliferation 1, GPNMB  -  glycoprotein (transmembrane) nmb, TAB2  -  tgf-beta activated kinase 1/map3k7 binding protein 2, FBLN1  -  fibulin 1, HMGXB4  -  hmg box domain containing 4, CAP1  -  cap, adenylate cyclase-associated protein 1 (yeast), VEGFC  -  vascular endothelial growth factor c, PLXND1  -  plexin d1, EZR  -  ezrin, EPB41L3  -  erythrocyte membrane protein band 4.1-like 3, DDR1  -  discoidin domain receptor tyrosine kinase 1, SEMA4F  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4f, B4GALT3  -  udp-gal:betaglcnac beta 1,4- galactosyltransferase, polypeptide 3, CFH  -  complement factor h, CFHR1  -  complement factor h-related 1, EZH2  -  enhancer of zeste homolog 2 (drosophila), VCAM1  -  vascular cell adhesion molecule 1, B3GALT4  -  udp-gal:betaglcnac beta 1,3-galactosyltransferase, polypeptide 4, VDAC1  -  voltage-dependent anion channel 1, ERF  -  ets2 repressor factor, TRADD  -  tnfrsf1a-associated via death domain, MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), MYCBP  -  myc binding protein, CTSF  -  cathepsin f, HOXB2  -  homeobox b2, ADAM19  -  adam metallopeptidase domain 19, UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, CTNNAL1  -  catenin (cadherin-associated protein), alpha-like 1, ARNT2  -  aryl-hydrocarbon receptor nuclear translocator 2, GBF1  -  golgi brefeldin a resistant guanine nucleotide exchange factor 1, CCNG1  -  cyclin g1, CD6  -  cd6 molecule, TNFSF4  -  tumor necrosis factor (ligand) superfamily, member 4, CD14  -  cd14 molecule, OXSR1  -  oxidative stress responsive 1, NDRG1  -  n-myc downstream regulated 1, RPS13  -  ribosomal protein s13, DLC1  -  deleted in liver cancer 1, TYRO3  -  tyro3 protein tyrosine kinase, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, TNFSF9  -  tumor necrosis factor (ligand) superfamily, member 9, TUBB4A  -  tubulin, beta 4a class iva, ZMIZ1  -  zinc finger, miz-type containing 1, SACS  -  spastic ataxia of charlevoix-saguenay (sacsin), TXNRD1  -  thioredoxin reductase 1, CBLB  -  cbl proto-oncogene b, e3 ubiquitin protein ligase, SLC23A2  -  solute carrier family 23 (ascorbic acid transporter), member 2, UCHL1  -  ubiquitin carboxyl-terminal esterase l1 (ubiquitin thiolesterase), MVP  -  major vault protein, UBTF  -  upstream binding transcription factor, rna polymerase i, EPB41L2  -  erythrocyte membrane protein band 4.1-like 2, GNB2L1  -  guanine nucleotide binding protein (g protein), beta polypeptide 2-like 1, CAT  -  catalase, RRS1  -  rrs1 ribosome biogenesis regulator homolog (s. cerevisiae), CAV2  -  caveolin 2, FADD  -  fas (tnfrsf6)-associated via death domain, RYK  -  receptor-like tyrosine kinase, SLC35A2  -  solute carrier family 35 (udp-galactose transporter), member a2, RUNX1T1  -  runt-related transcription factor 1; translocated to, 1 (cyclin d-related), UBE2G2  -  ubiquitin-conjugating enzyme e2g 2, KRIT1  -  krit1, ankyrin repeat containing, CFDP1  -  craniofacial development protein 1, RBM14  -  rna binding motif protein 14, CCND2  -  cyclin d2, RTN1  -  reticulon 1, NUP153  -  nucleoporin 153kda, CBS  -  cystathionine-beta-synthase, RRAS  -  related ras viral (r-ras) oncogene homolog, NUPR1  -  nuclear protein, transcriptional regulator, 1, MPG  -  n-methylpurine-dna glycosylase, FMOD  -  fibromodulin, PAICS  -  phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase, SSH1  -  slingshot protein phosphatase 1, TCF12  -  transcription factor 12, CDH2  -  cadherin 2, type 1, n-cadherin (neuronal), HEXIM1  -  hexamethylene bis-acetamide inducible 1, CDC34  -  cell division cycle 34, GAB2  -  grb2-associated binding protein 2, HTRA2  -  htra serine peptidase 2, FLNA  -  filamin a, alpha, CD59  -  cd59 molecule, complement regulatory protein, FLNB  -  filamin b, beta, CD151  -  cd151 molecule (raph blood group), ARC  -  activity-regulated cytoskeleton-associated protein, FARP2  -  ferm, rhogef and pleckstrin domain protein 2, FOXO1  -  forkhead box o1, PACS2  -  phosphofurin acidic cluster sorting protein 2, CD97  -  cd97 molecule, CDC14B  -  cell division cycle 14b, SIN3B  -  sin3 transcription regulator family member b, PIAS1  -  protein inhibitor of activated stat, 1, IL4R  -  interleukin 4 receptor, FOXC1  -  forkhead box c1, DOK5  -  docking protein 5, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, SCARB2  -  scavenger receptor class b, member 2, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, PSMB9  -  proteasome (prosome, macropain) subunit, beta type, 9, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, LMO4  -  lim domain only 4, YKT6  -  ykt6 v-snare homolog (s. cerevisiae), FOXF2  -  forkhead box f2, UBR2  -  ubiquitin protein ligase e3 component n-recognin 2, PSMB4  -  proteasome (prosome, macropain) subunit, beta type, 4, CAND1  -  cullin-associated and neddylation-dissociated 1, PDPN  -  podoplanin, OGDH  -  oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide), CAMK1  -  calcium/calmodulin-dependent protein kinase i, TDG  -  thymine-dna glycosylase, COASY  -  coa synthase, COPS3  -  cop9 signalosome subunit 3, LPPR4  -  lipid phosphate phosphatase-related protein type 4, NUAK1  -  nuak family, snf1-like kinase, 1, DYNLT3  -  dynein, light chain, tctex-type 3, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, IL6ST  -  interleukin 6 signal transducer (gp130, oncostatin m receptor), DGKZ  -  diacylglycerol kinase, zeta, TNFRSF11B  -  tumor necrosis factor receptor superfamily, member 11b, ITGA5  -  integrin, alpha 5 (fibronectin receptor, alpha polypeptide), PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), ITGA7  -  integrin, alpha 7, FGFR1  -  fibroblast growth factor receptor 1, BCAP29  -  b-cell receptor-associated protein 29, DDR2  -  discoidin domain receptor tyrosine kinase 2, TOMM20  -  translocase of outer mitochondrial membrane 20 homolog (yeast), ROR2  -  receptor tyrosine kinase-like orphan receptor 2, PTGDS  -  prostaglandin d2 synthase 21kda (brain), MAML1  -  mastermind-like 1 (drosophila), CETN3  -  centrin, ef-hand protein, 3, FGF5  -  fibroblast growth factor 5, ITGA3  -  integrin, alpha 3 (antigen cd49c, alpha 3 subunit of vla-3 receptor), CFL1  -  cofilin 1 (non-muscle), FGF7  -  fibroblast growth factor 7, ITGA2B  -  integrin, alpha 2b (platelet glycoprotein iib of iib/iiia complex, antigen cd41), SEMA3C  -  sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3c, ITGB5  -  integrin, beta 5, FGF2  -  fibroblast growth factor 2 (basic), FBLN5  -  fibulin 5, FGF4  -  fibroblast growth factor 4, GTF2H5  -  general transcription factor iih, polypeptide 5, PTGIR  -  prostaglandin i2 (prostacyclin) receptor (ip), DDX17  -  dead (asp-glu-ala-asp) box helicase 17, TAP1  -  transporter 1, atp-binding cassette, sub-family b (mdr/tap), CEBPB  -  ccaat/enhancer binding protein (c/ebp), beta, FDXR  -  ferredoxin reductase, INPPL1  -  inositol polyphosphate phosphatase-like 1, RNF114  -  ring finger protein 114, PTN  -  pleiotrophin, TBX2  -  t-box 2, NPR3  -  natriuretic peptide receptor c/guanylate cyclase c (atrionatriuretic peptide receptor c), CDKN1C  -  cyclin-dependent kinase inhibitor 1c (p57, kip2), TBCD  -  tubulin folding cofactor d, FCGRT  -  fc fragment of igg, receptor, transporter, alpha, CDKN2D  -  cyclin-dependent kinase inhibitor 2d (p19, inhibits cdk4), SRGAP2  -  slit-robo rho gtpase activating protein 2, INPP5A  -  inositol polyphosphate-5-phosphatase, 40kda, PTPN1  -  protein tyrosine phosphatase, non-receptor type 1, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), RUVBL1  -  ruvb-like 1 (e. coli), ARL6IP5  -  adp-ribosylation-like factor 6 interacting protein 5, RNF40  -  ring finger protein 40, e3 ubiquitin protein ligase, PPAP2B  -  phosphatidic acid phosphatase type 2b, CDH13  -  cadherin 13, h-cadherin (heart), EFEMP1  -  egf containing fibulin-like extracellular matrix protein 1, ITGA6  -  integrin, alpha 6, GRIP2  -  glutamate receptor interacting protein 2, FBLN2  -  fibulin 2, CRCP  -  cgrp receptor component, PTPRF  -  protein tyrosine phosphatase, receptor type, f, PDLIM3  -  pdz and lim domain 3, IRAK1  -  interleukin-1 receptor-associated kinase 1, RAD1  -  rad1 homolog (s. pombe), CHRND  -  cholinergic receptor, nicotinic, delta (muscle), TIMP3  -  timp metallopeptidase inhibitor 3, CHRNB1  -  cholinergic receptor, nicotinic, beta 1 (muscle), IFI16  -  interferon, gamma-inducible protein 16, SLC7A8  -  solute carrier family 7 (amino acid transporter light chain, l system), member 8, TKT  -  transketolase, TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), TLE2  -  transducin-like enhancer of split 2 (e(sp1) homolog, drosophila), NME4  -  nme/nm23 nucleoside diphosphate kinase 4, AHCYL1  -  adenosylhomocysteinase-like 1, NOVA1  -  neuro-oncological ventral antigen 1, SEC62  -  sec62 homolog (s. cerevisiae), PVR  -  poliovirus receptor, NOTCH3  -  notch 3, PVRL2  -  poliovirus receptor-related 2 (herpesvirus entry mediator b), ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, NFYA  -  nuclear transcription factor y, alpha, HDAC4  -  histone deacetylase 4, ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, RAB3B  -  rab3b, member ras oncogene family, NGF  -  nerve growth factor (beta polypeptide), RAB2A  -  rab2a, member ras oncogene family, TRAM1  -  translocation associated membrane protein 1, NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, NFIX  -  nuclear factor i/x (ccaat-binding transcription factor), RAD23B  -  rad23 homolog b (s. cerevisiae), TNFAIP6  -  tumor necrosis factor, alpha-induced protein 6, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, CGB  -  chorionic gonadotropin, beta polypeptide, TNNT3  -  troponin t type 3 (skeletal, fast), IDH3B  -  isocitrate dehydrogenase 3 (nad+) beta, CTSC  -  cathepsin c, RAB13  -  rab13, member ras oncogene family, IDH2  -  isocitrate dehydrogenase 2 (nadp+), mitochondrial, RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), TEK  -  tek tyrosine kinase, endothelial, DDIT4  -  dna-damage-inducible transcript 4, SUZ12  -  suz12 polycomb repressive complex 2 subunit, RECK  -  reversion-inducing-cysteine-rich protein with kazal motifs, RBPJ  -  recombination signal binding protein for immunoglobulin kappa j region, RAD51D  -  rad51 paralog d, PABPC1  -  poly(a) binding protein, cytoplasmic 1, TERF1  -  telomeric repeat binding factor (nima-interacting) 1, RARRES3  -  retinoic acid receptor responder (tazarotene induced) 3, FEZ1  -  fasciculation and elongation protein zeta 1 (zygin i), NR2F1  -  nuclear receptor subfamily 2, group f, member 1, CLU  -  clusterin, NF2  -  neurofibromin 2 (merlin), STX7  -  syntaxin 7, TPP1  -  tripeptidyl peptidase i, IK  -  ik cytokine, down-regulator of hla ii, RBL2  -  retinoblastoma-like 2 (p130), IGBP1  -  immunoglobulin (cd79a) binding protein 1, SMARCA5  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5, TGFBI  -  transforming growth factor, beta-induced, 68kda, IGF1R  -  insulin-like growth factor 1 receptor, IGF2  -  insulin-like growth factor 2 (somatomedin a), TGFB1  -  transforming growth factor, beta 1, OGT  -  o-linked n-acetylglucosamine (glcnac) transferase, TGFB1I1  -  transforming growth factor beta 1 induced transcript 1, TGIF1  -  tgfb-induced factor homeobox 1, TSPYL2  -  tspy-like 2, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), SND1  -  staphylococcal nuclease and tudor domain containing 1, TGFBR3  -  transforming growth factor, beta receptor iii, RBBP4  -  retinoblastoma binding protein 4, CUL4B  -  cullin 4b, FOS  -  fbj murine osteosarcoma viral oncogene homolog, THBS2  -  thrombospondin 2, KAT6B  -  k(lysine) acetyltransferase 6b, POLD3  -  polymerase (dna-directed), delta 3, accessory subunit, CKB  -  creatine kinase, brain, RBP1  -  retinol binding protein 1, cellular]"GO:0032502,developmental process,6.81E-05,2.05E-02,1.27,8230,2685,578,239,"[BNIP3  -  bcl2/adenovirus e1b 19kda interacting protein 3, NDN  -  necdin, melanoma antigen (mage) family member, BNIP2  -  bcl2/adenovirus e1b 19kda interacting protein 2, ABLIM1  -  actin binding lim protein 1, ELN  -  elastin, BPGM  -  2,3-bisphosphoglycerate mutase, IQGAP1  -  iq motif containing gtpase activating protein 1, LDHA  -  lactate dehydrogenase a, LGALS3  -  lectin, galactoside-binding, soluble, 3, HRAS  -  harvey rat sarcoma viral oncogene homolog, NBN  -  nibrin, NBL1  -  neuroblastoma 1, dan family bmp antagonist, TRAF4  -  tnf receptor-associated factor 4, ASIC2  -  acid-sensing (proton-gated) ion channel 2, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, SOX9  -  sry (sex determining region y)-box 9, SOX4  -  sry (sex determining region y)-box 4, PIKFYVE  -  phosphoinositide kinase, fyve finger containing, NDEL1  -  nude neurodevelopment protein 1-like 1, BMP1  -  bone morphogenetic protein 1, MYLK  -  myosin light chain kinase, GJA1  -  gap junction protein, alpha 1, 43kda, SOD2  -  superoxide dismutase 2, mitochondrial, BMPR1A  -  bone morphogenetic protein receptor, type ia, EIF4G1  -  eukaryotic translation initiation factor 4 gamma, 1, SERPINF2  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 2, LMNA  -  lamin a/c, BMP4  -  bone morphogenetic protein 4, PPL  -  periplakin, LITAF  -  lipopolysaccharide-induced tnf factor, MYH10  -  myosin, heavy chain 10, non-muscle, TBPL1  -  tbp-like 1, EGFR  -  epidermal growth factor receptor, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, FZD7  -  frizzled family receptor 7, ADA  -  adenosine deaminase, MED1  -  mediator complex subunit 1, CNR1  -  cannabinoid receptor 1 (brain), RNF2  -  ring finger protein 2, EFNB2  -  ephrin-b2, EFNB1  -  ephrin-b1, KRT16  -  keratin 16, KRT18  -  keratin 18, COL8A1  -  collagen, type viii, alpha 1, EIF4E2  -  eukaryotic translation initiation factor 4e family member 2, ADH5  -  alcohol dehydrogenase 5 (class iii), chi polypeptide, CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, SMARCA2  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, PARP1  -  poly (adp-ribose) polymerase 1, ADM  -  adrenomedullin, LAMA5  -  laminin, alpha 5, LAMA4  -  laminin, alpha 4, COL11A1  -  collagen, type xi, alpha 1, ECE1  -  endothelin converting enzyme 1, LAMB1  -  laminin, beta 1, ERC1  -  elks/rab6-interacting/cast family member 1, AKR1C3  -  aldo-keto reductase family 1, member c3, QKI  -  qki, kh domain containing, rna binding, CAMK2G  -  calcium/calmodulin-dependent protein kinase ii gamma, SPG20  -  spastic paraplegia 20 (troyer syndrome), COL14A1  -  collagen, type xiv, alpha 1, SVIL  -  supervillin, AIMP2  -  aminoacyl trna synthetase complex-interacting multifunctional protein 2, GPNMB  -  glycoprotein (transmembrane) nmb, TAB2  -  tgf-beta activated kinase 1/map3k7 binding protein 2, PITPNB  -  phosphatidylinositol transfer protein, beta, AK2  -  adenylate kinase 2, CTSH  -  cathepsin h, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, VEGFC  -  vascular endothelial growth factor c, PLXND1  -  plexin d1, EPB41L3  -  erythrocyte membrane protein band 4.1-like 3, DDR1  -  discoidin domain receptor tyrosine kinase 1, AHR  -  aryl hydrocarbon receptor, PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, VCAM1  -  vascular cell adhesion molecule 1, VDAC1  -  voltage-dependent anion channel 1, CRIP2  -  cysteine-rich protein 2, ERF  -  ets2 repressor factor, CRIP1  -  cysteine-rich protein 1 (intestinal), MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), FOSL1  -  fos-like antigen 1, HOXB2  -  homeobox b2, PRPS1  -  phosphoribosyl pyrophosphate synthetase 1, JUN  -  jun proto-oncogene, ADAM19  -  adam metallopeptidase domain 19, STAT1  -  signal transducer and activator of transcription 1, 91kda, ARNT2  -  aryl-hydrocarbon receptor nuclear translocator 2, CRYAB  -  crystallin, alpha b, ALDOC  -  aldolase c, fructose-bisphosphate, CCNG1  -  cyclin g1, JAK2  -  janus kinase 2, DLC1  -  deleted in liver cancer 1, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, TYRO3  -  tyro3 protein tyrosine kinase, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, MAP2K1  -  mitogen-activated protein kinase kinase 1, ZMIZ1  -  zinc finger, miz-type containing 1, TXNRD1  -  thioredoxin reductase 1, MAPK7  -  mitogen-activated protein kinase 7, SRPK2  -  srsf protein kinase 2, UCHL1  -  ubiquitin carboxyl-terminal esterase l1 (ubiquitin thiolesterase), CAT  -  catalase, CAV2  -  caveolin 2, PRKG1  -  protein kinase, cgmp-dependent, type i, COPS2  -  cop9 signalosome subunit 2, NREP  -  neuronal regeneration related protein, RUNX1T1  -  runt-related transcription factor 1; translocated to, 1 (cyclin d-related), KRIT1  -  krit1, ankyrin repeat containing, RTN1  -  reticulon 1, CSPG4  -  chondroitin sulfate proteoglycan 4, PRKCA  -  protein kinase c, alpha, GAS6  -  growth arrest-specific 6, GAS1  -  growth arrest-specific 1, CSRP2  -  cysteine and glycine-rich protein 2, GSN  -  gelsolin, CDH2  -  cadherin 2, type 1, n-cadherin (neuronal), TCF12  -  transcription factor 12, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), MID1  -  midline 1 (opitz/bbb syndrome), PAX7  -  paired box 7, PBX1  -  pre-b-cell leukemia homeobox 1, GAB2  -  grb2-associated binding protein 2, FLNA  -  filamin a, alpha, FLNB  -  filamin b, beta, PCDH1  -  protocadherin 1, ARC  -  activity-regulated cytoskeleton-associated protein, FARP2  -  ferm, rhogef and pleckstrin domain protein 2, FOXO1  -  forkhead box o1, DBP  -  d site of albumin promoter (albumin d-box) binding protein, KMT2A  -  lysine (k)-specific methyltransferase 2a, SIN3B  -  sin3 transcription regulator family member b, FOXC1  -  forkhead box c1, DOK5  -  docking protein 5, CRLF1  -  cytokine receptor-like factor 1, DFNA5  -  deafness, autosomal dominant 5, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, PDLIM7  -  pdz and lim domain 7 (enigma), PDCD10  -  programmed cell death 10, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, FOXF2  -  forkhead box f2, LMO4  -  lim domain only 4, MMP11  -  matrix metallopeptidase 11 (stromelysin 3), PDPN  -  podoplanin, TDG  -  thymine-dna glycosylase, GYS1  -  glycogen synthase 1 (muscle), LPPR4  -  lipid phosphate phosphatase-related protein type 4, APP  -  amyloid beta (a4) precursor protein, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, WWOX  -  ww domain containing oxidoreductase, TNFRSF11B  -  tumor necrosis factor receptor superfamily, member 11b, PDGFA  -  platelet-derived growth factor alpha polypeptide, ITGA5  -  integrin, alpha 5 (fibronectin receptor, alpha polypeptide), ITGA7  -  integrin, alpha 7, FGFR1  -  fibroblast growth factor receptor 1, MDK  -  midkine (neurite growth-promoting factor 2), ROR2  -  receptor tyrosine kinase-like orphan receptor 2, MAML1  -  mastermind-like 1 (drosophila), PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, ITGA3  -  integrin, alpha 3 (antigen cd49c, alpha 3 subunit of vla-3 receptor), FGF7  -  fibroblast growth factor 7, MECP2  -  methyl cpg binding protein 2 (rett syndrome), SEMA3C  -  sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3c, RHOB  -  ras homolog family member b, ITGB5  -  integrin, beta 5, PDPK1  -  3-phosphoinositide dependent protein kinase-1, MEA1  -  male-enhanced antigen 1, FGF4  -  fibroblast growth factor 4, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, INPPL1  -  inositol polyphosphate phosphatase-like 1, RNF114  -  ring finger protein 114, TBX2  -  t-box 2, DAG1  -  dystroglycan 1 (dystrophin-associated glycoprotein 1), CDKN1C  -  cyclin-dependent kinase inhibitor 1c (p57, kip2), KAT8  -  k(lysine) acetyltransferase 8, ASS1  -  argininosuccinate synthase 1, ASPH  -  aspartate beta-hydroxylase, SRGAP2  -  slit-robo rho gtpase activating protein 2, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), SAT1  -  spermidine/spermine n1-acetyltransferase 1, PPAP2B  -  phosphatidic acid phosphatase type 2b, CDH13  -  cadherin 13, h-cadherin (heart), HDAC1  -  histone deacetylase 1, ITGA6  -  integrin, alpha 6, SALL2  -  sal-like 2 (drosophila), PDLIM3  -  pdz and lim domain 3, RAD1  -  rad1 homolog (s. pombe), CHRND  -  cholinergic receptor, nicotinic, delta (muscle), PGK1  -  phosphoglycerate kinase 1, CHRNB1  -  cholinergic receptor, nicotinic, beta 1 (muscle), SMC3  -  structural maintenance of chromosomes 3, TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), ZHX2  -  zinc fingers and homeoboxes 2, INA  -  internexin neuronal intermediate filament protein, alpha, GPC1  -  glypican 1, RAB14  -  rab14, member ras oncogene family, GPI  -  glucose-6-phosphate isomerase, DPYSL2  -  dihydropyrimidinase-like 2, NOTCH3  -  notch 3, SLC12A2  -  solute carrier family 12 (sodium/potassium/chloride transporter), member 2, PVRL2  -  poliovirus receptor-related 2 (herpesvirus entry mediator b), ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, HDAC4  -  histone deacetylase 4, ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, WEE1  -  wee1 homolog (s. pombe), NFIX  -  nuclear factor i/x (ccaat-binding transcription factor), ATP6V1B1  -  atpase, h+ transporting, lysosomal 56/58kda, v1 subunit b1, WNT5A  -  wingless-type mmtv integration site family, member 5a, PFDN1  -  prefoldin subunit 1, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, RAB13  -  rab13, member ras oncogene family, SMTN  -  smoothelin, DLD  -  dihydrolipoamide dehydrogenase, TEK  -  tek tyrosine kinase, endothelial, RECK  -  reversion-inducing-cysteine-rich protein with kazal motifs, RBPJ  -  recombination signal binding protein for immunoglobulin kappa j region, SHH  -  sonic hedgehog, ATF5  -  activating transcription factor 5, LUM  -  lumican, PLAGL1  -  pleiomorphic adenoma gene-like 1, FEZ1  -  fasciculation and elongation protein zeta 1 (zygin i), ATR  -  ataxia telangiectasia and rad3 related, TPP1  -  tripeptidyl peptidase i, SMARCA5  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5, SERPINE2  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 2, IGF1R  -  insulin-like growth factor 1 receptor, IGF2  -  insulin-like growth factor 2 (somatomedin a), SRSF1  -  serine/arginine-rich splicing factor 1, TGFB1  -  transforming growth factor, beta 1, TGFB1I1  -  transforming growth factor beta 1 induced transcript 1, TGIF1  -  tgfb-induced factor homeobox 1, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), PHB2  -  prohibitin 2, TGFBR3  -  transforming growth factor, beta receptor iii, DMD  -  dystrophin, CXCL1  -  chemokine (c-x-c motif) ligand 1 (melanoma growth stimulating activity, alpha), SMAD6  -  smad family member 6, GSK3B  -  glycogen synthase kinase 3 beta, MAF  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog]"GO:1901565,organonitrogen compound catabolic process,7.11E-05,2.08E-02,1.77,8230,317,850,58,"[FMOD  -  fibromodulin, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, PDE5A  -  phosphodiesterase 5a, cgmp-specific, BCKDK  -  branched chain ketoacid dehydrogenase kinase, SEPT5  -  septin 5, GPC1  -  glypican 1, GCSH  -  glycine cleavage system protein h (aminomethyl carrier), RAB14  -  rab14, member ras oncogene family, PRELP  -  proline/arginine-rich end leucine-rich repeat protein, GTF2H1  -  general transcription factor iih, polypeptide 1, 62kda, GCH1  -  gtp cyclohydrolase 1, HRAS  -  harvey rat sarcoma viral oncogene homolog, DPYSL2  -  dihydropyrimidinase-like 2, MSH6  -  muts homolog 6 (e. coli), ACAN  -  aggrecan, RIT1  -  ras-like without caax 1, PEX6  -  peroxisomal biogenesis factor 6, CTSH  -  cathepsin h, BGN  -  biglycan, SMPD4  -  sphingomyelin phosphodiesterase 4, neutral membrane (neutral sphingomyelinase-3), MYO10  -  myosin x, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, RAB2A  -  rab2a, member ras oncogene family, ARF1  -  adp-ribosylation factor 1, OGDH  -  oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide), TDG  -  thymine-dna glycosylase, SDC2  -  syndecan 2, TNNT3  -  troponin t type 3 (skeletal, fast), RAB13  -  rab13, member ras oncogene family, DLD  -  dihydrolipoamide dehydrogenase, MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), RAB33A  -  rab33a, member ras oncogene family, RAB9A  -  rab9a, member ras oncogene family, MYH10  -  myosin, heavy chain 10, non-muscle, GPX1  -  glutathione peroxidase 1, RHOB  -  ras homolog family member b, FGF2  -  fibroblast growth factor 2 (basic), LUM  -  lumican, ADA  -  adenosine deaminase, DDX17  -  dead (asp-glu-ala-asp) box helicase 17, TPP1  -  tripeptidyl peptidase i, RHOG  -  ras homolog family member g, SMARCA5  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5, TGFB1  -  transforming growth factor, beta 1, DNM2  -  dynamin 2, GNB1  -  guanine nucleotide binding protein (g protein), beta polypeptide 1, CAT  -  catalase, SMARCA2  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, RBBP4  -  retinoblastoma binding protein 4, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, HEXA  -  hexosaminidase a (alpha polypeptide), SAT1  -  spermidine/spermine n1-acetyltransferase 1, CSPG4  -  chondroitin sulfate proteoglycan 4, CBS  -  cystathionine-beta-synthase, VCAN  -  versican, ECE1  -  endothelin converting enzyme 1, MPG  -  n-methylpurine-dna glycosylase, RAB7L1  -  rab7, member ras oncogene family-like 1]"GO:0048856,anatomical structure development,7.86E-05,2.25E-02,1.29,8230,1742,863,235,"[NDN  -  necdin, melanoma antigen (mage) family member, ELN  -  elastin, BPGM  -  2,3-bisphosphoglycerate mutase, IQGAP1  -  iq motif containing gtpase activating protein 1, SPG7  -  spastic paraplegia 7 (pure and complicated autosomal recessive), EPAS1  -  endothelial pas domain protein 1, LDHA  -  lactate dehydrogenase a, LGALS3  -  lectin, galactoside-binding, soluble, 3, NBL1  -  neuroblastoma 1, dan family bmp antagonist, TRAF4  -  tnf receptor-associated factor 4, ASIC2  -  acid-sensing (proton-gated) ion channel 2, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, SOX9  -  sry (sex determining region y)-box 9, SOX4  -  sry (sex determining region y)-box 4, BID  -  bh3 interacting domain death agonist, NACA  -  nascent polypeptide-associated complex alpha subunit, BMP1  -  bone morphogenetic protein 1, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, GJA1  -  gap junction protein, alpha 1, 43kda, SOD2  -  superoxide dismutase 2, mitochondrial, SOD1  -  superoxide dismutase 1, soluble, BMPR1A  -  bone morphogenetic protein receptor, type ia, EIF4G1  -  eukaryotic translation initiation factor 4 gamma, 1, CREB1  -  camp responsive element binding protein 1, LMNA  -  lamin a/c, BMP4  -  bone morphogenetic protein 4, ICAM1  -  intercellular adhesion molecule 1, MYH10  -  myosin, heavy chain 10, non-muscle, EGFR  -  epidermal growth factor receptor, FZD7  -  frizzled family receptor 7, ADA  -  adenosine deaminase, MED1  -  mediator complex subunit 1, EFNB2  -  ephrin-b2, EIF2B4  -  eukaryotic translation initiation factor 2b, subunit 4 delta, 67kda, KRT14  -  keratin 14, KRT16  -  keratin 16, COL9A2  -  collagen, type ix, alpha 2, ADD1  -  adducin 1 (alpha), GNB1  -  guanine nucleotide binding protein (g protein), beta polypeptide 1, EIF4E2  -  eukaryotic translation initiation factor 4e family member 2, SGCE  -  sarcoglycan, epsilon, CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, SMARCA2  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, ADM  -  adrenomedullin, LAMA5  -  laminin, alpha 5, LAMA4  -  laminin, alpha 4, FSTL3  -  follistatin-like 3 (secreted glycoprotein), COL11A1  -  collagen, type xi, alpha 1, ECE1  -  endothelin converting enzyme 1, AKR1C3  -  aldo-keto reductase family 1, member c3, QKI  -  qki, kh domain containing, rna binding, AEBP1  -  ae binding protein 1, CAMK2G  -  calcium/calmodulin-dependent protein kinase ii gamma, AGT  -  angiotensinogen (serpin peptidase inhibitor, clade a, member 8), SPG20  -  spastic paraplegia 20 (troyer syndrome), PRELP  -  proline/arginine-rich end leucine-rich repeat protein, NFASC  -  neurofascin, COL14A1  -  collagen, type xiv, alpha 1, SVIL  -  supervillin, ACAN  -  aggrecan, GPNMB  -  glycoprotein (transmembrane) nmb, TAB2  -  tgf-beta activated kinase 1/map3k7 binding protein 2, PITPNB  -  phosphatidylinositol transfer protein, beta, AK2  -  adenylate kinase 2, CTSH  -  cathepsin h, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, EZR  -  ezrin, AHR  -  aryl hydrocarbon receptor, DDR1  -  discoidin domain receptor tyrosine kinase 1, SEMA4F  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4f, PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, EZH2  -  enhancer of zeste homolog 2 (drosophila), VCAM1  -  vascular cell adhesion molecule 1, CRIP2  -  cysteine-rich protein 2, CRIP1  -  cysteine-rich protein 1 (intestinal), MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), CRKL  -  v-crk avian sarcoma virus ct10 oncogene homolog-like, FOSL1  -  fos-like antigen 1, HOXB2  -  homeobox b2, PRPS1  -  phosphoribosyl pyrophosphate synthetase 1, JUN  -  jun proto-oncogene, ADAM19  -  adam metallopeptidase domain 19, STAT1  -  signal transducer and activator of transcription 1, 91kda, STAT3  -  signal transducer and activator of transcription 3 (acute-phase response factor), ARNT2  -  aryl-hydrocarbon receptor nuclear translocator 2, CRYAB  -  crystallin, alpha b, ALDOC  -  aldolase c, fructose-bisphosphate, CCNG1  -  cyclin g1, FXR1  -  fragile x mental retardation, autosomal homolog 1, JAK2  -  janus kinase 2, DLC1  -  deleted in liver cancer 1, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, TYRO3  -  tyro3 protein tyrosine kinase, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, MAP2K1  -  mitogen-activated protein kinase kinase 1, ZMIZ1  -  zinc finger, miz-type containing 1, UCHL1  -  ubiquitin carboxyl-terminal esterase l1 (ubiquitin thiolesterase), MAPK3  -  mitogen-activated protein kinase 3, CAT  -  catalase, PLCE1  -  phospholipase c, epsilon 1, CAV2  -  caveolin 2, PRKG1  -  protein kinase, cgmp-dependent, type i, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, FADD  -  fas (tnfrsf6)-associated via death domain, RYK  -  receptor-like tyrosine kinase, NREP  -  neuronal regeneration related protein, VCAN  -  versican, CBS  -  cystathionine-beta-synthase, GAS6  -  growth arrest-specific 6, NUPR1  -  nuclear protein, transcriptional regulator, 1, GAS1  -  growth arrest-specific 1, SECTM1  -  secreted and transmembrane 1, FMR1  -  fragile x mental retardation 1, GSN  -  gelsolin, TCF12  -  transcription factor 12, HEXIM1  -  hexamethylene bis-acetamide inducible 1, PAX7  -  paired box 7, PBX1  -  pre-b-cell leukemia homeobox 1, HTRA2  -  htra serine peptidase 2, FLNB  -  filamin b, beta, PCDH1  -  protocadherin 1, ARC  -  activity-regulated cytoskeleton-associated protein, FOXO1  -  forkhead box o1, DBP  -  d site of albumin promoter (albumin d-box) binding protein, SEMA3F  -  sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3f, KMT2A  -  lysine (k)-specific methyltransferase 2a, SIN3B  -  sin3 transcription regulator family member b, FOXC1  -  forkhead box c1, DOK5  -  docking protein 5, CRLF1  -  cytokine receptor-like factor 1, FOXF2  -  forkhead box f2, LMO4  -  lim domain only 4, OGDH  -  oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide), PDPN  -  podoplanin, TDG  -  thymine-dna glycosylase, GYS1  -  glycogen synthase 1 (muscle), APOE  -  apolipoprotein e, COPS3  -  cop9 signalosome subunit 3, APP  -  amyloid beta (a4) precursor protein, AQP1  -  aquaporin 1 (colton blood group), TNFRSF11B  -  tumor necrosis factor receptor superfamily, member 11b, PDGFA  -  platelet-derived growth factor alpha polypeptide, ITGA7  -  integrin, alpha 7, FGFR1  -  fibroblast growth factor receptor 1, MDK  -  midkine (neurite growth-promoting factor 2), DDR2  -  discoidin domain receptor tyrosine kinase 2, MAML1  -  mastermind-like 1 (drosophila), FGF5  -  fibroblast growth factor 5, PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, ITGA3  -  integrin, alpha 3 (antigen cd49c, alpha 3 subunit of vla-3 receptor), FGF7  -  fibroblast growth factor 7, MECP2  -  methyl cpg binding protein 2 (rett syndrome), SEMA3C  -  sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3c, MEF2A  -  myocyte enhancer factor 2a, PDPK1  -  3-phosphoinositide dependent protein kinase-1, FGF2  -  fibroblast growth factor 2 (basic), MEA1  -  male-enhanced antigen 1, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, CEBPB  -  ccaat/enhancer binding protein (c/ebp), beta, MEOX2  -  mesenchyme homeobox 2, PTN  -  pleiotrophin, TBX2  -  t-box 2, NPR3  -  natriuretic peptide receptor c/guanylate cyclase c (atrionatriuretic peptide receptor c), CDKN1C  -  cyclin-dependent kinase inhibitor 1c (p57, kip2), ASS1  -  argininosuccinate synthase 1, ASPH  -  aspartate beta-hydroxylase, SRGAP2  -  slit-robo rho gtpase activating protein 2, TIPARP  -  tcdd-inducible poly(adp-ribose) polymerase, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), HEXA  -  hexosaminidase a (alpha polypeptide), PPAP2B  -  phosphatidic acid phosphatase type 2b, ZFAND5  -  zinc finger, an1-type domain 5, HDAC1  -  histone deacetylase 1, SALL2  -  sal-like 2 (drosophila), PDLIM3  -  pdz and lim domain 3, RAD1  -  rad1 homolog (s. pombe), PURA  -  purine-rich element binding protein a, CHRNB1  -  cholinergic receptor, nicotinic, beta 1 (muscle), EPN2  -  epsin 2, IFI16  -  interferon, gamma-inducible protein 16, INA  -  internexin neuronal intermediate filament protein, alpha, RAB14  -  rab14, member ras oncogene family, DZIP1  -  daz interacting zinc finger protein 1, DPYSL2  -  dihydropyrimidinase-like 2, NOTCH3  -  notch 3, PVRL2  -  poliovirus receptor-related 2 (herpesvirus entry mediator b), ZFHX3  -  zinc finger homeobox 3, ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, HDAC4  -  histone deacetylase 4, ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, NGF  -  nerve growth factor (beta polypeptide), MATN2  -  matrilin 2, NFIX  -  nuclear factor i/x (ccaat-binding transcription factor), WNT5A  -  wingless-type mmtv integration site family, member 5a, LDB2  -  lim domain binding 2, ASH2L  -  ash2 (absent, small, or homeotic)-like (drosophila), PFDN1  -  prefoldin subunit 1, RAB13  -  rab13, member ras oncogene family, SMTN  -  smoothelin, TEK  -  tek tyrosine kinase, endothelial, DDIT4  -  dna-damage-inducible transcript 4, LTB  -  lymphotoxin beta (tnf superfamily, member 3), RBPJ  -  recombination signal binding protein for immunoglobulin kappa j region, SHH  -  sonic hedgehog, GPX1  -  glutathione peroxidase 1, DLX5  -  distal-less homeobox 5, ATF5  -  activating transcription factor 5, LUM  -  lumican, FEZ1  -  fasciculation and elongation protein zeta 1 (zygin i), NF2  -  neurofibromin 2 (merlin), TPP1  -  tripeptidyl peptidase i, SMARCA5  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5, SERPINE2  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 2, IGF1R  -  insulin-like growth factor 1 receptor, IGF2  -  insulin-like growth factor 2 (somatomedin a), SRSF1  -  serine/arginine-rich splicing factor 1, TGFB1  -  transforming growth factor, beta 1, SMAD2  -  smad family member 2, IGFBP1  -  insulin-like growth factor binding protein 1, BCL6  -  b-cell cll/lymphoma 6, TGIF1  -  tgfb-induced factor homeobox 1, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), PHB2  -  prohibitin 2, TGFBR3  -  transforming growth factor, beta receptor iii, NR3C1  -  nuclear receptor subfamily 3, group c, member 1 (glucocorticoid receptor), DMD  -  dystrophin, FOS  -  fbj murine osteosarcoma viral oncogene homolog, CXCL1  -  chemokine (c-x-c motif) ligand 1 (melanoma growth stimulating activity, alpha), SMAD3  -  smad family member 3, CKB  -  creatine kinase, brain, SMAD6  -  smad family member 6, CCND1  -  cyclin d1, GSK3B  -  glycogen synthase kinase 3 beta, MAF  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog, SH3GL1  -  sh3-domain grb2-like 1]"GO:0071363,cellular response to growth factor stimulus,7.96E-05,2.22E-02,2.26,8230,458,262,33,"[PDGFA  -  platelet-derived growth factor alpha polypeptide, FGFR1  -  fibroblast growth factor receptor 1, FGF7  -  fibroblast growth factor 7, PDPK1  -  3-phosphoinositide dependent protein kinase-1, FGF4  -  fibroblast growth factor 4, NCOR2  -  nuclear receptor corepressor 2, FEZ1  -  fasciculation and elongation protein zeta 1 (zygin i), RAB14  -  rab14, member ras oncogene family, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, MED1  -  mediator complex subunit 1, MAP2K1  -  mitogen-activated protein kinase kinase 1, RIT1  -  ras-like without caax 1, ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, MAPK7  -  mitogen-activated protein kinase 7, NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, SOX9  -  sry (sex determining region y)-box 9, CAT  -  catalase, TGIF1  -  tgfb-induced factor homeobox 1, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), BAMBI  -  bmp and activin membrane-bound inhibitor, TGFBR3  -  transforming growth factor, beta receptor iii, PARP1  -  poly (adp-ribose) polymerase 1, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, SMAD6  -  smad family member 6, GSK3B  -  glycogen synthase kinase 3 beta, WWOX  -  ww domain containing oxidoreductase, GAS6  -  growth arrest-specific 6, HDAC1  -  histone deacetylase 1, ITSN1  -  intersectin 1 (sh3 domain protein), BMP4  -  bone morphogenetic protein 4]"GO:0048589,developmental growth,8.29E-05,2.25E-02,2.33,8230,117,906,30,"[CHRND  -  cholinergic receptor, nicotinic, delta (muscle), NDN  -  necdin, melanoma antigen (mage) family member, SHBG  -  sex hormone-binding globulin, SHH  -  sonic hedgehog, DDR2  -  discoidin domain receptor tyrosine kinase 2, GSN  -  gelsolin, SLIT2  -  slit homolog 2 (drosophila), GPX1  -  glutathione peroxidase 1, PAX7  -  paired box 7, AGT  -  angiotensinogen (serpin peptidase inhibitor, clade a, member 8), PSEN2  -  presenilin 2 (alzheimer disease 4), NBN  -  nibrin, SEMA3F  -  sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3f, ZMIZ1  -  zinc finger, miz-type containing 1, SLC12A2  -  solute carrier family 12 (sodium/potassium/chloride transporter), member 2, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, TBX2  -  t-box 2, TGFB1  -  transforming growth factor, beta 1, SMAD2  -  smad family member 2, IGFBP1  -  insulin-like growth factor binding protein 1, SOX9  -  sry (sex determining region y)-box 9, NACA  -  nascent polypeptide-associated complex alpha subunit, GJA1  -  gap junction protein, alpha 1, 43kda, GAP43  -  growth associated protein 43, ADM  -  adrenomedullin, APP  -  amyloid beta (a4) precursor protein, BMPR1A  -  bone morphogenetic protein receptor, type ia, SMAD3  -  smad family member 3, GAS1  -  growth arrest-specific 1, BMP4  -  bone morphogenetic protein 4]"GO:0044767,single-organism developmental process,8.30E-05,2.20E-02,1.28,8230,2440,578,220,"[BNIP3  -  bcl2/adenovirus e1b 19kda interacting protein 3, NDN  -  necdin, melanoma antigen (mage) family member, BNIP2  -  bcl2/adenovirus e1b 19kda interacting protein 2, ABLIM1  -  actin binding lim protein 1, ELN  -  elastin, BPGM  -  2,3-bisphosphoglycerate mutase, IQGAP1  -  iq motif containing gtpase activating protein 1, LGALS3  -  lectin, galactoside-binding, soluble, 3, HRAS  -  harvey rat sarcoma viral oncogene homolog, NBN  -  nibrin, NBL1  -  neuroblastoma 1, dan family bmp antagonist, TRAF4  -  tnf receptor-associated factor 4, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, SOX9  -  sry (sex determining region y)-box 9, SOX4  -  sry (sex determining region y)-box 4, PIKFYVE  -  phosphoinositide kinase, fyve finger containing, NDEL1  -  nude neurodevelopment protein 1-like 1, BMP1  -  bone morphogenetic protein 1, MYLK  -  myosin light chain kinase, GJA1  -  gap junction protein, alpha 1, 43kda, SOD2  -  superoxide dismutase 2, mitochondrial, BMPR1A  -  bone morphogenetic protein receptor, type ia, EIF4G1  -  eukaryotic translation initiation factor 4 gamma, 1, SERPINF2  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 2, LMNA  -  lamin a/c, BMP4  -  bone morphogenetic protein 4, PPL  -  periplakin, LITAF  -  lipopolysaccharide-induced tnf factor, MYH10  -  myosin, heavy chain 10, non-muscle, TBPL1  -  tbp-like 1, EGFR  -  epidermal growth factor receptor, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, FZD7  -  frizzled family receptor 7, ADA  -  adenosine deaminase, MED1  -  mediator complex subunit 1, CNR1  -  cannabinoid receptor 1 (brain), RNF2  -  ring finger protein 2, EFNB2  -  ephrin-b2, EFNB1  -  ephrin-b1, COL8A1  -  collagen, type viii, alpha 1, EIF4E2  -  eukaryotic translation initiation factor 4e family member 2, ADH5  -  alcohol dehydrogenase 5 (class iii), chi polypeptide, CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, SMARCA2  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, PARP1  -  poly (adp-ribose) polymerase 1, ADM  -  adrenomedullin, LAMA5  -  laminin, alpha 5, LAMA4  -  laminin, alpha 4, COL11A1  -  collagen, type xi, alpha 1, ECE1  -  endothelin converting enzyme 1, LAMB1  -  laminin, beta 1, ERC1  -  elks/rab6-interacting/cast family member 1, AKR1C3  -  aldo-keto reductase family 1, member c3, QKI  -  qki, kh domain containing, rna binding, CAMK2G  -  calcium/calmodulin-dependent protein kinase ii gamma, AIMP2  -  aminoacyl trna synthetase complex-interacting multifunctional protein 2, GPNMB  -  glycoprotein (transmembrane) nmb, TAB2  -  tgf-beta activated kinase 1/map3k7 binding protein 2, PITPNB  -  phosphatidylinositol transfer protein, beta, AK2  -  adenylate kinase 2, CTSH  -  cathepsin h, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, VEGFC  -  vascular endothelial growth factor c, PLXND1  -  plexin d1, EPB41L3  -  erythrocyte membrane protein band 4.1-like 3, AHR  -  aryl hydrocarbon receptor, DDR1  -  discoidin domain receptor tyrosine kinase 1, VCAM1  -  vascular cell adhesion molecule 1, VDAC1  -  voltage-dependent anion channel 1, CRIP2  -  cysteine-rich protein 2, ERF  -  ets2 repressor factor, CRIP1  -  cysteine-rich protein 1 (intestinal), MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), FOSL1  -  fos-like antigen 1, HOXB2  -  homeobox b2, ADAM19  -  adam metallopeptidase domain 19, JUN  -  jun proto-oncogene, STAT1  -  signal transducer and activator of transcription 1, 91kda, ARNT2  -  aryl-hydrocarbon receptor nuclear translocator 2, CRYAB  -  crystallin, alpha b, ALDOC  -  aldolase c, fructose-bisphosphate, CCNG1  -  cyclin g1, JAK2  -  janus kinase 2, DLC1  -  deleted in liver cancer 1, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, TYRO3  -  tyro3 protein tyrosine kinase, MAP2K1  -  mitogen-activated protein kinase kinase 1, ZMIZ1  -  zinc finger, miz-type containing 1, TXNRD1  -  thioredoxin reductase 1, MAPK7  -  mitogen-activated protein kinase 7, SRPK2  -  srsf protein kinase 2, UCHL1  -  ubiquitin carboxyl-terminal esterase l1 (ubiquitin thiolesterase), CAT  -  catalase, CAV2  -  caveolin 2, PRKG1  -  protein kinase, cgmp-dependent, type i, COPS2  -  cop9 signalosome subunit 2, RUNX1T1  -  runt-related transcription factor 1; translocated to, 1 (cyclin d-related), NREP  -  neuronal regeneration related protein, KRIT1  -  krit1, ankyrin repeat containing, RTN1  -  reticulon 1, CSPG4  -  chondroitin sulfate proteoglycan 4, PRKCA  -  protein kinase c, alpha, GAS6  -  growth arrest-specific 6, GAS1  -  growth arrest-specific 1, CSRP2  -  cysteine and glycine-rich protein 2, GSN  -  gelsolin, CDH2  -  cadherin 2, type 1, n-cadherin (neuronal), TCF12  -  transcription factor 12, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), MID1  -  midline 1 (opitz/bbb syndrome), PAX7  -  paired box 7, PBX1  -  pre-b-cell leukemia homeobox 1, GAB2  -  grb2-associated binding protein 2, FLNA  -  filamin a, alpha, FLNB  -  filamin b, beta, ARC  -  activity-regulated cytoskeleton-associated protein, FARP2  -  ferm, rhogef and pleckstrin domain protein 2, FOXO1  -  forkhead box o1, DBP  -  d site of albumin promoter (albumin d-box) binding protein, KMT2A  -  lysine (k)-specific methyltransferase 2a, FOXC1  -  forkhead box c1, DFNA5  -  deafness, autosomal dominant 5, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, PDCD10  -  programmed cell death 10, PDLIM7  -  pdz and lim domain 7 (enigma), PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, FOXF2  -  forkhead box f2, LMO4  -  lim domain only 4, MMP11  -  matrix metallopeptidase 11 (stromelysin 3), PDPN  -  podoplanin, TDG  -  thymine-dna glycosylase, GYS1  -  glycogen synthase 1 (muscle), LPPR4  -  lipid phosphate phosphatase-related protein type 4, APP  -  amyloid beta (a4) precursor protein, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, WWOX  -  ww domain containing oxidoreductase, PDGFA  -  platelet-derived growth factor alpha polypeptide, ITGA5  -  integrin, alpha 5 (fibronectin receptor, alpha polypeptide), ITGA7  -  integrin, alpha 7, FGFR1  -  fibroblast growth factor receptor 1, MDK  -  midkine (neurite growth-promoting factor 2), ROR2  -  receptor tyrosine kinase-like orphan receptor 2, MAML1  -  mastermind-like 1 (drosophila), PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, ITGA3  -  integrin, alpha 3 (antigen cd49c, alpha 3 subunit of vla-3 receptor), FGF7  -  fibroblast growth factor 7, MECP2  -  methyl cpg binding protein 2 (rett syndrome), SEMA3C  -  sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3c, RHOB  -  ras homolog family member b, ITGB5  -  integrin, beta 5, PDPK1  -  3-phosphoinositide dependent protein kinase-1, MEA1  -  male-enhanced antigen 1, FGF4  -  fibroblast growth factor 4, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, INPPL1  -  inositol polyphosphate phosphatase-like 1, RNF114  -  ring finger protein 114, TBX2  -  t-box 2, DAG1  -  dystroglycan 1 (dystrophin-associated glycoprotein 1), CDKN1C  -  cyclin-dependent kinase inhibitor 1c (p57, kip2), KAT8  -  k(lysine) acetyltransferase 8, ASS1  -  argininosuccinate synthase 1, ASPH  -  aspartate beta-hydroxylase, SRGAP2  -  slit-robo rho gtpase activating protein 2, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), SAT1  -  spermidine/spermine n1-acetyltransferase 1, PPAP2B  -  phosphatidic acid phosphatase type 2b, CDH13  -  cadherin 13, h-cadherin (heart), HDAC1  -  histone deacetylase 1, ITGA6  -  integrin, alpha 6, SALL2  -  sal-like 2 (drosophila), PDLIM3  -  pdz and lim domain 3, CHRND  -  cholinergic receptor, nicotinic, delta (muscle), PGK1  -  phosphoglycerate kinase 1, CHRNB1  -  cholinergic receptor, nicotinic, beta 1 (muscle), SMC3  -  structural maintenance of chromosomes 3, TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), ZHX2  -  zinc fingers and homeoboxes 2, INA  -  internexin neuronal intermediate filament protein, alpha, GPC1  -  glypican 1, RAB14  -  rab14, member ras oncogene family, GPI  -  glucose-6-phosphate isomerase, DPYSL2  -  dihydropyrimidinase-like 2, NOTCH3  -  notch 3, SLC12A2  -  solute carrier family 12 (sodium/potassium/chloride transporter), member 2, PVRL2  -  poliovirus receptor-related 2 (herpesvirus entry mediator b), ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, HDAC4  -  histone deacetylase 4, ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, WEE1  -  wee1 homolog (s. pombe), NFIX  -  nuclear factor i/x (ccaat-binding transcription factor), ATP6V1B1  -  atpase, h+ transporting, lysosomal 56/58kda, v1 subunit b1, WNT5A  -  wingless-type mmtv integration site family, member 5a, PFDN1  -  prefoldin subunit 1, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, SMTN  -  smoothelin, RAB13  -  rab13, member ras oncogene family, DLD  -  dihydrolipoamide dehydrogenase, TEK  -  tek tyrosine kinase, endothelial, RECK  -  reversion-inducing-cysteine-rich protein with kazal motifs, RBPJ  -  recombination signal binding protein for immunoglobulin kappa j region, SHH  -  sonic hedgehog, ATF5  -  activating transcription factor 5, PLAGL1  -  pleiomorphic adenoma gene-like 1, ATR  -  ataxia telangiectasia and rad3 related, TPP1  -  tripeptidyl peptidase i, SMARCA5  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5, SERPINE2  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 2, IGF1R  -  insulin-like growth factor 1 receptor, IGF2  -  insulin-like growth factor 2 (somatomedin a), SRSF1  -  serine/arginine-rich splicing factor 1, TGFB1  -  transforming growth factor, beta 1, TGFB1I1  -  transforming growth factor beta 1 induced transcript 1, TGIF1  -  tgfb-induced factor homeobox 1, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), PHB2  -  prohibitin 2, TGFBR3  -  transforming growth factor, beta receptor iii, DMD  -  dystrophin, SMAD6  -  smad family member 6, GSK3B  -  glycogen synthase kinase 3 beta, MAF  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog]"GO:0044281,small molecule metabolic process,8.44E-05,2.19E-02,1.34,8230,1171,995,189,"[FMOD  -  fibromodulin, GSTM2  -  glutathione s-transferase mu 2 (muscle), GSTM1  -  glutathione s-transferase mu 1, PAICS  -  phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, GSTM4  -  glutathione s-transferase mu 4, SACM1L  -  sac1 suppressor of actin mutations 1-like (yeast), BCKDK  -  branched chain ketoacid dehydrogenase kinase, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), SEPT5  -  septin 5, ABCA1  -  atp-binding cassette, sub-family a (abc1), member 1, LDHB  -  lactate dehydrogenase b, RPIA  -  ribose 5-phosphate isomerase a, NCOR2  -  nuclear receptor corepressor 2, IQGAP1  -  iq motif containing gtpase activating protein 1, GCSH  -  glycine cleavage system protein h (aminomethyl carrier), PC  -  pyruvate carboxylase, LDHA  -  lactate dehydrogenase a, GTF2H1  -  general transcription factor iih, polypeptide 1, 62kda, PSMA1  -  proteasome (prosome, macropain) subunit, alpha type, 1, GCH1  -  gtp cyclohydrolase 1, ENO2  -  enolase 2 (gamma, neuronal), HRAS  -  harvey rat sarcoma viral oncogene homolog, ENO1  -  enolase 1, (alpha), NUBP1  -  nucleotide binding protein 1, MSH6  -  muts homolog 6 (e. coli), SIN3B  -  sin3 transcription regulator family member b, RIT1  -  ras-like without caax 1, MYO10  -  myosin x, SMPD4  -  sphingomyelin phosphodiesterase 4, neutral membrane (neutral sphingomyelinase-3), BGN  -  biglycan, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, NT5C2  -  5'-nucleotidase, cytosolic ii, P4HB  -  prolyl 4-hydroxylase, beta polypeptide, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, PSMB9  -  proteasome (prosome, macropain) subunit, beta type, 9, CYB5R1  -  cytochrome b5 reductase 1, PIKFYVE  -  phosphoinositide kinase, fyve finger containing, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, PSMB7  -  proteasome (prosome, macropain) subunit, beta type, 7, ARF1  -  adp-ribosylation factor 1, PLSCR1  -  phospholipid scramblase 1, PLTP  -  phospholipid transfer protein, PSMB4  -  proteasome (prosome, macropain) subunit, beta type, 4, BMP1  -  bone morphogenetic protein 1, OGDH  -  oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide), PDPN  -  podoplanin, TDG  -  thymine-dna glycosylase, SORD  -  sorbitol dehydrogenase, PLCB2  -  phospholipase c, beta 2, SDC2  -  syndecan 2, GYS1  -  glycogen synthase 1 (muscle), SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, GHR  -  growth hormone receptor, SYNJ1  -  synaptojanin 1, TST  -  thiosulfate sulfurtransferase (rhodanese), COASY  -  coa synthase, POM121  -  pom121 transmembrane nucleoporin, SOD2  -  superoxide dismutase 2, mitochondrial, APOE  -  apolipoprotein e, SOD1  -  superoxide dismutase 1, soluble, BLVRB  -  biliverdin reductase b (flavin reductase (nadph)), APP  -  amyloid beta (a4) precursor protein, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, GUSB  -  glucuronidase, beta, AQP1  -  aquaporin 1 (colton blood group), ADIPOR2  -  adiponectin receptor 2, PSMD11  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 11, PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), GLUL  -  glutamate-ammonia ligase, CTSA  -  cathepsin a, GNG12  -  guanine nucleotide binding protein (g protein), gamma 12, MYH10  -  myosin, heavy chain 10, non-muscle, TBPL1  -  tbp-like 1, PTGDS  -  prostaglandin d2 synthase 21kda (brain), MECP2  -  methyl cpg binding protein 2 (rett syndrome), RHOB  -  ras homolog family member b, FGF2  -  fibroblast growth factor 2 (basic), NUP98  -  nucleoporin 98kda, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, PDK3  -  pyruvate dehydrogenase kinase, isozyme 3, HADH  -  hydroxyacyl-coa dehydrogenase, ADA  -  adenosine deaminase, DDX17  -  dead (asp-glu-ala-asp) box helicase 17, MED1  -  mediator complex subunit 1, FDXR  -  ferredoxin reductase, PTGES  -  prostaglandin e synthase, RHOG  -  ras homolog family member g, PLIN2  -  perilipin 2, CHST15  -  carbohydrate (n-acetylgalactosamine 4-sulfate 6-o) sulfotransferase 15, INPPL1  -  inositol polyphosphate phosphatase-like 1, PLA2G15  -  phospholipase a2, group xv, GNB1  -  guanine nucleotide binding protein (g protein), beta polypeptide 1, ADH5  -  alcohol dehydrogenase 5 (class iii), chi polypeptide, ASS1  -  argininosuccinate synthase 1, CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, SMARCA2  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, INPP5A  -  inositol polyphosphate-5-phosphatase, 40kda, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, HEXA  -  hexosaminidase a (alpha polypeptide), SAT1  -  spermidine/spermine n1-acetyltransferase 1, PPAP2B  -  phosphatidic acid phosphatase type 2b, ADM  -  adrenomedullin, RAB7L1  -  rab7, member ras oncogene family-like 1, ECH1  -  enoyl coa hydratase 1, peroxisomal, AKR1C3  -  aldo-keto reductase family 1, member c3, QKI  -  qki, kh domain containing, rna binding, PGK1  -  phosphoglycerate kinase 1, PRKACB  -  protein kinase, camp-dependent, catalytic, beta, NADK  -  nad kinase, ACAA2  -  acetyl-coa acyltransferase 2, RFK  -  riboflavin kinase, PDE5A  -  phosphodiesterase 5a, cgmp-specific, SLC7A8  -  solute carrier family 7 (amino acid transporter light chain, l system), member 8, TKT  -  transketolase, PGD  -  phosphogluconate dehydrogenase, SLC16A3  -  solute carrier family 16 (monocarboxylate transporter), member 3, NME4  -  nme/nm23 nucleoside diphosphate kinase 4, NUPL2  -  nucleoporin like 2, SUPV3L1  -  suppressor of var1, 3-like 1 (s. cerevisiae), AHCYL1  -  adenosylhomocysteinase-like 1, GPC1  -  glypican 1, AGT  -  angiotensinogen (serpin peptidase inhibitor, clade a, member 8), RAB14  -  rab14, member ras oncogene family, PRELP  -  proline/arginine-rich end leucine-rich repeat protein, GPI  -  glucose-6-phosphate isomerase, CTPS1  -  ctp synthase 1, DPYSL3  -  dihydropyrimidinase-like 3, AIMP2  -  aminoacyl trna synthetase complex-interacting multifunctional protein 2, DPYSL2  -  dihydropyrimidinase-like 2, RPE  -  ribulose-5-phosphate-3-epimerase, ACAN  -  aggrecan, NFYA  -  nuclear transcription factor y, alpha, PITPNB  -  phosphatidylinositol transfer protein, beta, AK2  -  adenylate kinase 2, PEX6  -  peroxisomal biogenesis factor 6, RAB2A  -  rab2a, member ras oncogene family, SULT2B1  -  sulfotransferase family, cytosolic, 2b, member 1, SLC2A1  -  solute carrier family 2 (facilitated glucose transporter), member 1, ATP6V1B1  -  atpase, h+ transporting, lysosomal 56/58kda, v1 subunit b1, CYB5A  -  cytochrome b5 type a (microsomal), PFKL  -  phosphofructokinase, liver, B4GALT3  -  udp-gal:betaglcnac beta 1,4- galactosyltransferase, polypeptide 3, SLC2A3  -  solute carrier family 2 (facilitated glucose transporter), member 3, PFKP  -  phosphofructokinase, platelet, TNNT3  -  troponin t type 3 (skeletal, fast), IDH3B  -  isocitrate dehydrogenase 3 (nad+) beta, ALDH2  -  aldehyde dehydrogenase 2 family (mitochondrial), IDH2  -  isocitrate dehydrogenase 2 (nadp+), mitochondrial, RAB13  -  rab13, member ras oncogene family, DLD  -  dihydrolipoamide dehydrogenase, MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), RAB33A  -  rab33a, member ras oncogene family, RAN  -  ran, member ras oncogene family, RAB9A  -  rab9a, member ras oncogene family, PRPS1  -  phosphoribosyl pyrophosphate synthetase 1, GPX1  -  glutathione peroxidase 1, ALDOC  -  aldolase c, fructose-bisphosphate, ST6GAL1  -  st6 beta-galactosamide alpha-2,6-sialyltranferase 1, TNFSF4  -  tumor necrosis factor (ligand) superfamily, member 4, LUM  -  lumican, ST3GAL4  -  st3 beta-galactoside alpha-2,3-sialyltransferase 4, PKM  -  pyruvate kinase, muscle, TXNRD1  -  thioredoxin reductase 1, SMARCA5  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5, MGLL  -  monoglyceride lipase, TGFB1  -  transforming growth factor, beta 1, SLC23A2  -  solute carrier family 23 (ascorbic acid transporter), member 2, DNM2  -  dynamin 2, ACOT7  -  acyl-coa thioesterase 7, CAT  -  catalase, PLCE1  -  phospholipase c, epsilon 1, PHYH  -  phytanoyl-coa 2-hydroxylase, RBBP4  -  retinoblastoma binding protein 4, GBE1  -  glucan (1,4-alpha-), branching enzyme 1, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, SLC25A6  -  solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6, CSPG4  -  chondroitin sulfate proteoglycan 4, SLC25A4  -  solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4, NUP153  -  nucleoporin 153kda, CKB  -  creatine kinase, brain, PRKCA  -  protein kinase c, alpha, VCAN  -  versican, PRKAR1B  -  protein kinase, camp-dependent, regulatory, type i, beta, CBS  -  cystathionine-beta-synthase, MPG  -  n-methylpurine-dna glycosylase, P4HA2  -  prolyl 4-hydroxylase, alpha polypeptide ii, RBP1  -  retinol binding protein 1, cellular]"GO:0070848,response to growth factor,8.53E-05,2.16E-02,2.14,8230,473,301,37,"[RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), PDGFA  -  platelet-derived growth factor alpha polypeptide, FGFR1  -  fibroblast growth factor receptor 1, UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, FGF7  -  fibroblast growth factor 7, PDPK1  -  3-phosphoinositide dependent protein kinase-1, FGF4  -  fibroblast growth factor 4, NCOR2  -  nuclear receptor corepressor 2, LUM  -  lumican, FEZ1  -  fasciculation and elongation protein zeta 1 (zygin i), RAB14  -  rab14, member ras oncogene family, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, MED1  -  mediator complex subunit 1, HRAS  -  harvey rat sarcoma viral oncogene homolog, MAP2K1  -  mitogen-activated protein kinase kinase 1, RIT1  -  ras-like without caax 1, ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, MAPK7  -  mitogen-activated protein kinase 7, NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, CAT  -  catalase, SOX9  -  sry (sex determining region y)-box 9, TGIF1  -  tgfb-induced factor homeobox 1, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), BAMBI  -  bmp and activin membrane-bound inhibitor, TGFBR3  -  transforming growth factor, beta receptor iii, PARP1  -  poly (adp-ribose) polymerase 1, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, GSK3B  -  glycogen synthase kinase 3 beta, SMAD6  -  smad family member 6, WWOX  -  ww domain containing oxidoreductase, GAS6  -  growth arrest-specific 6, HDAC1  -  histone deacetylase 1, ITSN1  -  intersectin 1 (sh3 domain protein), BMP4  -  bone morphogenetic protein 4]"GO:0044763,single-organism cellular process,9.13E-05,2.26E-02,1.11,8230,5184,854,597,"[MAD2L1BP  -  mad2l1 binding protein, WTAP  -  wilms tumor 1 associated protein, SVEP1  -  sushi, von willebrand factor type a, egf and pentraxin domain containing 1, ABLIM1  -  actin binding lim protein 1, ABCA1  -  atp-binding cassette, sub-family a (abc1), member 1, SEPT5  -  septin 5, GEM  -  gtp binding protein overexpressed in skeletal muscle, SPN  -  sialophorin, NCOR2  -  nuclear receptor corepressor 2, SPG7  -  spastic paraplegia 7 (pure and complicated autosomal recessive), GCSH  -  glycine cleavage system protein h (aminomethyl carrier), LDHA  -  lactate dehydrogenase a, LGALS3  -  lectin, galactoside-binding, soluble, 3, GCH1  -  gtp cyclohydrolase 1, TRAF4  -  tnf receptor-associated factor 4, BLOC1S1  -  biogenesis of lysosomal organelles complex-1, subunit 1, ASIC2  -  acid-sensing (proton-gated) ion channel 2, SMPD4  -  sphingomyelin phosphodiesterase 4, neutral membrane (neutral sphingomyelinase-3), CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, SOX9  -  sry (sex determining region y)-box 9, SOX4  -  sry (sex determining region y)-box 4, ACR  -  acrosin, PLP2  -  proteolipid protein 2 (colonic epithelium-enriched), PLSCR1  -  phospholipid scramblase 1, PLTP  -  phospholipid transfer protein, SORD  -  sorbitol dehydrogenase, PLCB2  -  phospholipase c, beta 2, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, PLAUR  -  plasminogen activator, urokinase receptor, GJA1  -  gap junction protein, alpha 1, 43kda, SOD2  -  superoxide dismutase 2, mitochondrial, PLEC  -  plectin, CREB1  -  camp responsive element binding protein 1, LMNA  -  lamin a/c, SERPINF2  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 2, SNTA1  -  syntrophin, alpha 1, KRT19  -  keratin 19, ACTN1  -  actinin, alpha 1, CTSA  -  cathepsin a, PPIA  -  peptidylprolyl isomerase a (cyclophilin a), CNN1  -  calponin 1, basic, smooth muscle, LITAF  -  lipopolysaccharide-induced tnf factor, TBPL1  -  tbp-like 1, ADAR  -  adenosine deaminase, rna-specific, FZD7  -  frizzled family receptor 7, COL4A1  -  collagen, type iv, alpha 1, ADA  -  adenosine deaminase, CNN3  -  calponin 3, acidic, MED1  -  mediator complex subunit 1, KRT14  -  keratin 14, PTGES  -  prostaglandin e synthase, KRT16  -  keratin 16, KRT18  -  keratin 18, COL8A1  -  collagen, type viii, alpha 1, PLIN2  -  perilipin 2, CHST15  -  carbohydrate (n-acetylgalactosamine 4-sulfate 6-o) sulfotransferase 15, LAMP1  -  lysosomal-associated membrane protein 1, COL9A2  -  collagen, type ix, alpha 2, PLA2G15  -  phospholipase a2, group xv, ADD1  -  adducin 1 (alpha), GNB1  -  guanine nucleotide binding protein (g protein), beta polypeptide 1, COL4A5  -  collagen, type iv, alpha 5, ADH5  -  alcohol dehydrogenase 5 (class iii), chi polypeptide, SMARCA2  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, PARP1  -  poly (adp-ribose) polymerase 1, FZR1  -  fizzy/cell division cycle 20 related 1 (drosophila), ADM  -  adrenomedullin, LAMA5  -  laminin, alpha 5, LAMA4  -  laminin, alpha 4, COL11A1  -  collagen, type xi, alpha 1, POLR2B  -  polymerase (rna) ii (dna directed) polypeptide b, 140kda, PARP4  -  poly (adp-ribose) polymerase family, member 4, LAMB1  -  laminin, beta 1, QKI  -  qki, kh domain containing, rna binding, AEBP1  -  ae binding protein 1, SYT1  -  synaptotagmin i, NUPL2  -  nucleoporin like 2, AGT  -  angiotensinogen (serpin peptidase inhibitor, clade a, member 8), PRELP  -  proline/arginine-rich end leucine-rich repeat protein, FTH1  -  ferritin, heavy polypeptide 1, CTPS1  -  ctp synthase 1, AIMP2  -  aminoacyl trna synthetase complex-interacting multifunctional protein 2, PPP5C  -  protein phosphatase 5, catalytic subunit, KCNMB1  -  potassium large conductance calcium-activated channel, subfamily m, beta member 1, MAP4K4  -  mitogen-activated protein kinase kinase kinase kinase 4, ACAN  -  aggrecan, LPXN  -  leupaxin, CTSL  -  cathepsin l, PITPNB  -  phosphatidylinositol transfer protein, beta, AK2  -  adenylate kinase 2, CTSK  -  cathepsin k, CTSH  -  cathepsin h, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, CTSD  -  cathepsin d, SULT2B1  -  sulfotransferase family, cytosolic, 2b, member 1, AHR  -  aryl hydrocarbon receptor, STK3  -  serine/threonine kinase 3, CYB5A  -  cytochrome b5 type a (microsomal), PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, ALDH2  -  aldehyde dehydrogenase 2 family (mitochondrial), NEK7  -  nima-related kinase 7, CRKL  -  v-crk avian sarcoma virus ct10 oncogene homolog-like, RAB33A  -  rab33a, member ras oncogene family, FOSL1  -  fos-like antigen 1, RASSF7  -  ras association (ralgds/af-6) domain family (n-terminal) member 7, RAB9A  -  rab9a, member ras oncogene family, PRPS1  -  phosphoribosyl pyrophosphate synthetase 1, MFAP5  -  microfibrillar associated protein 5, CRY1  -  cryptochrome 1 (photolyase-like), JUN  -  jun proto-oncogene, STAT1  -  signal transducer and activator of transcription 1, 91kda, STAT3  -  signal transducer and activator of transcription 3 (acute-phase response factor), PROS1  -  protein s (alpha), PRNP  -  prion protein, CRYAB  -  crystallin, alpha b, ALDOC  -  aldolase c, fructose-bisphosphate, KAL1  -  kallmann syndrome 1 sequence, FXR1  -  fragile x mental retardation, autosomal homolog 1, SSRP1  -  structure specific recognition protein 1, JAK2  -  janus kinase 2, MAP2K1  -  mitogen-activated protein kinase kinase 1, MAP2K3  -  mitogen-activated protein kinase kinase 3, TRIP10  -  thyroid hormone receptor interactor 10, MAPK10  -  mitogen-activated protein kinase 10, MAPK7  -  mitogen-activated protein kinase 7, SRPK2  -  srsf protein kinase 2, MAPK3  -  mitogen-activated protein kinase 3, ASIC3  -  acid-sensing (proton-gated) ion channel 3, TRIM21  -  tripartite motif containing 21, PLCE1  -  phospholipase c, epsilon 1, PRKG1  -  protein kinase, cgmp-dependent, type i, AMPH  -  amphiphysin, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, COPS2  -  cop9 signalosome subunit 2, NREP  -  neuronal regeneration related protein, BAMBI  -  bmp and activin membrane-bound inhibitor, GBE1  -  glucan (1,4-alpha-), branching enzyme 1, RPL23  -  ribosomal protein l23, PRKCG  -  protein kinase c, gamma, CSPG4  -  chondroitin sulfate proteoglycan 4, SLC25A4  -  solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4, PRKCA  -  protein kinase c, alpha, VCAN  -  versican, GAS6  -  growth arrest-specific 6, GAS1  -  growth arrest-specific 1, CSRP2  -  cysteine and glycine-rich protein 2, TMEM123  -  transmembrane protein 123, APEX1  -  apex nuclease (multifunctional dna repair enzyme) 1, GSTM2  -  glutathione s-transferase mu 2 (muscle), GSTM1  -  glutathione s-transferase mu 1, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, GSTM4  -  glutathione s-transferase mu 4, PAWR  -  prkc, apoptosis, wt1, regulator, GSN  -  gelsolin, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), MID1  -  midline 1 (opitz/bbb syndrome), PAX7  -  paired box 7, DDB1  -  damage-specific dna binding protein 1, 127kda, CYTH3  -  cytohesin 3, PC  -  pyruvate carboxylase, GTF2H1  -  general transcription factor iih, polypeptide 1, 62kda, PCDH1  -  protocadherin 1, MSH6  -  muts homolog 6 (e. coli), KMT2A  -  lysine (k)-specific methyltransferase 2a, MMP1  -  matrix metallopeptidase 1 (interstitial collagenase), DFNA5  -  deafness, autosomal dominant 5, P4HB  -  prolyl 4-hydroxylase, beta polypeptide, PDLIM7  -  pdz and lim domain 7 (enigma), PDCD10  -  programmed cell death 10, ARF1  -  adp-ribosylation factor 1, MMP11  -  matrix metallopeptidase 11 (stromelysin 3), FURIN  -  furin (paired basic amino acid cleaving enzyme), SDC2  -  syndecan 2, GYS1  -  glycogen synthase 1 (muscle), NOLC1  -  nucleolar and coiled-body phosphoprotein 1, APOE  -  apolipoprotein e, APP  -  amyloid beta (a4) precursor protein, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, WWOX  -  ww domain containing oxidoreductase, IL32  -  interleukin 32, AQP1  -  aquaporin 1 (colton blood group), CEP250  -  centrosomal protein 250kda, PDGFA  -  platelet-derived growth factor alpha polypeptide, MDK  -  midkine (neurite growth-promoting factor 2), TUBA1A  -  tubulin, alpha 1a, ATXN1  -  ataxin 1, PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, RHOB  -  ras homolog family member b, MECP2  -  methyl cpg binding protein 2 (rett syndrome), RHOC  -  ras homolog family member c, MEF2A  -  myocyte enhancer factor 2a, PDPK1  -  3-phosphoinositide dependent protein kinase-1, MEA1  -  male-enhanced antigen 1, HADH  -  hydroxyacyl-coa dehydrogenase, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, AMIGO2  -  adhesion molecule with ig-like domain 2, RHOG  -  ras homolog family member g, GORASP2  -  golgi reassembly stacking protein 2, 55kda, MEOX2  -  mesenchyme homeobox 2, ZYX  -  zyxin, DGKA  -  diacylglycerol kinase, alpha 80kda, DAG1  -  dystroglycan 1 (dystrophin-associated glycoprotein 1), KAT8  -  k(lysine) acetyltransferase 8, ASS1  -  argininosuccinate synthase 1, ASPH  -  aspartate beta-hydroxylase, DAPK1  -  death-associated protein kinase 1, MFAP4  -  microfibrillar-associated protein 4, TIPARP  -  tcdd-inducible poly(adp-ribose) polymerase, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, HEXA  -  hexosaminidase a (alpha polypeptide), ZFAND5  -  zinc finger, an1-type domain 5, HDAC1  -  histone deacetylase 1, KAT7  -  k(lysine) acetyltransferase 7, PGK1  -  phosphoglycerate kinase 1, ATP2B1  -  atpase, ca++ transporting, plasma membrane 1, RFK  -  riboflavin kinase, GOLGA2  -  golgin a2, CDK14  -  cyclin-dependent kinase 14, PGD  -  phosphogluconate dehydrogenase, SMC3  -  structural maintenance of chromosomes 3, SLC16A3  -  solute carrier family 16 (monocarboxylate transporter), member 3, ATP1B1  -  atpase, na+/k+ transporting, beta 1 polypeptide, INA  -  internexin neuronal intermediate filament protein, alpha, GPC1  -  glypican 1, RAB14  -  rab14, member ras oncogene family, MAP1A  -  microtubule-associated protein 1a, DZIP1  -  daz interacting zinc finger protein 1, GPI  -  glucose-6-phosphate isomerase, DPYSL2  -  dihydropyrimidinase-like 2, SLC12A2  -  solute carrier family 12 (sodium/potassium/chloride transporter), member 2, ZFHX3  -  zinc finger homeobox 3, PEX6  -  peroxisomal biogenesis factor 6, SLC1A1  -  solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system xag), member 1, UNC119  -  unc-119 homolog (c. elegans), WEE1  -  wee1 homolog (s. pombe), MATN2  -  matrilin 2, SLC2A1  -  solute carrier family 2 (facilitated glucose transporter), member 1, ATP6V1B1  -  atpase, h+ transporting, lysosomal 56/58kda, v1 subunit b1, WNT5A  -  wingless-type mmtv integration site family, member 5a, ATP6V0C  -  atpase, h+ transporting, lysosomal 16kda, v0 subunit c, GULP1  -  gulp, engulfment adaptor ptb domain containing 1, SLC2A3  -  solute carrier family 2 (facilitated glucose transporter), member 3, TSC22D3  -  tsc22 domain family, member 3, PFKP  -  phosphofructokinase, platelet, ASH2L  -  ash2 (absent, small, or homeotic)-like (drosophila), ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, PFDN1  -  prefoldin subunit 1, DLGAP4  -  discs, large (drosophila) homolog-associated protein 4, DLD  -  dihydrolipoamide dehydrogenase, LTB  -  lymphotoxin beta (tnf superfamily, member 3), SHBG  -  sex hormone-binding globulin, SHH  -  sonic hedgehog, BAG1  -  bcl2-associated athanogene, RPL14  -  ribosomal protein l14, GPX1  -  glutathione peroxidase 1, DLX5  -  distal-less homeobox 5, ST6GAL1  -  st6 beta-galactosamide alpha-2,6-sialyltranferase 1, PLAU  -  plasminogen activator, urokinase, ATF5  -  activating transcription factor 5, PLAT  -  plasminogen activator, tissue, PLAGL1  -  pleiomorphic adenoma gene-like 1, LUM  -  lumican, ST3GAL4  -  st3 beta-galactoside alpha-2,3-sialyltransferase 4, UBA3  -  ubiquitin-like modifier activating enzyme 3, ATR  -  ataxia telangiectasia and rad3 related, NID2  -  nidogen 2 (osteonidogen), PKM  -  pyruvate kinase, muscle, BCAM  -  basal cell adhesion molecule (lutheran blood group), TWF2  -  twinfilin actin-binding protein 2, DYNC1H1  -  dynein, cytoplasmic 1, heavy chain 1, MPZL1  -  myelin protein zero-like 1, BDKRB2  -  bradykinin receptor b2, MGLL  -  monoglyceride lipase, SERPINE2  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 2, DNM2  -  dynamin 2, SMAD2  -  smad family member 2, TDP2  -  tyrosyl-dna phosphodiesterase 2, BCL6  -  b-cell cll/lymphoma 6, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, DMD  -  dystrophin, YES1  -  v-yes-1 yamaguchi sarcoma viral oncogene homolog 1, CXCL1  -  chemokine (c-x-c motif) ligand 1 (melanoma growth stimulating activity, alpha), DMPK  -  dystrophia myotonica-protein kinase, SGK1  -  serum/glucocorticoid regulated kinase 1, SMAD3  -  smad family member 3, CCND1  -  cyclin d1, GSK3B  -  glycogen synthase kinase 3 beta, SMAD6  -  smad family member 6, P4HA2  -  prolyl 4-hydroxylase, alpha polypeptide ii, DNASE1  -  deoxyribonuclease i, MAF  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog, NCBP2  -  nuclear cap binding protein subunit 2, 20kda, BNIP3  -  bcl2/adenovirus e1b 19kda interacting protein 3, RFC2  -  replication factor c (activator 1) 2, 40kda, NDN  -  necdin, melanoma antigen (mage) family member, BNIP2  -  bcl2/adenovirus e1b 19kda interacting protein 2, REV3L  -  rev3-like, polymerase (dna directed), zeta, catalytic subunit, NCK1  -  nck adaptor protein 1, TRAK1  -  trafficking protein, kinesin binding 1, ELF4  -  e74-like factor 4 (ets domain transcription factor), BCKDK  -  branched chain ketoacid dehydrogenase kinase, ELN  -  elastin, TICAM1  -  toll-like receptor adaptor molecule 1, BPGM  -  2,3-bisphosphoglycerate mutase, IQGAP1  -  iq motif containing gtpase activating protein 1, EPAS1  -  endothelial pas domain protein 1, TRPM2  -  transient receptor potential cation channel, subfamily m, member 2, ENO2  -  enolase 2 (gamma, neuronal), HRAS  -  harvey rat sarcoma viral oncogene homolog, NBN  -  nibrin, ENO1  -  enolase 1, (alpha), NUBP1  -  nucleotide binding protein 1, NBL1  -  neuroblastoma 1, dan family bmp antagonist, RIT1  -  ras-like without caax 1, MYO9B  -  myosin ixb, TUBA4A  -  tubulin, alpha 4a, BGN  -  biglycan, MYO10  -  myosin x, PPP1R12B  -  protein phosphatase 1, regulatory subunit 12b, PIKFYVE  -  phosphoinositide kinase, fyve finger containing, NDEL1  -  nude neurodevelopment protein 1-like 1, NAB1  -  ngfi-a binding protein 1 (egr1 binding protein 1), BID  -  bh3 interacting domain death agonist, BMP1  -  bone morphogenetic protein 1, SYNJ1  -  synaptojanin 1, MYLK  -  myosin light chain kinase, BMPR1A  -  bone morphogenetic protein receptor, type ia, EIF4G1  -  eukaryotic translation initiation factor 4 gamma, 1, BMP4  -  bone morphogenetic protein 4, TPM2  -  tropomyosin 2 (beta), SH3YL1  -  sh3 domain containing, ysc84-like 1 (s. cerevisiae), GADD45B  -  growth arrest and dna-damage-inducible, beta, DAAM1  -  dishevelled associated activator of morphogenesis 1, MYH10  -  myosin, heavy chain 10, non-muscle, EGFR  -  epidermal growth factor receptor, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, HTR7  -  5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled, EIF2B4  -  eukaryotic translation initiation factor 2b, subunit 4 delta, 67kda, RNF2  -  ring finger protein 2, EFNB2  -  ephrin-b2, EFNB1  -  ephrin-b1, PDZRN3  -  pdz domain containing ring finger 3, ROCK1  -  rho-associated, coiled-coil containing protein kinase 1, ARPC2  -  actin related protein 2/3 complex, subunit 2, 34kda, SERPING1  -  serpin peptidase inhibitor, clade g (c1 inhibitor), member 1, SGCE  -  sarcoglycan, epsilon, CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, SWAP70  -  swap switching b-cell complex 70kda subunit, LRPPRC  -  leucine-rich pentatricopeptide repeat containing, TRAF2  -  tnf receptor-associated factor 2, FSTL3  -  follistatin-like 3 (secreted glycoprotein), STAG1  -  stromal antigen 1, HSPA4  -  heat shock 70kda protein 4, EFS  -  embryonal fyn-associated substrate, RAB7L1  -  rab7, member ras oncogene family-like 1, OPTN  -  optineurin, ECH1  -  enoyl coa hydratase 1, peroxisomal, TPT1  -  tumor protein, translationally-controlled 1, CAPZA2  -  capping protein (actin filament) muscle z-line, alpha 2, AKR1C3  -  aldo-keto reductase family 1, member c3, CAPZA1  -  capping protein (actin filament) muscle z-line, alpha 1, NADK  -  nad kinase, RPL23A  -  ribosomal protein l23a, ACAA2  -  acetyl-coa acyltransferase 2, PDE5A  -  phosphodiesterase 5a, cgmp-specific, RPL15  -  ribosomal protein l15, CAMK2G  -  calcium/calmodulin-dependent protein kinase ii gamma, SIK1  -  salt-inducible kinase 1, RPL12  -  ribosomal protein l12, CAMK2B  -  calcium/calmodulin-dependent protein kinase ii beta, SPG20  -  spastic paraplegia 20 (troyer syndrome), RPL5  -  ribosomal protein l5, COL14A1  -  collagen, type xiv, alpha 1, NFASC  -  neurofascin, CASP4  -  caspase 4, apoptosis-related cysteine peptidase, UNG  -  uracil-dna glycosylase, RPL4  -  ribosomal protein l4, RPA3  -  replication protein a3, 14kda, RPE  -  ribulose-5-phosphate-3-epimerase, TAB2  -  tgf-beta activated kinase 1/map3k7 binding protein 2, FBLN1  -  fibulin 1, GPNMB  -  glycoprotein (transmembrane) nmb, CAP1  -  cap, adenylate cyclase-associated protein 1 (yeast), VEGFC  -  vascular endothelial growth factor c, PLXND1  -  plexin d1, EZR  -  ezrin, EPB41L3  -  erythrocyte membrane protein band 4.1-like 3, DDR1  -  discoidin domain receptor tyrosine kinase 1, SEMA4F  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4f, B4GALT3  -  udp-gal:betaglcnac beta 1,4- galactosyltransferase, polypeptide 3, EZH2  -  enhancer of zeste homolog 2 (drosophila), VCAM1  -  vascular cell adhesion molecule 1, B3GALT4  -  udp-gal:betaglcnac beta 1,3-galactosyltransferase, polypeptide 4, VDAC1  -  voltage-dependent anion channel 1, ERF  -  ets2 repressor factor, TRADD  -  tnfrsf1a-associated via death domain, MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), CTSF  -  cathepsin f, UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, CTNNAL1  -  catenin (cadherin-associated protein), alpha-like 1, CCNG1  -  cyclin g1, CD6  -  cd6 molecule, TNFSF4  -  tumor necrosis factor (ligand) superfamily, member 4, CD14  -  cd14 molecule, OXSR1  -  oxidative stress responsive 1, NDRG1  -  n-myc downstream regulated 1, RPS13  -  ribosomal protein s13, DLC1  -  deleted in liver cancer 1, TYRO3  -  tyro3 protein tyrosine kinase, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, TNFSF9  -  tumor necrosis factor (ligand) superfamily, member 9, TUBB4A  -  tubulin, beta 4a class iva, ZMIZ1  -  zinc finger, miz-type containing 1, SACS  -  spastic ataxia of charlevoix-saguenay (sacsin), TXNRD1  -  thioredoxin reductase 1, CBLB  -  cbl proto-oncogene b, e3 ubiquitin protein ligase, SLC23A2  -  solute carrier family 23 (ascorbic acid transporter), member 2, UCHL1  -  ubiquitin carboxyl-terminal esterase l1 (ubiquitin thiolesterase), UBTF  -  upstream binding transcription factor, rna polymerase i, EPB41L2  -  erythrocyte membrane protein band 4.1-like 2, GNB2L1  -  guanine nucleotide binding protein (g protein), beta polypeptide 2-like 1, RRS1  -  rrs1 ribosome biogenesis regulator homolog (s. cerevisiae), CAT  -  catalase, CAV2  -  caveolin 2, FADD  -  fas (tnfrsf6)-associated via death domain, RYK  -  receptor-like tyrosine kinase, SLC35A2  -  solute carrier family 35 (udp-galactose transporter), member a2, RUNX1T1  -  runt-related transcription factor 1; translocated to, 1 (cyclin d-related), UBE2G2  -  ubiquitin-conjugating enzyme e2g 2, KRIT1  -  krit1, ankyrin repeat containing, CFDP1  -  craniofacial development protein 1, RBM14  -  rna binding motif protein 14, CCND2  -  cyclin d2, RTN1  -  reticulon 1, NUP153  -  nucleoporin 153kda, CBS  -  cystathionine-beta-synthase, RRAS  -  related ras viral (r-ras) oncogene homolog, NUPR1  -  nuclear protein, transcriptional regulator, 1, MPG  -  n-methylpurine-dna glycosylase, FMOD  -  fibromodulin, PAICS  -  phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase, SSH1  -  slingshot protein phosphatase 1, CDH2  -  cadherin 2, type 1, n-cadherin (neuronal), CDC34  -  cell division cycle 34, GAB2  -  grb2-associated binding protein 2, HTRA2  -  htra serine peptidase 2, FLNA  -  filamin a, alpha, FLNB  -  filamin b, beta, CD59  -  cd59 molecule, complement regulatory protein, CD151  -  cd151 molecule (raph blood group), ARC  -  activity-regulated cytoskeleton-associated protein, FARP2  -  ferm, rhogef and pleckstrin domain protein 2, FOXO1  -  forkhead box o1, PACS2  -  phosphofurin acidic cluster sorting protein 2, CD97  -  cd97 molecule, CDC14B  -  cell division cycle 14b, SIN3B  -  sin3 transcription regulator family member b, FOXC1  -  forkhead box c1, DOK5  -  docking protein 5, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, SCARB2  -  scavenger receptor class b, member 2, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, PSMB9  -  proteasome (prosome, macropain) subunit, beta type, 9, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, LMO4  -  lim domain only 4, YKT6  -  ykt6 v-snare homolog (s. cerevisiae), FOXF2  -  forkhead box f2, UBR2  -  ubiquitin protein ligase e3 component n-recognin 2, PSMB4  -  proteasome (prosome, macropain) subunit, beta type, 4, CAND1  -  cullin-associated and neddylation-dissociated 1, PDPN  -  podoplanin, OGDH  -  oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide), CAMK1  -  calcium/calmodulin-dependent protein kinase i, TDG  -  thymine-dna glycosylase, COASY  -  coa synthase, LPPR4  -  lipid phosphate phosphatase-related protein type 4, NUAK1  -  nuak family, snf1-like kinase, 1, DYNLT3  -  dynein, light chain, tctex-type 3, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, IL6ST  -  interleukin 6 signal transducer (gp130, oncostatin m receptor), DGKZ  -  diacylglycerol kinase, zeta, TNFRSF11B  -  tumor necrosis factor receptor superfamily, member 11b, ITGA5  -  integrin, alpha 5 (fibronectin receptor, alpha polypeptide), PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), ITGA7  -  integrin, alpha 7, FGFR1  -  fibroblast growth factor receptor 1, BCAP29  -  b-cell receptor-associated protein 29, DDR2  -  discoidin domain receptor tyrosine kinase 2, TOMM20  -  translocase of outer mitochondrial membrane 20 homolog (yeast), ROR2  -  receptor tyrosine kinase-like orphan receptor 2, PTGDS  -  prostaglandin d2 synthase 21kda (brain), MAML1  -  mastermind-like 1 (drosophila), CETN3  -  centrin, ef-hand protein, 3, FGF5  -  fibroblast growth factor 5, ITGA3  -  integrin, alpha 3 (antigen cd49c, alpha 3 subunit of vla-3 receptor), CFL1  -  cofilin 1 (non-muscle), FGF7  -  fibroblast growth factor 7, ITGA2B  -  integrin, alpha 2b (platelet glycoprotein iib of iib/iiia complex, antigen cd41), SEMA3C  -  sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3c, ITGB5  -  integrin, beta 5, FGF2  -  fibroblast growth factor 2 (basic), FBLN5  -  fibulin 5, FGF4  -  fibroblast growth factor 4, GTF2H5  -  general transcription factor iih, polypeptide 5, PTGIR  -  prostaglandin i2 (prostacyclin) receptor (ip), DDX17  -  dead (asp-glu-ala-asp) box helicase 17, TAP1  -  transporter 1, atp-binding cassette, sub-family b (mdr/tap), CEBPB  -  ccaat/enhancer binding protein (c/ebp), beta, FDXR  -  ferredoxin reductase, INPPL1  -  inositol polyphosphate phosphatase-like 1, RNF114  -  ring finger protein 114, TBX2  -  t-box 2, CDKN1C  -  cyclin-dependent kinase inhibitor 1c (p57, kip2), TBCD  -  tubulin folding cofactor d, CDKN2D  -  cyclin-dependent kinase inhibitor 2d (p19, inhibits cdk4), SRGAP2  -  slit-robo rho gtpase activating protein 2, INPP5A  -  inositol polyphosphate-5-phosphatase, 40kda, PTPN1  -  protein tyrosine phosphatase, non-receptor type 1, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), RUVBL1  -  ruvb-like 1 (e. coli), RNF40  -  ring finger protein 40, e3 ubiquitin protein ligase, PPAP2B  -  phosphatidic acid phosphatase type 2b, CDH13  -  cadherin 13, h-cadherin (heart), EFEMP1  -  egf containing fibulin-like extracellular matrix protein 1, ITGA6  -  integrin, alpha 6, GRIP2  -  glutamate receptor interacting protein 2, FBLN2  -  fibulin 2, CRCP  -  cgrp receptor component, PTPRF  -  protein tyrosine phosphatase, receptor type, f, IRAK1  -  interleukin-1 receptor-associated kinase 1, RAD1  -  rad1 homolog (s. pombe), CHRND  -  cholinergic receptor, nicotinic, delta (muscle), CHRNB1  -  cholinergic receptor, nicotinic, beta 1 (muscle), IFI16  -  interferon, gamma-inducible protein 16, SLC7A8  -  solute carrier family 7 (amino acid transporter light chain, l system), member 8, TKT  -  transketolase, NME4  -  nme/nm23 nucleoside diphosphate kinase 4, AHCYL1  -  adenosylhomocysteinase-like 1, NOVA1  -  neuro-oncological ventral antigen 1, PVR  -  poliovirus receptor, NOTCH3  -  notch 3, PVRL2  -  poliovirus receptor-related 2 (herpesvirus entry mediator b), ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, NFYA  -  nuclear transcription factor y, alpha, HDAC4  -  histone deacetylase 4, ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, RAB3B  -  rab3b, member ras oncogene family, NGF  -  nerve growth factor (beta polypeptide), RAB2A  -  rab2a, member ras oncogene family, NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, NFIX  -  nuclear factor i/x (ccaat-binding transcription factor), RAD23B  -  rad23 homolog b (s. cerevisiae), TNFAIP6  -  tumor necrosis factor, alpha-induced protein 6, CGB  -  chorionic gonadotropin, beta polypeptide, TNNT3  -  troponin t type 3 (skeletal, fast), IDH3B  -  isocitrate dehydrogenase 3 (nad+) beta, RAB13  -  rab13, member ras oncogene family, IDH2  -  isocitrate dehydrogenase 2 (nadp+), mitochondrial, RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), TEK  -  tek tyrosine kinase, endothelial, DDIT4  -  dna-damage-inducible transcript 4, SUZ12  -  suz12 polycomb repressive complex 2 subunit, RECK  -  reversion-inducing-cysteine-rich protein with kazal motifs, RBPJ  -  recombination signal binding protein for immunoglobulin kappa j region, RAD51D  -  rad51 paralog d, PABPC1  -  poly(a) binding protein, cytoplasmic 1, TERF1  -  telomeric repeat binding factor (nima-interacting) 1, RARRES3  -  retinoic acid receptor responder (tazarotene induced) 3, FEZ1  -  fasciculation and elongation protein zeta 1 (zygin i), NR2F1  -  nuclear receptor subfamily 2, group f, member 1, CLU  -  clusterin, NF2  -  neurofibromin 2 (merlin), STX7  -  syntaxin 7, TPP1  -  tripeptidyl peptidase i, IK  -  ik cytokine, down-regulator of hla ii, RBL2  -  retinoblastoma-like 2 (p130), IGBP1  -  immunoglobulin (cd79a) binding protein 1, SMARCA5  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5, TGFBI  -  transforming growth factor, beta-induced, 68kda, IGF1R  -  insulin-like growth factor 1 receptor, IGF2  -  insulin-like growth factor 2 (somatomedin a), TGFB1  -  transforming growth factor, beta 1, OGT  -  o-linked n-acetylglucosamine (glcnac) transferase, TGFB1I1  -  transforming growth factor beta 1 induced transcript 1, TSPYL2  -  tspy-like 2, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), SND1  -  staphylococcal nuclease and tudor domain containing 1, TGFBR3  -  transforming growth factor, beta receptor iii, RBBP4  -  retinoblastoma binding protein 4, CUL4B  -  cullin 4b, FOS  -  fbj murine osteosarcoma viral oncogene homolog, THBS2  -  thrombospondin 2, KAT6B  -  k(lysine) acetyltransferase 6b, POLD3  -  polymerase (dna-directed), delta 3, accessory subunit, CKB  -  creatine kinase, brain, RBP1  -  retinol binding protein 1, cellular]"GO:1901575,organic substance catabolic process,9.34E-05,2.26E-02,1.38,8230,921,995,154,"[FMOD  -  fibromodulin, APEX1  -  apex nuclease (multifunctional dna repair enzyme) 1, NCBP2  -  nuclear cap binding protein subunit 2, 20kda, BNIP3  -  bcl2/adenovirus e1b 19kda interacting protein 3, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, BCKDK  -  branched chain ketoacid dehydrogenase kinase, SEPT5  -  septin 5, CDC34  -  cell division cycle 34, BPGM  -  2,3-bisphosphoglycerate mutase, DDB1  -  damage-specific dna binding protein 1, 127kda, LDHB  -  lactate dehydrogenase b, RPIA  -  ribose 5-phosphate isomerase a, GCSH  -  glycine cleavage system protein h (aminomethyl carrier), GTF2H1  -  general transcription factor iih, polypeptide 1, 62kda, LDHA  -  lactate dehydrogenase a, PSMA1  -  proteasome (prosome, macropain) subunit, alpha type, 1, GCH1  -  gtp cyclohydrolase 1, ENO2  -  enolase 2 (gamma, neuronal), HRAS  -  harvey rat sarcoma viral oncogene homolog, ENO1  -  enolase 1, (alpha), MSH6  -  muts homolog 6 (e. coli), RIT1  -  ras-like without caax 1, EIF4A2  -  eukaryotic translation initiation factor 4a2, MYO10  -  myosin x, BGN  -  biglycan, SMPD4  -  sphingomyelin phosphodiesterase 4, neutral membrane (neutral sphingomyelinase-3), EIF4B  -  eukaryotic translation initiation factor 4b, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, NT5C2  -  5'-nucleotidase, cytosolic ii, UBE2L6  -  ubiquitin-conjugating enzyme e2l 6, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, PSMB9  -  proteasome (prosome, macropain) subunit, beta type, 9, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, PSMB7  -  proteasome (prosome, macropain) subunit, beta type, 7, UBR2  -  ubiquitin protein ligase e3 component n-recognin 2, ARF1  -  adp-ribosylation factor 1, LSM2  -  lsm2 homolog, u6 small nuclear rna associated (s. cerevisiae), PSMB4  -  proteasome (prosome, macropain) subunit, beta type, 4, OGDH  -  oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide), TDG  -  thymine-dna glycosylase, PLCB2  -  phospholipase c, beta 2, SORD  -  sorbitol dehydrogenase, SDC2  -  syndecan 2, TST  -  thiosulfate sulfurtransferase (rhodanese), APOE  -  apolipoprotein e, BLVRB  -  biliverdin reductase b (flavin reductase (nadph)), SOD1  -  superoxide dismutase 1, soluble, EIF4G1  -  eukaryotic translation initiation factor 4 gamma, 1, SMG7  -  smg7 nonsense mediated mrna decay factor, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, GUSB  -  glucuronidase, beta, PSMD11  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 11, GLUL  -  glutamate-ammonia ligase, PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), MYH10  -  myosin, heavy chain 10, non-muscle, USP9Y  -  ubiquitin specific peptidase 9, y-linked, RHOB  -  ras homolog family member b, FGF2  -  fibroblast growth factor 2 (basic), HADH  -  hydroxyacyl-coa dehydrogenase, ADA  -  adenosine deaminase, DDX17  -  dead (asp-glu-ala-asp) box helicase 17, RHOG  -  ras homolog family member g, PLA2G15  -  phospholipase a2, group xv, GNB1  -  guanine nucleotide binding protein (g protein), beta polypeptide 1, ADH5  -  alcohol dehydrogenase 5 (class iii), chi polypeptide, SMARCA2  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, HEXA  -  hexosaminidase a (alpha polypeptide), SAT1  -  spermidine/spermine n1-acetyltransferase 1, RNF40  -  ring finger protein 40, e3 ubiquitin protein ligase, FZR1  -  fizzy/cell division cycle 20 related 1 (drosophila), TRAF2  -  tnf receptor-associated factor 2, EIF3E  -  eukaryotic translation initiation factor 3, subunit e, ECE1  -  endothelin converting enzyme 1, RAB7L1  -  rab7, member ras oncogene family-like 1, ECH1  -  enoyl coa hydratase 1, peroxisomal, AKR1C3  -  aldo-keto reductase family 1, member c3, PGK1  -  phosphoglycerate kinase 1, PRKACB  -  protein kinase, camp-dependent, catalytic, beta, RPL23A  -  ribosomal protein l23a, MAGOH  -  mago-nashi homolog, proliferation-associated (drosophila), PDE5A  -  phosphodiesterase 5a, cgmp-specific, XPC  -  xeroderma pigmentosum, complementation group c, RPL18A  -  ribosomal protein l18a, TKT  -  transketolase, PGD  -  phosphogluconate dehydrogenase, RPL15  -  ribosomal protein l15, RPL13  -  ribosomal protein l13, RPL12  -  ribosomal protein l12, ZHX2  -  zinc fingers and homeoboxes 2, SUPV3L1  -  suppressor of var1, 3-like 1 (s. cerevisiae), GPC1  -  glypican 1, RAB14  -  rab14, member ras oncogene family, RPL5  -  ribosomal protein l5, PRELP  -  proline/arginine-rich end leucine-rich repeat protein, GPI  -  glucose-6-phosphate isomerase, RPL4  -  ribosomal protein l4, DPYSL3  -  dihydropyrimidinase-like 3, DPYSL2  -  dihydropyrimidinase-like 2, RPA3  -  replication protein a3, 14kda, RPE  -  ribulose-5-phosphate-3-epimerase, ACAN  -  aggrecan, RPA2  -  replication protein a2, 32kda, PEX6  -  peroxisomal biogenesis factor 6, CTSH  -  cathepsin h, RAB2A  -  rab2a, member ras oncogene family, WWP2  -  ww domain containing e3 ubiquitin protein ligase 2, RAD23B  -  rad23 homolog b (s. cerevisiae), PFKL  -  phosphofructokinase, liver, PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, PFKP  -  phosphofructokinase, platelet, TNNT3  -  troponin t type 3 (skeletal, fast), ALDH2  -  aldehyde dehydrogenase 2 family (mitochondrial), RAB13  -  rab13, member ras oncogene family, DLD  -  dihydrolipoamide dehydrogenase, MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), RAB33A  -  rab33a, member ras oncogene family, RAB9A  -  rab9a, member ras oncogene family, UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, RPL14  -  ribosomal protein l14, UBE4A  -  ubiquitination factor e4a, GPX1  -  glutathione peroxidase 1, PABPC1  -  poly(a) binding protein, cytoplasmic 1, ALDOC  -  aldolase c, fructose-bisphosphate, NFE2L2  -  nuclear factor (erythroid-derived 2)-like 2, LUM  -  lumican, ISG15  -  isg15 ubiquitin-like modifier, RARRES3  -  retinoic acid receptor responder (tazarotene induced) 3, RPS13  -  ribosomal protein s13, PKM  -  pyruvate kinase, muscle, TPP1  -  tripeptidyl peptidase i, MGLL  -  monoglyceride lipase, SMARCA5  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5, PABPC4  -  poly(a) binding protein, cytoplasmic 4 (inducible form), TGFB1  -  transforming growth factor, beta 1, UCHL1  -  ubiquitin carboxyl-terminal esterase l1 (ubiquitin thiolesterase), TGFB1I1  -  transforming growth factor beta 1 induced transcript 1, DNM2  -  dynamin 2, ACOT7  -  acyl-coa thioesterase 7, CAT  -  catalase, PLCE1  -  phospholipase c, epsilon 1, PHYH  -  phytanoyl-coa 2-hydroxylase, RBBP4  -  retinoblastoma binding protein 4, CUL4B  -  cullin 4b, UBE2G2  -  ubiquitin-conjugating enzyme e2g 2, RPL23  -  ribosomal protein l23, CSPG4  -  chondroitin sulfate proteoglycan 4, NBAS  -  neuroblastoma amplified sequence, ARIH1  -  ariadne homolog, ubiquitin-conjugating enzyme e2 binding protein, 1 (drosophila), VCAN  -  versican, CBS  -  cystathionine-beta-synthase, MPG  -  n-methylpurine-dna glycosylase, FBXL2  -  f-box and leucine-rich repeat protein 2]"GO:0043067,regulation of programmed cell death,1.01E-04,2.39E-02,1.38,8230,996,913,153,"[BNIP3  -  bcl2/adenovirus e1b 19kda interacting protein 3, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, BNIP2  -  bcl2/adenovirus e1b 19kda interacting protein 2, PAWR  -  prkc, apoptosis, wt1, regulator, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), CDC34  -  cell division cycle 34, PAX7  -  paired box 7, HTRA2  -  htra serine peptidase 2, CD59  -  cd59 molecule, complement regulatory protein, PSEN2  -  presenilin 2 (alzheimer disease 4), PSMA1  -  proteasome (prosome, macropain) subunit, alpha type, 1, FOXO1  -  forkhead box o1, HRAS  -  harvey rat sarcoma viral oncogene homolog, TRAF4  -  tnf receptor-associated factor 4, ASIC2  -  acid-sensing (proton-gated) ion channel 2, FOXC1  -  forkhead box c1, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, CRLF1  -  cytokine receptor-like factor 1, DFNA5  -  deafness, autosomal dominant 5, P4HB  -  prolyl 4-hydroxylase, beta polypeptide, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, PDCD10  -  programmed cell death 10, PSMB9  -  proteasome (prosome, macropain) subunit, beta type, 9, SOX9  -  sry (sex determining region y)-box 9, SOX4  -  sry (sex determining region y)-box 4, STK17B  -  serine/threonine kinase 17b, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, BID  -  bh3 interacting domain death agonist, NACA  -  nascent polypeptide-associated complex alpha subunit, PSMB4  -  proteasome (prosome, macropain) subunit, beta type, 4, APOE  -  apolipoprotein e, SOD2  -  superoxide dismutase 2, mitochondrial, SOD1  -  superoxide dismutase 1, soluble, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, WWOX  -  ww domain containing oxidoreductase, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, IL6ST  -  interleukin 6 signal transducer (gp130, oncostatin m receptor), LMNA  -  lamin a/c, BMP4  -  bone morphogenetic protein 4, AQP1  -  aquaporin 1 (colton blood group), ITGA5  -  integrin, alpha 5 (fibronectin receptor, alpha polypeptide), PSMD11  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 11, PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), ACTN1  -  actinin, alpha 1, FGFR1  -  fibroblast growth factor receptor 1, GADD45B  -  growth arrest and dna-damage-inducible, beta, MDK  -  midkine (neurite growth-promoting factor 2), EEF1A2  -  eukaryotic translation elongation factor 1 alpha 2, CFL1  -  cofilin 1 (non-muscle), BCLAF1  -  bcl2-associated transcription factor 1, MECP2  -  methyl cpg binding protein 2 (rett syndrome), ADAR  -  adenosine deaminase, rna-specific, RHOB  -  ras homolog family member b, FGF2  -  fibroblast growth factor 2 (basic), PDPK1  -  3-phosphoinositide dependent protein kinase-1, EGFR  -  epidermal growth factor receptor, FGF4  -  fibroblast growth factor 4, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, ADA  -  adenosine deaminase, TRIM2  -  tripartite motif containing 2, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, MED1  -  mediator complex subunit 1, CNR1  -  cannabinoid receptor 1 (brain), CEBPB  -  ccaat/enhancer binding protein (c/ebp), beta, AMIGO2  -  adhesion molecule with ig-like domain 2, KRT18  -  keratin 18, ROCK1  -  rho-associated, coiled-coil containing protein kinase 1, HSPE1  -  heat shock 10kda protein 1 (chaperonin 10), CDKN2D  -  cyclin-dependent kinase inhibitor 2d (p19, inhibits cdk4), DAPK1  -  death-associated protein kinase 1, MAPK8IP1  -  mitogen-activated protein kinase 8 interacting protein 1, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, ARL6IP5  -  adp-ribosylation-like factor 6 interacting protein 5, EDNRA  -  endothelin receptor type a, TRAF2  -  tnf receptor-associated factor 2, ADM  -  adrenomedullin, HDAC1  -  histone deacetylase 1, ITGA6  -  integrin, alpha 6, TPT1  -  tumor protein, translationally-controlled 1, IRAK1  -  interleukin-1 receptor-associated kinase 1, AKR1C3  -  aldo-keto reductase family 1, member c3, IFIT3  -  interferon-induced protein with tetratricopeptide repeats 3, ACAA2  -  acetyl-coa acyltransferase 2, IFI27  -  interferon, alpha-inducible protein 27, TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), SIK1  -  salt-inducible kinase 1, CAMK2B  -  calcium/calmodulin-dependent protein kinase ii beta, AGT  -  angiotensinogen (serpin peptidase inhibitor, clade a, member 8), CASP4  -  caspase 4, apoptosis-related cysteine peptidase, UNG  -  uracil-dna glycosylase, GPI  -  glucose-6-phosphate isomerase, CAST  -  calpastatin, CTSH  -  cathepsin h, ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, NGF  -  nerve growth factor (beta polypeptide), NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, WNT5A  -  wingless-type mmtv integration site family, member 5a, STK3  -  serine/threonine kinase 3, TSC22D3  -  tsc22 domain family, member 3, CTSC  -  cathepsin c, TEK  -  tek tyrosine kinase, endothelial, MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), TRADD  -  tnfrsf1a-associated via death domain, FOSL1  -  fos-like antigen 1, SHH  -  sonic hedgehog, JUN  -  jun proto-oncogene, BAG1  -  bcl2-associated athanogene, STAT1  -  signal transducer and activator of transcription 1, 91kda, SLIT2  -  slit homolog 2 (drosophila), GPX1  -  glutathione peroxidase 1, TERF1  -  telomeric repeat binding factor (nima-interacting) 1, PRNP  -  prion protein, ARNT2  -  aryl-hydrocarbon receptor nuclear translocator 2, CRYAB  -  crystallin, alpha b, CCNG1  -  cyclin g1, ATF5  -  activating transcription factor 5, NFE2L2  -  nuclear factor (erythroid-derived 2)-like 2, JAK2  -  janus kinase 2, DLC1  -  deleted in liver cancer 1, TYRO3  -  tyro3 protein tyrosine kinase, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, CLU  -  clusterin, IGBP1  -  immunoglobulin (cd79a) binding protein 1, SFRP1  -  secreted frizzled-related protein 1, BDKRB2  -  bradykinin receptor b2, MAPK7  -  mitogen-activated protein kinase 7, IGF1R  -  insulin-like growth factor 1 receptor, SRPK2  -  srsf protein kinase 2, TGFB1  -  transforming growth factor, beta 1, SERPINB9  -  serpin peptidase inhibitor, clade b (ovalbumin), member 9, DNM2  -  dynamin 2, GNB2L1  -  guanine nucleotide binding protein (g protein), beta polypeptide 2-like 1, CAT  -  catalase, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, FADD  -  fas (tnfrsf6)-associated via death domain, BCL6  -  b-cell cll/lymphoma 6, NR3C1  -  nuclear receptor subfamily 3, group c, member 1 (glucocorticoid receptor), KRIT1  -  krit1, ankyrin repeat containing, CFDP1  -  craniofacial development protein 1, PRKCG  -  protein kinase c, gamma, SGK1  -  serum/glucocorticoid regulated kinase 1, SLC25A4  -  solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4, SMAD3  -  smad family member 3, PRKCA  -  protein kinase c, alpha, SMAD6  -  smad family member 6, GSK3B  -  glycogen synthase kinase 3 beta, CBS  -  cystathionine-beta-synthase, GAS6  -  growth arrest-specific 6, NUPR1  -  nuclear protein, transcriptional regulator, 1, ITSN1  -  intersectin 1 (sh3 domain protein), GAS1  -  growth arrest-specific 1]"GO:0008152,metabolic process,1.03E-04,2.39E-02,1.12,8230,4644,999,629,"[WTAP  -  wilms tumor 1 associated protein, HNRNPA0  -  heterogeneous nuclear ribonucleoprotein a0, ABCA1  -  atp-binding cassette, sub-family a (abc1), member 1, SEPT5  -  septin 5, LDHB  -  lactate dehydrogenase b, NCOR2  -  nuclear receptor corepressor 2, SPG7  -  spastic paraplegia 7 (pure and complicated autosomal recessive), RNF14  -  ring finger protein 14, GCSH  -  glycine cleavage system protein h (aminomethyl carrier), LDHA  -  lactate dehydrogenase a, LGALS3  -  lectin, galactoside-binding, soluble, 3, GCH1  -  gtp cyclohydrolase 1, BLOC1S1  -  biogenesis of lysosomal organelles complex-1, subunit 1, LOXL1  -  lysyl oxidase-like 1, SMPD4  -  sphingomyelin phosphodiesterase 4, neutral membrane (neutral sphingomyelinase-3), CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, SOX9  -  sry (sex determining region y)-box 9, ACR  -  acrosin, LSM2  -  lsm2 homolog, u6 small nuclear rna associated (s. cerevisiae), PLSCR1  -  phospholipid scramblase 1, PLTP  -  phospholipid transfer protein, SORD  -  sorbitol dehydrogenase, PLCB2  -  phospholipase c, beta 2, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, GHR  -  growth hormone receptor, PLAUR  -  plasminogen activator, urokinase receptor, SOD2  -  superoxide dismutase 2, mitochondrial, SOD1  -  superoxide dismutase 1, soluble, SUB1  -  sub1 homolog (s. cerevisiae), LIMK2  -  lim domain kinase 2, CREB1  -  camp responsive element binding protein 1, LMNA  -  lamin a/c, GLUL  -  glutamate-ammonia ligase, SNRPE  -  small nuclear ribonucleoprotein polypeptide e, CTSA  -  cathepsin a, PPIA  -  peptidylprolyl isomerase a (cyclophilin a), LITAF  -  lipopolysaccharide-induced tnf factor, PPM1B  -  protein phosphatase, mg2+/mn2+ dependent, 1b, TBPL1  -  tbp-like 1, USP9Y  -  ubiquitin specific peptidase 9, y-linked, ADAR  -  adenosine deaminase, rna-specific, SNAPC1  -  small nuclear rna activating complex, polypeptide 1, 43kda, COL4A1  -  collagen, type iv, alpha 1, ADA  -  adenosine deaminase, POLR1C  -  polymerase (rna) i polypeptide c, 30kda, BAG2  -  bcl2-associated athanogene 2, MED1  -  mediator complex subunit 1, PTGES  -  prostaglandin e synthase, COL8A1  -  collagen, type viii, alpha 1, PLIN2  -  perilipin 2, PON2  -  paraoxonase 2, HLTF  -  helicase-like transcription factor, CHST15  -  carbohydrate (n-acetylgalactosamine 4-sulfate 6-o) sulfotransferase 15, LAMP1  -  lysosomal-associated membrane protein 1, COL9A2  -  collagen, type ix, alpha 2, PLA2G15  -  phospholipase a2, group xv, ADD1  -  adducin 1 (alpha), COL9A1  -  collagen, type ix, alpha 1, GNB1  -  guanine nucleotide binding protein (g protein), beta polypeptide 1, COL4A5  -  collagen, type iv, alpha 5, ADH5  -  alcohol dehydrogenase 5 (class iii), chi polypeptide, SMARCA2  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, MAPK8IP1  -  mitogen-activated protein kinase 8 interacting protein 1, PARP1  -  poly (adp-ribose) polymerase 1, TAOK3  -  tao kinase 3, FZR1  -  fizzy/cell division cycle 20 related 1 (drosophila), ADM  -  adrenomedullin, COL11A1  -  collagen, type xi, alpha 1, POLR2B  -  polymerase (rna) ii (dna directed) polypeptide b, 140kda, PARP4  -  poly (adp-ribose) polymerase family, member 4, QKI  -  qki, kh domain containing, rna binding, AEBP1  -  ae binding protein 1, PRKACB  -  protein kinase, camp-dependent, catalytic, beta, ASCC2  -  activating signal cointegrator 1 complex subunit 2, CSTF3  -  cleavage stimulation factor, 3' pre-rna, subunit 3, 77kda, NUPL2  -  nucleoporin like 2, SUPV3L1  -  suppressor of var1, 3-like 1 (s. cerevisiae), AGT  -  angiotensinogen (serpin peptidase inhibitor, clade a, member 8), PRCP  -  prolylcarboxypeptidase (angiotensinase c), SUPT5H  -  suppressor of ty 5 homolog (s. cerevisiae), PRELP  -  proline/arginine-rich end leucine-rich repeat protein, CTPS1  -  ctp synthase 1, AIMP2  -  aminoacyl trna synthetase complex-interacting multifunctional protein 2, PPP5C  -  protein phosphatase 5, catalytic subunit, AGA  -  aspartylglucosaminidase, MAP4K4  -  mitogen-activated protein kinase kinase kinase kinase 4, ACAN  -  aggrecan, LPXN  -  leupaxin, PITPNB  -  phosphatidylinositol transfer protein, beta, CTSL  -  cathepsin l, AK2  -  adenylate kinase 2, SEP15  -  15 kda selenoprotein, CTSK  -  cathepsin k, CTSH  -  cathepsin h, PPP2R5B  -  protein phosphatase 2, regulatory subunit b', beta, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, CTSD  -  cathepsin d, SULT2B1  -  sulfotransferase family, cytosolic, 2b, member 1, NUDT21  -  nudix (nucleoside diphosphate linked moiety x)-type motif 21, WWP2  -  ww domain containing e3 ubiquitin protein ligase 2, AHR  -  aryl hydrocarbon receptor, STK3  -  serine/threonine kinase 3, CYB5A  -  cytochrome b5 type a (microsomal), PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, SNRNP40  -  small nuclear ribonucleoprotein 40kda (u5), ALDH2  -  aldehyde dehydrogenase 2 family (mitochondrial), NEK7  -  nima-related kinase 7, ST13  -  suppression of tumorigenicity 13 (colon carcinoma) (hsp70 interacting protein), CRKL  -  v-crk avian sarcoma virus ct10 oncogene homolog-like, RBPMS  -  rna binding protein with multiple splicing, RAB33A  -  rab33a, member ras oncogene family, FOSL1  -  fos-like antigen 1, RAB9A  -  rab9a, member ras oncogene family, PRPS1  -  phosphoribosyl pyrophosphate synthetase 1, STAT2  -  signal transducer and activator of transcription 2, 113kda, CRY1  -  cryptochrome 1 (photolyase-like), JUN  -  jun proto-oncogene, STAT1  -  signal transducer and activator of transcription 1, 91kda, UBE4A  -  ubiquitination factor e4a, STAT4  -  signal transducer and activator of transcription 4, STAT3  -  signal transducer and activator of transcription 3 (acute-phase response factor), PROS1  -  protein s (alpha), PRNP  -  prion protein, CRYAB  -  crystallin, alpha b, ALDOC  -  aldolase c, fructose-bisphosphate, ADRM1  -  adhesion regulating molecule 1, SSRP1  -  structure specific recognition protein 1, JAK2  -  janus kinase 2, CRYZ  -  crystallin, zeta (quinone reductase), MAP2K1  -  mitogen-activated protein kinase kinase 1, MAP2K3  -  mitogen-activated protein kinase kinase 3, MAPK10  -  mitogen-activated protein kinase 10, MAPK7  -  mitogen-activated protein kinase 7, SRPK2  -  srsf protein kinase 2, MAPK3  -  mitogen-activated protein kinase 3, TRIM21  -  tripartite motif containing 21, PLCE1  -  phospholipase c, epsilon 1, PRKG1  -  protein kinase, cgmp-dependent, type i, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, COPS2  -  cop9 signalosome subunit 2, GBE1  -  glucan (1,4-alpha-), branching enzyme 1, RPL23  -  ribosomal protein l23, PRKCG  -  protein kinase c, gamma, SLC25A6  -  solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6, CSPG4  -  chondroitin sulfate proteoglycan 4, SLC25A4  -  solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4, PRKCA  -  protein kinase c, alpha, VCAN  -  versican, ARIH1  -  ariadne homolog, ubiquitin-conjugating enzyme e2 binding protein, 1 (drosophila), PRKAR1B  -  protein kinase, camp-dependent, regulatory, type i, beta, GAS6  -  growth arrest-specific 6, FBXL2  -  f-box and leucine-rich repeat protein 2, APEX1  -  apex nuclease (multifunctional dna repair enzyme) 1, GSTM2  -  glutathione s-transferase mu 2 (muscle), GSTM1  -  glutathione s-transferase mu 1, SRSF11  -  serine/arginine-rich splicing factor 11, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, LUC7L3  -  luc7-like 3 (s. cerevisiae), GSTM4  -  glutathione s-transferase mu 4, PAWR  -  prkc, apoptosis, wt1, regulator, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), SREK1  -  splicing regulatory glutamine/lysine-rich protein 1, DDB1  -  damage-specific dna binding protein 1, 127kda, PBX1  -  pre-b-cell leukemia homeobox 1, PC  -  pyruvate carboxylase, GTF2H1  -  general transcription factor iih, polypeptide 1, 62kda, MSH6  -  muts homolog 6 (e. coli), KMT2A  -  lysine (k)-specific methyltransferase 2a, MMP2  -  matrix metallopeptidase 2 (gelatinase a, 72kda gelatinase, 72kda type iv collagenase), GTF3C2  -  general transcription factor iiic, polypeptide 2, beta 110kda, MMP1  -  matrix metallopeptidase 1 (interstitial collagenase), UBE2L6  -  ubiquitin-conjugating enzyme e2l 6, GTF2I  -  general transcription factor iii, P4HB  -  prolyl 4-hydroxylase, beta polypeptide, CYB5R1  -  cytochrome b5 reductase 1, STK17B  -  serine/threonine kinase 17b, ARF1  -  adp-ribosylation factor 1, GTF3C1  -  general transcription factor iiic, polypeptide 1, alpha 220kda, MMP11  -  matrix metallopeptidase 11 (stromelysin 3), FURIN  -  furin (paired basic amino acid cleaving enzyme), SDC2  -  syndecan 2, GYS1  -  glycogen synthase 1 (muscle), NOLC1  -  nucleolar and coiled-body phosphoprotein 1, ZNF473  -  zinc finger protein 473, APOE  -  apolipoprotein e, APP  -  amyloid beta (a4) precursor protein, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, WWOX  -  ww domain containing oxidoreductase, GUSB  -  glucuronidase, beta, AQP1  -  aquaporin 1 (colton blood group), DHX15  -  deah (asp-glu-ala-his) box helicase 15, ADIPOR2  -  adiponectin receptor 2, MCM7  -  minichromosome maintenance complex component 7, TUBA1A  -  tubulin, alpha 1a, ATXN1  -  ataxin 1, WBP4  -  ww domain binding protein 4, PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, RHOB  -  ras homolog family member b, MECP2  -  methyl cpg binding protein 2 (rett syndrome), MEF2A  -  myocyte enhancer factor 2a, PDPK1  -  3-phosphoinositide dependent protein kinase-1, PSIP1  -  pc4 and sfrs1 interacting protein 1, PDK3  -  pyruvate dehydrogenase kinase, isozyme 3, MEF2D  -  myocyte enhancer factor 2d, HADH  -  hydroxyacyl-coa dehydrogenase, RHOG  -  ras homolog family member g, PTP4A3  -  protein tyrosine phosphatase type iva, member 3, PCOLCE  -  procollagen c-endopeptidase enhancer, MEP1A  -  meprin a, alpha (paba peptide hydrolase), SCAF11  -  sr-related ctd-associated factor 11, DAG1  -  dystroglycan 1 (dystrophin-associated glycoprotein 1), KAT8  -  k(lysine) acetyltransferase 8, ASS1  -  argininosuccinate synthase 1, ASPH  -  aspartate beta-hydroxylase, DAPK1  -  death-associated protein kinase 1, TIPARP  -  tcdd-inducible poly(adp-ribose) polymerase, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, HEXA  -  hexosaminidase a (alpha polypeptide), SAT1  -  spermidine/spermine n1-acetyltransferase 1, HDAC1  -  histone deacetylase 1, SALL2  -  sal-like 2 (drosophila), KAT7  -  k(lysine) acetyltransferase 7, PGK1  -  phosphoglycerate kinase 1, MAGOH  -  mago-nashi homolog, proliferation-associated (drosophila), RFK  -  riboflavin kinase, XPC  -  xeroderma pigmentosum, complementation group c, PGD  -  phosphogluconate dehydrogenase, SMC3  -  structural maintenance of chromosomes 3, SLC16A3  -  solute carrier family 16 (monocarboxylate transporter), member 3, BAHD1  -  bromo adjacent homology domain containing 1, ZHX2  -  zinc fingers and homeoboxes 2, GPC1  -  glypican 1, ABLIM3  -  actin binding lim protein family, member 3, RAB14  -  rab14, member ras oncogene family, NMI  -  n-myc (and stat) interactor, GPI  -  glucose-6-phosphate isomerase, DPYSL3  -  dihydropyrimidinase-like 3, DPYSL2  -  dihydropyrimidinase-like 2, MLXIP  -  mlx interacting protein, MAN2B1  -  mannosidase, alpha, class 2b, member 1, ZFHX3  -  zinc finger homeobox 3, PEX6  -  peroxisomal biogenesis factor 6, SLC2A1  -  solute carrier family 2 (facilitated glucose transporter), member 1, ATP6V1B1  -  atpase, h+ transporting, lysosomal 56/58kda, v1 subunit b1, WNT5A  -  wingless-type mmtv integration site family, member 5a, PFKL  -  phosphofructokinase, liver, SLC2A3  -  solute carrier family 2 (facilitated glucose transporter), member 3, PFKP  -  phosphofructokinase, platelet, ASH2L  -  ash2 (absent, small, or homeotic)-like (drosophila), PFDN1  -  prefoldin subunit 1, PFDN4  -  prefoldin subunit 4, DLD  -  dihydrolipoamide dehydrogenase, LTB  -  lymphotoxin beta (tnf superfamily, member 3), SHH  -  sonic hedgehog, BAG1  -  bcl2-associated athanogene, RPL14  -  ribosomal protein l14, GPX1  -  glutathione peroxidase 1, ST6GAL1  -  st6 beta-galactosamide alpha-2,6-sialyltranferase 1, ATF5  -  activating transcription factor 5, PLAU  -  plasminogen activator, urokinase, PLAT  -  plasminogen activator, tissue, PLAGL1  -  pleiomorphic adenoma gene-like 1, LUM  -  lumican, ST3GAL4  -  st3 beta-galactoside alpha-2,3-sialyltransferase 4, UBA3  -  ubiquitin-like modifier activating enzyme 3, ATR  -  ataxia telangiectasia and rad3 related, PKM  -  pyruvate kinase, muscle, SFRP1  -  secreted frizzled-related protein 1, BDKRB2  -  bradykinin receptor b2, MGLL  -  monoglyceride lipase, SRSF1  -  serine/arginine-rich splicing factor 1, SMAD1  -  smad family member 1, DNM2  -  dynamin 2, SMAD2  -  smad family member 2, ACOT7  -  acyl-coa thioesterase 7, TDP2  -  tyrosyl-dna phosphodiesterase 2, BCL6  -  b-cell cll/lymphoma 6, TRA2B  -  transformer 2 beta homolog (drosophila), PHYH  -  phytanoyl-coa 2-hydroxylase, PHB2  -  prohibitin 2, NR3C1  -  nuclear receptor subfamily 3, group c, member 1 (glucocorticoid receptor), RPS6KA4  -  ribosomal protein s6 kinase, 90kda, polypeptide 4, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, DMD  -  dystrophin, YES1  -  v-yes-1 yamaguchi sarcoma viral oncogene homolog 1, DMPK  -  dystrophia myotonica-protein kinase, SCG5  -  secretogranin v (7b2 protein), SGK1  -  serum/glucocorticoid regulated kinase 1, NBAS  -  neuroblastoma amplified sequence, SMAD3  -  smad family member 3, CCND1  -  cyclin d1, GSK3B  -  glycogen synthase kinase 3 beta, SMAD6  -  smad family member 6, P4HA2  -  prolyl 4-hydroxylase, alpha polypeptide ii, MAF  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog, TRIM27  -  tripartite motif containing 27, YAF2  -  yy1 associated factor 2, RFC4  -  replication factor c (activator 1) 4, 37kda, NCBP2  -  nuclear cap binding protein subunit 2, 20kda, BNIP3  -  bcl2/adenovirus e1b 19kda interacting protein 3, RFC2  -  replication factor c (activator 1) 2, 40kda, HSF2  -  heat shock transcription factor 2, NDN  -  necdin, melanoma antigen (mage) family member, REV3L  -  rev3-like, polymerase (dna directed), zeta, catalytic subunit, SACM1L  -  sac1 suppressor of actin mutations 1-like (yeast), TRAK1  -  trafficking protein, kinesin binding 1, ELF4  -  e74-like factor 4 (ets domain transcription factor), BCKDK  -  branched chain ketoacid dehydrogenase kinase, TSC22D4  -  tsc22 domain family, member 4, BPGM  -  2,3-bisphosphoglycerate mutase, MAP1LC3B  -  microtubule-associated protein 1 light chain 3 beta, IQGAP1  -  iq motif containing gtpase activating protein 1, RPIA  -  ribose 5-phosphate isomerase a, EPAS1  -  endothelial pas domain protein 1, ATP6AP2  -  atpase, h+ transporting, lysosomal accessory protein 2, NASP  -  nuclear autoantigenic sperm protein (histone-binding), HABP4  -  hyaluronan binding protein 4, ATF6  -  activating transcription factor 6, ENO2  -  enolase 2 (gamma, neuronal), HRAS  -  harvey rat sarcoma viral oncogene homolog, NBN  -  nibrin, ENO1  -  enolase 1, (alpha), KLF5  -  kruppel-like factor 5 (intestinal), NUBP1  -  nucleotide binding protein 1, RELB  -  v-rel avian reticuloendotheliosis viral oncogene homolog b, RIT1  -  ras-like without caax 1, TUBA4A  -  tubulin, alpha 4a, EIF4A2  -  eukaryotic translation initiation factor 4a2, BGN  -  biglycan, MYO10  -  myosin x, EIF4B  -  eukaryotic translation initiation factor 4b, NT5C2  -  5'-nucleotidase, cytosolic ii, CFB  -  complement factor b, TNK2  -  tyrosine kinase, non-receptor, 2, BLMH  -  bleomycin hydrolase, HPN  -  hepsin, PIKFYVE  -  phosphoinositide kinase, fyve finger containing, EIF2S1  -  eukaryotic translation initiation factor 2, subunit 1 alpha, 35kda, NAB1  -  ngfi-a binding protein 1 (egr1 binding protein 1), BID  -  bh3 interacting domain death agonist, NACA  -  nascent polypeptide-associated complex alpha subunit, PRMT3  -  protein arginine methyltransferase 3, BMP1  -  bone morphogenetic protein 1, SYNJ1  -  synaptojanin 1, TST  -  thiosulfate sulfurtransferase (rhodanese), MYLK  -  myosin light chain kinase, BLVRB  -  biliverdin reductase b (flavin reductase (nadph)), BMPR1A  -  bone morphogenetic protein receptor, type ia, EIF4G1  -  eukaryotic translation initiation factor 4 gamma, 1, BMP4  -  bone morphogenetic protein 4, C9  -  complement component 9, STK38L  -  serine/threonine kinase 38 like, SH3YL1  -  sh3 domain containing, ysc84-like 1 (s. cerevisiae), MYH10  -  myosin, heavy chain 10, non-muscle, SNUPN  -  snurportin 1, HUWE1  -  hect, uba and wwe domain containing 1, e3 ubiquitin protein ligase, EGFR  -  epidermal growth factor receptor, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, PQBP1  -  polyglutamine binding protein 1, EIF2B4  -  eukaryotic translation initiation factor 2b, subunit 4 delta, 67kda, RNF2  -  ring finger protein 2, HNRNPR  -  heterogeneous nuclear ribonucleoprotein r, PDZRN3  -  pdz domain containing ring finger 3, ROCK1  -  rho-associated, coiled-coil containing protein kinase 1, ZHX3  -  zinc fingers and homeoboxes 3, SERPING1  -  serpin peptidase inhibitor, clade g (c1 inhibitor), member 1, CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, HSPE1  -  heat shock 10kda protein 1 (chaperonin 10), C1R  -  complement component 1, r subcomponent, C1S  -  complement component 1, s subcomponent, RRP1B  -  ribosomal rna processing 1b, SWAP70  -  swap switching b-cell complex 70kda subunit, LRPPRC  -  leucine-rich pentatricopeptide repeat containing, EDNRA  -  endothelin receptor type a, C4A  -  complement component 4a (rodgers blood group), TRAF2  -  tnf receptor-associated factor 2, FSTL3  -  follistatin-like 3 (secreted glycoprotein), MBD2  -  methyl-cpg binding domain protein 2, ECE1  -  endothelin converting enzyme 1, RAB7L1  -  rab7, member ras oncogene family-like 1, ECH1  -  enoyl coa hydratase 1, peroxisomal, TRAP1  -  tnf receptor-associated protein 1, ERC1  -  elks/rab6-interacting/cast family member 1, AKR1C3  -  aldo-keto reductase family 1, member c3, NADK  -  nad kinase, RPL23A  -  ribosomal protein l23a, CAPNS1  -  calpain, small subunit 1, ACAA2  -  acetyl-coa acyltransferase 2, PDE5A  -  phosphodiesterase 5a, cgmp-specific, RPL18A  -  ribosomal protein l18a, PPP4R1  -  protein phosphatase 4, regulatory subunit 1, RPL15  -  ribosomal protein l15, CAMK2G  -  calcium/calmodulin-dependent protein kinase ii gamma, RPL13  -  ribosomal protein l13, SIK1  -  salt-inducible kinase 1, RPL12  -  ribosomal protein l12, CAMK2B  -  calcium/calmodulin-dependent protein kinase ii beta, EMG1  -  emg1 n1-specific pseudouridine methyltransferase, EIF3C  -  eukaryotic translation initiation factor 3, subunit c, EIF3D  -  eukaryotic translation initiation factor 3, subunit d, RPL5  -  ribosomal protein l5, CASP7  -  caspase 7, apoptosis-related cysteine peptidase, COL14A1  -  collagen, type xiv, alpha 1, CASP4  -  caspase 4, apoptosis-related cysteine peptidase, UNG  -  uracil-dna glycosylase, RPL4  -  ribosomal protein l4, RPA3  -  replication protein a3, 14kda, EIF3I  -  eukaryotic translation initiation factor 3, subunit i, RPE  -  ribulose-5-phosphate-3-epimerase, RPA2  -  replication protein a2, 32kda, TAB2  -  tgf-beta activated kinase 1/map3k7 binding protein 2, EIF3M  -  eukaryotic translation initiation factor 3, subunit m, HIVEP2  -  human immunodeficiency virus type i enhancer binding protein 2, EZR  -  ezrin, ACD  -  adrenocortical dysplasia homolog (mouse), HLA-DMA  -  major histocompatibility complex, class ii, dm alpha, DDR1  -  discoidin domain receptor tyrosine kinase 1, B4GALT3  -  udp-gal:betaglcnac beta 1,4- galactosyltransferase, polypeptide 3, CFH  -  complement factor h, PTRF  -  polymerase i and transcript release factor, CFHR1  -  complement factor h-related 1, EZH2  -  enhancer of zeste homolog 2 (drosophila), VCAM1  -  vascular cell adhesion molecule 1, F2R  -  coagulation factor ii (thrombin) receptor, HIVEP1  -  human immunodeficiency virus type i enhancer binding protein 1, B3GALT4  -  udp-gal:betaglcnac beta 1,3-galactosyltransferase, polypeptide 4, ERF  -  ets2 repressor factor, TRADD  -  tnfrsf1a-associated via death domain, MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), MYCBP  -  myc binding protein, CTSF  -  cathepsin f, HOXB2  -  homeobox b2, ADAM19  -  adam metallopeptidase domain 19, UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, KIAA1199  -  kiaa1199, EED  -  embryonic ectoderm development, ARNT2  -  aryl-hydrocarbon receptor nuclear translocator 2, HMG20B  -  high mobility group 20b, HNRNPU  -  heterogeneous nuclear ribonucleoprotein u (scaffold attachment factor a), TNFSF4  -  tumor necrosis factor (ligand) superfamily, member 4, OXSR1  -  oxidative stress responsive 1, RPS13  -  ribosomal protein s13, DLC1  -  deleted in liver cancer 1, TYRO3  -  tyro3 protein tyrosine kinase, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, TUBB4B  -  tubulin, beta 4b class ivb, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, MRPS18B  -  mitochondrial ribosomal protein s18b, TUBB4A  -  tubulin, beta 4a class iva, ZMIZ1  -  zinc finger, miz-type containing 1, SACS  -  spastic ataxia of charlevoix-saguenay (sacsin), TXNRD1  -  thioredoxin reductase 1, PABPC4  -  poly(a) binding protein, cytoplasmic 4 (inducible form), SLC23A2  -  solute carrier family 23 (ascorbic acid transporter), member 2, UCHL1  -  ubiquitin carboxyl-terminal esterase l1 (ubiquitin thiolesterase), MVP  -  major vault protein, UBTF  -  upstream binding transcription factor, rna polymerase i, HNRNPA1  -  heterogeneous nuclear ribonucleoprotein a1, GNB2L1  -  guanine nucleotide binding protein (g protein), beta polypeptide 2-like 1, CAT  -  catalase, FADD  -  fas (tnfrsf6)-associated via death domain, RYK  -  receptor-like tyrosine kinase, SLC35A2  -  solute carrier family 35 (udp-galactose transporter), member a2, RUNX1T1  -  runt-related transcription factor 1; translocated to, 1 (cyclin d-related), UBE2G2  -  ubiquitin-conjugating enzyme e2g 2, RBM14  -  rna binding motif protein 14, NUP153  -  nucleoporin 153kda, CCS  -  copper chaperone for superoxide dismutase, CBS  -  cystathionine-beta-synthase, NR1D2  -  nuclear receptor subfamily 1, group d, member 2, NUPR1  -  nuclear protein, transcriptional regulator, 1, RRBP1  -  ribosome binding protein 1, MPG  -  n-methylpurine-dna glycosylase, FMOD  -  fibromodulin, PAICS  -  phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase, SSH1  -  slingshot protein phosphatase 1, ZNF638  -  zinc finger protein 638, PJA2  -  praja ring finger 2, e3 ubiquitin protein ligase, TCF12  -  transcription factor 12, HEXIM1  -  hexamethylene bis-acetamide inducible 1, CDC34  -  cell division cycle 34, INHBA  -  inhibin, beta a, HTRA2  -  htra serine peptidase 2, FLNA  -  filamin a, alpha, LMO3  -  lim domain only 3 (rhombotin-like 2), PSEN2  -  presenilin 2 (alzheimer disease 4), PSMA1  -  proteasome (prosome, macropain) subunit, alpha type, 1, FOXO1  -  forkhead box o1, CDC14B  -  cell division cycle 14b, SIN3B  -  sin3 transcription regulator family member b, PIAS1  -  protein inhibitor of activated stat, 1, FOXC1  -  forkhead box c1, DOK5  -  docking protein 5, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, PSMB9  -  proteasome (prosome, macropain) subunit, beta type, 9, PIR  -  pirin (iron-binding nuclear protein), PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, LMO4  -  lim domain only 4, PSMB7  -  proteasome (prosome, macropain) subunit, beta type, 7, FOXF2  -  forkhead box f2, YKT6  -  ykt6 v-snare homolog (s. cerevisiae), UBR2  -  ubiquitin protein ligase e3 component n-recognin 2, PSMB4  -  proteasome (prosome, macropain) subunit, beta type, 4, CAND1  -  cullin-associated and neddylation-dissociated 1, PDPN  -  podoplanin, OGDH  -  oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide), CAMK1  -  calcium/calmodulin-dependent protein kinase i, TDG  -  thymine-dna glycosylase, TXNIP  -  thioredoxin interacting protein, COASY  -  coa synthase, POM121  -  pom121 transmembrane nucleoporin, COPS3  -  cop9 signalosome subunit 3, LPPR4  -  lipid phosphate phosphatase-related protein type 4, SMG7  -  smg7 nonsense mediated mrna decay factor, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, IL6ST  -  interleukin 6 signal transducer (gp130, oncostatin m receptor), DGKZ  -  diacylglycerol kinase, zeta, PSMD11  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 11, UBR4  -  ubiquitin protein ligase e3 component n-recognin 4, TAF11  -  taf11 rna polymerase ii, tata box binding protein (tbp)-associated factor, 28kda, PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), FGFR1  -  fibroblast growth factor receptor 1, GNG12  -  guanine nucleotide binding protein (g protein), gamma 12, PTBP1  -  polypyrimidine tract binding protein 1, DDR2  -  discoidin domain receptor tyrosine kinase 2, TOMM20  -  translocase of outer mitochondrial membrane 20 homolog (yeast), ROR2  -  receptor tyrosine kinase-like orphan receptor 2, PTGDS  -  prostaglandin d2 synthase 21kda (brain), MAML1  -  mastermind-like 1 (drosophila), CFL1  -  cofilin 1 (non-muscle), BCLAF1  -  bcl2-associated transcription factor 1, FGF2  -  fibroblast growth factor 2 (basic), APPBP2  -  amyloid beta precursor protein (cytoplasmic tail) binding protein 2, NUP98  -  nucleoporin 98kda, MKNK1  -  map kinase interacting serine/threonine kinase 1, GTF2H5  -  general transcription factor iih, polypeptide 5, DDX17  -  dead (asp-glu-ala-asp) box helicase 17, CEBPB  -  ccaat/enhancer binding protein (c/ebp), beta, FDXR  -  ferredoxin reductase, CEBPD  -  ccaat/enhancer binding protein (c/ebp), delta, INPPL1  -  inositol polyphosphate phosphatase-like 1, TBX2  -  t-box 2, TBCD  -  tubulin folding cofactor d, CDKN2D  -  cyclin-dependent kinase inhibitor 2d (p19, inhibits cdk4), INPP5A  -  inositol polyphosphate-5-phosphatase, 40kda, PTPN1  -  protein tyrosine phosphatase, non-receptor type 1, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), RUVBL1  -  ruvb-like 1 (e. coli), RNF40  -  ring finger protein 40, e3 ubiquitin protein ligase, PPAP2B  -  phosphatidic acid phosphatase type 2b, PTPN13  -  protein tyrosine phosphatase, non-receptor type 13 (apo-1/cd95 (fas)-associated phosphatase), EFEMP1  -  egf containing fibulin-like extracellular matrix protein 1, EIF3E  -  eukaryotic translation initiation factor 3, subunit e, CRCP  -  cgrp receptor component, PTPRF  -  protein tyrosine phosphatase, receptor type, f, IRAK1  -  interleukin-1 receptor-associated kinase 1, RAD1  -  rad1 homolog (s. pombe), PURA  -  purine-rich element binding protein a, IFI16  -  interferon, gamma-inducible protein 16, IFI27  -  interferon, alpha-inducible protein 27, SLC7A8  -  solute carrier family 7 (amino acid transporter light chain, l system), member 8, TKT  -  transketolase, ZMYND11  -  zinc finger, mynd-type containing 11, TLE2  -  transducin-like enhancer of split 2 (e(sp1) homolog, drosophila), NME4  -  nme/nm23 nucleoside diphosphate kinase 4, AHCYL1  -  adenosylhomocysteinase-like 1, NOVA1  -  neuro-oncological ventral antigen 1, PXN  -  paxillin, FOXN3  -  forkhead box n3, NOTCH3  -  notch 3, NFYA  -  nuclear transcription factor y, alpha, HDAC4  -  histone deacetylase 4, CHD4  -  chromodomain helicase dna binding protein 4, ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, NFX1  -  nuclear transcription factor, x-box binding 1, RAB3B  -  rab3b, member ras oncogene family, NGF  -  nerve growth factor (beta polypeptide), RAB2A  -  rab2a, member ras oncogene family, TRAM1  -  translocation associated membrane protein 1, NFIX  -  nuclear factor i/x (ccaat-binding transcription factor), RAD23B  -  rad23 homolog b (s. cerevisiae), NHP2L1  -  nhp2 non-histone chromosome protein 2-like 1 (s. cerevisiae), CGB  -  chorionic gonadotropin, beta polypeptide, TNNT3  -  troponin t type 3 (skeletal, fast), IDH3B  -  isocitrate dehydrogenase 3 (nad+) beta, CTSC  -  cathepsin c, RAB13  -  rab13, member ras oncogene family, IDH2  -  isocitrate dehydrogenase 2 (nadp+), mitochondrial, TEK  -  tek tyrosine kinase, endothelial, DDIT4  -  dna-damage-inducible transcript 4, SUZ12  -  suz12 polycomb repressive complex 2 subunit, RAN  -  ran, member ras oncogene family, RBPJ  -  recombination signal binding protein for immunoglobulin kappa j region, RAD51D  -  rad51 paralog d, PABPC1  -  poly(a) binding protein, cytoplasmic 1, TERF1  -  telomeric repeat binding factor (nima-interacting) 1, DYRK2  -  dual-specificity tyrosine-(y)-phosphorylation regulated kinase 2, NFE2L2  -  nuclear factor (erythroid-derived 2)-like 2, CLNS1A  -  chloride channel, nucleotide-sensitive, 1a, ISG15  -  isg15 ubiquitin-like modifier, RARRES3  -  retinoic acid receptor responder (tazarotene induced) 3, NR2F1  -  nuclear receptor subfamily 2, group f, member 1, CLU  -  clusterin, TPP1  -  tripeptidyl peptidase i, RBL2  -  retinoblastoma-like 2 (p130), SMARCA5  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5, RBMS1  -  rna binding motif, single stranded interacting protein 1, IGF1R  -  insulin-like growth factor 1 receptor, IGF2  -  insulin-like growth factor 2 (somatomedin a), TGFB1  -  transforming growth factor, beta 1, OGT  -  o-linked n-acetylglucosamine (glcnac) transferase, TGFB1I1  -  transforming growth factor beta 1 induced transcript 1, IGFBP1  -  insulin-like growth factor binding protein 1, TGIF1  -  tgfb-induced factor homeobox 1, TSPYL2  -  tspy-like 2, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), SND1  -  staphylococcal nuclease and tudor domain containing 1, TGFBR3  -  transforming growth factor, beta receptor iii, RBBP4  -  retinoblastoma binding protein 4, CUL4B  -  cullin 4b, FOSL2  -  fos-like antigen 2, FOSB  -  fbj murine osteosarcoma viral oncogene homolog b, FOS  -  fbj murine osteosarcoma viral oncogene homolog, KAT6B  -  k(lysine) acetyltransferase 6b, FNTB  -  farnesyltransferase, caax box, beta, POLD3  -  polymerase (dna-directed), delta 3, accessory subunit, CKB  -  creatine kinase, brain, RBP1  -  retinol binding protein 1, cellular]"GO:0042981,regulation of apoptotic process,1.05E-04,2.39E-02,1.58,8230,987,448,85,"[AKR1C3  -  aldo-keto reductase family 1, member c3, BNIP3  -  bcl2/adenovirus e1b 19kda interacting protein 3, IFIT3  -  interferon-induced protein with tetratricopeptide repeats 3, ACAA2  -  acetyl-coa acyltransferase 2, PAWR  -  prkc, apoptosis, wt1, regulator, IFI27  -  interferon, alpha-inducible protein 27, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), CDC34  -  cell division cycle 34, CASP4  -  caspase 4, apoptosis-related cysteine peptidase, UNG  -  uracil-dna glycosylase, GPI  -  glucose-6-phosphate isomerase, FOXO1  -  forkhead box o1, HRAS  -  harvey rat sarcoma viral oncogene homolog, TRAF4  -  tnf receptor-associated factor 4, ASIC2  -  acid-sensing (proton-gated) ion channel 2, CTSH  -  cathepsin h, FOXC1  -  forkhead box c1, ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, P4HB  -  prolyl 4-hydroxylase, beta polypeptide, NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, SOX9  -  sry (sex determining region y)-box 9, PDCD10  -  programmed cell death 10, SOX4  -  sry (sex determining region y)-box 4, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, WNT5A  -  wingless-type mmtv integration site family, member 5a, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, WWOX  -  ww domain containing oxidoreductase, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, LMNA  -  lamin a/c, BMP4  -  bone morphogenetic protein 4, TEK  -  tek tyrosine kinase, endothelial, MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), ACTN1  -  actinin, alpha 1, FGFR1  -  fibroblast growth factor receptor 1, SHH  -  sonic hedgehog, MDK  -  midkine (neurite growth-promoting factor 2), JUN  -  jun proto-oncogene, STAT1  -  signal transducer and activator of transcription 1, 91kda, ARNT2  -  aryl-hydrocarbon receptor nuclear translocator 2, CRYAB  -  crystallin, alpha b, CCNG1  -  cyclin g1, MECP2  -  methyl cpg binding protein 2 (rett syndrome), ATF5  -  activating transcription factor 5, RHOB  -  ras homolog family member b, ADAR  -  adenosine deaminase, rna-specific, NFE2L2  -  nuclear factor (erythroid-derived 2)-like 2, PDPK1  -  3-phosphoinositide dependent protein kinase-1, FGF4  -  fibroblast growth factor 4, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, JAK2  -  janus kinase 2, ADA  -  adenosine deaminase, TRIM2  -  tripartite motif containing 2, TYRO3  -  tyro3 protein tyrosine kinase, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, MED1  -  mediator complex subunit 1, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, CLU  -  clusterin, CNR1  -  cannabinoid receptor 1 (brain), AMIGO2  -  adhesion molecule with ig-like domain 2, KRT18  -  keratin 18, BDKRB2  -  bradykinin receptor b2, MAPK7  -  mitogen-activated protein kinase 7, IGF1R  -  insulin-like growth factor 1 receptor, SRPK2  -  srsf protein kinase 2, TGFB1  -  transforming growth factor, beta 1, CAT  -  catalase, CDKN2D  -  cyclin-dependent kinase inhibitor 2d (p19, inhibits cdk4), DAPK1  -  death-associated protein kinase 1, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, KRIT1  -  krit1, ankyrin repeat containing, ARL6IP5  -  adp-ribosylation-like factor 6 interacting protein 5, TRAF2  -  tnf receptor-associated factor 2, SGK1  -  serum/glucocorticoid regulated kinase 1, ADM  -  adrenomedullin, PRKCA  -  protein kinase c, alpha, SMAD6  -  smad family member 6, GSK3B  -  glycogen synthase kinase 3 beta, HDAC1  -  histone deacetylase 1, GAS6  -  growth arrest-specific 6, ITSN1  -  intersectin 1 (sh3 domain protein), ITGA6  -  integrin, alpha 6, GAS1  -  growth arrest-specific 1]"GO:0007568,aging,1.09E-04,2.43E-02,2.24,8230,154,716,30,"[APEX1  -  apex nuclease (multifunctional dna repair enzyme) 1, JUN  -  jun proto-oncogene, LITAF  -  lipopolysaccharide-induced tnf factor, GSN  -  gelsolin, GPX1  -  glutathione peroxidase 1, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), CRYAB  -  crystallin, alpha b, ALDOC  -  aldolase c, fructose-bisphosphate, AGT  -  angiotensinogen (serpin peptidase inhibitor, clade a, member 8), ADA  -  adenosine deaminase, PRELP  -  proline/arginine-rich end leucine-rich repeat protein, CNR1  -  cannabinoid receptor 1 (brain), SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, ATR  -  ataxia telangiectasia and rad3 related, HRAS  -  harvey rat sarcoma viral oncogene homolog, MAP2K1  -  mitogen-activated protein kinase kinase 1, ZMIZ1  -  zinc finger, miz-type containing 1, ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, TBX2  -  t-box 2, TGFB1  -  transforming growth factor, beta 1, ADH5  -  alcohol dehydrogenase 5 (class iii), chi polypeptide, ASS1  -  argininosuccinate synthase 1, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), FOS  -  fbj murine osteosarcoma viral oncogene homolog, APOE  -  apolipoprotein e, ADM  -  adrenomedullin, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, VCAM1  -  vascular cell adhesion molecule 1, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, CTSC  -  cathepsin c]"GO:0010605,negative regulation of macromolecule metabolic process,1.28E-04,2.79E-02,1.36,8230,1127,892,166,"[NCBP2  -  nuclear cap binding protein subunit 2, 20kda, YAF2  -  yy1 associated factor 2, FMR1  -  fragile x mental retardation 1, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, NCK1  -  nck adaptor protein 1, PAWR  -  prkc, apoptosis, wt1, regulator, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), HEXIM1  -  hexamethylene bis-acetamide inducible 1, TSC22D4  -  tsc22 domain family, member 4, NCOR2  -  nuclear receptor corepressor 2, FLNA  -  filamin a, alpha, CD59  -  cd59 molecule, complement regulatory protein, PSMA1  -  proteasome (prosome, macropain) subunit, alpha type, 1, FOXO1  -  forkhead box o1, HRAS  -  harvey rat sarcoma viral oncogene homolog, ENO1  -  enolase 1, (alpha), MSH6  -  muts homolog 6 (e. coli), SIN3B  -  sin3 transcription regulator family member b, PIAS1  -  protein inhibitor of activated stat, 1, FOXC1  -  forkhead box c1, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, PSMB9  -  proteasome (prosome, macropain) subunit, beta type, 9, SOX9  -  sry (sex determining region y)-box 9, SOX4  -  sry (sex determining region y)-box 4, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, FOXF2  -  forkhead box f2, UBR2  -  ubiquitin protein ligase e3 component n-recognin 2, NAB1  -  ngfi-a binding protein 1 (egr1 binding protein 1), FURIN  -  furin (paired basic amino acid cleaving enzyme), NACA  -  nascent polypeptide-associated complex alpha subunit, PSMB4  -  proteasome (prosome, macropain) subunit, beta type, 4, TDG  -  thymine-dna glycosylase, GJA1  -  gap junction protein, alpha 1, 43kda, APOE  -  apolipoprotein e, RGS3  -  regulator of g-protein signaling 3, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, CREB1  -  camp responsive element binding protein 1, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, SERPINF2  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 2, BMP4  -  bone morphogenetic protein 4, SNTA1  -  syntrophin, alpha 1, PSMD11  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 11, PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), FGFR1  -  fibroblast growth factor receptor 1, GADD45B  -  growth arrest and dna-damage-inducible, beta, ATXN1  -  ataxin 1, PTBP1  -  polypyrimidine tract binding protein 1, BCLAF1  -  bcl2-associated transcription factor 1, MECP2  -  methyl cpg binding protein 2 (rett syndrome), ADAR  -  adenosine deaminase, rna-specific, FGF2  -  fibroblast growth factor 2 (basic), MEF2A  -  myocyte enhancer factor 2a, PDPK1  -  3-phosphoinositide dependent protein kinase-1, EGFR  -  epidermal growth factor receptor, SAMD4A  -  sterile alpha motif domain containing 4a, MED1  -  mediator complex subunit 1, RNF2  -  ring finger protein 2, EIF2B4  -  eukaryotic translation initiation factor 2b, subunit 4 delta, 67kda, CEBPB  -  ccaat/enhancer binding protein (c/ebp), beta, INPPL1  -  inositol polyphosphate phosphatase-like 1, TBX2  -  t-box 2, ZHX3  -  zinc fingers and homeoboxes 3, EIF4E2  -  eukaryotic translation initiation factor 4e family member 2, SERPING1  -  serpin peptidase inhibitor, clade g (c1 inhibitor), member 1, CDKN1C  -  cyclin-dependent kinase inhibitor 1c (p57, kip2), KAT8  -  k(lysine) acetyltransferase 8, CDKN2D  -  cyclin-dependent kinase inhibitor 2d (p19, inhibits cdk4), SMARCA2  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, DAPK1  -  death-associated protein kinase 1, MAPK8IP1  -  mitogen-activated protein kinase 8 interacting protein 1, PARP1  -  poly (adp-ribose) polymerase 1, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), LRPPRC  -  leucine-rich pentatricopeptide repeat containing, TAOK3  -  tao kinase 3, FZR1  -  fizzy/cell division cycle 20 related 1 (drosophila), PPAP2B  -  phosphatidic acid phosphatase type 2b, EIF3E  -  eukaryotic translation initiation factor 3, subunit e, MBD2  -  methyl-cpg binding domain protein 2, HDAC1  -  histone deacetylase 1, PKIG  -  protein kinase (camp-dependent, catalytic) inhibitor gamma, SALL2  -  sal-like 2 (drosophila), PURA  -  purine-rich element binding protein a, TIMP3  -  timp metallopeptidase inhibitor 3, IFI16  -  interferon, gamma-inducible protein 16, STRN3  -  striatin, calmodulin binding protein 3, TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), SIK1  -  salt-inducible kinase 1, SMC3  -  structural maintenance of chromosomes 3, TLE2  -  transducin-like enhancer of split 2 (e(sp1) homolog, drosophila), BAHD1  -  bromo adjacent homology domain containing 1, ZHX2  -  zinc fingers and homeoboxes 2, TLE4  -  transducin-like enhancer of split 4 (e(sp1) homolog, drosophila), SUPT5H  -  suppressor of ty 5 homolog (s. cerevisiae), ZFHX3  -  zinc finger homeobox 3, ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, HDAC4  -  histone deacetylase 4, NFX1  -  nuclear transcription factor, x-box binding 1, ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, NFIX  -  nuclear factor i/x (ccaat-binding transcription factor), WWP2  -  ww domain containing e3 ubiquitin protein ligase 2, WNT5A  -  wingless-type mmtv integration site family, member 5a, AHR  -  aryl hydrocarbon receptor, PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, EZH2  -  enhancer of zeste homolog 2 (drosophila), TSC22D3  -  tsc22 domain family, member 3, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, HIVEP1  -  human immunodeficiency virus type i enhancer binding protein 1, ERF  -  ets2 repressor factor, SUZ12  -  suz12 polycomb repressive complex 2 subunit, MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), DDIT4  -  dna-damage-inducible transcript 4, ST13  -  suppression of tumorigenicity 13 (colon carcinoma) (hsp70 interacting protein), RBPJ  -  recombination signal binding protein for immunoglobulin kappa j region, UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, SHH  -  sonic hedgehog, CRY1  -  cryptochrome 1 (photolyase-like), JUN  -  jun proto-oncogene, STAT1  -  signal transducer and activator of transcription 1, 91kda, EED  -  embryonic ectoderm development, PABPC1  -  poly(a) binding protein, cytoplasmic 1, SLIT2  -  slit homolog 2 (drosophila), STAT3  -  signal transducer and activator of transcription 3 (acute-phase response factor), TERF1  -  telomeric repeat binding factor (nima-interacting) 1, PRNP  -  prion protein, CRYAB  -  crystallin, alpha b, PLAT  -  plasminogen activator, tissue, TNFSF4  -  tumor necrosis factor (ligand) superfamily, member 4, FXR1  -  fragile x mental retardation, autosomal homolog 1, ISG15  -  isg15 ubiquitin-like modifier, NR2F1  -  nuclear receptor subfamily 2, group f, member 1, RPS13  -  ribosomal protein s13, NF2  -  neurofibromin 2 (merlin), ATR  -  ataxia telangiectasia and rad3 related, IGBP1  -  immunoglobulin (cd79a) binding protein 1, SFRP1  -  secreted frizzled-related protein 1, BDKRB2  -  bradykinin receptor b2, SMARCA5  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5, SERPINE2  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 2, IGF1R  -  insulin-like growth factor 1 receptor, TGFB1  -  transforming growth factor, beta 1, UCHL1  -  ubiquitin carboxyl-terminal esterase l1 (ubiquitin thiolesterase), UBTF  -  upstream binding transcription factor, rna polymerase i, MVP  -  major vault protein, SMAD2  -  smad family member 2, GNB2L1  -  guanine nucleotide binding protein (g protein), beta polypeptide 2-like 1, TRIM21  -  tripartite motif containing 21, TGIF1  -  tgfb-induced factor homeobox 1, BCL6  -  b-cell cll/lymphoma 6, COPS2  -  cop9 signalosome subunit 2, TSPYL2  -  tspy-like 2, SND1  -  staphylococcal nuclease and tudor domain containing 1, PHB2  -  prohibitin 2, DMD  -  dystrophin, PRKCG  -  protein kinase c, gamma, KAT6B  -  k(lysine) acetyltransferase 6b, SMAD3  -  smad family member 3, NBAS  -  neuroblastoma amplified sequence, PRKCA  -  protein kinase c, alpha, SMAD6  -  smad family member 6, GSK3B  -  glycogen synthase kinase 3 beta, CCND1  -  cyclin d1, NR1D2  -  nuclear receptor subfamily 1, group d, member 2, GAS6  -  growth arrest-specific 6, GAS1  -  growth arrest-specific 1, MAF  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog]"GO:0009887,organ morphogenesis,1.39E-04,2.98E-02,2.66,8230,302,236,23,"[ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, PDGFA  -  platelet-derived growth factor alpha polypeptide, ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, FOXC1  -  forkhead box c1, HOXB2  -  homeobox b2, FGFR1  -  fibroblast growth factor receptor 1, SOX9  -  sry (sex determining region y)-box 9, ABLIM1  -  actin binding lim protein 1, SOX4  -  sry (sex determining region y)-box 4, FOXF2  -  forkhead box f2, TGFBR3  -  transforming growth factor, beta receptor iii, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), PBX1  -  pre-b-cell leukemia homeobox 1, FGF4  -  fibroblast growth factor 4, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, LAMA5  -  laminin, alpha 5, GSK3B  -  glycogen synthase kinase 3 beta, HDAC1  -  histone deacetylase 1, WWOX  -  ww domain containing oxidoreductase, ITGA6  -  integrin, alpha 6, BMP4  -  bone morphogenetic protein 4, ZMIZ1  -  zinc finger, miz-type containing 1, LAMB1  -  laminin, beta 1]"GO:0060744,mammary gland branching involved in thelarche,1.40E-04,2.95E-02,14.66,8230,5,449,4,"[TGFB1  -  transforming growth factor, beta 1, MED1  -  mediator complex subunit 1, WNT5A  -  wingless-type mmtv integration site family, member 5a, PHB2  -  prohibitin 2]"GO:0009892,negative regulation of metabolic process,1.42E-04,2.92E-02,1.34,8230,1219,892,177,"[YAF2  -  yy1 associated factor 2, NCBP2  -  nuclear cap binding protein subunit 2, 20kda, FMR1  -  fragile x mental retardation 1, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, NCK1  -  nck adaptor protein 1, PAWR  -  prkc, apoptosis, wt1, regulator, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), HEXIM1  -  hexamethylene bis-acetamide inducible 1, TSC22D4  -  tsc22 domain family, member 4, IQGAP1  -  iq motif containing gtpase activating protein 1, NCOR2  -  nuclear receptor corepressor 2, FLNA  -  filamin a, alpha, CD59  -  cd59 molecule, complement regulatory protein, PSMA1  -  proteasome (prosome, macropain) subunit, alpha type, 1, FOXO1  -  forkhead box o1, HRAS  -  harvey rat sarcoma viral oncogene homolog, ENO1  -  enolase 1, (alpha), MSH6  -  muts homolog 6 (e. coli), SIN3B  -  sin3 transcription regulator family member b, PIAS1  -  protein inhibitor of activated stat, 1, FOXC1  -  forkhead box c1, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, PSMB9  -  proteasome (prosome, macropain) subunit, beta type, 9, SOX9  -  sry (sex determining region y)-box 9, SOX4  -  sry (sex determining region y)-box 4, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, FOXF2  -  forkhead box f2, UBR2  -  ubiquitin protein ligase e3 component n-recognin 2, NAB1  -  ngfi-a binding protein 1 (egr1 binding protein 1), FURIN  -  furin (paired basic amino acid cleaving enzyme), NACA  -  nascent polypeptide-associated complex alpha subunit, PSMB4  -  proteasome (prosome, macropain) subunit, beta type, 4, TDG  -  thymine-dna glycosylase, GJA1  -  gap junction protein, alpha 1, 43kda, APOE  -  apolipoprotein e, RGS3  -  regulator of g-protein signaling 3, SOD1  -  superoxide dismutase 1, soluble, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, CREB1  -  camp responsive element binding protein 1, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, SERPINF2  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 2, BMP4  -  bone morphogenetic protein 4, SNTA1  -  syntrophin, alpha 1, PDGFA  -  platelet-derived growth factor alpha polypeptide, PSMD11  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 11, PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), FGFR1  -  fibroblast growth factor receptor 1, GADD45B  -  growth arrest and dna-damage-inducible, beta, ATXN1  -  ataxin 1, PTBP1  -  polypyrimidine tract binding protein 1, BCLAF1  -  bcl2-associated transcription factor 1, MECP2  -  methyl cpg binding protein 2 (rett syndrome), ADAR  -  adenosine deaminase, rna-specific, FGF2  -  fibroblast growth factor 2 (basic), MEF2A  -  myocyte enhancer factor 2a, PDPK1  -  3-phosphoinositide dependent protein kinase-1, EGFR  -  epidermal growth factor receptor, SAMD4A  -  sterile alpha motif domain containing 4a, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, MED1  -  mediator complex subunit 1, RNF2  -  ring finger protein 2, EIF2B4  -  eukaryotic translation initiation factor 2b, subunit 4 delta, 67kda, CNR1  -  cannabinoid receptor 1 (brain), CEBPB  -  ccaat/enhancer binding protein (c/ebp), beta, INPPL1  -  inositol polyphosphate phosphatase-like 1, TBX2  -  t-box 2, ZHX3  -  zinc fingers and homeoboxes 3, EIF4E2  -  eukaryotic translation initiation factor 4e family member 2, NPR3  -  natriuretic peptide receptor c/guanylate cyclase c (atrionatriuretic peptide receptor c), SERPING1  -  serpin peptidase inhibitor, clade g (c1 inhibitor), member 1, DAG1  -  dystroglycan 1 (dystrophin-associated glycoprotein 1), CDKN1C  -  cyclin-dependent kinase inhibitor 1c (p57, kip2), KAT8  -  k(lysine) acetyltransferase 8, CDKN2D  -  cyclin-dependent kinase inhibitor 2d (p19, inhibits cdk4), SMARCA2  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, DAPK1  -  death-associated protein kinase 1, MAPK8IP1  -  mitogen-activated protein kinase 8 interacting protein 1, PARP1  -  poly (adp-ribose) polymerase 1, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), LRPPRC  -  leucine-rich pentatricopeptide repeat containing, EDNRA  -  endothelin receptor type a, TAOK3  -  tao kinase 3, FZR1  -  fizzy/cell division cycle 20 related 1 (drosophila), PPAP2B  -  phosphatidic acid phosphatase type 2b, EIF3E  -  eukaryotic translation initiation factor 3, subunit e, MBD2  -  methyl-cpg binding domain protein 2, HDAC1  -  histone deacetylase 1, PKIG  -  protein kinase (camp-dependent, catalytic) inhibitor gamma, SALL2  -  sal-like 2 (drosophila), TRAP1  -  tnf receptor-associated protein 1, AKR1C3  -  aldo-keto reductase family 1, member c3, PURA  -  purine-rich element binding protein a, TIMP3  -  timp metallopeptidase inhibitor 3, IFI16  -  interferon, gamma-inducible protein 16, STRN3  -  striatin, calmodulin binding protein 3, TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), SIK1  -  salt-inducible kinase 1, SMC3  -  structural maintenance of chromosomes 3, TLE2  -  transducin-like enhancer of split 2 (e(sp1) homolog, drosophila), BAHD1  -  bromo adjacent homology domain containing 1, ZHX2  -  zinc fingers and homeoboxes 2, TLE4  -  transducin-like enhancer of split 4 (e(sp1) homolog, drosophila), SUPT5H  -  suppressor of ty 5 homolog (s. cerevisiae), ZFHX3  -  zinc finger homeobox 3, ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, HDAC4  -  histone deacetylase 4, NFX1  -  nuclear transcription factor, x-box binding 1, ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, NFIX  -  nuclear factor i/x (ccaat-binding transcription factor), WWP2  -  ww domain containing e3 ubiquitin protein ligase 2, WNT5A  -  wingless-type mmtv integration site family, member 5a, AHR  -  aryl hydrocarbon receptor, PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, EZH2  -  enhancer of zeste homolog 2 (drosophila), TSC22D3  -  tsc22 domain family, member 3, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, HIVEP1  -  human immunodeficiency virus type i enhancer binding protein 1, ERF  -  ets2 repressor factor, SUZ12  -  suz12 polycomb repressive complex 2 subunit, MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), DDIT4  -  dna-damage-inducible transcript 4, ST13  -  suppression of tumorigenicity 13 (colon carcinoma) (hsp70 interacting protein), RBPJ  -  recombination signal binding protein for immunoglobulin kappa j region, UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, SHH  -  sonic hedgehog, CRY1  -  cryptochrome 1 (photolyase-like), JUN  -  jun proto-oncogene, STAT1  -  signal transducer and activator of transcription 1, 91kda, EED  -  embryonic ectoderm development, STAT3  -  signal transducer and activator of transcription 3 (acute-phase response factor), SLIT2  -  slit homolog 2 (drosophila), PABPC1  -  poly(a) binding protein, cytoplasmic 1, TERF1  -  telomeric repeat binding factor (nima-interacting) 1, PRNP  -  prion protein, CRYAB  -  crystallin, alpha b, PLAT  -  plasminogen activator, tissue, TNFSF4  -  tumor necrosis factor (ligand) superfamily, member 4, FXR1  -  fragile x mental retardation, autosomal homolog 1, ISG15  -  isg15 ubiquitin-like modifier, NR2F1  -  nuclear receptor subfamily 2, group f, member 1, RPS13  -  ribosomal protein s13, NF2  -  neurofibromin 2 (merlin), ATR  -  ataxia telangiectasia and rad3 related, IGBP1  -  immunoglobulin (cd79a) binding protein 1, SFRP1  -  secreted frizzled-related protein 1, BDKRB2  -  bradykinin receptor b2, SMARCA5  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5, SERPINE2  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 2, MAPK7  -  mitogen-activated protein kinase 7, IGF1R  -  insulin-like growth factor 1 receptor, TGFB1  -  transforming growth factor, beta 1, UCHL1  -  ubiquitin carboxyl-terminal esterase l1 (ubiquitin thiolesterase), UBTF  -  upstream binding transcription factor, rna polymerase i, MVP  -  major vault protein, SMAD2  -  smad family member 2, GNB2L1  -  guanine nucleotide binding protein (g protein), beta polypeptide 2-like 1, TRIM21  -  tripartite motif containing 21, TGIF1  -  tgfb-induced factor homeobox 1, COPS2  -  cop9 signalosome subunit 2, BCL6  -  b-cell cll/lymphoma 6, TSPYL2  -  tspy-like 2, SND1  -  staphylococcal nuclease and tudor domain containing 1, PHB2  -  prohibitin 2, DMD  -  dystrophin, PRKCG  -  protein kinase c, gamma, KAT6B  -  k(lysine) acetyltransferase 6b, NBAS  -  neuroblastoma amplified sequence, SMAD3  -  smad family member 3, PRKCA  -  protein kinase c, alpha, SMAD6  -  smad family member 6, CCND1  -  cyclin d1, GSK3B  -  glycogen synthase kinase 3 beta, NR1D2  -  nuclear receptor subfamily 1, group d, member 2, GAS6  -  growth arrest-specific 6, GAS1  -  growth arrest-specific 1, MAF  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog]"GO:0010941,regulation of cell death,1.47E-04,2.98E-02,1.37,8230,1027,892,153,"[BNIP3  -  bcl2/adenovirus e1b 19kda interacting protein 3, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, BNIP2  -  bcl2/adenovirus e1b 19kda interacting protein 2, NCK1  -  nck adaptor protein 1, PAWR  -  prkc, apoptosis, wt1, regulator, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), CDC34  -  cell division cycle 34, PAX7  -  paired box 7, HTRA2  -  htra serine peptidase 2, CD59  -  cd59 molecule, complement regulatory protein, PSMA1  -  proteasome (prosome, macropain) subunit, alpha type, 1, FOXO1  -  forkhead box o1, HRAS  -  harvey rat sarcoma viral oncogene homolog, TRAF4  -  tnf receptor-associated factor 4, ASIC2  -  acid-sensing (proton-gated) ion channel 2, FOXC1  -  forkhead box c1, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, CRLF1  -  cytokine receptor-like factor 1, DFNA5  -  deafness, autosomal dominant 5, P4HB  -  prolyl 4-hydroxylase, beta polypeptide, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, PDCD10  -  programmed cell death 10, PSMB9  -  proteasome (prosome, macropain) subunit, beta type, 9, SOX9  -  sry (sex determining region y)-box 9, SOX4  -  sry (sex determining region y)-box 4, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, BID  -  bh3 interacting domain death agonist, NACA  -  nascent polypeptide-associated complex alpha subunit, PSMB4  -  proteasome (prosome, macropain) subunit, beta type, 4, APOE  -  apolipoprotein e, SOD2  -  superoxide dismutase 2, mitochondrial, SOD1  -  superoxide dismutase 1, soluble, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, WWOX  -  ww domain containing oxidoreductase, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, IL6ST  -  interleukin 6 signal transducer (gp130, oncostatin m receptor), LMNA  -  lamin a/c, BMP4  -  bone morphogenetic protein 4, AQP1  -  aquaporin 1 (colton blood group), ITGA5  -  integrin, alpha 5 (fibronectin receptor, alpha polypeptide), PSMD11  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 11, PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), ACTN1  -  actinin, alpha 1, FGFR1  -  fibroblast growth factor receptor 1, GADD45B  -  growth arrest and dna-damage-inducible, beta, MDK  -  midkine (neurite growth-promoting factor 2), EEF1A2  -  eukaryotic translation elongation factor 1 alpha 2, CFL1  -  cofilin 1 (non-muscle), BCLAF1  -  bcl2-associated transcription factor 1, MECP2  -  methyl cpg binding protein 2 (rett syndrome), ADAR  -  adenosine deaminase, rna-specific, RHOB  -  ras homolog family member b, FGF2  -  fibroblast growth factor 2 (basic), PDPK1  -  3-phosphoinositide dependent protein kinase-1, EGFR  -  epidermal growth factor receptor, FGF4  -  fibroblast growth factor 4, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, ADA  -  adenosine deaminase, TRIM2  -  tripartite motif containing 2, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, MED1  -  mediator complex subunit 1, CNR1  -  cannabinoid receptor 1 (brain), CEBPB  -  ccaat/enhancer binding protein (c/ebp), beta, AMIGO2  -  adhesion molecule with ig-like domain 2, KRT18  -  keratin 18, ROCK1  -  rho-associated, coiled-coil containing protein kinase 1, CDKN2D  -  cyclin-dependent kinase inhibitor 2d (p19, inhibits cdk4), DAPK1  -  death-associated protein kinase 1, MAPK8IP1  -  mitogen-activated protein kinase 8 interacting protein 1, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, ARL6IP5  -  adp-ribosylation-like factor 6 interacting protein 5, EDNRA  -  endothelin receptor type a, TRAF2  -  tnf receptor-associated factor 2, ADM  -  adrenomedullin, HDAC1  -  histone deacetylase 1, ITGA6  -  integrin, alpha 6, TPT1  -  tumor protein, translationally-controlled 1, IRAK1  -  interleukin-1 receptor-associated kinase 1, AKR1C3  -  aldo-keto reductase family 1, member c3, IFIT3  -  interferon-induced protein with tetratricopeptide repeats 3, ACAA2  -  acetyl-coa acyltransferase 2, IFI27  -  interferon, alpha-inducible protein 27, TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), SIK1  -  salt-inducible kinase 1, CAMK2B  -  calcium/calmodulin-dependent protein kinase ii beta, AGT  -  angiotensinogen (serpin peptidase inhibitor, clade a, member 8), CASP4  -  caspase 4, apoptosis-related cysteine peptidase, UNG  -  uracil-dna glycosylase, GPI  -  glucose-6-phosphate isomerase, CAST  -  calpastatin, CTSH  -  cathepsin h, ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, NGF  -  nerve growth factor (beta polypeptide), NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, WNT5A  -  wingless-type mmtv integration site family, member 5a, STK3  -  serine/threonine kinase 3, TSC22D3  -  tsc22 domain family, member 3, CTSC  -  cathepsin c, TEK  -  tek tyrosine kinase, endothelial, MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), TRADD  -  tnfrsf1a-associated via death domain, DDIT4  -  dna-damage-inducible transcript 4, FOSL1  -  fos-like antigen 1, SHH  -  sonic hedgehog, JUN  -  jun proto-oncogene, BAG1  -  bcl2-associated athanogene, STAT1  -  signal transducer and activator of transcription 1, 91kda, SLIT2  -  slit homolog 2 (drosophila), STAT3  -  signal transducer and activator of transcription 3 (acute-phase response factor), GPX1  -  glutathione peroxidase 1, TERF1  -  telomeric repeat binding factor (nima-interacting) 1, PRNP  -  prion protein, ARNT2  -  aryl-hydrocarbon receptor nuclear translocator 2, CRYAB  -  crystallin, alpha b, CCNG1  -  cyclin g1, ATF5  -  activating transcription factor 5, NFE2L2  -  nuclear factor (erythroid-derived 2)-like 2, JAK2  -  janus kinase 2, DLC1  -  deleted in liver cancer 1, TYRO3  -  tyro3 protein tyrosine kinase, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, CLU  -  clusterin, IGBP1  -  immunoglobulin (cd79a) binding protein 1, SFRP1  -  secreted frizzled-related protein 1, BDKRB2  -  bradykinin receptor b2, MAPK7  -  mitogen-activated protein kinase 7, IGF1R  -  insulin-like growth factor 1 receptor, SRPK2  -  srsf protein kinase 2, TGFB1  -  transforming growth factor, beta 1, SERPINB9  -  serpin peptidase inhibitor, clade b (ovalbumin), member 9, DNM2  -  dynamin 2, GNB2L1  -  guanine nucleotide binding protein (g protein), beta polypeptide 2-like 1, CAT  -  catalase, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, FADD  -  fas (tnfrsf6)-associated via death domain, BCL6  -  b-cell cll/lymphoma 6, NR3C1  -  nuclear receptor subfamily 3, group c, member 1 (glucocorticoid receptor), KRIT1  -  krit1, ankyrin repeat containing, CFDP1  -  craniofacial development protein 1, PRKCG  -  protein kinase c, gamma, SGK1  -  serum/glucocorticoid regulated kinase 1, SLC25A4  -  solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4, SMAD3  -  smad family member 3, PRKCA  -  protein kinase c, alpha, SMAD6  -  smad family member 6, GSK3B  -  glycogen synthase kinase 3 beta, CBS  -  cystathionine-beta-synthase, GAS6  -  growth arrest-specific 6, NUPR1  -  nuclear protein, transcriptional regulator, 1, ITSN1  -  intersectin 1 (sh3 domain protein), GAS1  -  growth arrest-specific 1]"GO:0007155,cell adhesion,1.48E-04,2.94E-02,1.69,8230,521,608,65,"[CDH2  -  cadherin 2, type 1, n-cadherin (neuronal), ATP1B1  -  atpase, na+/k+ transporting, beta 1 polypeptide, PCDH1  -  protocadherin 1, COL14A1  -  collagen, type xiv, alpha 1, CD151  -  cd151 molecule (raph blood group), FARP2  -  ferm, rhogef and pleckstrin domain protein 2, PVRL2  -  poliovirus receptor-related 2 (herpesvirus entry mediator b), GPNMB  -  glycoprotein (transmembrane) nmb, LPXN  -  leupaxin, SCARB2  -  scavenger receptor class b, member 2, SOX9  -  sry (sex determining region y)-box 9, EZR  -  ezrin, DDR1  -  discoidin domain receptor tyrosine kinase 1, BMP1  -  bone morphogenetic protein 1, PDPN  -  podoplanin, TNFAIP6  -  tumor necrosis factor, alpha-induced protein 6, APP  -  amyloid beta (a4) precursor protein, VCAM1  -  vascular cell adhesion molecule 1, NUAK1  -  nuak family, snf1-like kinase, 1, IL32  -  interleukin 32, ERF  -  ets2 repressor factor, ITGA5  -  integrin, alpha 5 (fibronectin receptor, alpha polypeptide), TEK  -  tek tyrosine kinase, endothelial, ITGA7  -  integrin, alpha 7, CTNNAL1  -  catenin (cadherin-associated protein), alpha-like 1, MYH10  -  myosin, heavy chain 10, non-muscle, ROR2  -  receptor tyrosine kinase-like orphan receptor 2, ITGA3  -  integrin, alpha 3 (antigen cd49c, alpha 3 subunit of vla-3 receptor), PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, KAL1  -  kallmann syndrome 1 sequence, ITGB5  -  integrin, beta 5, RHOB  -  ras homolog family member b, EGFR  -  epidermal growth factor receptor, FGF4  -  fibroblast growth factor 4, FBLN5  -  fibulin 5, FZD7  -  frizzled family receptor 7, FEZ1  -  fasciculation and elongation protein zeta 1 (zygin i), ADA  -  adenosine deaminase, TYRO3  -  tyro3 protein tyrosine kinase, EFNB2  -  ephrin-b2, NID2  -  nidogen 2 (osteonidogen), EFNB1  -  ephrin-b1, BCAM  -  basal cell adhesion molecule (lutheran blood group), AMIGO2  -  adhesion molecule with ig-like domain 2, COL8A1  -  collagen, type viii, alpha 1, ROCK1  -  rho-associated, coiled-coil containing protein kinase 1, INPPL1  -  inositol polyphosphate phosphatase-like 1, ZYX  -  zyxin, TGFB1I1  -  transforming growth factor beta 1 induced transcript 1, DAG1  -  dystroglycan 1 (dystrophin-associated glycoprotein 1), SRGAP2  -  slit-robo rho gtpase activating protein 2, MFAP4  -  microfibrillar-associated protein 4, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, PPAP2B  -  phosphatidic acid phosphatase type 2b, CDH13  -  cadherin 13, h-cadherin (heart), LAMA5  -  laminin, alpha 5, LAMA4  -  laminin, alpha 4, PRKCA  -  protein kinase c, alpha, COL11A1  -  collagen, type xi, alpha 1, SMAD6  -  smad family member 6, GAS6  -  growth arrest-specific 6, ITGA6  -  integrin, alpha 6, EFS  -  embryonal fyn-associated substrate, PTPRF  -  protein tyrosine phosphatase, receptor type, f, LAMB1  -  laminin, beta 1]"GO:0019320,hexose catabolic process,1.48E-04,2.89E-02,3.12,8230,43,981,16,"[PGK1  -  phosphoglycerate kinase 1, TKT  -  transketolase, PGD  -  phosphogluconate dehydrogenase, ALDOC  -  aldolase c, fructose-bisphosphate, BPGM  -  2,3-bisphosphoglycerate mutase, OGDH  -  oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide), LDHB  -  lactate dehydrogenase b, PFKL  -  phosphofructokinase, liver, RPIA  -  ribose 5-phosphate isomerase a, PFKP  -  phosphofructokinase, platelet, LDHA  -  lactate dehydrogenase a, GPI  -  glucose-6-phosphate isomerase, ENO2  -  enolase 2 (gamma, neuronal), PKM  -  pyruvate kinase, muscle, RPE  -  ribulose-5-phosphate-3-epimerase, ENO1  -  enolase 1, (alpha)]"GO:0034308,primary alcohol metabolic process,1.50E-04,2.87E-02,195.95,8230,6,14,2,"[AKR1C3  -  aldo-keto reductase family 1, member c3, ADH5  -  alcohol dehydrogenase 5 (class iii), chi polypeptide]"GO:0040011,locomotion,1.60E-04,3.02E-02,1.65,8230,583,598,70,"[NDN  -  necdin, melanoma antigen (mage) family member, NCK1  -  nck adaptor protein 1, SLC7A8  -  solute carrier family 7 (amino acid transporter light chain, l system), member 8, CDH2  -  cadherin 2, type 1, n-cadherin (neuronal), MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), SLC16A3  -  solute carrier family 16 (monocarboxylate transporter), member 3, ATP1B1  -  atpase, na+/k+ transporting, beta 1 polypeptide, CD151  -  cd151 molecule (raph blood group), ARC  -  activity-regulated cytoskeleton-associated protein, LGALS3  -  lectin, galactoside-binding, soluble, 3, HRAS  -  harvey rat sarcoma viral oncogene homolog, CAP1  -  cap, adenylate cyclase-associated protein 1 (yeast), ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, FOXC1  -  forkhead box c1, PLXND1  -  plexin d1, VEGFC  -  vascular endothelial growth factor c, WWP2  -  ww domain containing e3 ubiquitin protein ligase 2, NDEL1  -  nude neurodevelopment protein 1-like 1, WNT5A  -  wingless-type mmtv integration site family, member 5a, DDR1  -  discoidin domain receptor tyrosine kinase 1, PLTP  -  phospholipid transfer protein, SORD  -  sorbitol dehydrogenase, GJA1  -  gap junction protein, alpha 1, 43kda, VCAM1  -  vascular cell adhesion molecule 1, BMP4  -  bone morphogenetic protein 4, RAB13  -  rab13, member ras oncogene family, DGKZ  -  diacylglycerol kinase, zeta, RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), ITGA5  -  integrin, alpha 5 (fibronectin receptor, alpha polypeptide), PDGFA  -  platelet-derived growth factor alpha polypeptide, TEK  -  tek tyrosine kinase, endothelial, ITGA7  -  integrin, alpha 7, FOSL1  -  fos-like antigen 1, PPIA  -  peptidylprolyl isomerase a (cyclophilin a), FGFR1  -  fibroblast growth factor receptor 1, SHH  -  sonic hedgehog, MDK  -  midkine (neurite growth-promoting factor 2), MYH10  -  myosin, heavy chain 10, non-muscle, PROS1  -  protein s (alpha), GPX1  -  glutathione peroxidase 1, ITGA3  -  integrin, alpha 3 (antigen cd49c, alpha 3 subunit of vla-3 receptor), PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, FGF7  -  fibroblast growth factor 7, KAL1  -  kallmann syndrome 1 sequence, SEMA3C  -  sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3c, PLAT  -  plasminogen activator, tissue, EGFR  -  epidermal growth factor receptor, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, TYRO3  -  tyro3 protein tyrosine kinase, EFNB2  -  ephrin-b2, EFNB1  -  ephrin-b1, MAP2K1  -  mitogen-activated protein kinase kinase 1, RHOG  -  ras homolog family member g, ROCK1  -  rho-associated, coiled-coil containing protein kinase 1, TGFB1  -  transforming growth factor, beta 1, PRKG1  -  protein kinase, cgmp-dependent, type i, BAMBI  -  bmp and activin membrane-bound inhibitor, TGFBR3  -  transforming growth factor, beta receptor iii, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, YES1  -  v-yes-1 yamaguchi sarcoma viral oncogene homolog 1, CXCL1  -  chemokine (c-x-c motif) ligand 1 (melanoma growth stimulating activity, alpha), PPAP2B  -  phosphatidic acid phosphatase type 2b, CDH13  -  cadherin 13, h-cadherin (heart), CSPG4  -  chondroitin sulfate proteoglycan 4, LAMA5  -  laminin, alpha 5, PRKCA  -  protein kinase c, alpha, NUP153  -  nucleoporin 153kda, GSK3B  -  glycogen synthase kinase 3 beta, GAS6  -  growth arrest-specific 6, ITGA6  -  integrin, alpha 6]"GO:0033554,cellular response to stress,1.69E-04,3.14E-02,1.42,8230,816,892,126,"[APEX1  -  apex nuclease (multifunctional dna repair enzyme) 1, GSTM2  -  glutathione s-transferase mu 2 (muscle), GSTM1  -  glutathione s-transferase mu 1, BNIP3  -  bcl2/adenovirus e1b 19kda interacting protein 3, RFC2  -  replication factor c (activator 1) 2, 40kda, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, REV3L  -  rev3-like, polymerase (dna directed), zeta, catalytic subunit, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), DDB1  -  damage-specific dna binding protein 1, 127kda, HTRA2  -  htra serine peptidase 2, EPAS1  -  endothelial pas domain protein 1, GTF2H1  -  general transcription factor iih, polypeptide 1, 62kda, PSMA1  -  proteasome (prosome, macropain) subunit, alpha type, 1, ATF6  -  activating transcription factor 6, FOXO1  -  forkhead box o1, HRAS  -  harvey rat sarcoma viral oncogene homolog, NBN  -  nibrin, MSH6  -  muts homolog 6 (e. coli), CDC14B  -  cell division cycle 14b, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, P4HB  -  prolyl 4-hydroxylase, beta polypeptide, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, PSMB9  -  proteasome (prosome, macropain) subunit, beta type, 9, SOX4  -  sry (sex determining region y)-box 4, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, EIF2S1  -  eukaryotic translation initiation factor 2, subunit 1 alpha, 35kda, BID  -  bh3 interacting domain death agonist, PSMB4  -  proteasome (prosome, macropain) subunit, beta type, 4, TDG  -  thymine-dna glycosylase, MYLK  -  myosin light chain kinase, APOE  -  apolipoprotein e, SOD2  -  superoxide dismutase 2, mitochondrial, SOD1  -  superoxide dismutase 1, soluble, NUAK1  -  nuak family, snf1-like kinase, 1, CREB1  -  camp responsive element binding protein 1, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, LMNA  -  lamin a/c, AQP1  -  aquaporin 1 (colton blood group), DGKZ  -  diacylglycerol kinase, zeta, ICAM1  -  intercellular adhesion molecule 1, PSMD11  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 11, PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), MCM7  -  minichromosome maintenance complex component 7, ROR2  -  receptor tyrosine kinase-like orphan receptor 2, BCLAF1  -  bcl2-associated transcription factor 1, RHOB  -  ras homolog family member b, MEF2A  -  myocyte enhancer factor 2a, GTF2H5  -  general transcription factor iih, polypeptide 5, PDK3  -  pyruvate dehydrogenase kinase, isozyme 3, EIF2B4  -  eukaryotic translation initiation factor 2b, subunit 4 delta, 67kda, CEBPB  -  ccaat/enhancer binding protein (c/ebp), beta, TBX2  -  t-box 2, ADD1  -  adducin 1 (alpha), GNB1  -  guanine nucleotide binding protein (g protein), beta polypeptide 1, PTPN1  -  protein tyrosine phosphatase, non-receptor type 1, PARP1  -  poly (adp-ribose) polymerase 1, RUVBL1  -  ruvb-like 1 (e. coli), ARL6IP5  -  adp-ribosylation-like factor 6 interacting protein 5, TAOK3  -  tao kinase 3, FZR1  -  fizzy/cell division cycle 20 related 1 (drosophila), ADM  -  adrenomedullin, POLR2B  -  polymerase (rna) ii (dna directed) polypeptide b, 140kda, PARP4  -  poly (adp-ribose) polymerase family, member 4, IRAK1  -  interleukin-1 receptor-associated kinase 1, RAD1  -  rad1 homolog (s. pombe), AKR1C3  -  aldo-keto reductase family 1, member c3, IFI16  -  interferon, gamma-inducible protein 16, XPC  -  xeroderma pigmentosum, complementation group c, SMC3  -  structural maintenance of chromosomes 3, AGT  -  angiotensinogen (serpin peptidase inhibitor, clade a, member 8), UNG  -  uracil-dna glycosylase, PPP5C  -  protein phosphatase 5, catalytic subunit, RPA3  -  replication protein a3, 14kda, TAB2  -  tgf-beta activated kinase 1/map3k7 binding protein 2, ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, MATN2  -  matrilin 2, SLC2A1  -  solute carrier family 2 (facilitated glucose transporter), member 1, RAD23B  -  rad23 homolog b (s. cerevisiae), ASH2L  -  ash2 (absent, small, or homeotic)-like (drosophila), TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, CRIP1  -  cysteine-rich protein 1 (intestinal), MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), DDIT4  -  dna-damage-inducible transcript 4, CRKL  -  v-crk avian sarcoma virus ct10 oncogene homolog-like, UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, JUN  -  jun proto-oncogene, CRY1  -  cryptochrome 1 (photolyase-like), GPX1  -  glutathione peroxidase 1, RAD51D  -  rad51 paralog d, CRYAB  -  crystallin, alpha b, DYRK2  -  dual-specificity tyrosine-(y)-phosphorylation regulated kinase 2, CCNG1  -  cyclin g1, NFE2L2  -  nuclear factor (erythroid-derived 2)-like 2, SSRP1  -  structure specific recognition protein 1, NDRG1  -  n-myc downstream regulated 1, JAK2  -  janus kinase 2, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, ATR  -  ataxia telangiectasia and rad3 related, MAP2K1  -  mitogen-activated protein kinase kinase 1, TPP1  -  tripeptidyl peptidase i, MAP2K3  -  mitogen-activated protein kinase kinase 3, MAPK10  -  mitogen-activated protein kinase 10, SFRP1  -  secreted frizzled-related protein 1, SMARCA5  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5, MAPK7  -  mitogen-activated protein kinase 7, MAPK3  -  mitogen-activated protein kinase 3, IGFBP1  -  insulin-like growth factor binding protein 1, CAT  -  catalase, TDP2  -  tyrosyl-dna phosphodiesterase 2, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, BCL6  -  b-cell cll/lymphoma 6, TSPYL2  -  tspy-like 2, NREP  -  neuronal regeneration related protein, CUL4B  -  cullin 4b, FOS  -  fbj murine osteosarcoma viral oncogene homolog, RBM14  -  rna binding motif protein 14, SGK1  -  serum/glucocorticoid regulated kinase 1, POLD3  -  polymerase (dna-directed), delta 3, accessory subunit, CBS  -  cystathionine-beta-synthase, GSK3B  -  glycogen synthase kinase 3 beta, CCND1  -  cyclin d1, NUPR1  -  nuclear protein, transcriptional regulator, 1, GAS6  -  growth arrest-specific 6, MPG  -  n-methylpurine-dna glycosylase]"GO:0009968,negative regulation of signal transduction,1.80E-04,3.28E-02,1.63,8230,601,604,72,"[PAWR  -  prkc, apoptosis, wt1, regulator, STRN3  -  striatin, calmodulin binding protein 3, CDH2  -  cadherin 2, type 1, n-cadherin (neuronal), MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), CDC34  -  cell division cycle 34, GPC1  -  glypican 1, SPG20  -  spastic paraplegia 20 (troyer syndrome), FOXO1  -  forkhead box o1, RGS5  -  regulator of g-protein signaling 5, NBL1  -  neuroblastoma 1, dan family bmp antagonist, LPXN  -  leupaxin, HMGXB4  -  hmg box domain containing 4, NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, SOX9  -  sry (sex determining region y)-box 9, UBR2  -  ubiquitin protein ligase e3 component n-recognin 2, WNT5A  -  wingless-type mmtv integration site family, member 5a, RGS7  -  regulator of g-protein signaling 7, PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, APOE  -  apolipoprotein e, SOD2  -  superoxide dismutase 2, mitochondrial, RGS3  -  regulator of g-protein signaling 3, EZH2  -  enhancer of zeste homolog 2 (drosophila), SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, WWOX  -  ww domain containing oxidoreductase, IL6ST  -  interleukin 6 signal transducer (gp130, oncostatin m receptor), LMNA  -  lamin a/c, RGS16  -  regulator of g-protein signaling 16, BMP4  -  bone morphogenetic protein 4, DGKZ  -  diacylglycerol kinase, zeta, SHH  -  sonic hedgehog, ATXN1  -  ataxin 1, STAT1  -  signal transducer and activator of transcription 1, 91kda, ROR2  -  receptor tyrosine kinase-like orphan receptor 2, PPM1B  -  protein phosphatase, mg2+/mn2+ dependent, 1b, GPX1  -  glutathione peroxidase 1, NFE2L2  -  nuclear factor (erythroid-derived 2)-like 2, PDPK1  -  3-phosphoinositide dependent protein kinase-1, EGFR  -  epidermal growth factor receptor, PTGIR  -  prostaglandin i2 (prostacyclin) receptor (ip), ADA  -  adenosine deaminase, DLC1  -  deleted in liver cancer 1, TYRO3  -  tyro3 protein tyrosine kinase, CLU  -  clusterin, IGBP1  -  immunoglobulin (cd79a) binding protein 1, BDKRB2  -  bradykinin receptor b2, IGF1R  -  insulin-like growth factor 1 receptor, MAPK7  -  mitogen-activated protein kinase 7, SERPINE2  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 2, CBLB  -  cbl proto-oncogene b, e3 ubiquitin protein ligase, TGFB1  -  transforming growth factor, beta 1, UCHL1  -  ubiquitin carboxyl-terminal esterase l1 (ubiquitin thiolesterase), TGFB1I1  -  transforming growth factor beta 1 induced transcript 1, DAG1  -  dystroglycan 1 (dystrophin-associated glycoprotein 1), CAV2  -  caveolin 2, TGIF1  -  tgfb-induced factor homeobox 1, CDKN2D  -  cyclin-dependent kinase inhibitor 2d (p19, inhibits cdk4), TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), DAPK1  -  death-associated protein kinase 1, BAMBI  -  bmp and activin membrane-bound inhibitor, TGFBR3  -  transforming growth factor, beta receptor iii, PTPN1  -  protein tyrosine phosphatase, non-receptor type 1, PHB2  -  prohibitin 2, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), STAM  -  signal transducing adaptor molecule (sh3 domain and itam motif) 1, PRKCA  -  protein kinase c, alpha, GSK3B  -  glycogen synthase kinase 3 beta, SMAD6  -  smad family member 6, HDAC1  -  histone deacetylase 1, GAS6  -  growth arrest-specific 6, ITGA6  -  integrin, alpha 6, GAS1  -  growth arrest-specific 1]"GO:0022610,biological adhesion,1.85E-04,3.32E-02,1.68,8230,523,608,65,"[CDH2  -  cadherin 2, type 1, n-cadherin (neuronal), ATP1B1  -  atpase, na+/k+ transporting, beta 1 polypeptide, PCDH1  -  protocadherin 1, COL14A1  -  collagen, type xiv, alpha 1, CD151  -  cd151 molecule (raph blood group), FARP2  -  ferm, rhogef and pleckstrin domain protein 2, PVRL2  -  poliovirus receptor-related 2 (herpesvirus entry mediator b), GPNMB  -  glycoprotein (transmembrane) nmb, LPXN  -  leupaxin, SCARB2  -  scavenger receptor class b, member 2, SOX9  -  sry (sex determining region y)-box 9, EZR  -  ezrin, DDR1  -  discoidin domain receptor tyrosine kinase 1, BMP1  -  bone morphogenetic protein 1, PDPN  -  podoplanin, TNFAIP6  -  tumor necrosis factor, alpha-induced protein 6, APP  -  amyloid beta (a4) precursor protein, VCAM1  -  vascular cell adhesion molecule 1, NUAK1  -  nuak family, snf1-like kinase, 1, IL32  -  interleukin 32, ERF  -  ets2 repressor factor, ITGA5  -  integrin, alpha 5 (fibronectin receptor, alpha polypeptide), TEK  -  tek tyrosine kinase, endothelial, ITGA7  -  integrin, alpha 7, CTNNAL1  -  catenin (cadherin-associated protein), alpha-like 1, MYH10  -  myosin, heavy chain 10, non-muscle, ROR2  -  receptor tyrosine kinase-like orphan receptor 2, ITGA3  -  integrin, alpha 3 (antigen cd49c, alpha 3 subunit of vla-3 receptor), PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, KAL1  -  kallmann syndrome 1 sequence, ITGB5  -  integrin, beta 5, RHOB  -  ras homolog family member b, EGFR  -  epidermal growth factor receptor, FBLN5  -  fibulin 5, FGF4  -  fibroblast growth factor 4, FZD7  -  frizzled family receptor 7, FEZ1  -  fasciculation and elongation protein zeta 1 (zygin i), ADA  -  adenosine deaminase, TYRO3  -  tyro3 protein tyrosine kinase, EFNB2  -  ephrin-b2, NID2  -  nidogen 2 (osteonidogen), EFNB1  -  ephrin-b1, BCAM  -  basal cell adhesion molecule (lutheran blood group), AMIGO2  -  adhesion molecule with ig-like domain 2, COL8A1  -  collagen, type viii, alpha 1, ROCK1  -  rho-associated, coiled-coil containing protein kinase 1, INPPL1  -  inositol polyphosphate phosphatase-like 1, ZYX  -  zyxin, TGFB1I1  -  transforming growth factor beta 1 induced transcript 1, DAG1  -  dystroglycan 1 (dystrophin-associated glycoprotein 1), SRGAP2  -  slit-robo rho gtpase activating protein 2, MFAP4  -  microfibrillar-associated protein 4, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, PPAP2B  -  phosphatidic acid phosphatase type 2b, CDH13  -  cadherin 13, h-cadherin (heart), LAMA5  -  laminin, alpha 5, LAMA4  -  laminin, alpha 4, PRKCA  -  protein kinase c, alpha, COL11A1  -  collagen, type xi, alpha 1, SMAD6  -  smad family member 6, GAS6  -  growth arrest-specific 6, ITGA6  -  integrin, alpha 6, EFS  -  embryonal fyn-associated substrate, PTPRF  -  protein tyrosine phosphatase, receptor type, f, LAMB1  -  laminin, beta 1]"GO:0002576,platelet degranulation,1.88E-04,3.32E-02,3.31,8230,75,531,16,"[PDGFA  -  platelet-derived growth factor alpha polypeptide, CAP1  -  cap, adenylate cyclase-associated protein 1 (yeast), TUBA4A  -  tubulin, alpha 4a, ACTN1  -  actinin, alpha 1, VEGFC  -  vascular endothelial growth factor c, IGF2  -  insulin-like growth factor 2 (somatomedin a), TGFB1  -  transforming growth factor, beta 1, PPIA  -  peptidylprolyl isomerase a (cyclophilin a), SERPING1  -  serpin peptidase inhibitor, clade g (c1 inhibitor), member 1, PROS1  -  protein s (alpha), FLNA  -  filamin a, alpha, APP  -  amyloid beta (a4) precursor protein, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, CLU  -  clusterin, GAS6  -  growth arrest-specific 6, SERPINF2  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 2]"GO:0050793,regulation of developmental process,1.90E-04,3.30E-02,1.33,8230,1227,896,178,"[BNIP3  -  bcl2/adenovirus e1b 19kda interacting protein 3, PDLIM5  -  pdz and lim domain 5, BNIP2  -  bcl2/adenovirus e1b 19kda interacting protein 2, SSH1  -  slingshot protein phosphatase 1, TCF12  -  transcription factor 12, CDH2  -  cadherin 2, type 1, n-cadherin (neuronal), MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), ABCA1  -  atp-binding cassette, sub-family a (abc1), member 1, PAX7  -  paired box 7, PBX1  -  pre-b-cell leukemia homeobox 1, ARC  -  activity-regulated cytoskeleton-associated protein, PMP22  -  peripheral myelin protein 22, FOXO1  -  forkhead box o1, SEMA3F  -  sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3f, NBL1  -  neuroblastoma 1, dan family bmp antagonist, ASIC2  -  acid-sensing (proton-gated) ion channel 2, CDC42EP4  -  cdc42 effector protein (rho gtpase binding) 4, PIAS1  -  protein inhibitor of activated stat, 1, MYO10  -  myosin x, IL4R  -  interleukin 4 receptor, FOXC1  -  forkhead box c1, PDLIM7  -  pdz and lim domain 7 (enigma), SOX9  -  sry (sex determining region y)-box 9, SOX4  -  sry (sex determining region y)-box 4, NDEL1  -  nude neurodevelopment protein 1-like 1, LMO4  -  lim domain only 4, NAB1  -  ngfi-a binding protein 1 (egr1 binding protein 1), MMP11  -  matrix metallopeptidase 11 (stromelysin 3), NACA  -  nascent polypeptide-associated complex alpha subunit, BMP1  -  bone morphogenetic protein 1, PDPN  -  podoplanin, CAMK1  -  calcium/calmodulin-dependent protein kinase i, SDC2  -  syndecan 2, GJA1  -  gap junction protein, alpha 1, 43kda, APOE  -  apolipoprotein e, SOD2  -  superoxide dismutase 2, mitochondrial, SOD1  -  superoxide dismutase 1, soluble, BMPR1A  -  bone morphogenetic protein receptor, type ia, APP  -  amyloid beta (a4) precursor protein, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, NUAK1  -  nuak family, snf1-like kinase, 1, CREB1  -  camp responsive element binding protein 1, SERPINF2  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 2, IL6ST  -  interleukin 6 signal transducer (gp130, oncostatin m receptor), LMNA  -  lamin a/c, BMP4  -  bone morphogenetic protein 4, AQP1  -  aquaporin 1 (colton blood group), TNFRSF11B  -  tumor necrosis factor receptor superfamily, member 11b, PDGFA  -  platelet-derived growth factor alpha polypeptide, ICAM1  -  intercellular adhesion molecule 1, ITGA7  -  integrin, alpha 7, FGFR1  -  fibroblast growth factor receptor 1, PTBP1  -  polypyrimidine tract binding protein 1, DDR2  -  discoidin domain receptor tyrosine kinase 2, MYH10  -  myosin, heavy chain 10, non-muscle, ROR2  -  receptor tyrosine kinase-like orphan receptor 2, MAML1  -  mastermind-like 1 (drosophila), PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, ITGA3  -  integrin, alpha 3 (antigen cd49c, alpha 3 subunit of vla-3 receptor), FGF7  -  fibroblast growth factor 7, CFL1  -  cofilin 1 (non-muscle), MECP2  -  methyl cpg binding protein 2 (rett syndrome), RHOB  -  ras homolog family member b, FGF2  -  fibroblast growth factor 2 (basic), MEF2A  -  myocyte enhancer factor 2a, FGF4  -  fibroblast growth factor 4, FZD7  -  frizzled family receptor 7, ADA  -  adenosine deaminase, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, DDX17  -  dead (asp-glu-ala-asp) box helicase 17, MED1  -  mediator complex subunit 1, EFNB2  -  ephrin-b2, CNR1  -  cannabinoid receptor 1 (brain), SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, CEBPB  -  ccaat/enhancer binding protein (c/ebp), beta, ROCK1  -  rho-associated, coiled-coil containing protein kinase 1, ARPC2  -  actin related protein 2/3 complex, subunit 2, 34kda, TBX2  -  t-box 2, ADD1  -  adducin 1 (alpha), ZHX3  -  zinc fingers and homeoboxes 3, SRGAP2  -  slit-robo rho gtpase activating protein 2, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), EDNRA  -  endothelin receptor type a, FZR1  -  fizzy/cell division cycle 20 related 1 (drosophila), ADM  -  adrenomedullin, EFEMP1  -  egf containing fibulin-like extracellular matrix protein 1, LAMA5  -  laminin, alpha 5, FSTL3  -  follistatin-like 3 (secreted glycoprotein), LAMA4  -  laminin, alpha 4, TPT1  -  tumor protein, translationally-controlled 1, PDE5A  -  phosphodiesterase 5a, cgmp-specific, SIK1  -  salt-inducible kinase 1, SMC3  -  structural maintenance of chromosomes 3, CAMK2B  -  calcium/calmodulin-dependent protein kinase ii beta, ZHX2  -  zinc fingers and homeoboxes 2, GPC1  -  glypican 1, SPG20  -  spastic paraplegia 20 (troyer syndrome), AGT  -  angiotensinogen (serpin peptidase inhibitor, clade a, member 8), COL14A1  -  collagen, type xiv, alpha 1, DPYSL2  -  dihydropyrimidinase-like 2, NOTCH3  -  notch 3, ZFHX3  -  zinc finger homeobox 3, ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, HDAC4  -  histone deacetylase 4, CTSH  -  cathepsin h, ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, VEGFC  -  vascular endothelial growth factor c, PLXND1  -  plexin d1, NGF  -  nerve growth factor (beta polypeptide), NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, EZR  -  ezrin, EPB41L3  -  erythrocyte membrane protein band 4.1-like 3, WNT5A  -  wingless-type mmtv integration site family, member 5a, HLA-DMA  -  major histocompatibility complex, class ii, dm alpha, DVL3  -  dishevelled segment polarity protein 3, CREB3L1  -  camp responsive element binding protein 3-like 1, LDB2  -  lim domain binding 2, SEMA4F  -  sema domain, immunoglobulin domain (ig), transmembrane domain (tm) and short cytoplasmic domain, (semaphorin) 4f, PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, EZH2  -  enhancer of zeste homolog 2 (drosophila), TSC22D3  -  tsc22 domain family, member 3, TEK  -  tek tyrosine kinase, endothelial, SUZ12  -  suz12 polycomb repressive complex 2 subunit, TRADD  -  tnfrsf1a-associated via death domain, MYL12B  -  myosin, light chain 12b, regulatory, RBPJ  -  recombination signal binding protein for immunoglobulin kappa j region, SHH  -  sonic hedgehog, JUN  -  jun proto-oncogene, STAT1  -  signal transducer and activator of transcription 1, 91kda, SLIT2  -  slit homolog 2 (drosophila), GPX1  -  glutathione peroxidase 1, STAT3  -  signal transducer and activator of transcription 3 (acute-phase response factor), DLX5  -  distal-less homeobox 5, ATF5  -  activating transcription factor 5, NFE2L2  -  nuclear factor (erythroid-derived 2)-like 2, TNFSF4  -  tumor necrosis factor (ligand) superfamily, member 4, ISG15  -  isg15 ubiquitin-like modifier, JAK2  -  janus kinase 2, FEZ1  -  fasciculation and elongation protein zeta 1 (zygin i), NR2F1  -  nuclear receptor subfamily 2, group f, member 1, DLC1  -  deleted in liver cancer 1, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, TNFSF9  -  tumor necrosis factor (ligand) superfamily, member 9, MAP2K1  -  mitogen-activated protein kinase kinase 1, TWF2  -  twinfilin actin-binding protein 2, SFRP1  -  secreted frizzled-related protein 1, SERPINE2  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 2, MAPK7  -  mitogen-activated protein kinase 7, CBLB  -  cbl proto-oncogene b, e3 ubiquitin protein ligase, TGFB1  -  transforming growth factor, beta 1, TGFB1I1  -  transforming growth factor beta 1 induced transcript 1, SMAD2  -  smad family member 2, OGT  -  o-linked n-acetylglucosamine (glcnac) transferase, GNB2L1  -  guanine nucleotide binding protein (g protein), beta polypeptide 2-like 1, FADD  -  fas (tnfrsf6)-associated via death domain, TGIF1  -  tgfb-induced factor homeobox 1, BCL6  -  b-cell cll/lymphoma 6, RYK  -  receptor-like tyrosine kinase, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), BAMBI  -  bmp and activin membrane-bound inhibitor, NREP  -  neuronal regeneration related protein, TGFBR3  -  transforming growth factor, beta receptor iii, PHB2  -  prohibitin 2, DMD  -  dystrophin, FOS  -  fbj murine osteosarcoma viral oncogene homolog, KRIT1  -  krit1, ankyrin repeat containing, CFDP1  -  craniofacial development protein 1, DMPK  -  dystrophia myotonica-protein kinase, THBS2  -  thrombospondin 2, SMAD3  -  smad family member 3, PRKCA  -  protein kinase c, alpha, GSK3B  -  glycogen synthase kinase 3 beta, CCND1  -  cyclin d1, NR1D2  -  nuclear receptor subfamily 1, group d, member 2, GAS6  -  growth arrest-specific 6, NUPR1  -  nuclear protein, transcriptional regulator, 1, RRAS  -  related ras viral (r-ras) oncogene homolog, MAF  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog]"GO:0050679,positive regulation of epithelial cell proliferation,1.97E-04,3.37E-02,3.1,8230,111,431,18,"[TEK  -  tek tyrosine kinase, endothelial, VEGFC  -  vascular endothelial growth factor c, TGFB1  -  transforming growth factor, beta 1, JUN  -  jun proto-oncogene, SHH  -  sonic hedgehog, SOX9  -  sry (sex determining region y)-box 9, WNT5A  -  wingless-type mmtv integration site family, member 5a, FGF7  -  fibroblast growth factor 7, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, FZD7  -  frizzled family receptor 7, CDH13  -  cadherin 13, h-cadherin (heart), PRKCA  -  protein kinase c, alpha, MED1  -  mediator complex subunit 1, HRAS  -  harvey rat sarcoma viral oncogene homolog, GAS1  -  growth arrest-specific 1, BMP4  -  bone morphogenetic protein 4, LAMB1  -  laminin, beta 1]"GO:0006027,glycosaminoglycan catabolic process,2.01E-04,3.39E-02,3.49,8230,31,989,13,"[FMOD  -  fibromodulin, BGN  -  biglycan, TGFB1  -  transforming growth factor, beta 1, FGF2  -  fibroblast growth factor 2 (basic), HEXA  -  hexosaminidase a (alpha polypeptide), LUM  -  lumican, SDC2  -  syndecan 2, GPC1  -  glypican 1, PRELP  -  proline/arginine-rich end leucine-rich repeat protein, CSPG4  -  chondroitin sulfate proteoglycan 4, VCAN  -  versican, GUSB  -  glucuronidase, beta, ACAN  -  aggrecan]"GO:0009966,regulation of signal transduction,2.24E-04,3.73E-02,1.36,8230,1509,604,151,"[BNIP3  -  bcl2/adenovirus e1b 19kda interacting protein 3, NCK1  -  nck adaptor protein 1, PAWR  -  prkc, apoptosis, wt1, regulator, CDH2  -  cadherin 2, type 1, n-cadherin (neuronal), MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), MID1  -  midline 1 (opitz/bbb syndrome), ABCA1  -  atp-binding cassette, sub-family a (abc1), member 1, TICAM1  -  toll-like receptor adaptor molecule 1, CDC34  -  cell division cycle 34, GAB2  -  grb2-associated binding protein 2, FLNA  -  filamin a, alpha, RNF14  -  ring finger protein 14, FOXO1  -  forkhead box o1, HRAS  -  harvey rat sarcoma viral oncogene homolog, RGS5  -  regulator of g-protein signaling 5, NBL1  -  neuroblastoma 1, dan family bmp antagonist, TRAF4  -  tnf receptor-associated factor 4, RRAGB  -  ras-related gtp binding b, CRLF1  -  cytokine receptor-like factor 1, DFNA5  -  deafness, autosomal dominant 5, P4HB  -  prolyl 4-hydroxylase, beta polypeptide, PDCD10  -  programmed cell death 10, SOX9  -  sry (sex determining region y)-box 9, SOX4  -  sry (sex determining region y)-box 4, UBR2  -  ubiquitin protein ligase e3 component n-recognin 2, PLSCR1  -  phospholipid scramblase 1, FURIN  -  furin (paired basic amino acid cleaving enzyme), RGS7  -  regulator of g-protein signaling 7, GJA1  -  gap junction protein, alpha 1, 43kda, APOE  -  apolipoprotein e, SOD2  -  superoxide dismutase 2, mitochondrial, RGS3  -  regulator of g-protein signaling 3, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, APP  -  amyloid beta (a4) precursor protein, BMPR1A  -  bone morphogenetic protein receptor, type ia, WWOX  -  ww domain containing oxidoreductase, SERPINF2  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 2, IL6ST  -  interleukin 6 signal transducer (gp130, oncostatin m receptor), LMNA  -  lamin a/c, RGS16  -  regulator of g-protein signaling 16, BMP4  -  bone morphogenetic protein 4, DGKZ  -  diacylglycerol kinase, zeta, PDGFA  -  platelet-derived growth factor alpha polypeptide, ITGA5  -  integrin, alpha 5 (fibronectin receptor, alpha polypeptide), FGFR1  -  fibroblast growth factor receptor 1, ATXN1  -  ataxin 1, LITAF  -  lipopolysaccharide-induced tnf factor, ROR2  -  receptor tyrosine kinase-like orphan receptor 2, PPM1B  -  protein phosphatase, mg2+/mn2+ dependent, 1b, PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, RHOB  -  ras homolog family member b, PDPK1  -  3-phosphoinositide dependent protein kinase-1, EGFR  -  epidermal growth factor receptor, FGF4  -  fibroblast growth factor 4, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, FZD7  -  frizzled family receptor 7, PTGIR  -  prostaglandin i2 (prostacyclin) receptor (ip), ADA  -  adenosine deaminase, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, DDX17  -  dead (asp-glu-ala-asp) box helicase 17, MED1  -  mediator complex subunit 1, ARHGAP1  -  rho gtpase activating protein 1, RHOG  -  ras homolog family member g, DAG1  -  dystroglycan 1 (dystrophin-associated glycoprotein 1), CDKN1C  -  cyclin-dependent kinase inhibitor 1c (p57, kip2), SRGAP2  -  slit-robo rho gtpase activating protein 2, ASPH  -  aspartate beta-hydroxylase, CDKN2D  -  cyclin-dependent kinase inhibitor 2d (p19, inhibits cdk4), DAPK1  -  death-associated protein kinase 1, LY96  -  lymphocyte antigen 96, PTPN1  -  protein tyrosine phosphatase, non-receptor type 1, PARP1  -  poly (adp-ribose) polymerase 1, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), ARL6IP5  -  adp-ribosylation-like factor 6 interacting protein 5, CDC37  -  cell division cycle 37, TRAF2  -  tnf receptor-associated factor 2, PPAP2B  -  phosphatidic acid phosphatase type 2b, CDH13  -  cadherin 13, h-cadherin (heart), HDAC1  -  histone deacetylase 1, MBD2  -  methyl-cpg binding domain protein 2, ITGA6  -  integrin, alpha 6, AKR1C3  -  aldo-keto reductase family 1, member c3, ACAA2  -  acetyl-coa acyltransferase 2, PDE5A  -  phosphodiesterase 5a, cgmp-specific, STRN3  -  striatin, calmodulin binding protein 3, CDK14  -  cyclin-dependent kinase 14, TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), GPC1  -  glypican 1, SPG20  -  spastic paraplegia 20 (troyer syndrome), PPP5C  -  protein phosphatase 5, catalytic subunit, IFNGR1  -  interferon gamma receptor 1, TAB2  -  tgf-beta activated kinase 1/map3k7 binding protein 2, LPXN  -  leupaxin, HMGXB4  -  hmg box domain containing 4, CTSH  -  cathepsin h, ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, VEGFC  -  vascular endothelial growth factor c, NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, WNT5A  -  wingless-type mmtv integration site family, member 5a, DVL3  -  dishevelled segment polarity protein 3, PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, EZH2  -  enhancer of zeste homolog 2 (drosophila), ARHGAP29  -  rho gtpase activating protein 29, TEK  -  tek tyrosine kinase, endothelial, RBPMS  -  rna binding protein with multiple splicing, RBPJ  -  recombination signal binding protein for immunoglobulin kappa j region, SHH  -  sonic hedgehog, STAT2  -  signal transducer and activator of transcription 2, 113kda, STAT1  -  signal transducer and activator of transcription 1, 91kda, GPX1  -  glutathione peroxidase 1, GBF1  -  golgi brefeldin a resistant guanine nucleotide exchange factor 1, NFE2L2  -  nuclear factor (erythroid-derived 2)-like 2, JAK2  -  janus kinase 2, DLC1  -  deleted in liver cancer 1, TYRO3  -  tyro3 protein tyrosine kinase, CLU  -  clusterin, ATR  -  ataxia telangiectasia and rad3 related, MAP2K1  -  mitogen-activated protein kinase kinase 1, MAP2K3  -  mitogen-activated protein kinase kinase 3, IGBP1  -  immunoglobulin (cd79a) binding protein 1, BDKRB2  -  bradykinin receptor b2, MGLL  -  monoglyceride lipase, SERPINE2  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 2, MAPK7  -  mitogen-activated protein kinase 7, CBLB  -  cbl proto-oncogene b, e3 ubiquitin protein ligase, IGF1R  -  insulin-like growth factor 1 receptor, IGF2  -  insulin-like growth factor 2 (somatomedin a), TGFB1  -  transforming growth factor, beta 1, UCHL1  -  ubiquitin carboxyl-terminal esterase l1 (ubiquitin thiolesterase), TGFB1I1  -  transforming growth factor beta 1 induced transcript 1, OGT  -  o-linked n-acetylglucosamine (glcnac) transferase, CAT  -  catalase, CAV2  -  caveolin 2, TGIF1  -  tgfb-induced factor homeobox 1, TSPYL2  -  tspy-like 2, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), BAMBI  -  bmp and activin membrane-bound inhibitor, NREP  -  neuronal regeneration related protein, TGFBR3  -  transforming growth factor, beta receptor iii, PHB2  -  prohibitin 2, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, STAM  -  signal transducing adaptor molecule (sh3 domain and itam motif) 1, FNTB  -  farnesyltransferase, caax box, beta, CSPG4  -  chondroitin sulfate proteoglycan 4, PRKCA  -  protein kinase c, alpha, SMAD6  -  smad family member 6, GSK3B  -  glycogen synthase kinase 3 beta, SH3BGR  -  sh3 domain binding glutamic acid-rich protein, GAS6  -  growth arrest-specific 6, ITSN1  -  intersectin 1 (sh3 domain protein), GAS1  -  growth arrest-specific 1]"GO:0016310,phosphorylation,2.38E-04,3.91E-02,1.48,8230,571,986,101,"[TRIM27  -  tripartite motif containing 27, BCKDK  -  branched chain ketoacid dehydrogenase kinase, GTF2H1  -  general transcription factor iih, polypeptide 1, 62kda, HRAS  -  harvey rat sarcoma viral oncogene homolog, DOK5  -  docking protein 5, NT5C2  -  5'-nucleotidase, cytosolic ii, SOX9  -  sry (sex determining region y)-box 9, STK17B  -  serine/threonine kinase 17b, PIKFYVE  -  phosphoinositide kinase, fyve finger containing, TNK2  -  tyrosine kinase, non-receptor, 2, EIF2S1  -  eukaryotic translation initiation factor 2, subunit 1 alpha, 35kda, CAMK1  -  calcium/calmodulin-dependent protein kinase i, GHR  -  growth hormone receptor, MYLK  -  myosin light chain kinase, LIMK2  -  lim domain kinase 2, APP  -  amyloid beta (a4) precursor protein, BMPR1A  -  bone morphogenetic protein receptor, type ia, CREB1  -  camp responsive element binding protein 1, BMP4  -  bone morphogenetic protein 4, DGKZ  -  diacylglycerol kinase, zeta, STK38L  -  serine/threonine kinase 38 like, FGFR1  -  fibroblast growth factor receptor 1, DDR2  -  discoidin domain receptor tyrosine kinase 2, ROR2  -  receptor tyrosine kinase-like orphan receptor 2, MAML1  -  mastermind-like 1 (drosophila), PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, CFL1  -  cofilin 1 (non-muscle), PDPK1  -  3-phosphoinositide dependent protein kinase-1, MEF2A  -  myocyte enhancer factor 2a, EGFR  -  epidermal growth factor receptor, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, PDK3  -  pyruvate dehydrogenase kinase, isozyme 3, MKNK1  -  map kinase interacting serine/threonine kinase 1, MED1  -  mediator complex subunit 1, ROCK1  -  rho-associated, coiled-coil containing protein kinase 1, DAPK1  -  death-associated protein kinase 1, MAPK8IP1  -  mitogen-activated protein kinase 8 interacting protein 1, TAOK3  -  tao kinase 3, EFEMP1  -  egf containing fibulin-like extracellular matrix protein 1, IRAK1  -  interleukin-1 receptor-associated kinase 1, ERC1  -  elks/rab6-interacting/cast family member 1, PGK1  -  phosphoglycerate kinase 1, PRKACB  -  protein kinase, camp-dependent, catalytic, beta, NADK  -  nad kinase, PPP4R1  -  protein phosphatase 4, regulatory subunit 1, CAMK2G  -  calcium/calmodulin-dependent protein kinase ii gamma, SIK1  -  salt-inducible kinase 1, CAMK2B  -  calcium/calmodulin-dependent protein kinase ii beta, AGT  -  angiotensinogen (serpin peptidase inhibitor, clade a, member 8), PXN  -  paxillin, MAP4K4  -  mitogen-activated protein kinase kinase kinase kinase 4, TAB2  -  tgf-beta activated kinase 1/map3k7 binding protein 2, AK2  -  adenylate kinase 2, CTSH  -  cathepsin h, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, WNT5A  -  wingless-type mmtv integration site family, member 5a, DDR1  -  discoidin domain receptor tyrosine kinase 1, STK3  -  serine/threonine kinase 3, PFKL  -  phosphofructokinase, liver, PFKP  -  phosphofructokinase, platelet, F2R  -  coagulation factor ii (thrombin) receptor, NEK7  -  nima-related kinase 7, TEK  -  tek tyrosine kinase, endothelial, CRKL  -  v-crk avian sarcoma virus ct10 oncogene homolog-like, MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), JUN  -  jun proto-oncogene, STAT4  -  signal transducer and activator of transcription 4, STAT3  -  signal transducer and activator of transcription 3 (acute-phase response factor), CRYAB  -  crystallin, alpha b, DYRK2  -  dual-specificity tyrosine-(y)-phosphorylation regulated kinase 2, JAK2  -  janus kinase 2, OXSR1  -  oxidative stress responsive 1, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, TYRO3  -  tyro3 protein tyrosine kinase, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, ATR  -  ataxia telangiectasia and rad3 related, MAP2K1  -  mitogen-activated protein kinase kinase 1, MAP2K3  -  mitogen-activated protein kinase kinase 3, MAPK10  -  mitogen-activated protein kinase 10, MAPK7  -  mitogen-activated protein kinase 7, IGF1R  -  insulin-like growth factor 1 receptor, SRPK2  -  srsf protein kinase 2, TGFB1  -  transforming growth factor, beta 1, SMAD1  -  smad family member 1, SMAD2  -  smad family member 2, MAPK3  -  mitogen-activated protein kinase 3, PRKG1  -  protein kinase, cgmp-dependent, type i, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, RYK  -  receptor-like tyrosine kinase, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), TGFBR3  -  transforming growth factor, beta receptor iii, RPS6KA4  -  ribosomal protein s6 kinase, 90kda, polypeptide 4, FOS  -  fbj murine osteosarcoma viral oncogene homolog, YES1  -  v-yes-1 yamaguchi sarcoma viral oncogene homolog 1, DMPK  -  dystrophia myotonica-protein kinase, PRKCG  -  protein kinase c, gamma, SGK1  -  serum/glucocorticoid regulated kinase 1, PRKCA  -  protein kinase c, alpha, PRKAR1B  -  protein kinase, camp-dependent, regulatory, type i, beta, GSK3B  -  glycogen synthase kinase 3 beta, GAS6  -  growth arrest-specific 6]"GO:0019637,organophosphate metabolic process,2.41E-04,3.90E-02,1.68,8230,487,634,63,"[NADK  -  nad kinase, PAICS  -  phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase, RFK  -  riboflavin kinase, PDE5A  -  phosphodiesterase 5a, cgmp-specific, TKT  -  transketolase, PGD  -  phosphogluconate dehydrogenase, SEPT5  -  septin 5, NME4  -  nme/nm23 nucleoside diphosphate kinase 4, RAB14  -  rab14, member ras oncogene family, GTF2H1  -  general transcription factor iih, polypeptide 1, 62kda, GPI  -  glucose-6-phosphate isomerase, CTPS1  -  ctp synthase 1, HRAS  -  harvey rat sarcoma viral oncogene homolog, RPE  -  ribulose-5-phosphate-3-epimerase, MSH6  -  muts homolog 6 (e. coli), AK2  -  adenylate kinase 2, PITPNB  -  phosphatidylinositol transfer protein, beta, PEX6  -  peroxisomal biogenesis factor 6, RIT1  -  ras-like without caax 1, SMPD4  -  sphingomyelin phosphodiesterase 4, neutral membrane (neutral sphingomyelinase-3), CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, RAB2A  -  rab2a, member ras oncogene family, SULT2B1  -  sulfotransferase family, cytosolic, 2b, member 1, PIKFYVE  -  phosphoinositide kinase, fyve finger containing, ATP6V1B1  -  atpase, h+ transporting, lysosomal 56/58kda, v1 subunit b1, PLSCR1  -  phospholipid scramblase 1, TDG  -  thymine-dna glycosylase, SYNJ1  -  synaptojanin 1, PFKP  -  phosphofructokinase, platelet, TNNT3  -  troponin t type 3 (skeletal, fast), IDH3B  -  isocitrate dehydrogenase 3 (nad+) beta, RAB13  -  rab13, member ras oncogene family, MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), RAB33A  -  rab33a, member ras oncogene family, RAB9A  -  rab9a, member ras oncogene family, PRPS1  -  phosphoribosyl pyrophosphate synthetase 1, MYH10  -  myosin, heavy chain 10, non-muscle, GPX1  -  glutathione peroxidase 1, TBPL1  -  tbp-like 1, ALDOC  -  aldolase c, fructose-bisphosphate, RHOB  -  ras homolog family member b, MECP2  -  methyl cpg binding protein 2 (rett syndrome), HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, RARRES3  -  retinoic acid receptor responder (tazarotene induced) 3, ADA  -  adenosine deaminase, DDX17  -  dead (asp-glu-ala-asp) box helicase 17, FDXR  -  ferredoxin reductase, RHOG  -  ras homolog family member g, SMARCA5  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5, INPPL1  -  inositol polyphosphate phosphatase-like 1, MGLL  -  monoglyceride lipase, PLA2G15  -  phospholipase a2, group xv, TGFB1  -  transforming growth factor, beta 1, CAT  -  catalase, SMARCA2  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, INPP5A  -  inositol polyphosphate-5-phosphatase, 40kda, RBBP4  -  retinoblastoma binding protein 4, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, PPAP2B  -  phosphatidic acid phosphatase type 2b, ADM  -  adrenomedullin, MPG  -  n-methylpurine-dna glycosylase, RAB7L1  -  rab7, member ras oncogene family-like 1]"GO:0002682,regulation of immune system process,2.43E-04,3.87E-02,1.6,8230,860,448,75,"[IFIT1  -  interferon-induced protein with tetratricopeptide repeats 1, PAWR  -  prkc, apoptosis, wt1, regulator, PDE5A  -  phosphodiesterase 5a, cgmp-specific, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), TICAM1  -  toll-like receptor adaptor molecule 1, GAB2  -  grb2-associated binding protein 2, LGALS3  -  lectin, galactoside-binding, soluble, 3, FOXO1  -  forkhead box o1, HRAS  -  harvey rat sarcoma viral oncogene homolog, IFNGR1  -  interferon gamma receptor 1, TAB2  -  tgf-beta activated kinase 1/map3k7 binding protein 2, NBL1  -  neuroblastoma 1, dan family bmp antagonist, PVRL2  -  poliovirus receptor-related 2 (herpesvirus entry mediator b), ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, LPXN  -  leupaxin, CTSK  -  cathepsin k, CTSH  -  cathepsin h, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, VEGFC  -  vascular endothelial growth factor c, CFB  -  complement factor b, NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, SOX9  -  sry (sex determining region y)-box 9, WNT5A  -  wingless-type mmtv integration site family, member 5a, PLSCR1  -  phospholipid scramblase 1, AHR  -  aryl hydrocarbon receptor, CFH  -  complement factor h, CFHR1  -  complement factor h-related 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, CD200  -  cd200 molecule, BMP4  -  bone morphogenetic protein 4, PDGFA  -  platelet-derived growth factor alpha polypeptide, C9  -  complement component 9, FGFR1  -  fibroblast growth factor receptor 1, UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, SHH  -  sonic hedgehog, STAT2  -  signal transducer and activator of transcription 2, 113kda, JUN  -  jun proto-oncogene, STAT1  -  signal transducer and activator of transcription 1, 91kda, PPM1B  -  protein phosphatase, mg2+/mn2+ dependent, 1b, PROS1  -  protein s (alpha), FGF7  -  fibroblast growth factor 7, PDPK1  -  3-phosphoinositide dependent protein kinase-1, FGF4  -  fibroblast growth factor 4, ISG15  -  isg15 ubiquitin-like modifier, CD14  -  cd14 molecule, JAK2  -  janus kinase 2, ADA  -  adenosine deaminase, TYRO3  -  tyro3 protein tyrosine kinase, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, MED1  -  mediator complex subunit 1, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, CLU  -  clusterin, CNR1  -  cannabinoid receptor 1 (brain), MAP2K1  -  mitogen-activated protein kinase kinase 1, MAP2K3  -  mitogen-activated protein kinase kinase 3, ARPC2  -  actin related protein 2/3 complex, subunit 2, 34kda, MAPK7  -  mitogen-activated protein kinase 7, CBLB  -  cbl proto-oncogene b, e3 ubiquitin protein ligase, IGF2  -  insulin-like growth factor 2 (somatomedin a), TGFB1  -  transforming growth factor, beta 1, TNFRSF14  -  tumor necrosis factor receptor superfamily, member 14, OGT  -  o-linked n-acetylglucosamine (glcnac) transferase, C1R  -  complement component 1, r subcomponent, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), C1S  -  complement component 1, s subcomponent, LY96  -  lymphocyte antigen 96, PTPN1  -  protein tyrosine phosphatase, non-receptor type 1, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, YES1  -  v-yes-1 yamaguchi sarcoma viral oncogene homolog 1, C4A  -  complement component 4a (rodgers blood group), TRAF2  -  tnf receptor-associated factor 2, PRKCA  -  protein kinase c, alpha, GSK3B  -  glycogen synthase kinase 3 beta, PIGR  -  polymeric immunoglobulin receptor, GAS6  -  growth arrest-specific 6]"GO:1900053,negative regulation of retinoic acid biosynthetic process,2.43E-04,3.81E-02,"4,115.00",8230,1,2,1,"[AKR1C3  -  aldo-keto reductase family 1, member c3]"GO:1900052,regulation of retinoic acid biosynthetic process,2.43E-04,3.76E-02,"4,115.00",8230,1,2,1,"[AKR1C3  -  aldo-keto reductase family 1, member c3]"GO:0006714,sesquiterpenoid metabolic process,2.43E-04,3.71E-02,"4,115.00",8230,1,2,1,"[AKR1C3  -  aldo-keto reductase family 1, member c3]"GO:0071395,cellular response to jasmonic acid stimulus,2.43E-04,3.66E-02,"4,115.00",8230,1,2,1,"[AKR1C3  -  aldo-keto reductase family 1, member c3]"GO:0008300,isoprenoid catabolic process,2.43E-04,3.61E-02,"4,115.00",8230,1,2,1,"[AKR1C3  -  aldo-keto reductase family 1, member c3]"GO:0045827,negative regulation of isoprenoid metabolic process,2.43E-04,3.56E-02,"4,115.00",8230,1,2,1,"[AKR1C3  -  aldo-keto reductase family 1, member c3]"GO:0016107,sesquiterpenoid catabolic process,2.43E-04,3.52E-02,"4,115.00",8230,1,2,1,"[AKR1C3  -  aldo-keto reductase family 1, member c3]"GO:0016115,terpenoid catabolic process,2.43E-04,3.47E-02,"4,115.00",8230,1,2,1,"[AKR1C3  -  aldo-keto reductase family 1, member c3]"GO:0016488,farnesol catabolic process,2.43E-04,3.43E-02,"4,115.00",8230,1,2,1,"[AKR1C3  -  aldo-keto reductase family 1, member c3]"GO:0016487,farnesol metabolic process,2.43E-04,3.38E-02,"4,115.00",8230,1,2,1,"[AKR1C3  -  aldo-keto reductase family 1, member c3]"GO:0009753,response to jasmonic acid,2.43E-04,3.34E-02,"4,115.00",8230,1,2,1,"[AKR1C3  -  aldo-keto reductase family 1, member c3]"GO:0019852,L-ascorbic acid metabolic process,2.54E-04,3.45E-02,14.98,8230,7,314,4,"[CYB5A  -  cytochrome b5 type a (microsomal), SLC2A3  -  solute carrier family 2 (facilitated glucose transporter), member 3, SLC23A2  -  solute carrier family 23 (ascorbic acid transporter), member 2, SLC2A1  -  solute carrier family 2 (facilitated glucose transporter), member 1]"GO:0031099,regeneration,2.58E-04,3.47E-02,2.61,8230,74,894,21,"[TEK  -  tek tyrosine kinase, endothelial, TGFB1  -  transforming growth factor, beta 1, IGFBP1  -  insulin-like growth factor binding protein 1, JUN  -  jun proto-oncogene, MATN2  -  matrilin 2, GSN  -  gelsolin, GPX1  -  glutathione peroxidase 1, NREP  -  neuronal regeneration related protein, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), ALDOC  -  aldolase c, fructose-bisphosphate, TGFBR3  -  transforming growth factor, beta receptor iii, PAX7  -  paired box 7, NACA  -  nascent polypeptide-associated complex alpha subunit, GJA1  -  gap junction protein, alpha 1, 43kda, JAK2  -  janus kinase 2, APOE  -  apolipoprotein e, GAP43  -  growth associated protein 43, ADM  -  adrenomedullin, MED1  -  mediator complex subunit 1, CCND1  -  cyclin d1, GAS6  -  growth arrest-specific 6]"GO:0050789,regulation of biological process,2.84E-04,3.76E-02,1.11,8230,5444,613,452,"[SH3BP1  -  sh3-domain binding protein 1, HNRNPA0  -  heterogeneous nuclear ribonucleoprotein a0, ABCA1  -  atp-binding cassette, sub-family a (abc1), member 1, SEPT5  -  septin 5, GEM  -  gtp binding protein overexpressed in skeletal muscle, NCOR2  -  nuclear receptor corepressor 2, RNF14  -  ring finger protein 14, LGALS3  -  lectin, galactoside-binding, soluble, 3, TRAF4  -  tnf receptor-associated factor 4, ASIC2  -  acid-sensing (proton-gated) ion channel 2, CDC42EP4  -  cdc42 effector protein (rho gtpase binding) 4, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, SOX9  -  sry (sex determining region y)-box 9, ACR  -  acrosin, PLP2  -  proteolipid protein 2 (colonic epithelium-enriched), SOX4  -  sry (sex determining region y)-box 4, PLSCR1  -  phospholipid scramblase 1, GJA1  -  gap junction protein, alpha 1, 43kda, SOD2  -  superoxide dismutase 2, mitochondrial, LMNA  -  lamin a/c, SERPINF2  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 2, SNX1  -  sorting nexin 1, SNTA1  -  syntrophin, alpha 1, ACTN1  -  actinin, alpha 1, CTSA  -  cathepsin a, PPIA  -  peptidylprolyl isomerase a (cyclophilin a), CNN1  -  calponin 1, basic, smooth muscle, LITAF  -  lipopolysaccharide-induced tnf factor, PPM1B  -  protein phosphatase, mg2+/mn2+ dependent, 1b, TBPL1  -  tbp-like 1, ADAR  -  adenosine deaminase, rna-specific, FZD7  -  frizzled family receptor 7, SNAPC1  -  small nuclear rna activating complex, polypeptide 1, 43kda, ADA  -  adenosine deaminase, MED1  -  mediator complex subunit 1, CNR1  -  cannabinoid receptor 1 (brain), PTGES  -  prostaglandin e synthase, AMOTL2  -  angiomotin like 2, KRT18  -  keratin 18, SH3BP5  -  sh3-domain binding protein 5 (btk-associated), COL8A1  -  collagen, type viii, alpha 1, HLTF  -  helicase-like transcription factor, ADD1  -  adducin 1 (alpha), EIF4E2  -  eukaryotic translation initiation factor 4e family member 2, SMARCA2  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, LY96  -  lymphocyte antigen 96, PARP1  -  poly (adp-ribose) polymerase 1, ADM  -  adrenomedullin, LAMA5  -  laminin, alpha 5, LAMA4  -  laminin, alpha 4, POLR2B  -  polymerase (rna) ii (dna directed) polypeptide b, 140kda, LAMB1  -  laminin, beta 1, QKI  -  qki, kh domain containing, rna binding, AP1G1  -  adaptor-related protein complex 1, gamma 1 subunit, ASCC2  -  activating signal cointegrator 1 complex subunit 2, SYT1  -  synaptotagmin i, NUPL2  -  nucleoporin like 2, HOMER3  -  homer homolog 3 (drosophila), PPP5C  -  protein phosphatase 5, catalytic subunit, AIMP2  -  aminoacyl trna synthetase complex-interacting multifunctional protein 2, LPXN  -  leupaxin, CTSK  -  cathepsin k, CTSH  -  cathepsin h, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, WWP2  -  ww domain containing e3 ubiquitin protein ligase 2, AHR  -  aryl hydrocarbon receptor, PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, ARHGAP29  -  rho gtpase activating protein 29, CRIP2  -  cysteine-rich protein 2, CRIP1  -  cysteine-rich protein 1 (intestinal), RBPMS  -  rna binding protein with multiple splicing, ST13  -  suppression of tumorigenicity 13 (colon carcinoma) (hsp70 interacting protein), RAB33A  -  rab33a, member ras oncogene family, FOSL1  -  fos-like antigen 1, RAB9A  -  rab9a, member ras oncogene family, JUN  -  jun proto-oncogene, STAT2  -  signal transducer and activator of transcription 2, 113kda, STAT1  -  signal transducer and activator of transcription 1, 91kda, STAT4  -  signal transducer and activator of transcription 4, PROS1  -  protein s (alpha), CRYAB  -  crystallin, alpha b, ADRM1  -  adhesion regulating molecule 1, SSRP1  -  structure specific recognition protein 1, JAK2  -  janus kinase 2, MAP2K1  -  mitogen-activated protein kinase kinase 1, MAP2K3  -  mitogen-activated protein kinase kinase 3, MAPK7  -  mitogen-activated protein kinase 7, SRPK2  -  srsf protein kinase 2, RAB32  -  rab32, member ras oncogene family, PRKG1  -  protein kinase, cgmp-dependent, type i, TRIM21  -  tripartite motif containing 21, COPS2  -  cop9 signalosome subunit 2, NREP  -  neuronal regeneration related protein, GBP1  -  guanylate binding protein 1, interferon-inducible, BAMBI  -  bmp and activin membrane-bound inhibitor, STAM  -  signal transducing adaptor molecule (sh3 domain and itam motif) 1, CSPG4  -  chondroitin sulfate proteoglycan 4, SLC25A4  -  solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4, PRKCA  -  protein kinase c, alpha, GAS6  -  growth arrest-specific 6, GAS1  -  growth arrest-specific 1, APEX1  -  apex nuclease (multifunctional dna repair enzyme) 1, PAWR  -  prkc, apoptosis, wt1, regulator, GSN  -  gelsolin, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), MID1  -  midline 1 (opitz/bbb syndrome), PAX7  -  paired box 7, DDB1  -  damage-specific dna binding protein 1, 127kda, PBX1  -  pre-b-cell leukemia homeobox 1, ANXA6  -  annexin a6, DBP  -  d site of albumin promoter (albumin d-box) binding protein, AFF1  -  af4/fmr2 family, member 1, MSH6  -  muts homolog 6 (e. coli), KMT2A  -  lysine (k)-specific methyltransferase 2a, CRLF1  -  cytokine receptor-like factor 1, UBE2L6  -  ubiquitin-conjugating enzyme e2l 6, DFNA5  -  deafness, autosomal dominant 5, P4HB  -  prolyl 4-hydroxylase, beta polypeptide, PDLIM7  -  pdz and lim domain 7 (enigma), PDCD10  -  programmed cell death 10, RAB22A  -  rab22a, member ras oncogene family, MMP11  -  matrix metallopeptidase 11 (stromelysin 3), FURIN  -  furin (paired basic amino acid cleaving enzyme), ZNF473  -  zinc finger protein 473, APOE  -  apolipoprotein e, APP  -  amyloid beta (a4) precursor protein, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, WWOX  -  ww domain containing oxidoreductase, CD200  -  cd200 molecule, PDGFA  -  platelet-derived growth factor alpha polypeptide, MDK  -  midkine (neurite growth-promoting factor 2), ATXN1  -  ataxin 1, PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, RHOB  -  ras homolog family member b, MECP2  -  methyl cpg binding protein 2 (rett syndrome), PDPK1  -  3-phosphoinositide dependent protein kinase-1, PSIP1  -  pc4 and sfrs1 interacting protein 1, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, ARHGAP1  -  rho gtpase activating protein 1, AMIGO2  -  adhesion molecule with ig-like domain 2, RHOG  -  ras homolog family member g, ZYX  -  zyxin, DAG1  -  dystroglycan 1 (dystrophin-associated glycoprotein 1), KAT8  -  k(lysine) acetyltransferase 8, ASPH  -  aspartate beta-hydroxylase, DAPK1  -  death-associated protein kinase 1, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, CDC37  -  cell division cycle 37, SAT1  -  spermidine/spermine n1-acetyltransferase 1, HDAC1  -  histone deacetylase 1, PKIG  -  protein kinase (camp-dependent, catalytic) inhibitor gamma, KAT7  -  k(lysine) acetyltransferase 7, SALL2  -  sal-like 2 (drosophila), RFK  -  riboflavin kinase, CDK14  -  cyclin-dependent kinase 14, SMC3  -  structural maintenance of chromosomes 3, ZHX2  -  zinc fingers and homeoboxes 2, GPC1  -  glypican 1, RAB14  -  rab14, member ras oncogene family, GPI  -  glucose-6-phosphate isomerase, DPYSL2  -  dihydropyrimidinase-like 2, MLXIP  -  mlx interacting protein, SLC12A2  -  solute carrier family 12 (sodium/potassium/chloride transporter), member 2, PEX6  -  peroxisomal biogenesis factor 6, WEE1  -  wee1 homolog (s. pombe), SLC2A1  -  solute carrier family 2 (facilitated glucose transporter), member 1, ATP6V1B1  -  atpase, h+ transporting, lysosomal 56/58kda, v1 subunit b1, WNT5A  -  wingless-type mmtv integration site family, member 5a, DVL3  -  dishevelled segment polarity protein 3, GULP1  -  gulp, engulfment adaptor ptb domain containing 1, TSC22D3  -  tsc22 domain family, member 3, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, PFDN1  -  prefoldin subunit 1, DLD  -  dihydrolipoamide dehydrogenase, BAG1  -  bcl2-associated athanogene, SHH  -  sonic hedgehog, GPX1  -  glutathione peroxidase 1, ATF5  -  activating transcription factor 5, PLAT  -  plasminogen activator, tissue, LUM  -  lumican, PLAGL1  -  pleiomorphic adenoma gene-like 1, UBA3  -  ubiquitin-like modifier activating enzyme 3, ATR  -  ataxia telangiectasia and rad3 related, BCAM  -  basal cell adhesion molecule (lutheran blood group), MPZL1  -  myelin protein zero-like 1, BDKRB2  -  bradykinin receptor b2, MGLL  -  monoglyceride lipase, SERPINE2  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 2, SERPINB9  -  serpin peptidase inhibitor, clade b (ovalbumin), member 9, TDP2  -  tyrosyl-dna phosphodiesterase 2, SERPINB6  -  serpin peptidase inhibitor, clade b (ovalbumin), member 6, PHB2  -  prohibitin 2, DMD  -  dystrophin, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, YES1  -  v-yes-1 yamaguchi sarcoma viral oncogene homolog 1, CXCL1  -  chemokine (c-x-c motif) ligand 1 (melanoma growth stimulating activity, alpha), DMPK  -  dystrophia myotonica-protein kinase, SCG5  -  secretogranin v (7b2 protein), SGK1  -  serum/glucocorticoid regulated kinase 1, GSK3B  -  glycogen synthase kinase 3 beta, SMAD6  -  smad family member 6, PIGR  -  polymeric immunoglobulin receptor, SH3BGR  -  sh3 domain binding glutamic acid-rich protein, ITSN1  -  intersectin 1 (sh3 domain protein), MAF  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog, YAF2  -  yy1 associated factor 2, NCBP2  -  nuclear cap binding protein subunit 2, 20kda, BNIP3  -  bcl2/adenovirus e1b 19kda interacting protein 3, HSF2  -  heat shock transcription factor 2, NDN  -  necdin, melanoma antigen (mage) family member, BNIP2  -  bcl2/adenovirus e1b 19kda interacting protein 2, NCK1  -  nck adaptor protein 1, TRAK1  -  trafficking protein, kinesin binding 1, ELF4  -  e74-like factor 4 (ets domain transcription factor), ELN  -  elastin, TSC22D4  -  tsc22 domain family, member 4, TICAM1  -  toll-like receptor adaptor molecule 1, IQGAP1  -  iq motif containing gtpase activating protein 1, ATF6  -  activating transcription factor 6, HRAS  -  harvey rat sarcoma viral oncogene homolog, NBN  -  nibrin, NBL1  -  neuroblastoma 1, dan family bmp antagonist, RIT1  -  ras-like without caax 1, EIF4A2  -  eukaryotic translation initiation factor 4a2, RRAGB  -  ras-related gtp binding b, EIF4B  -  eukaryotic translation initiation factor 4b, CFB  -  complement factor b, PPP1R12B  -  protein phosphatase 1, regulatory subunit 12b, PIKFYVE  -  phosphoinositide kinase, fyve finger containing, NDEL1  -  nude neurodevelopment protein 1-like 1, BMP1  -  bone morphogenetic protein 1, RGS7  -  regulator of g-protein signaling 7, MYLK  -  myosin light chain kinase, RGS3  -  regulator of g-protein signaling 3, BMPR1A  -  bone morphogenetic protein receptor, type ia, EIF4G1  -  eukaryotic translation initiation factor 4 gamma, 1, ASAP2  -  arfgap with sh3 domain, ankyrin repeat and ph domain 2, BMP4  -  bone morphogenetic protein 4, RGS16  -  regulator of g-protein signaling 16, C9  -  complement component 9, TPM2  -  tropomyosin 2 (beta), STK38L  -  serine/threonine kinase 38 like, MYH10  -  myosin, heavy chain 10, non-muscle, EGFR  -  epidermal growth factor receptor, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, EFNB2  -  ephrin-b2, RNF2  -  ring finger protein 2, EFNB1  -  ephrin-b1, ROCK1  -  rho-associated, coiled-coil containing protein kinase 1, ARPC2  -  actin related protein 2/3 complex, subunit 2, 34kda, SERPING1  -  serpin peptidase inhibitor, clade g (c1 inhibitor), member 1, CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, C1R  -  complement component 1, r subcomponent, C1S  -  complement component 1, s subcomponent, C4A  -  complement component 4a (rodgers blood group), TRAF2  -  tnf receptor-associated factor 2, MBD2  -  methyl-cpg binding domain protein 2, ECE1  -  endothelin converting enzyme 1, EFS  -  embryonal fyn-associated substrate, RAB7L1  -  rab7, member ras oncogene family-like 1, OPTN  -  optineurin, TRAP1  -  tnf receptor-associated protein 1, ERC1  -  elks/rab6-interacting/cast family member 1, CAPZA2  -  capping protein (actin filament) muscle z-line, alpha 2, AKR1C3  -  aldo-keto reductase family 1, member c3, ACAA2  -  acetyl-coa acyltransferase 2, PDE5A  -  phosphodiesterase 5a, cgmp-specific, OSTF1  -  osteoclast stimulating factor 1, CAMK2G  -  calcium/calmodulin-dependent protein kinase ii gamma, SIK1  -  salt-inducible kinase 1, EIF3D  -  eukaryotic translation initiation factor 3, subunit d, SPG20  -  spastic paraplegia 20 (troyer syndrome), EIF4G3  -  eukaryotic translation initiation factor 4 gamma, 3, CASP4  -  caspase 4, apoptosis-related cysteine peptidase, COL14A1  -  collagen, type xiv, alpha 1, TANK  -  traf family member-associated nfkb activator, UNG  -  uracil-dna glycosylase, TAB2  -  tgf-beta activated kinase 1/map3k7 binding protein 2, GPNMB  -  glycoprotein (transmembrane) nmb, HMGXB4  -  hmg box domain containing 4, CAP1  -  cap, adenylate cyclase-associated protein 1 (yeast), PLXND1  -  plexin d1, EIF3M  -  eukaryotic translation initiation factor 3, subunit m, VEGFC  -  vascular endothelial growth factor c, EZR  -  ezrin, EPB41L3  -  erythrocyte membrane protein band 4.1-like 3, DDR1  -  discoidin domain receptor tyrosine kinase 1, CREB3L1  -  camp responsive element binding protein 3-like 1, CFH  -  complement factor h, PTRF  -  polymerase i and transcript release factor, CFHR1  -  complement factor h-related 1, HSPB6  -  heat shock protein, alpha-crystallin-related, b6, EZH2  -  enhancer of zeste homolog 2 (drosophila), VCAM1  -  vascular cell adhesion molecule 1, HIVEP1  -  human immunodeficiency virus type i enhancer binding protein 1, ERF  -  ets2 repressor factor, MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), MYCBP  -  myc binding protein, UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, CTNNAL1  -  catenin (cadherin-associated protein), alpha-like 1, KIAA1199  -  kiaa1199, ARNT2  -  aryl-hydrocarbon receptor nuclear translocator 2, GBF1  -  golgi brefeldin a resistant guanine nucleotide exchange factor 1, CCNG1  -  cyclin g1, HNRNPU  -  heterogeneous nuclear ribonucleoprotein u (scaffold attachment factor a), CD14  -  cd14 molecule, OXSR1  -  oxidative stress responsive 1, DLC1  -  deleted in liver cancer 1, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, TYRO3  -  tyro3 protein tyrosine kinase, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, TNFSF9  -  tumor necrosis factor (ligand) superfamily, member 9, SACS  -  spastic ataxia of charlevoix-saguenay (sacsin), ZMIZ1  -  zinc finger, miz-type containing 1, TXNRD1  -  thioredoxin reductase 1, CBLB  -  cbl proto-oncogene b, e3 ubiquitin protein ligase, UCHL1  -  ubiquitin carboxyl-terminal esterase l1 (ubiquitin thiolesterase), TNFRSF14  -  tumor necrosis factor receptor superfamily, member 14, CAT  -  catalase, CAV2  -  caveolin 2, KRIT1  -  krit1, ankyrin repeat containing, TBC1D1  -  tbc1 (tre-2/usp6, bub2, cdc16) domain family, member 1, RBM14  -  rna binding motif protein 14, CCND2  -  cyclin d2, NUP153  -  nucleoporin 153kda, RRAD  -  ras-related associated with diabetes, NR1D2  -  nuclear receptor subfamily 1, group d, member 2, RRAS  -  related ras viral (r-ras) oncogene homolog, PDLIM5  -  pdz and lim domain 5, SSH1  -  slingshot protein phosphatase 1, CDH2  -  cadherin 2, type 1, n-cadherin (neuronal), TCF12  -  transcription factor 12, CDC34  -  cell division cycle 34, GAB2  -  grb2-associated binding protein 2, FLNA  -  filamin a, alpha, FLNB  -  filamin b, beta, ARC  -  activity-regulated cytoskeleton-associated protein, FARP2  -  ferm, rhogef and pleckstrin domain protein 2, FOXO1  -  forkhead box o1, RGS5  -  regulator of g-protein signaling 5, CDC14B  -  cell division cycle 14b, SIN3B  -  sin3 transcription regulator family member b, FOXC1  -  forkhead box c1, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, DOK5  -  docking protein 5, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, LMO4  -  lim domain only 4, IL1R1  -  interleukin 1 receptor, type i, FOXF2  -  forkhead box f2, UBR2  -  ubiquitin protein ligase e3 component n-recognin 2, PDPN  -  podoplanin, CAMK1  -  calcium/calmodulin-dependent protein kinase i, TDG  -  thymine-dna glycosylase, NUAK1  -  nuak family, snf1-like kinase, 1, DYNLT3  -  dynein, light chain, tctex-type 3, SMG7  -  smg7 nonsense mediated mrna decay factor, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, IL6ST  -  interleukin 6 signal transducer (gp130, oncostatin m receptor), DGKZ  -  diacylglycerol kinase, zeta, TNFRSF11B  -  tumor necrosis factor receptor superfamily, member 11b, ITGA5  -  integrin, alpha 5 (fibronectin receptor, alpha polypeptide), PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), ITGA7  -  integrin, alpha 7, FGFR1  -  fibroblast growth factor receptor 1, ROR2  -  receptor tyrosine kinase-like orphan receptor 2, MAML1  -  mastermind-like 1 (drosophila), ITGA3  -  integrin, alpha 3 (antigen cd49c, alpha 3 subunit of vla-3 receptor), FGF7  -  fibroblast growth factor 7, PTGER1  -  prostaglandin e receptor 1 (subtype ep1), 42kda, ITGB5  -  integrin, beta 5, FGF4  -  fibroblast growth factor 4, FBLN5  -  fibulin 5, GTF2H5  -  general transcription factor iih, polypeptide 5, PTGIR  -  prostaglandin i2 (prostacyclin) receptor (ip), TRIM2  -  tripartite motif containing 2, DDX17  -  dead (asp-glu-ala-asp) box helicase 17, INPPL1  -  inositol polyphosphate phosphatase-like 1, TBX2  -  t-box 2, CDKN1C  -  cyclin-dependent kinase inhibitor 1c (p57, kip2), TBCD  -  tubulin folding cofactor d, SRGAP2  -  slit-robo rho gtpase activating protein 2, CDKN2D  -  cyclin-dependent kinase inhibitor 2d (p19, inhibits cdk4), PTPN1  -  protein tyrosine phosphatase, non-receptor type 1, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), ARL6IP5  -  adp-ribosylation-like factor 6 interacting protein 5, PPAP2B  -  phosphatidic acid phosphatase type 2b, EFEMP1  -  egf containing fibulin-like extracellular matrix protein 1, CDH13  -  cadherin 13, h-cadherin (heart), EIF3E  -  eukaryotic translation initiation factor 3, subunit e, ITGA6  -  integrin, alpha 6, CRCP  -  cgrp receptor component, FBLN2  -  fibulin 2, PTPRF  -  protein tyrosine phosphatase, receptor type, f, CHRND  -  cholinergic receptor, nicotinic, delta (muscle), IFIT1  -  interferon-induced protein with tetratricopeptide repeats 1, IFIT3  -  interferon-induced protein with tetratricopeptide repeats 3, TIMP3  -  timp metallopeptidase inhibitor 3, CHRNB1  -  cholinergic receptor, nicotinic, beta 1 (muscle), IFI27  -  interferon, alpha-inducible protein 27, IFI35  -  interferon-induced protein 35, PTX3  -  pentraxin 3, long, STRN3  -  striatin, calmodulin binding protein 3, TKT  -  transketolase, TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), NOV  -  nephroblastoma overexpressed, IFNGR1  -  interferon gamma receptor 1, NOTCH3  -  notch 3, PVRL2  -  poliovirus receptor-related 2 (herpesvirus entry mediator b), ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, HDAC4  -  histone deacetylase 4, ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, NFX1  -  nuclear transcription factor, x-box binding 1, RAB2A  -  rab2a, member ras oncogene family, NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, NFIX  -  nuclear factor i/x (ccaat-binding transcription factor), RAD23B  -  rad23 homolog b (s. cerevisiae), TNFAIP6  -  tumor necrosis factor, alpha-induced protein 6, CGB  -  chorionic gonadotropin, beta polypeptide, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, RAB13  -  rab13, member ras oncogene family, RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), TEK  -  tek tyrosine kinase, endothelial, SUZ12  -  suz12 polycomb repressive complex 2 subunit, RECK  -  reversion-inducing-cysteine-rich protein with kazal motifs, RBPJ  -  recombination signal binding protein for immunoglobulin kappa j region, NFE2L2  -  nuclear factor (erythroid-derived 2)-like 2, ISG15  -  isg15 ubiquitin-like modifier, RARRES3  -  retinoic acid receptor responder (tazarotene induced) 3, FEZ1  -  fasciculation and elongation protein zeta 1 (zygin i), CLU  -  clusterin, RAP1GDS1  -  rap1, gtp-gdp dissociation stimulator 1, TPP1  -  tripeptidyl peptidase i, IGBP1  -  immunoglobulin (cd79a) binding protein 1, RBL2  -  retinoblastoma-like 2 (p130), SMARCA5  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5, IGF1R  -  insulin-like growth factor 1 receptor, IGF2  -  insulin-like growth factor 2 (somatomedin a), TGFB1  -  transforming growth factor, beta 1, OGT  -  o-linked n-acetylglucosamine (glcnac) transferase, TGFB1I1  -  transforming growth factor beta 1 induced transcript 1, TGIF1  -  tgfb-induced factor homeobox 1, TSPYL2  -  tspy-like 2, SND1  -  staphylococcal nuclease and tudor domain containing 1, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), RBBP4  -  retinoblastoma binding protein 4, TGFBR3  -  transforming growth factor, beta receptor iii, CUL4B  -  cullin 4b, CABIN1  -  calcineurin binding protein 1, FNTB  -  farnesyltransferase, caax box, beta, RBP1  -  retinol binding protein 1, cellular]"GO:1901564,organonitrogen compound metabolic process,2.94E-04,3.85E-02,1.46,8230,694,861,106,"[GSTM2  -  glutathione s-transferase mu 2 (muscle), FMOD  -  fibromodulin, GSTM1  -  glutathione s-transferase mu 1, PAICS  -  phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, GSTM4  -  glutathione s-transferase mu 4, BCKDK  -  branched chain ketoacid dehydrogenase kinase, SEPT5  -  septin 5, HTRA2  -  htra serine peptidase 2, EPAS1  -  endothelial pas domain protein 1, GCSH  -  glycine cleavage system protein h (aminomethyl carrier), PC  -  pyruvate carboxylase, GTF2H1  -  general transcription factor iih, polypeptide 1, 62kda, GCH1  -  gtp cyclohydrolase 1, HRAS  -  harvey rat sarcoma viral oncogene homolog, MSH6  -  muts homolog 6 (e. coli), RIT1  -  ras-like without caax 1, SMPD4  -  sphingomyelin phosphodiesterase 4, neutral membrane (neutral sphingomyelinase-3), BGN  -  biglycan, MYO10  -  myosin x, FOXC1  -  forkhead box c1, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, P4HB  -  prolyl 4-hydroxylase, beta polypeptide, ARF1  -  adp-ribosylation factor 1, FURIN  -  furin (paired basic amino acid cleaving enzyme), PLSCR1  -  phospholipid scramblase 1, OGDH  -  oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide), TDG  -  thymine-dna glycosylase, SDC2  -  syndecan 2, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, COASY  -  coa synthase, SOD2  -  superoxide dismutase 2, mitochondrial, SOD1  -  superoxide dismutase 1, soluble, AQP1  -  aquaporin 1 (colton blood group), CTSA  -  cathepsin a, MYH10  -  myosin, heavy chain 10, non-muscle, TBPL1  -  tbp-like 1, MECP2  -  methyl cpg binding protein 2 (rett syndrome), RHOB  -  ras homolog family member b, FGF2  -  fibroblast growth factor 2 (basic), HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, ADA  -  adenosine deaminase, DDX17  -  dead (asp-glu-ala-asp) box helicase 17, MED1  -  mediator complex subunit 1, FDXR  -  ferredoxin reductase, RHOG  -  ras homolog family member g, CHST15  -  carbohydrate (n-acetylgalactosamine 4-sulfate 6-o) sulfotransferase 15, PLA2G15  -  phospholipase a2, group xv, GNB1  -  guanine nucleotide binding protein (g protein), beta polypeptide 1, ASS1  -  argininosuccinate synthase 1, SMARCA2  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, HEXA  -  hexosaminidase a (alpha polypeptide), SAT1  -  spermidine/spermine n1-acetyltransferase 1, ADM  -  adrenomedullin, PPAP2B  -  phosphatidic acid phosphatase type 2b, ECE1  -  endothelin converting enzyme 1, RAB7L1  -  rab7, member ras oncogene family-like 1, NADK  -  nad kinase, RFK  -  riboflavin kinase, PDE5A  -  phosphodiesterase 5a, cgmp-specific, SLC7A8  -  solute carrier family 7 (amino acid transporter light chain, l system), member 8, TKT  -  transketolase, PGD  -  phosphogluconate dehydrogenase, NME4  -  nme/nm23 nucleoside diphosphate kinase 4, GPC1  -  glypican 1, RAB14  -  rab14, member ras oncogene family, PRELP  -  proline/arginine-rich end leucine-rich repeat protein, CTPS1  -  ctp synthase 1, AIMP2  -  aminoacyl trna synthetase complex-interacting multifunctional protein 2, DPYSL2  -  dihydropyrimidinase-like 2, RPE  -  ribulose-5-phosphate-3-epimerase, ACAN  -  aggrecan, AK2  -  adenylate kinase 2, PEX6  -  peroxisomal biogenesis factor 6, CTSH  -  cathepsin h, RAB2A  -  rab2a, member ras oncogene family, SULT2B1  -  sulfotransferase family, cytosolic, 2b, member 1, ATP6V1B1  -  atpase, h+ transporting, lysosomal 56/58kda, v1 subunit b1, B4GALT3  -  udp-gal:betaglcnac beta 1,4- galactosyltransferase, polypeptide 3, PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, VCAM1  -  vascular cell adhesion molecule 1, TNNT3  -  troponin t type 3 (skeletal, fast), IDH3B  -  isocitrate dehydrogenase 3 (nad+) beta, RAB13  -  rab13, member ras oncogene family, DLD  -  dihydrolipoamide dehydrogenase, MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), RAB33A  -  rab33a, member ras oncogene family, RAB9A  -  rab9a, member ras oncogene family, PRPS1  -  phosphoribosyl pyrophosphate synthetase 1, GPX1  -  glutathione peroxidase 1, LUM  -  lumican, ST3GAL4  -  st3 beta-galactoside alpha-2,3-sialyltransferase 4, TPP1  -  tripeptidyl peptidase i, SMARCA5  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5, TGFB1  -  transforming growth factor, beta 1, DNM2  -  dynamin 2, CAT  -  catalase, RBBP4  -  retinoblastoma binding protein 4, DMD  -  dystrophin, CSPG4  -  chondroitin sulfate proteoglycan 4, CKB  -  creatine kinase, brain, VCAN  -  versican, CBS  -  cystathionine-beta-synthase, P4HA2  -  prolyl 4-hydroxylase, alpha polypeptide ii, MPG  -  n-methylpurine-dna glycosylase]"GO:0006026,aminoglycan catabolic process,2.95E-04,3.82E-02,3.38,8230,32,989,13,"[FMOD  -  fibromodulin, BGN  -  biglycan, TGFB1  -  transforming growth factor, beta 1, FGF2  -  fibroblast growth factor 2 (basic), HEXA  -  hexosaminidase a (alpha polypeptide), LUM  -  lumican, SDC2  -  syndecan 2, GPC1  -  glypican 1, PRELP  -  proline/arginine-rich end leucine-rich repeat protein, CSPG4  -  chondroitin sulfate proteoglycan 4, VCAN  -  versican, GUSB  -  glucuronidase, beta, ACAN  -  aggrecan]"GO:0005996,monosaccharide metabolic process,3.02E-04,3.87E-02,2.91,8230,132,407,19,"[CHST15  -  carbohydrate (n-acetylgalactosamine 4-sulfate 6-o) sulfotransferase 15, INPPL1  -  inositol polyphosphate phosphatase-like 1, PGK1  -  phosphoglycerate kinase 1, IGF2  -  insulin-like growth factor 2 (somatomedin a), SLC23A2  -  solute carrier family 23 (ascorbic acid transporter), member 2, SLC2A1  -  solute carrier family 2 (facilitated glucose transporter), member 1, PGD  -  phosphogluconate dehydrogenase, CRYAB  -  crystallin, alpha b, ALDOC  -  aldolase c, fructose-bisphosphate, SORD  -  sorbitol dehydrogenase, CYB5A  -  cytochrome b5 type a (microsomal), GYS1  -  glycogen synthase 1 (muscle), SLC2A3  -  solute carrier family 2 (facilitated glucose transporter), member 3, PFKP  -  phosphofructokinase, platelet, LDHA  -  lactate dehydrogenase a, GPI  -  glucose-6-phosphate isomerase, PKM  -  pyruvate kinase, muscle, ENO2  -  enolase 2 (gamma, neuronal), RPE  -  ribulose-5-phosphate-3-epimerase]"GO:0046365,monosaccharide catabolic process,3.07E-04,3.89E-02,2.98,8230,45,981,16,"[PGK1  -  phosphoglycerate kinase 1, TKT  -  transketolase, PGD  -  phosphogluconate dehydrogenase, ALDOC  -  aldolase c, fructose-bisphosphate, BPGM  -  2,3-bisphosphoglycerate mutase, OGDH  -  oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide), LDHB  -  lactate dehydrogenase b, PFKL  -  phosphofructokinase, liver, RPIA  -  ribose 5-phosphate isomerase a, PFKP  -  phosphofructokinase, platelet, LDHA  -  lactate dehydrogenase a, GPI  -  glucose-6-phosphate isomerase, ENO2  -  enolase 2 (gamma, neuronal), PKM  -  pyruvate kinase, muscle, RPE  -  ribulose-5-phosphate-3-epimerase, ENO1  -  enolase 1, (alpha)]"GO:0044419,interspecies interaction between organisms,3.08E-04,3.86E-02,1.51,8230,552,888,90,"[IFIT1  -  interferon-induced protein with tetratricopeptide repeats 1, NCBP2  -  nuclear cap binding protein subunit 2, 20kda, BNIP3  -  bcl2/adenovirus e1b 19kda interacting protein 3, RPL23A  -  ribosomal protein l23a, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, AP1G1  -  adaptor-related protein complex 1, gamma 1 subunit, RPL18A  -  ribosomal protein l18a, RPL15  -  ribosomal protein l15, RPL12  -  ribosomal protein l12, NUPL2  -  nucleoporin like 2, DDB1  -  damage-specific dna binding protein 1, 127kda, RPL5  -  ribosomal protein l5, GTF2H1  -  general transcription factor iih, polypeptide 1, 62kda, SUPT5H  -  suppressor of ty 5 homolog (s. cerevisiae), EIF4G3  -  eukaryotic translation initiation factor 4 gamma, 3, UNG  -  uracil-dna glycosylase, RPL4  -  ribosomal protein l4, PSMA1  -  proteasome (prosome, macropain) subunit, alpha type, 1, PVR  -  poliovirus receptor, PACS2  -  phosphofurin acidic cluster sorting protein 2, PVRL2  -  poliovirus receptor-related 2 (herpesvirus entry mediator b), FBLN1  -  fibulin 1, MMP1  -  matrix metallopeptidase 1 (interstitial collagenase), EIF4A2  -  eukaryotic translation initiation factor 4a2, NFX1  -  nuclear transcription factor, x-box binding 1, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, TRAM1  -  translocation associated membrane protein 1, NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, PSMB9  -  proteasome (prosome, macropain) subunit, beta type, 9, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, WWP2  -  ww domain containing e3 ubiquitin protein ligase 2, ATP6V1B1  -  atpase, h+ transporting, lysosomal 56/58kda, v1 subunit b1, ARF1  -  adp-ribosylation factor 1, FURIN  -  furin (paired basic amino acid cleaving enzyme), ATP6V0C  -  atpase, h+ transporting, lysosomal 16kda, v0 subunit c, PSMB4  -  proteasome (prosome, macropain) subunit, beta type, 4, NACA  -  nascent polypeptide-associated complex alpha subunit, VCAM1  -  vascular cell adhesion molecule 1, EIF4G1  -  eukaryotic translation initiation factor 4 gamma, 1, CREB1  -  camp responsive element binding protein 1, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, IL6ST  -  interleukin 6 signal transducer (gp130, oncostatin m receptor), VDAC1  -  voltage-dependent anion channel 1, AQP1  -  aquaporin 1 (colton blood group), RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), ITGA5  -  integrin, alpha 5 (fibronectin receptor, alpha polypeptide), UBR4  -  ubiquitin protein ligase e3 component n-recognin 4, PSMD11  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 11, KRT19  -  keratin 19, ICAM1  -  intercellular adhesion molecule 1, TAF11  -  taf11 rna polymerase ii, tata box binding protein (tbp)-associated factor, 28kda, PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), C9  -  complement component 9, RAN  -  ran, member ras oncogene family, PPIA  -  peptidylprolyl isomerase a (cyclophilin a), STAT2  -  signal transducer and activator of transcription 2, 113kda, JUN  -  jun proto-oncogene, STAT1  -  signal transducer and activator of transcription 1, 91kda, RPL14  -  ribosomal protein l14, STAT3  -  signal transducer and activator of transcription 3 (acute-phase response factor), GPX1  -  glutathione peroxidase 1, PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, GBF1  -  golgi brefeldin a resistant guanine nucleotide exchange factor 1, SSRP1  -  structure specific recognition protein 1, ISG15  -  isg15 ubiquitin-like modifier, PSIP1  -  pc4 and sfrs1 interacting protein 1, KRT7  -  keratin 7, RPS13  -  ribosomal protein s13, EFNB2  -  ephrin-b2, TAP1  -  transporter 1, atp-binding cassette, sub-family b (mdr/tap), KRT18  -  keratin 18, TGFB1  -  transforming growth factor, beta 1, ZYX  -  zyxin, HNRNPA1  -  heterogeneous nuclear ribonucleoprotein a1, TNFRSF14  -  tumor necrosis factor receptor superfamily, member 14, MAPK3  -  mitogen-activated protein kinase 3, GNB2L1  -  guanine nucleotide binding protein (g protein), beta polypeptide 2-like 1, DAG1  -  dystroglycan 1 (dystrophin-associated glycoprotein 1), FADD  -  fas (tnfrsf6)-associated via death domain, SND1  -  staphylococcal nuclease and tudor domain containing 1, RPL23  -  ribosomal protein l23, SLC25A6  -  solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6, SLC25A4  -  solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4, NUP153  -  nucleoporin 153kda, SMAD3  -  smad family member 3, GAS6  -  growth arrest-specific 6, HDAC1  -  histone deacetylase 1, FBXL2  -  f-box and leucine-rich repeat protein 2, POLR2B  -  polymerase (rna) ii (dna directed) polypeptide b, 140kda]"GO:0032092,positive regulation of protein binding,3.08E-04,3.82E-02,7.27,8230,36,220,7,"[TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), KRIT1  -  krit1, ankyrin repeat containing, GSK3B  -  glycogen synthase kinase 3 beta, BMP4  -  bone morphogenetic protein 4, BAMBI  -  bmp and activin membrane-bound inhibitor, TICAM1  -  toll-like receptor adaptor molecule 1, TRAF4  -  tnf receptor-associated factor 4]"GO:0002376,immune system process,3.30E-04,4.04E-02,1.34,8230,1222,832,165,"[BNIP3  -  bcl2/adenovirus e1b 19kda interacting protein 3, SECTM1  -  secreted and transmembrane 1, NCK1  -  nck adaptor protein 1, ELF4  -  e74-like factor 4 (ets domain transcription factor), TCF12  -  transcription factor 12, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), TICAM1  -  toll-like receptor adaptor molecule 1, GEM  -  gtp binding protein overexpressed in skeletal muscle, SPN  -  sialophorin, GAB2  -  grb2-associated binding protein 2, CD59  -  cd59 molecule, complement regulatory protein, CD151  -  cd151 molecule (raph blood group), LGALS3  -  lectin, galactoside-binding, soluble, 3, FOXO1  -  forkhead box o1, HRAS  -  harvey rat sarcoma viral oncogene homolog, NBN  -  nibrin, MSH6  -  muts homolog 6 (e. coli), CD97  -  cd97 molecule, MYO9B  -  myosin ixb, MMP1  -  matrix metallopeptidase 1 (interstitial collagenase), MYO10  -  myosin x, IL4R  -  interleukin 4 receptor, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, UBE2L6  -  ubiquitin-conjugating enzyme e2l 6, CFB  -  complement factor b, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, PSMB9  -  proteasome (prosome, macropain) subunit, beta type, 9, SOX4  -  sry (sex determining region y)-box 4, BLMH  -  bleomycin hydrolase, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, IL1R1  -  interleukin 1 receptor, type i, ARF1  -  adp-ribosylation factor 1, PLSCR1  -  phospholipid scramblase 1, PSMB4  -  proteasome (prosome, macropain) subunit, beta type, 4, SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, BMPR1A  -  bone morphogenetic protein receptor, type ia, APP  -  amyloid beta (a4) precursor protein, CREB1  -  camp responsive element binding protein 1, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, IL32  -  interleukin 32, PDGFA  -  platelet-derived growth factor alpha polypeptide, ITGA5  -  integrin, alpha 5 (fibronectin receptor, alpha polypeptide), C9  -  complement component 9, PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), PPIA  -  peptidylprolyl isomerase a (cyclophilin a), FGFR1  -  fibroblast growth factor receptor 1, FGF5  -  fibroblast growth factor 5, PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, ITGA3  -  integrin, alpha 3 (antigen cd49c, alpha 3 subunit of vla-3 receptor), FGF7  -  fibroblast growth factor 7, CFL1  -  cofilin 1 (non-muscle), ADAR  -  adenosine deaminase, rna-specific, ITGB5  -  integrin, beta 5, SEMA3C  -  sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3c, FGF2  -  fibroblast growth factor 2 (basic), MEF2A  -  myocyte enhancer factor 2a, PDPK1  -  3-phosphoinositide dependent protein kinase-1, EGFR  -  epidermal growth factor receptor, FGF4  -  fibroblast growth factor 4, FZD7  -  frizzled family receptor 7, ADA  -  adenosine deaminase, POLR1C  -  polymerase (rna) i polypeptide c, 30kda, CEBPB  -  ccaat/enhancer binding protein (c/ebp), beta, ROCK1  -  rho-associated, coiled-coil containing protein kinase 1, ARPC2  -  actin related protein 2/3 complex, subunit 2, 34kda, INPPL1  -  inositol polyphosphate phosphatase-like 1, SERPING1  -  serpin peptidase inhibitor, clade g (c1 inhibitor), member 1, FCGRT  -  fc fragment of igg, receptor, transporter, alpha, C1R  -  complement component 1, r subcomponent, LY96  -  lymphocyte antigen 96, C1S  -  complement component 1, s subcomponent, SWAP70  -  swap switching b-cell complex 70kda subunit, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, C4A  -  complement component 4a (rodgers blood group), TRAF2  -  tnf receptor-associated factor 2, ITGA6  -  integrin, alpha 6, CRCP  -  cgrp receptor component, IRAK1  -  interleukin-1 receptor-associated kinase 1, CAPZA2  -  capping protein (actin filament) muscle z-line, alpha 2, CAPZA1  -  capping protein (actin filament) muscle z-line, alpha 1, IFIT1  -  interferon-induced protein with tetratricopeptide repeats 1, IFIT3  -  interferon-induced protein with tetratricopeptide repeats 3, AP1G1  -  adaptor-related protein complex 1, gamma 1 subunit, IFI16  -  interferon, gamma-inducible protein 16, PTX3  -  pentraxin 3, long, SLC7A8  -  solute carrier family 7 (amino acid transporter light chain, l system), member 8, SLC16A3  -  solute carrier family 16 (monocarboxylate transporter), member 3, ATP1B1  -  atpase, na+/k+ transporting, beta 1 polypeptide, TANK  -  traf family member-associated nfkb activator, UNG  -  uracil-dna glycosylase, GPI  -  glucose-6-phosphate isomerase, FTH1  -  ferritin, heavy polypeptide 1, TAB2  -  tgf-beta activated kinase 1/map3k7 binding protein 2, CTSL  -  cathepsin l, ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, CTSK  -  cathepsin k, HDAC4  -  histone deacetylase 4, CTSH  -  cathepsin h, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, CTSD  -  cathepsin d, RAB3B  -  rab3b, member ras oncogene family, NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, CFH  -  complement factor h, CFHR1  -  complement factor h-related 1, VCAM1  -  vascular cell adhesion molecule 1, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, PFDN1  -  prefoldin subunit 1, CTSC  -  cathepsin c, TEK  -  tek tyrosine kinase, endothelial, CRIP1  -  cysteine-rich protein 1 (intestinal), MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), DDIT4  -  dna-damage-inducible transcript 4, RAB33A  -  rab33a, member ras oncogene family, LTB  -  lymphotoxin beta (tnf superfamily, member 3), CTSF  -  cathepsin f, RBPJ  -  recombination signal binding protein for immunoglobulin kappa j region, UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, SHH  -  sonic hedgehog, JUN  -  jun proto-oncogene, STAT2  -  signal transducer and activator of transcription 2, 113kda, STAT1  -  signal transducer and activator of transcription 1, 91kda, PROS1  -  protein s (alpha), ST6GAL1  -  st6 beta-galactosamide alpha-2,6-sialyltranferase 1, TNFSF4  -  tumor necrosis factor (ligand) superfamily, member 4, ISG15  -  isg15 ubiquitin-like modifier, CD14  -  cd14 molecule, NDRG1  -  n-myc downstream regulated 1, TYRO3  -  tyro3 protein tyrosine kinase, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, CLU  -  clusterin, TNFSF9  -  tumor necrosis factor (ligand) superfamily, member 9, MAP2K1  -  mitogen-activated protein kinase kinase 1, IK  -  ik cytokine, down-regulator of hla ii, MAP2K3  -  mitogen-activated protein kinase kinase 3, MAPK10  -  mitogen-activated protein kinase 10, IGBP1  -  immunoglobulin (cd79a) binding protein 1, DYNC1H1  -  dynein, cytoplasmic 1, heavy chain 1, MAPK7  -  mitogen-activated protein kinase 7, CBLB  -  cbl proto-oncogene b, e3 ubiquitin protein ligase, IGF1R  -  insulin-like growth factor 1 receptor, SRPK2  -  srsf protein kinase 2, TGFB1  -  transforming growth factor, beta 1, SERPINB9  -  serpin peptidase inhibitor, clade b (ovalbumin), member 9, DNM2  -  dynamin 2, MAPK3  -  mitogen-activated protein kinase 3, TNFRSF14  -  tumor necrosis factor receptor superfamily, member 14, TRIM21  -  tripartite motif containing 21, RAB32  -  rab32, member ras oncogene family, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, FADD  -  fas (tnfrsf6)-associated via death domain, BCL6  -  b-cell cll/lymphoma 6, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), GBP1  -  guanylate binding protein 1, interferon-inducible, TGFBR3  -  transforming growth factor, beta receptor iii, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, FOS  -  fbj murine osteosarcoma viral oncogene homolog, YES1  -  v-yes-1 yamaguchi sarcoma viral oncogene homolog 1, CXCL1  -  chemokine (c-x-c motif) ligand 1 (melanoma growth stimulating activity, alpha), PRKCG  -  protein kinase c, gamma, SMAD3  -  smad family member 3, PRKCA  -  protein kinase c, alpha, SMAD6  -  smad family member 6, GSK3B  -  glycogen synthase kinase 3 beta, GAS6  -  growth arrest-specific 6]"GO:0030449,regulation of complement activation,3.32E-04,4.02E-02,12.01,8230,25,137,5,"[C9  -  complement component 9, C4A  -  complement component 4a (rodgers blood group), CFH  -  complement factor h, CFB  -  complement factor b, PROS1  -  protein s (alpha)]"GO:0007167,enzyme linked receptor protein signaling pathway,3.44E-04,4.12E-02,1.89,8230,622,301,43,"[RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), PDGFA  -  platelet-derived growth factor alpha polypeptide, TEK  -  tek tyrosine kinase, endothelial, FGFR1  -  fibroblast growth factor receptor 1, UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, FGF7  -  fibroblast growth factor 7, PDPK1  -  3-phosphoinositide dependent protein kinase-1, FGF4  -  fibroblast growth factor 4, GAB2  -  grb2-associated binding protein 2, NCOR2  -  nuclear receptor corepressor 2, RAB14  -  rab14, member ras oncogene family, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, HRAS  -  harvey rat sarcoma viral oncogene homolog, MAP2K1  -  mitogen-activated protein kinase kinase 1, RIT1  -  ras-like without caax 1, ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, FOXC1  -  forkhead box c1, BDKRB2  -  bradykinin receptor b2, EIF4B  -  eukaryotic translation initiation factor 4b, IGF1R  -  insulin-like growth factor 1 receptor, DOK5  -  docking protein 5, MAPK7  -  mitogen-activated protein kinase 7, NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, SOX9  -  sry (sex determining region y)-box 9, TGIF1  -  tgfb-induced factor homeobox 1, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), BAMBI  -  bmp and activin membrane-bound inhibitor, TGFBR3  -  transforming growth factor, beta receptor iii, PARP1  -  poly (adp-ribose) polymerase 1, STAM  -  signal transducing adaptor molecule (sh3 domain and itam motif) 1, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, EFEMP1  -  egf containing fibulin-like extracellular matrix protein 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, SMAD6  -  smad family member 6, GSK3B  -  glycogen synthase kinase 3 beta, GAS6  -  growth arrest-specific 6, HDAC1  -  histone deacetylase 1, PIGR  -  polymeric immunoglobulin receptor, ITSN1  -  intersectin 1 (sh3 domain protein), BMP4  -  bone morphogenetic protein 4, PTPRF  -  protein tyrosine phosphatase, receptor type, f]"GO:0044764,multi-organism cellular process,3.49E-04,4.14E-02,1.53,8230,502,888,83,"[IFIT1  -  interferon-induced protein with tetratricopeptide repeats 1, BNIP3  -  bcl2/adenovirus e1b 19kda interacting protein 3, NCBP2  -  nuclear cap binding protein subunit 2, 20kda, RPL23A  -  ribosomal protein l23a, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, AP1G1  -  adaptor-related protein complex 1, gamma 1 subunit, RPL18A  -  ribosomal protein l18a, RPL15  -  ribosomal protein l15, RPL12  -  ribosomal protein l12, NUPL2  -  nucleoporin like 2, DDB1  -  damage-specific dna binding protein 1, 127kda, RPL5  -  ribosomal protein l5, GTF2H1  -  general transcription factor iih, polypeptide 1, 62kda, SUPT5H  -  suppressor of ty 5 homolog (s. cerevisiae), EIF4G3  -  eukaryotic translation initiation factor 4 gamma, 3, RPL4  -  ribosomal protein l4, UNG  -  uracil-dna glycosylase, PSMA1  -  proteasome (prosome, macropain) subunit, alpha type, 1, PVR  -  poliovirus receptor, PACS2  -  phosphofurin acidic cluster sorting protein 2, FBLN1  -  fibulin 1, MMP1  -  matrix metallopeptidase 1 (interstitial collagenase), EIF4A2  -  eukaryotic translation initiation factor 4a2, NFX1  -  nuclear transcription factor, x-box binding 1, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, TRAM1  -  translocation associated membrane protein 1, PSMB9  -  proteasome (prosome, macropain) subunit, beta type, 9, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, ARF1  -  adp-ribosylation factor 1, FURIN  -  furin (paired basic amino acid cleaving enzyme), ATP6V0C  -  atpase, h+ transporting, lysosomal 16kda, v0 subunit c, PSMB4  -  proteasome (prosome, macropain) subunit, beta type, 4, NACA  -  nascent polypeptide-associated complex alpha subunit, VCAM1  -  vascular cell adhesion molecule 1, EIF4G1  -  eukaryotic translation initiation factor 4 gamma, 1, CREB1  -  camp responsive element binding protein 1, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, IL6ST  -  interleukin 6 signal transducer (gp130, oncostatin m receptor), VDAC1  -  voltage-dependent anion channel 1, RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), ITGA5  -  integrin, alpha 5 (fibronectin receptor, alpha polypeptide), PSMD11  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 11, UBR4  -  ubiquitin protein ligase e3 component n-recognin 4, KRT19  -  keratin 19, TAF11  -  taf11 rna polymerase ii, tata box binding protein (tbp)-associated factor, 28kda, PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), C9  -  complement component 9, RAN  -  ran, member ras oncogene family, PPIA  -  peptidylprolyl isomerase a (cyclophilin a), STAT2  -  signal transducer and activator of transcription 2, 113kda, STAT1  -  signal transducer and activator of transcription 1, 91kda, RPL14  -  ribosomal protein l14, STAT3  -  signal transducer and activator of transcription 3 (acute-phase response factor), PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, GBF1  -  golgi brefeldin a resistant guanine nucleotide exchange factor 1, SSRP1  -  structure specific recognition protein 1, ISG15  -  isg15 ubiquitin-like modifier, PSIP1  -  pc4 and sfrs1 interacting protein 1, KRT7  -  keratin 7, RPS13  -  ribosomal protein s13, EFNB2  -  ephrin-b2, TAP1  -  transporter 1, atp-binding cassette, sub-family b (mdr/tap), KRT18  -  keratin 18, TGFB1  -  transforming growth factor, beta 1, ZYX  -  zyxin, TNFRSF14  -  tumor necrosis factor receptor superfamily, member 14, HNRNPA1  -  heterogeneous nuclear ribonucleoprotein a1, MAPK3  -  mitogen-activated protein kinase 3, GNB2L1  -  guanine nucleotide binding protein (g protein), beta polypeptide 2-like 1, DAG1  -  dystroglycan 1 (dystrophin-associated glycoprotein 1), FADD  -  fas (tnfrsf6)-associated via death domain, SND1  -  staphylococcal nuclease and tudor domain containing 1, RPL23  -  ribosomal protein l23, SLC25A6  -  solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6, SLC25A4  -  solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4, NUP153  -  nucleoporin 153kda, SMAD3  -  smad family member 3, GAS6  -  growth arrest-specific 6, HDAC1  -  histone deacetylase 1, FBXL2  -  f-box and leucine-rich repeat protein 2, POLR2B  -  polymerase (rna) ii (dna directed) polypeptide b, 140kda]"GO:0031324,negative regulation of cellular metabolic process,3.50E-04,4.10E-02,1.34,8230,1133,892,164,"[YAF2  -  yy1 associated factor 2, FMR1  -  fragile x mental retardation 1, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, NCK1  -  nck adaptor protein 1, PAWR  -  prkc, apoptosis, wt1, regulator, HEXIM1  -  hexamethylene bis-acetamide inducible 1, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), TSC22D4  -  tsc22 domain family, member 4, IQGAP1  -  iq motif containing gtpase activating protein 1, NCOR2  -  nuclear receptor corepressor 2, PSMA1  -  proteasome (prosome, macropain) subunit, alpha type, 1, FOXO1  -  forkhead box o1, ENO1  -  enolase 1, (alpha), MSH6  -  muts homolog 6 (e. coli), SIN3B  -  sin3 transcription regulator family member b, PIAS1  -  protein inhibitor of activated stat, 1, FOXC1  -  forkhead box c1, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, PSMB9  -  proteasome (prosome, macropain) subunit, beta type, 9, SOX9  -  sry (sex determining region y)-box 9, SOX4  -  sry (sex determining region y)-box 4, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, FOXF2  -  forkhead box f2, UBR2  -  ubiquitin protein ligase e3 component n-recognin 2, NAB1  -  ngfi-a binding protein 1 (egr1 binding protein 1), FURIN  -  furin (paired basic amino acid cleaving enzyme), NACA  -  nascent polypeptide-associated complex alpha subunit, PSMB4  -  proteasome (prosome, macropain) subunit, beta type, 4, TDG  -  thymine-dna glycosylase, APOE  -  apolipoprotein e, RGS3  -  regulator of g-protein signaling 3, CREB1  -  camp responsive element binding protein 1, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, BMP4  -  bone morphogenetic protein 4, SNTA1  -  syntrophin, alpha 1, PDGFA  -  platelet-derived growth factor alpha polypeptide, PSMD11  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 11, PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), FGFR1  -  fibroblast growth factor receptor 1, GADD45B  -  growth arrest and dna-damage-inducible, beta, PTBP1  -  polypyrimidine tract binding protein 1, ATXN1  -  ataxin 1, BCLAF1  -  bcl2-associated transcription factor 1, MECP2  -  methyl cpg binding protein 2 (rett syndrome), ADAR  -  adenosine deaminase, rna-specific, FGF2  -  fibroblast growth factor 2 (basic), MEF2A  -  myocyte enhancer factor 2a, PDPK1  -  3-phosphoinositide dependent protein kinase-1, SAMD4A  -  sterile alpha motif domain containing 4a, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, MED1  -  mediator complex subunit 1, RNF2  -  ring finger protein 2, EIF2B4  -  eukaryotic translation initiation factor 2b, subunit 4 delta, 67kda, CNR1  -  cannabinoid receptor 1 (brain), CEBPB  -  ccaat/enhancer binding protein (c/ebp), beta, TBX2  -  t-box 2, ZHX3  -  zinc fingers and homeoboxes 3, EIF4E2  -  eukaryotic translation initiation factor 4e family member 2, NPR3  -  natriuretic peptide receptor c/guanylate cyclase c (atrionatriuretic peptide receptor c), DAG1  -  dystroglycan 1 (dystrophin-associated glycoprotein 1), CDKN1C  -  cyclin-dependent kinase inhibitor 1c (p57, kip2), KAT8  -  k(lysine) acetyltransferase 8, CDKN2D  -  cyclin-dependent kinase inhibitor 2d (p19, inhibits cdk4), SMARCA2  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, DAPK1  -  death-associated protein kinase 1, MAPK8IP1  -  mitogen-activated protein kinase 8 interacting protein 1, PARP1  -  poly (adp-ribose) polymerase 1, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), LRPPRC  -  leucine-rich pentatricopeptide repeat containing, EDNRA  -  endothelin receptor type a, TAOK3  -  tao kinase 3, FZR1  -  fizzy/cell division cycle 20 related 1 (drosophila), PPAP2B  -  phosphatidic acid phosphatase type 2b, EIF3E  -  eukaryotic translation initiation factor 3, subunit e, MBD2  -  methyl-cpg binding domain protein 2, HDAC1  -  histone deacetylase 1, PKIG  -  protein kinase (camp-dependent, catalytic) inhibitor gamma, SALL2  -  sal-like 2 (drosophila), TRAP1  -  tnf receptor-associated protein 1, AKR1C3  -  aldo-keto reductase family 1, member c3, PURA  -  purine-rich element binding protein a, TIMP3  -  timp metallopeptidase inhibitor 3, IFI16  -  interferon, gamma-inducible protein 16, STRN3  -  striatin, calmodulin binding protein 3, TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), SIK1  -  salt-inducible kinase 1, SMC3  -  structural maintenance of chromosomes 3, TLE2  -  transducin-like enhancer of split 2 (e(sp1) homolog, drosophila), BAHD1  -  bromo adjacent homology domain containing 1, ZHX2  -  zinc fingers and homeoboxes 2, TLE4  -  transducin-like enhancer of split 4 (e(sp1) homolog, drosophila), SUPT5H  -  suppressor of ty 5 homolog (s. cerevisiae), ZFHX3  -  zinc finger homeobox 3, ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, HDAC4  -  histone deacetylase 4, NFX1  -  nuclear transcription factor, x-box binding 1, ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, NFIX  -  nuclear factor i/x (ccaat-binding transcription factor), WWP2  -  ww domain containing e3 ubiquitin protein ligase 2, WNT5A  -  wingless-type mmtv integration site family, member 5a, AHR  -  aryl hydrocarbon receptor, PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, EZH2  -  enhancer of zeste homolog 2 (drosophila), TSC22D3  -  tsc22 domain family, member 3, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, HIVEP1  -  human immunodeficiency virus type i enhancer binding protein 1, ERF  -  ets2 repressor factor, SUZ12  -  suz12 polycomb repressive complex 2 subunit, MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), DDIT4  -  dna-damage-inducible transcript 4, ST13  -  suppression of tumorigenicity 13 (colon carcinoma) (hsp70 interacting protein), RBPJ  -  recombination signal binding protein for immunoglobulin kappa j region, UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, SHH  -  sonic hedgehog, CRY1  -  cryptochrome 1 (photolyase-like), JUN  -  jun proto-oncogene, STAT1  -  signal transducer and activator of transcription 1, 91kda, EED  -  embryonic ectoderm development, PABPC1  -  poly(a) binding protein, cytoplasmic 1, SLIT2  -  slit homolog 2 (drosophila), STAT3  -  signal transducer and activator of transcription 3 (acute-phase response factor), TERF1  -  telomeric repeat binding factor (nima-interacting) 1, PRNP  -  prion protein, CRYAB  -  crystallin, alpha b, PLAT  -  plasminogen activator, tissue, TNFSF4  -  tumor necrosis factor (ligand) superfamily, member 4, FXR1  -  fragile x mental retardation, autosomal homolog 1, ISG15  -  isg15 ubiquitin-like modifier, NR2F1  -  nuclear receptor subfamily 2, group f, member 1, RPS13  -  ribosomal protein s13, NF2  -  neurofibromin 2 (merlin), ATR  -  ataxia telangiectasia and rad3 related, IGBP1  -  immunoglobulin (cd79a) binding protein 1, SFRP1  -  secreted frizzled-related protein 1, BDKRB2  -  bradykinin receptor b2, SMARCA5  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5, SERPINE2  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 2, MAPK7  -  mitogen-activated protein kinase 7, IGF1R  -  insulin-like growth factor 1 receptor, TGFB1  -  transforming growth factor, beta 1, UCHL1  -  ubiquitin carboxyl-terminal esterase l1 (ubiquitin thiolesterase), UBTF  -  upstream binding transcription factor, rna polymerase i, MVP  -  major vault protein, SMAD2  -  smad family member 2, GNB2L1  -  guanine nucleotide binding protein (g protein), beta polypeptide 2-like 1, TRIM21  -  tripartite motif containing 21, TGIF1  -  tgfb-induced factor homeobox 1, BCL6  -  b-cell cll/lymphoma 6, COPS2  -  cop9 signalosome subunit 2, TSPYL2  -  tspy-like 2, PHB2  -  prohibitin 2, DMD  -  dystrophin, PRKCG  -  protein kinase c, gamma, KAT6B  -  k(lysine) acetyltransferase 6b, SMAD3  -  smad family member 3, NBAS  -  neuroblastoma amplified sequence, PRKCA  -  protein kinase c, alpha, SMAD6  -  smad family member 6, GSK3B  -  glycogen synthase kinase 3 beta, CCND1  -  cyclin d1, NR1D2  -  nuclear receptor subfamily 1, group d, member 2, GAS6  -  growth arrest-specific 6, MAF  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog]"GO:0009117,nucleotide metabolic process,3.57E-04,4.14E-02,1.82,8230,328,634,46,"[MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), RAB33A  -  rab33a, member ras oncogene family, NADK  -  nad kinase, PAICS  -  phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase, RFK  -  riboflavin kinase, PRPS1  -  phosphoribosyl pyrophosphate synthetase 1, RAB9A  -  rab9a, member ras oncogene family, PDE5A  -  phosphodiesterase 5a, cgmp-specific, MYH10  -  myosin, heavy chain 10, non-muscle, GPX1  -  glutathione peroxidase 1, TKT  -  transketolase, PGD  -  phosphogluconate dehydrogenase, TBPL1  -  tbp-like 1, SEPT5  -  septin 5, NME4  -  nme/nm23 nucleoside diphosphate kinase 4, RHOB  -  ras homolog family member b, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, RAB14  -  rab14, member ras oncogene family, ADA  -  adenosine deaminase, GTF2H1  -  general transcription factor iih, polypeptide 1, 62kda, DDX17  -  dead (asp-glu-ala-asp) box helicase 17, CTPS1  -  ctp synthase 1, FDXR  -  ferredoxin reductase, HRAS  -  harvey rat sarcoma viral oncogene homolog, RPE  -  ribulose-5-phosphate-3-epimerase, MSH6  -  muts homolog 6 (e. coli), RHOG  -  ras homolog family member g, PEX6  -  peroxisomal biogenesis factor 6, RIT1  -  ras-like without caax 1, AK2  -  adenylate kinase 2, SMARCA5  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5, TGFB1  -  transforming growth factor, beta 1, RAB2A  -  rab2a, member ras oncogene family, CAT  -  catalase, SULT2B1  -  sulfotransferase family, cytosolic, 2b, member 1, ATP6V1B1  -  atpase, h+ transporting, lysosomal 56/58kda, v1 subunit b1, SMARCA2  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, RBBP4  -  retinoblastoma binding protein 4, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, TDG  -  thymine-dna glycosylase, ADM  -  adrenomedullin, TNNT3  -  troponin t type 3 (skeletal, fast), MPG  -  n-methylpurine-dna glycosylase, IDH3B  -  isocitrate dehydrogenase 3 (nad+) beta, RAB7L1  -  rab7, member ras oncogene family-like 1, RAB13  -  rab13, member ras oncogene family]"GO:0007599,hemostasis,3.58E-04,4.11E-02,1.88,8230,398,473,43,"[CAPZA2  -  capping protein (actin filament) muscle z-line, alpha 2, PDGFA  -  platelet-derived growth factor alpha polypeptide, TEK  -  tek tyrosine kinase, endothelial, ACTN1  -  actinin, alpha 1, ATP2B1  -  atpase, ca++ transporting, plasma membrane 1, PPIA  -  peptidylprolyl isomerase a (cyclophilin a), PDE5A  -  phosphodiesterase 5a, cgmp-specific, SHH  -  sonic hedgehog, SLC7A8  -  solute carrier family 7 (amino acid transporter light chain, l system), member 8, PROS1  -  protein s (alpha), ITGA3  -  integrin, alpha 3 (antigen cd49c, alpha 3 subunit of vla-3 receptor), SLC16A3  -  solute carrier family 16 (monocarboxylate transporter), member 3, RHOB  -  ras homolog family member b, PDPK1  -  3-phosphoinositide dependent protein kinase-1, PLAT  -  plasminogen activator, tissue, FLNA  -  filamin a, alpha, PTGIR  -  prostaglandin i2 (prostacyclin) receptor (ip), JAK2  -  janus kinase 2, PRCP  -  prolylcarboxypeptidase (angiotensinase c), CLU  -  clusterin, GPI  -  glucose-6-phosphate isomerase, HRAS  -  harvey rat sarcoma viral oncogene homolog, KCNMB1  -  potassium large conductance calcium-activated channel, subfamily m, beta member 1, RHOG  -  ras homolog family member g, CAP1  -  cap, adenylate cyclase-associated protein 1 (yeast), TUBA4A  -  tubulin, alpha 4a, MGLL  -  monoglyceride lipase, IGF2  -  insulin-like growth factor 2 (somatomedin a), VEGFC  -  vascular endothelial growth factor c, WEE1  -  wee1 homolog (s. pombe), TGFB1  -  transforming growth factor, beta 1, PRKG1  -  protein kinase, cgmp-dependent, type i, PTPN1  -  protein tyrosine phosphatase, non-receptor type 1, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, YES1  -  v-yes-1 yamaguchi sarcoma viral oncogene homolog 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, APP  -  amyloid beta (a4) precursor protein, PRKCA  -  protein kinase c, alpha, GAS6  -  growth arrest-specific 6, HDAC1  -  histone deacetylase 1, ITGA6  -  integrin, alpha 6, SERPINF2  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 2]"GO:0021682,nerve maturation,3.65E-04,4.14E-02,"2,743.33",8230,1,3,1,[DAG1  -  dystroglycan 1 (dystrophin-associated glycoprotein 1)]GO:0023057,negative regulation of signaling,3.69E-04,4.16E-02,1.52,8230,633,745,87,"[PAWR  -  prkc, apoptosis, wt1, regulator, STRN3  -  striatin, calmodulin binding protein 3, CDH2  -  cadherin 2, type 1, n-cadherin (neuronal), MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), TLE2  -  transducin-like enhancer of split 2 (e(sp1) homolog, drosophila), CDC34  -  cell division cycle 34, GPC1  -  glypican 1, SPG20  -  spastic paraplegia 20 (troyer syndrome), AGT  -  angiotensinogen (serpin peptidase inhibitor, clade a, member 8), FOXO1  -  forkhead box o1, RGS5  -  regulator of g-protein signaling 5, NBL1  -  neuroblastoma 1, dan family bmp antagonist, LPXN  -  leupaxin, HMGXB4  -  hmg box domain containing 4, NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, SOX9  -  sry (sex determining region y)-box 9, UBR2  -  ubiquitin protein ligase e3 component n-recognin 2, ARF1  -  adp-ribosylation factor 1, WNT5A  -  wingless-type mmtv integration site family, member 5a, STK3  -  serine/threonine kinase 3, RGS7  -  regulator of g-protein signaling 7, PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, APOE  -  apolipoprotein e, SOD2  -  superoxide dismutase 2, mitochondrial, EZH2  -  enhancer of zeste homolog 2 (drosophila), RGS3  -  regulator of g-protein signaling 3, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, WWOX  -  ww domain containing oxidoreductase, IL6ST  -  interleukin 6 signal transducer (gp130, oncostatin m receptor), LMNA  -  lamin a/c, RGS16  -  regulator of g-protein signaling 16, BMP4  -  bone morphogenetic protein 4, SNX13  -  sorting nexin 13, DGKZ  -  diacylglycerol kinase, zeta, SHH  -  sonic hedgehog, ATXN1  -  ataxin 1, STAT1  -  signal transducer and activator of transcription 1, 91kda, ROR2  -  receptor tyrosine kinase-like orphan receptor 2, PPM1B  -  protein phosphatase, mg2+/mn2+ dependent, 1b, GPX1  -  glutathione peroxidase 1, PRNP  -  prion protein, NFE2L2  -  nuclear factor (erythroid-derived 2)-like 2, PDPK1  -  3-phosphoinositide dependent protein kinase-1, EGFR  -  epidermal growth factor receptor, PTGIR  -  prostaglandin i2 (prostacyclin) receptor (ip), DLC1  -  deleted in liver cancer 1, ADA  -  adenosine deaminase, TYRO3  -  tyro3 protein tyrosine kinase, CLU  -  clusterin, NF2  -  neurofibromin 2 (merlin), IGBP1  -  immunoglobulin (cd79a) binding protein 1, MGLL  -  monoglyceride lipase, BDKRB2  -  bradykinin receptor b2, IGF1R  -  insulin-like growth factor 1 receptor, CBLB  -  cbl proto-oncogene b, e3 ubiquitin protein ligase, MAPK7  -  mitogen-activated protein kinase 7, SERPINE2  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 2, TGFB1  -  transforming growth factor, beta 1, UCHL1  -  ubiquitin carboxyl-terminal esterase l1 (ubiquitin thiolesterase), TGFB1I1  -  transforming growth factor beta 1 induced transcript 1, MVP  -  major vault protein, SMAD2  -  smad family member 2, DAG1  -  dystroglycan 1 (dystrophin-associated glycoprotein 1), CAV2  -  caveolin 2, TGIF1  -  tgfb-induced factor homeobox 1, BCL6  -  b-cell cll/lymphoma 6, CDKN2D  -  cyclin-dependent kinase inhibitor 2d (p19, inhibits cdk4), TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), BAMBI  -  bmp and activin membrane-bound inhibitor, DAPK1  -  death-associated protein kinase 1, TGFBR3  -  transforming growth factor, beta receptor iii, PTPN1  -  protein tyrosine phosphatase, non-receptor type 1, MAPK8IP1  -  mitogen-activated protein kinase 8 interacting protein 1, PHB2  -  prohibitin 2, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), STAM  -  signal transducing adaptor molecule (sh3 domain and itam motif) 1, PRKCA  -  protein kinase c, alpha, SMAD3  -  smad family member 3, GSK3B  -  glycogen synthase kinase 3 beta, CCND1  -  cyclin d1, SMAD6  -  smad family member 6, GAS6  -  growth arrest-specific 6, HDAC1  -  histone deacetylase 1, ITGA6  -  integrin, alpha 6, GAS1  -  growth arrest-specific 1, TPT1  -  tumor protein, translationally-controlled 1]"GO:0033993,response to lipid,3.73E-04,4.16E-02,1.52,8230,481,944,84,"[AKR1C3  -  aldo-keto reductase family 1, member c3, STRN3  -  striatin, calmodulin binding protein 3, HNRNPA0  -  heterogeneous nuclear ribonucleoprotein a0, ABCA1  -  atp-binding cassette, sub-family a (abc1), member 1, TICAM1  -  toll-like receptor adaptor molecule 1, INHBA  -  inhibin, beta a, RNF14  -  ring finger protein 14, GCH1  -  gtp cyclohydrolase 1, IL4R  -  interleukin 4 receptor, CTSH  -  cathepsin h, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, NGF  -  nerve growth factor (beta polypeptide), NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, SOX9  -  sry (sex determining region y)-box 9, ACR  -  acrosin, WNT5A  -  wingless-type mmtv integration site family, member 5a, BID  -  bh3 interacting domain death agonist, TXNIP  -  thioredoxin interacting protein, GHR  -  growth hormone receptor, SOD2  -  superoxide dismutase 2, mitochondrial, APOE  -  apolipoprotein e, VCAM1  -  vascular cell adhesion molecule 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, ASH2L  -  ash2 (absent, small, or homeotic)-like (drosophila), TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, BMP4  -  bone morphogenetic protein 4, AQP1  -  aquaporin 1 (colton blood group), TNFRSF11B  -  tumor necrosis factor receptor superfamily, member 11b, PDGFA  -  platelet-derived growth factor alpha polypeptide, TEK  -  tek tyrosine kinase, endothelial, ICAM1  -  intercellular adhesion molecule 1, KRT19  -  keratin 19, FOSL1  -  fos-like antigen 1, JUN  -  jun proto-oncogene, MDK  -  midkine (neurite growth-promoting factor 2), GNG12  -  guanine nucleotide binding protein (g protein), gamma 12, STAT1  -  signal transducer and activator of transcription 1, 91kda, LITAF  -  lipopolysaccharide-induced tnf factor, STAT3  -  signal transducer and activator of transcription 3 (acute-phase response factor), SLIT2  -  slit homolog 2 (drosophila), GPX1  -  glutathione peroxidase 1, PTGDS  -  prostaglandin d2 synthase 21kda (brain), ARNT2  -  aryl-hydrocarbon receptor nuclear translocator 2, CRYAB  -  crystallin, alpha b, PTGER1  -  prostaglandin e receptor 1 (subtype ep1), 42kda, PLAT  -  plasminogen activator, tissue, EGFR  -  epidermal growth factor receptor, TNFSF4  -  tumor necrosis factor (ligand) superfamily, member 4, CD14  -  cd14 molecule, FZD7  -  frizzled family receptor 7, PDK3  -  pyruvate dehydrogenase kinase, isozyme 3, PTGIR  -  prostaglandin i2 (prostacyclin) receptor (ip), JAK2  -  janus kinase 2, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, MED1  -  mediator complex subunit 1, CNR1  -  cannabinoid receptor 1 (brain), SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, CEBPB  -  ccaat/enhancer binding protein (c/ebp), beta, PTGES  -  prostaglandin e synthase, MAP2K1  -  mitogen-activated protein kinase kinase 1, TWF2  -  twinfilin actin-binding protein 2, SFRP1  -  secreted frizzled-related protein 1, ADD1  -  adducin 1 (alpha), TGFB1  -  transforming growth factor, beta 1, SERPINB9  -  serpin peptidase inhibitor, clade b (ovalbumin), member 9, OGT  -  o-linked n-acetylglucosamine (glcnac) transferase, GNB1  -  guanine nucleotide binding protein (g protein), beta polypeptide 1, MAPK3  -  mitogen-activated protein kinase 3, SMAD2  -  smad family member 2, ADH5  -  alcohol dehydrogenase 5 (class iii), chi polypeptide, ASS1  -  argininosuccinate synthase 1, CDKN2D  -  cyclin-dependent kinase inhibitor 2d (p19, inhibits cdk4), TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), LY96  -  lymphocyte antigen 96, TGFBR3  -  transforming growth factor, beta receptor iii, FOSL2  -  fos-like antigen 2, FOSB  -  fbj murine osteosarcoma viral oncogene homolog b, FOS  -  fbj murine osteosarcoma viral oncogene homolog, EDNRA  -  endothelin receptor type a, THBD  -  thrombomodulin, ADM  -  adrenomedullin, CCND1  -  cyclin d1, SMAD6  -  smad family member 6, IRAK1  -  interleukin-1 receptor-associated kinase 1]"GO:0050678,regulation of epithelial cell proliferation,3.82E-04,4.22E-02,2.13,8230,193,600,30,"[TEK  -  tek tyrosine kinase, endothelial, SHH  -  sonic hedgehog, JUN  -  jun proto-oncogene, STAT1  -  signal transducer and activator of transcription 1, 91kda, GPX1  -  glutathione peroxidase 1, FGF7  -  fibroblast growth factor 7, EGFR  -  epidermal growth factor receptor, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, FZD7  -  frizzled family receptor 7, MED1  -  mediator complex subunit 1, EFNB2  -  ephrin-b2, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, HRAS  -  harvey rat sarcoma viral oncogene homolog, VEGFC  -  vascular endothelial growth factor c, TGFB1  -  transforming growth factor, beta 1, SOX9  -  sry (sex determining region y)-box 9, CDKN1C  -  cyclin-dependent kinase inhibitor 1c (p57, kip2), CAV2  -  caveolin 2, WNT5A  -  wingless-type mmtv integration site family, member 5a, TGFBR3  -  transforming growth factor, beta receptor iii, PHB2  -  prohibitin 2, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), KRIT1  -  krit1, ankyrin repeat containing, APOE  -  apolipoprotein e, BMPR1A  -  bone morphogenetic protein receptor, type ia, CDH13  -  cadherin 13, h-cadherin (heart), PRKCA  -  protein kinase c, alpha, BMP4  -  bone morphogenetic protein 4, GAS1  -  growth arrest-specific 1, LAMB1  -  laminin, beta 1]"GO:0010464,regulation of mesenchymal cell proliferation,3.95E-04,4.32E-02,4.99,8230,36,412,9,"[PDGFA  -  platelet-derived growth factor alpha polypeptide, FGFR1  -  fibroblast growth factor receptor 1, SHH  -  sonic hedgehog, SOX9  -  sry (sex determining region y)-box 9, STAT1  -  signal transducer and activator of transcription 1, 91kda, BMP4  -  bone morphogenetic protein 4, GAS1  -  growth arrest-specific 1, WNT5A  -  wingless-type mmtv integration site family, member 5a, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda)]"GO:0007165,signal transduction,3.97E-04,4.29E-02,1.19,8230,2813,860,349,"[BNIP3  -  bcl2/adenovirus e1b 19kda interacting protein 3, SH3BP1  -  sh3-domain binding protein 1, NDN  -  necdin, melanoma antigen (mage) family member, NCK1  -  nck adaptor protein 1, ABCA1  -  atp-binding cassette, sub-family a (abc1), member 1, TICAM1  -  toll-like receptor adaptor molecule 1, GEM  -  gtp binding protein overexpressed in skeletal muscle, SPN  -  sialophorin, NCOR2  -  nuclear receptor corepressor 2, IQGAP1  -  iq motif containing gtpase activating protein 1, EPAS1  -  endothelial pas domain protein 1, RNF14  -  ring finger protein 14, ATF6  -  activating transcription factor 6, HRAS  -  harvey rat sarcoma viral oncogene homolog, NBN  -  nibrin, TRAF4  -  tnf receptor-associated factor 4, RIT1  -  ras-like without caax 1, ASIC2  -  acid-sensing (proton-gated) ion channel 2, CDC42EP4  -  cdc42 effector protein (rho gtpase binding) 4, MYO9B  -  myosin ixb, MYO10  -  myosin x, EIF4A2  -  eukaryotic translation initiation factor 4a2, EIF4B  -  eukaryotic translation initiation factor 4b, SOX9  -  sry (sex determining region y)-box 9, PPP1R12B  -  protein phosphatase 1, regulatory subunit 12b, PLP2  -  proteolipid protein 2 (colonic epithelium-enriched), SOX4  -  sry (sex determining region y)-box 4, TNK2  -  tyrosine kinase, non-receptor, 2, PIKFYVE  -  phosphoinositide kinase, fyve finger containing, EIF2S1  -  eukaryotic translation initiation factor 2, subunit 1 alpha, 35kda, BID  -  bh3 interacting domain death agonist, RGS7  -  regulator of g-protein signaling 7, PLCB2  -  phospholipase c, beta 2, PLAUR  -  plasminogen activator, urokinase receptor, GJA1  -  gap junction protein, alpha 1, 43kda, SOD2  -  superoxide dismutase 2, mitochondrial, BMPR1A  -  bone morphogenetic protein receptor, type ia, EIF4G1  -  eukaryotic translation initiation factor 4 gamma, 1, CREB1  -  camp responsive element binding protein 1, LMNA  -  lamin a/c, BMP4  -  bone morphogenetic protein 4, ICAM1  -  intercellular adhesion molecule 1, STK38L  -  serine/threonine kinase 38 like, LITAF  -  lipopolysaccharide-induced tnf factor, PPM1B  -  protein phosphatase, mg2+/mn2+ dependent, 1b, ADAR  -  adenosine deaminase, rna-specific, EGFR  -  epidermal growth factor receptor, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, FZD7  -  frizzled family receptor 7, HTR7  -  5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled, MED1  -  mediator complex subunit 1, CNR1  -  cannabinoid receptor 1 (brain), EFNB2  -  ephrin-b2, EFNB1  -  ephrin-b1, PTGES  -  prostaglandin e synthase, AMOTL2  -  angiomotin like 2, KRT18  -  keratin 18, SH3BP5  -  sh3-domain binding protein 5 (btk-associated), ROCK1  -  rho-associated, coiled-coil containing protein kinase 1, ARPC2  -  actin related protein 2/3 complex, subunit 2, 34kda, ADD1  -  adducin 1 (alpha), EIF4E2  -  eukaryotic translation initiation factor 4e family member 2, GNB1  -  guanine nucleotide binding protein (g protein), beta polypeptide 1, LY96  -  lymphocyte antigen 96, PARP1  -  poly (adp-ribose) polymerase 1, ADM  -  adrenomedullin, TRAF2  -  tnf receptor-associated factor 2, LAMA5  -  laminin, alpha 5, EFS  -  embryonal fyn-associated substrate, RAB7L1  -  rab7, member ras oncogene family-like 1, OPTN  -  optineurin, AKR1C3  -  aldo-keto reductase family 1, member c3, OSTF1  -  osteoclast stimulating factor 1, PDE5A  -  phosphodiesterase 5a, cgmp-specific, PPP4R1  -  protein phosphatase 4, regulatory subunit 1, CAMK2G  -  calcium/calmodulin-dependent protein kinase ii gamma, SIK1  -  salt-inducible kinase 1, CAMK2B  -  calcium/calmodulin-dependent protein kinase ii beta, NUPL2  -  nucleoporin like 2, HOMER3  -  homer homolog 3 (drosophila), AGT  -  angiotensinogen (serpin peptidase inhibitor, clade a, member 8), EIF4G3  -  eukaryotic translation initiation factor 4 gamma, 3, TANK  -  traf family member-associated nfkb activator, PPP5C  -  protein phosphatase 5, catalytic subunit, MAP4K4  -  mitogen-activated protein kinase kinase kinase kinase 4, TAB2  -  tgf-beta activated kinase 1/map3k7 binding protein 2, LPXN  -  leupaxin, CTSL  -  cathepsin l, CTSK  -  cathepsin k, HMGXB4  -  hmg box domain containing 4, CAP1  -  cap, adenylate cyclase-associated protein 1 (yeast), CTSH  -  cathepsin h, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, VEGFC  -  vascular endothelial growth factor c, PLXND1  -  plexin d1, DDR1  -  discoidin domain receptor tyrosine kinase 1, AHR  -  aryl hydrocarbon receptor, STK3  -  serine/threonine kinase 3, PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, VCAM1  -  vascular cell adhesion molecule 1, ARHGAP29  -  rho gtpase activating protein 29, CRIP1  -  cysteine-rich protein 1 (intestinal), MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), TRADD  -  tnfrsf1a-associated via death domain, CRKL  -  v-crk avian sarcoma virus ct10 oncogene homolog-like, RAB33A  -  rab33a, member ras oncogene family, RASSF7  -  ras association (ralgds/af-6) domain family (n-terminal) member 7, RAB9A  -  rab9a, member ras oncogene family, JUN  -  jun proto-oncogene, CRY1  -  cryptochrome 1 (photolyase-like), STAT2  -  signal transducer and activator of transcription 2, 113kda, UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, CTNNAL1  -  catenin (cadherin-associated protein), alpha-like 1, STAT1  -  signal transducer and activator of transcription 1, 91kda, STAT4  -  signal transducer and activator of transcription 4, STAT3  -  signal transducer and activator of transcription 3 (acute-phase response factor), CRYAB  -  crystallin, alpha b, TNFSF4  -  tumor necrosis factor (ligand) superfamily, member 4, CD14  -  cd14 molecule, OXSR1  -  oxidative stress responsive 1, JAK2  -  janus kinase 2, NDRG1  -  n-myc downstream regulated 1, DLC1  -  deleted in liver cancer 1, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, TYRO3  -  tyro3 protein tyrosine kinase, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, TNFSF9  -  tumor necrosis factor (ligand) superfamily, member 9, MAP2K1  -  mitogen-activated protein kinase kinase 1, MAP2K3  -  mitogen-activated protein kinase kinase 3, TXNRD1  -  thioredoxin reductase 1, TRIP10  -  thyroid hormone receptor interactor 10, MAPK10  -  mitogen-activated protein kinase 10, CBLB  -  cbl proto-oncogene b, e3 ubiquitin protein ligase, MAPK7  -  mitogen-activated protein kinase 7, SRPK2  -  srsf protein kinase 2, MVP  -  major vault protein, TNFRSF14  -  tumor necrosis factor receptor superfamily, member 14, MAPK3  -  mitogen-activated protein kinase 3, PLCE1  -  phospholipase c, epsilon 1, ASIC3  -  acid-sensing (proton-gated) ion channel 3, RAB32  -  rab32, member ras oncogene family, PRKG1  -  protein kinase, cgmp-dependent, type i, FADD  -  fas (tnfrsf6)-associated via death domain, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, COPS2  -  cop9 signalosome subunit 2, RYK  -  receptor-like tyrosine kinase, GBP1  -  guanylate binding protein 1, interferon-inducible, BAMBI  -  bmp and activin membrane-bound inhibitor, STAM  -  signal transducing adaptor molecule (sh3 domain and itam motif) 1, KRIT1  -  krit1, ankyrin repeat containing, RBM14  -  rna binding motif protein 14, PRKCG  -  protein kinase c, gamma, CSPG4  -  chondroitin sulfate proteoglycan 4, NUP153  -  nucleoporin 153kda, PRKCA  -  protein kinase c, alpha, RRAD  -  ras-related associated with diabetes, ARIH1  -  ariadne homolog, ubiquitin-conjugating enzyme e2 binding protein, 1 (drosophila), NR1D2  -  nuclear receptor subfamily 1, group d, member 2, NUPR1  -  nuclear protein, transcriptional regulator, 1, GAS6  -  growth arrest-specific 6, RRAS  -  related ras viral (r-ras) oncogene homolog, GSTM2  -  glutathione s-transferase mu 2 (muscle), SECTM1  -  secreted and transmembrane 1, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, PAWR  -  prkc, apoptosis, wt1, regulator, GSN  -  gelsolin, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), DDB1  -  damage-specific dna binding protein 1, 127kda, GAB2  -  grb2-associated binding protein 2, HTRA2  -  htra serine peptidase 2, FLNA  -  filamin a, alpha, CD59  -  cd59 molecule, complement regulatory protein, FLNB  -  filamin b, beta, FARP2  -  ferm, rhogef and pleckstrin domain protein 2, FOXO1  -  forkhead box o1, RGS5  -  regulator of g-protein signaling 5, SEMA3F  -  sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3f, MSH6  -  muts homolog 6 (e. coli), CD97  -  cd97 molecule, PIAS1  -  protein inhibitor of activated stat, 1, IL4R  -  interleukin 4 receptor, FOXC1  -  forkhead box c1, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, DOK5  -  docking protein 5, UBE2L6  -  ubiquitin-conjugating enzyme e2l 6, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, PSMB9  -  proteasome (prosome, macropain) subunit, beta type, 9, RAB22A  -  rab22a, member ras oncogene family, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, IL1R1  -  interleukin 1 receptor, type i, ARF1  -  adp-ribosylation factor 1, FURIN  -  furin (paired basic amino acid cleaving enzyme), PSMB4  -  proteasome (prosome, macropain) subunit, beta type, 4, PDPN  -  podoplanin, CAMK1  -  calcium/calmodulin-dependent protein kinase i, SDC2  -  syndecan 2, APOE  -  apolipoprotein e, COPS3  -  cop9 signalosome subunit 3, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, APP  -  amyloid beta (a4) precursor protein, WWOX  -  ww domain containing oxidoreductase, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, IL6ST  -  interleukin 6 signal transducer (gp130, oncostatin m receptor), TNFRSF11B  -  tumor necrosis factor receptor superfamily, member 11b, DGKZ  -  diacylglycerol kinase, zeta, ITGA5  -  integrin, alpha 5 (fibronectin receptor, alpha polypeptide), PDGFA  -  platelet-derived growth factor alpha polypeptide, PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), ITGA7  -  integrin, alpha 7, FGFR1  -  fibroblast growth factor receptor 1, MDK  -  midkine (neurite growth-promoting factor 2), DDR2  -  discoidin domain receptor tyrosine kinase 2, ROR2  -  receptor tyrosine kinase-like orphan receptor 2, MAML1  -  mastermind-like 1 (drosophila), FGF5  -  fibroblast growth factor 5, ITGA3  -  integrin, alpha 3 (antigen cd49c, alpha 3 subunit of vla-3 receptor), PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, ITGA2B  -  integrin, alpha 2b (platelet glycoprotein iib of iib/iiia complex, antigen cd41), PTGER1  -  prostaglandin e receptor 1 (subtype ep1), 42kda, CFL1  -  cofilin 1 (non-muscle), FGF7  -  fibroblast growth factor 7, ITGB5  -  integrin, beta 5, RHOB  -  ras homolog family member b, MEF2A  -  myocyte enhancer factor 2a, RHOC  -  ras homolog family member c, PDPK1  -  3-phosphoinositide dependent protein kinase-1, FGF2  -  fibroblast growth factor 2 (basic), FGF4  -  fibroblast growth factor 4, MKNK1  -  map kinase interacting serine/threonine kinase 1, PTGIR  -  prostaglandin i2 (prostacyclin) receptor (ip), DAP3  -  death associated protein 3, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, ARHGAP1  -  rho gtpase activating protein 1, RHOG  -  ras homolog family member g, PTN  -  pleiotrophin, ZYX  -  zyxin, NPR3  -  natriuretic peptide receptor c/guanylate cyclase c (atrionatriuretic peptide receptor c), DGKA  -  diacylglycerol kinase, alpha 80kda, FCGRT  -  fc fragment of igg, receptor, transporter, alpha, ASPH  -  aspartate beta-hydroxylase, SRGAP2  -  slit-robo rho gtpase activating protein 2, DAPK1  -  death-associated protein kinase 1, PTPN1  -  protein tyrosine phosphatase, non-receptor type 1, TIPARP  -  tcdd-inducible poly(adp-ribose) polymerase, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), ARL6IP5  -  adp-ribosylation-like factor 6 interacting protein 5, PPAP2B  -  phosphatidic acid phosphatase type 2b, CDH13  -  cadherin 13, h-cadherin (heart), EFEMP1  -  egf containing fibulin-like extracellular matrix protein 1, HDAC1  -  histone deacetylase 1, ZFAND5  -  zinc finger, an1-type domain 5, ITGA6  -  integrin, alpha 6, CRCP  -  cgrp receptor component, PKIG  -  protein kinase (camp-dependent, catalytic) inhibitor gamma, IRAK1  -  interleukin-1 receptor-associated kinase 1, PTPRF  -  protein tyrosine phosphatase, receptor type, f, CHRND  -  cholinergic receptor, nicotinic, delta (muscle), IFIT1  -  interferon-induced protein with tetratricopeptide repeats 1, IFIT3  -  interferon-induced protein with tetratricopeptide repeats 3, IFI16  -  interferon, gamma-inducible protein 16, EPN2  -  epsin 2, CHRNB1  -  cholinergic receptor, nicotinic, beta 1 (muscle), IFI27  -  interferon, alpha-inducible protein 27, IFI35  -  interferon-induced protein 35, CDK14  -  cyclin-dependent kinase 14, SMC3  -  structural maintenance of chromosomes 3, TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), TLE2  -  transducin-like enhancer of split 2 (e(sp1) homolog, drosophila), TLE4  -  transducin-like enhancer of split 4 (e(sp1) homolog, drosophila), GPC1  -  glypican 1, RAB14  -  rab14, member ras oncogene family, DPYSL2  -  dihydropyrimidinase-like 2, NOTCH3  -  notch 3, IFNGR1  -  interferon gamma receptor 1, PVRL2  -  poliovirus receptor-related 2 (herpesvirus entry mediator b), SLC12A2  -  solute carrier family 12 (sodium/potassium/chloride transporter), member 2, HDAC4  -  histone deacetylase 4, ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, UNC119  -  unc-119 homolog (c. elegans), NGF  -  nerve growth factor (beta polypeptide), RAB3B  -  rab3b, member ras oncogene family, RAB2A  -  rab2a, member ras oncogene family, NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, ATP6V1B1  -  atpase, h+ transporting, lysosomal 56/58kda, v1 subunit b1, WNT5A  -  wingless-type mmtv integration site family, member 5a, ATP6V0C  -  atpase, h+ transporting, lysosomal 16kda, v0 subunit c, DVL3  -  dishevelled segment polarity protein 3, GULP1  -  gulp, engulfment adaptor ptb domain containing 1, TNFAIP6  -  tumor necrosis factor, alpha-induced protein 6, CGB  -  chorionic gonadotropin, beta polypeptide, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, RAB13  -  rab13, member ras oncogene family, RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), TEK  -  tek tyrosine kinase, endothelial, DDIT4  -  dna-damage-inducible transcript 4, LTB  -  lymphotoxin beta (tnf superfamily, member 3), RBPJ  -  recombination signal binding protein for immunoglobulin kappa j region, BAG1  -  bcl2-associated athanogene, SHH  -  sonic hedgehog, GPX1  -  glutathione peroxidase 1, DLX5  -  distal-less homeobox 5, DYRK2  -  dual-specificity tyrosine-(y)-phosphorylation regulated kinase 2, PLAU  -  plasminogen activator, urokinase, NFE2L2  -  nuclear factor (erythroid-derived 2)-like 2, PLAT  -  plasminogen activator, tissue, ISG15  -  isg15 ubiquitin-like modifier, NR2F1  -  nuclear receptor subfamily 2, group f, member 1, RRAS2  -  related ras viral (r-ras) oncogene homolog 2, BCAR3  -  breast cancer anti-estrogen resistance 3, CLU  -  clusterin, BCAM  -  basal cell adhesion molecule (lutheran blood group), TPP1  -  tripeptidyl peptidase i, IGBP1  -  immunoglobulin (cd79a) binding protein 1, MPZL1  -  myelin protein zero-like 1, BDKRB2  -  bradykinin receptor b2, IGF1R  -  insulin-like growth factor 1 receptor, IGF2  -  insulin-like growth factor 2 (somatomedin a), TGFB1  -  transforming growth factor, beta 1, SMAD2  -  smad family member 2, OGT  -  o-linked n-acetylglucosamine (glcnac) transferase, TGFB1I1  -  transforming growth factor beta 1 induced transcript 1, DNM2  -  dynamin 2, IGFBP1  -  insulin-like growth factor binding protein 1, TDP2  -  tyrosyl-dna phosphodiesterase 2, TGIF1  -  tgfb-induced factor homeobox 1, BCL6  -  b-cell cll/lymphoma 6, TSPYL2  -  tspy-like 2, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), NR3C1  -  nuclear receptor subfamily 3, group c, member 1 (glucocorticoid receptor), TGFBR3  -  transforming growth factor, beta receptor iii, RPS6KA4  -  ribosomal protein s6 kinase, 90kda, polypeptide 4, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, DMD  -  dystrophin, YES1  -  v-yes-1 yamaguchi sarcoma viral oncogene homolog 1, FOS  -  fbj murine osteosarcoma viral oncogene homolog, CXCL1  -  chemokine (c-x-c motif) ligand 1 (melanoma growth stimulating activity, alpha), DMPK  -  dystrophia myotonica-protein kinase, CABIN1  -  calcineurin binding protein 1, SCG5  -  secretogranin v (7b2 protein), FNTB  -  farnesyltransferase, caax box, beta, SMAD3  -  smad family member 3, SMAD6  -  smad family member 6, GSK3B  -  glycogen synthase kinase 3 beta, CCND1  -  cyclin d1, PIGR  -  polymeric immunoglobulin receptor, ITSN1  -  intersectin 1 (sh3 domain protein), RBP1  -  retinol binding protein 1, cellular, SH3GL1  -  sh3-domain grb2-like 1]"GO:0006753,nucleoside phosphate metabolic process,4.10E-04,4.39E-02,1.81,8230,330,634,46,"[MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), RAB33A  -  rab33a, member ras oncogene family, NADK  -  nad kinase, PAICS  -  phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase, RFK  -  riboflavin kinase, RAB9A  -  rab9a, member ras oncogene family, PRPS1  -  phosphoribosyl pyrophosphate synthetase 1, PDE5A  -  phosphodiesterase 5a, cgmp-specific, MYH10  -  myosin, heavy chain 10, non-muscle, GPX1  -  glutathione peroxidase 1, TKT  -  transketolase, PGD  -  phosphogluconate dehydrogenase, TBPL1  -  tbp-like 1, SEPT5  -  septin 5, NME4  -  nme/nm23 nucleoside diphosphate kinase 4, RHOB  -  ras homolog family member b, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, RAB14  -  rab14, member ras oncogene family, ADA  -  adenosine deaminase, GTF2H1  -  general transcription factor iih, polypeptide 1, 62kda, DDX17  -  dead (asp-glu-ala-asp) box helicase 17, CTPS1  -  ctp synthase 1, FDXR  -  ferredoxin reductase, HRAS  -  harvey rat sarcoma viral oncogene homolog, RPE  -  ribulose-5-phosphate-3-epimerase, MSH6  -  muts homolog 6 (e. coli), RHOG  -  ras homolog family member g, PEX6  -  peroxisomal biogenesis factor 6, RIT1  -  ras-like without caax 1, AK2  -  adenylate kinase 2, SMARCA5  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5, TGFB1  -  transforming growth factor, beta 1, RAB2A  -  rab2a, member ras oncogene family, CAT  -  catalase, SULT2B1  -  sulfotransferase family, cytosolic, 2b, member 1, ATP6V1B1  -  atpase, h+ transporting, lysosomal 56/58kda, v1 subunit b1, SMARCA2  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, RBBP4  -  retinoblastoma binding protein 4, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, TDG  -  thymine-dna glycosylase, ADM  -  adrenomedullin, TNNT3  -  troponin t type 3 (skeletal, fast), MPG  -  n-methylpurine-dna glycosylase, IDH3B  -  isocitrate dehydrogenase 3 (nad+) beta, RAB7L1  -  rab7, member ras oncogene family-like 1, RAB13  -  rab13, member ras oncogene family]"GO:0008284,positive regulation of cell proliferation,4.18E-04,4.44E-02,1.64,8230,567,576,65,"[AKR1C3  -  aldo-keto reductase family 1, member c3, NCK1  -  nck adaptor protein 1, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), TICAM1  -  toll-like receptor adaptor molecule 1, PAX7  -  paired box 7, PBX1  -  pre-b-cell leukemia homeobox 1, GAB2  -  grb2-associated binding protein 2, HRAS  -  harvey rat sarcoma viral oncogene homolog, NOTCH3  -  notch 3, ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, HDAC4  -  histone deacetylase 4, CTSH  -  cathepsin h, CRLF1  -  cytokine receptor-like factor 1, VEGFC  -  vascular endothelial growth factor c, PDCD10  -  programmed cell death 10, SOX9  -  sry (sex determining region y)-box 9, SOX4  -  sry (sex determining region y)-box 4, WNT5A  -  wingless-type mmtv integration site family, member 5a, BMPR1A  -  bone morphogenetic protein receptor, type ia, VCAM1  -  vascular cell adhesion molecule 1, SERPINF2  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 2, IL6ST  -  interleukin 6 signal transducer (gp130, oncostatin m receptor), BMP4  -  bone morphogenetic protein 4, PDGFA  -  platelet-derived growth factor alpha polypeptide, CRIP2  -  cysteine-rich protein 2, TEK  -  tek tyrosine kinase, endothelial, SUZ12  -  suz12 polycomb repressive complex 2 subunit, FOSL1  -  fos-like antigen 1, RBPJ  -  recombination signal binding protein for immunoglobulin kappa j region, FGFR1  -  fibroblast growth factor receptor 1, JUN  -  jun proto-oncogene, SHH  -  sonic hedgehog, STAT1  -  signal transducer and activator of transcription 1, 91kda, ARNT2  -  aryl-hydrocarbon receptor nuclear translocator 2, PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, FGF7  -  fibroblast growth factor 7, MECP2  -  methyl cpg binding protein 2 (rett syndrome), EGFR  -  epidermal growth factor receptor, FGF4  -  fibroblast growth factor 4, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, FZD7  -  frizzled family receptor 7, JAK2  -  janus kinase 2, ADA  -  adenosine deaminase, MED1  -  mediator complex subunit 1, EFNB1  -  ephrin-b1, ZMIZ1  -  zinc finger, miz-type containing 1, RHOG  -  ras homolog family member g, IGF1R  -  insulin-like growth factor 1 receptor, IGF2  -  insulin-like growth factor 2 (somatomedin a), TBX2  -  t-box 2, SRPK2  -  srsf protein kinase 2, TGFB1  -  transforming growth factor, beta 1, CAV2  -  caveolin 2, TGIF1  -  tgfb-induced factor homeobox 1, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), BAMBI  -  bmp and activin membrane-bound inhibitor, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), FNTB  -  farnesyltransferase, caax box, beta, ADM  -  adrenomedullin, CDH13  -  cadherin 13, h-cadherin (heart), PRKCA  -  protein kinase c, alpha, GAS6  -  growth arrest-specific 6, HDAC1  -  histone deacetylase 1, GAS1  -  growth arrest-specific 1, LAMB1  -  laminin, beta 1]"GO:2000257,regulation of protein activation cascade,4.24E-04,4.45E-02,11.55,8230,26,137,5,"[C9  -  complement component 9, C4A  -  complement component 4a (rodgers blood group), CFH  -  complement factor h, CFB  -  complement factor b, PROS1  -  protein s (alpha)]"GO:0016032,viral process,4.31E-04,4.49E-02,1.53,8230,498,888,82,"[IFIT1  -  interferon-induced protein with tetratricopeptide repeats 1, BNIP3  -  bcl2/adenovirus e1b 19kda interacting protein 3, NCBP2  -  nuclear cap binding protein subunit 2, 20kda, RPL23A  -  ribosomal protein l23a, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, AP1G1  -  adaptor-related protein complex 1, gamma 1 subunit, RPL18A  -  ribosomal protein l18a, RPL15  -  ribosomal protein l15, RPL12  -  ribosomal protein l12, NUPL2  -  nucleoporin like 2, DDB1  -  damage-specific dna binding protein 1, 127kda, RPL5  -  ribosomal protein l5, GTF2H1  -  general transcription factor iih, polypeptide 1, 62kda, SUPT5H  -  suppressor of ty 5 homolog (s. cerevisiae), EIF4G3  -  eukaryotic translation initiation factor 4 gamma, 3, RPL4  -  ribosomal protein l4, UNG  -  uracil-dna glycosylase, PSMA1  -  proteasome (prosome, macropain) subunit, alpha type, 1, PVR  -  poliovirus receptor, PACS2  -  phosphofurin acidic cluster sorting protein 2, FBLN1  -  fibulin 1, MMP1  -  matrix metallopeptidase 1 (interstitial collagenase), EIF4A2  -  eukaryotic translation initiation factor 4a2, NFX1  -  nuclear transcription factor, x-box binding 1, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, TRAM1  -  translocation associated membrane protein 1, NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, PSMB9  -  proteasome (prosome, macropain) subunit, beta type, 9, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, ARF1  -  adp-ribosylation factor 1, FURIN  -  furin (paired basic amino acid cleaving enzyme), ATP6V0C  -  atpase, h+ transporting, lysosomal 16kda, v0 subunit c, PSMB4  -  proteasome (prosome, macropain) subunit, beta type, 4, NACA  -  nascent polypeptide-associated complex alpha subunit, VCAM1  -  vascular cell adhesion molecule 1, EIF4G1  -  eukaryotic translation initiation factor 4 gamma, 1, CREB1  -  camp responsive element binding protein 1, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, IL6ST  -  interleukin 6 signal transducer (gp130, oncostatin m receptor), VDAC1  -  voltage-dependent anion channel 1, RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), ITGA5  -  integrin, alpha 5 (fibronectin receptor, alpha polypeptide), UBR4  -  ubiquitin protein ligase e3 component n-recognin 4, PSMD11  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 11, KRT19  -  keratin 19, PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), TAF11  -  taf11 rna polymerase ii, tata box binding protein (tbp)-associated factor, 28kda, RAN  -  ran, member ras oncogene family, PPIA  -  peptidylprolyl isomerase a (cyclophilin a), STAT2  -  signal transducer and activator of transcription 2, 113kda, STAT1  -  signal transducer and activator of transcription 1, 91kda, RPL14  -  ribosomal protein l14, STAT3  -  signal transducer and activator of transcription 3 (acute-phase response factor), PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, GBF1  -  golgi brefeldin a resistant guanine nucleotide exchange factor 1, SSRP1  -  structure specific recognition protein 1, ISG15  -  isg15 ubiquitin-like modifier, PSIP1  -  pc4 and sfrs1 interacting protein 1, KRT7  -  keratin 7, RPS13  -  ribosomal protein s13, EFNB2  -  ephrin-b2, TAP1  -  transporter 1, atp-binding cassette, sub-family b (mdr/tap), KRT18  -  keratin 18, TGFB1  -  transforming growth factor, beta 1, ZYX  -  zyxin, TNFRSF14  -  tumor necrosis factor receptor superfamily, member 14, HNRNPA1  -  heterogeneous nuclear ribonucleoprotein a1, MAPK3  -  mitogen-activated protein kinase 3, GNB2L1  -  guanine nucleotide binding protein (g protein), beta polypeptide 2-like 1, DAG1  -  dystroglycan 1 (dystrophin-associated glycoprotein 1), FADD  -  fas (tnfrsf6)-associated via death domain, SND1  -  staphylococcal nuclease and tudor domain containing 1, RPL23  -  ribosomal protein l23, SLC25A6  -  solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6, SLC25A4  -  solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4, NUP153  -  nucleoporin 153kda, SMAD3  -  smad family member 3, GAS6  -  growth arrest-specific 6, HDAC1  -  histone deacetylase 1, FBXL2  -  f-box and leucine-rich repeat protein 2, POLR2B  -  polymerase (rna) ii (dna directed) polypeptide b, 140kda]"GO:0044403,"symbiosis, encompassing mutualism through parasitism",4.31E-04,4.45E-02,1.53,8230,498,888,82,"[IFIT1  -  interferon-induced protein with tetratricopeptide repeats 1, NCBP2  -  nuclear cap binding protein subunit 2, 20kda, BNIP3  -  bcl2/adenovirus e1b 19kda interacting protein 3, RPL23A  -  ribosomal protein l23a, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, AP1G1  -  adaptor-related protein complex 1, gamma 1 subunit, RPL18A  -  ribosomal protein l18a, RPL15  -  ribosomal protein l15, RPL12  -  ribosomal protein l12, NUPL2  -  nucleoporin like 2, DDB1  -  damage-specific dna binding protein 1, 127kda, RPL5  -  ribosomal protein l5, GTF2H1  -  general transcription factor iih, polypeptide 1, 62kda, SUPT5H  -  suppressor of ty 5 homolog (s. cerevisiae), EIF4G3  -  eukaryotic translation initiation factor 4 gamma, 3, RPL4  -  ribosomal protein l4, UNG  -  uracil-dna glycosylase, PSMA1  -  proteasome (prosome, macropain) subunit, alpha type, 1, PVR  -  poliovirus receptor, PACS2  -  phosphofurin acidic cluster sorting protein 2, FBLN1  -  fibulin 1, MMP1  -  matrix metallopeptidase 1 (interstitial collagenase), EIF4A2  -  eukaryotic translation initiation factor 4a2, NFX1  -  nuclear transcription factor, x-box binding 1, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, TRAM1  -  translocation associated membrane protein 1, PSMB9  -  proteasome (prosome, macropain) subunit, beta type, 9, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, ARF1  -  adp-ribosylation factor 1, FURIN  -  furin (paired basic amino acid cleaving enzyme), ATP6V0C  -  atpase, h+ transporting, lysosomal 16kda, v0 subunit c, PSMB4  -  proteasome (prosome, macropain) subunit, beta type, 4, NACA  -  nascent polypeptide-associated complex alpha subunit, VCAM1  -  vascular cell adhesion molecule 1, EIF4G1  -  eukaryotic translation initiation factor 4 gamma, 1, CREB1  -  camp responsive element binding protein 1, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, IL6ST  -  interleukin 6 signal transducer (gp130, oncostatin m receptor), VDAC1  -  voltage-dependent anion channel 1, RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), ITGA5  -  integrin, alpha 5 (fibronectin receptor, alpha polypeptide), PSMD11  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 11, UBR4  -  ubiquitin protein ligase e3 component n-recognin 4, KRT19  -  keratin 19, TAF11  -  taf11 rna polymerase ii, tata box binding protein (tbp)-associated factor, 28kda, PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), RAN  -  ran, member ras oncogene family, PPIA  -  peptidylprolyl isomerase a (cyclophilin a), STAT2  -  signal transducer and activator of transcription 2, 113kda, STAT1  -  signal transducer and activator of transcription 1, 91kda, RPL14  -  ribosomal protein l14, STAT3  -  signal transducer and activator of transcription 3 (acute-phase response factor), PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, GBF1  -  golgi brefeldin a resistant guanine nucleotide exchange factor 1, SSRP1  -  structure specific recognition protein 1, ISG15  -  isg15 ubiquitin-like modifier, PSIP1  -  pc4 and sfrs1 interacting protein 1, KRT7  -  keratin 7, RPS13  -  ribosomal protein s13, EFNB2  -  ephrin-b2, TAP1  -  transporter 1, atp-binding cassette, sub-family b (mdr/tap), KRT18  -  keratin 18, TGFB1  -  transforming growth factor, beta 1, ZYX  -  zyxin, TNFRSF14  -  tumor necrosis factor receptor superfamily, member 14, HNRNPA1  -  heterogeneous nuclear ribonucleoprotein a1, MAPK3  -  mitogen-activated protein kinase 3, GNB2L1  -  guanine nucleotide binding protein (g protein), beta polypeptide 2-like 1, DAG1  -  dystroglycan 1 (dystrophin-associated glycoprotein 1), FADD  -  fas (tnfrsf6)-associated via death domain, SND1  -  staphylococcal nuclease and tudor domain containing 1, RPL23  -  ribosomal protein l23, SLC25A6  -  solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6, SLC25A4  -  solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4, NUP153  -  nucleoporin 153kda, SMAD3  -  smad family member 3, GAS6  -  growth arrest-specific 6, HDAC1  -  histone deacetylase 1, FBXL2  -  f-box and leucine-rich repeat protein 2, POLR2B  -  polymerase (rna) ii (dna directed) polypeptide b, 140kda]"GO:0032268,regulation of cellular protein metabolic process,4.45E-04,4.55E-02,1.33,8230,1138,892,164,"[NCBP2  -  nuclear cap binding protein subunit 2, 20kda, FMR1  -  fragile x mental retardation 1, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, SSH1  -  slingshot protein phosphatase 1, NCK1  -  nck adaptor protein 1, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), HEXIM1  -  hexamethylene bis-acetamide inducible 1, TICAM1  -  toll-like receptor adaptor molecule 1, PAX7  -  paired box 7, IQGAP1  -  iq motif containing gtpase activating protein 1, GTF2H1  -  general transcription factor iih, polypeptide 1, 62kda, PSMA1  -  proteasome (prosome, macropain) subunit, alpha type, 1, ATF6  -  activating transcription factor 6, HRAS  -  harvey rat sarcoma viral oncogene homolog, NBN  -  nibrin, KMT2A  -  lysine (k)-specific methyltransferase 2a, TRAF4  -  tnf receptor-associated factor 4, CDC14B  -  cell division cycle 14b, PIAS1  -  protein inhibitor of activated stat, 1, EIF4A2  -  eukaryotic translation initiation factor 4a2, EIF4B  -  eukaryotic translation initiation factor 4b, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, CRLF1  -  cytokine receptor-like factor 1, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, PDCD10  -  programmed cell death 10, PSMB9  -  proteasome (prosome, macropain) subunit, beta type, 9, SOX9  -  sry (sex determining region y)-box 9, SOX4  -  sry (sex determining region y)-box 4, TNK2  -  tyrosine kinase, non-receptor, 2, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, EIF2S1  -  eukaryotic translation initiation factor 2, subunit 1 alpha, 35kda, FURIN  -  furin (paired basic amino acid cleaving enzyme), PSMB4  -  proteasome (prosome, macropain) subunit, beta type, 4, CAMK1  -  calcium/calmodulin-dependent protein kinase i, APOE  -  apolipoprotein e, RGS3  -  regulator of g-protein signaling 3, SOD1  -  superoxide dismutase 1, soluble, BMPR1A  -  bone morphogenetic protein receptor, type ia, APP  -  amyloid beta (a4) precursor protein, EIF4G1  -  eukaryotic translation initiation factor 4 gamma, 1, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, IL6ST  -  interleukin 6 signal transducer (gp130, oncostatin m receptor), LMNA  -  lamin a/c, BMP4  -  bone morphogenetic protein 4, SNTA1  -  syntrophin, alpha 1, PDGFA  -  platelet-derived growth factor alpha polypeptide, ITGA5  -  integrin, alpha 5 (fibronectin receptor, alpha polypeptide), ICAM1  -  intercellular adhesion molecule 1, PSMD11  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 11, PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), FGFR1  -  fibroblast growth factor receptor 1, GADD45B  -  growth arrest and dna-damage-inducible, beta, DDR2  -  discoidin domain receptor tyrosine kinase 2, FGF7  -  fibroblast growth factor 7, MECP2  -  methyl cpg binding protein 2 (rett syndrome), ADAR  -  adenosine deaminase, rna-specific, FGF2  -  fibroblast growth factor 2 (basic), PDPK1  -  3-phosphoinositide dependent protein kinase-1, EGFR  -  epidermal growth factor receptor, FGF4  -  fibroblast growth factor 4, SAMD4A  -  sterile alpha motif domain containing 4a, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, MKNK1  -  map kinase interacting serine/threonine kinase 1, EIF2B4  -  eukaryotic translation initiation factor 2b, subunit 4 delta, 67kda, ADD1  -  adducin 1 (alpha), EIF4E2  -  eukaryotic translation initiation factor 4e family member 2, CDKN1C  -  cyclin-dependent kinase inhibitor 1c (p57, kip2), ASPH  -  aspartate beta-hydroxylase, CDKN2D  -  cyclin-dependent kinase inhibitor 2d (p19, inhibits cdk4), DAPK1  -  death-associated protein kinase 1, MAPK8IP1  -  mitogen-activated protein kinase 8 interacting protein 1, LRPPRC  -  leucine-rich pentatricopeptide repeat containing, EDNRA  -  endothelin receptor type a, CDC37  -  cell division cycle 37, TAOK3  -  tao kinase 3, FZR1  -  fizzy/cell division cycle 20 related 1 (drosophila), TRAF2  -  tnf receptor-associated factor 2, PPAP2B  -  phosphatidic acid phosphatase type 2b, EIF3E  -  eukaryotic translation initiation factor 3, subunit e, PKIG  -  protein kinase (camp-dependent, catalytic) inhibitor gamma, IRAK1  -  interleukin-1 receptor-associated kinase 1, QKI  -  qki, kh domain containing, rna binding, TIMP3  -  timp metallopeptidase inhibitor 3, MAGOH  -  mago-nashi homolog, proliferation-associated (drosophila), PDE5A  -  phosphodiesterase 5a, cgmp-specific, EIF3C  -  eukaryotic translation initiation factor 3, subunit c, EIF3D  -  eukaryotic translation initiation factor 3, subunit d, AGT  -  angiotensinogen (serpin peptidase inhibitor, clade a, member 8), EIF4G3  -  eukaryotic translation initiation factor 4 gamma, 3, AIMP2  -  aminoacyl trna synthetase complex-interacting multifunctional protein 2, TAB2  -  tgf-beta activated kinase 1/map3k7 binding protein 2, HDAC4  -  histone deacetylase 4, VEGFC  -  vascular endothelial growth factor c, EIF3M  -  eukaryotic translation initiation factor 3, subunit m, NGF  -  nerve growth factor (beta polypeptide), NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, WNT5A  -  wingless-type mmtv integration site family, member 5a, DVL3  -  dishevelled segment polarity protein 3, STK3  -  serine/threonine kinase 3, RAD23B  -  rad23 homolog b (s. cerevisiae), PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, EZH2  -  enhancer of zeste homolog 2 (drosophila), ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, TEK  -  tek tyrosine kinase, endothelial, ST13  -  suppression of tumorigenicity 13 (colon carcinoma) (hsp70 interacting protein), CRKL  -  v-crk avian sarcoma virus ct10 oncogene homolog-like, RBPMS  -  rna binding protein with multiple splicing, DDIT4  -  dna-damage-inducible transcript 4, UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, SHH  -  sonic hedgehog, JUN  -  jun proto-oncogene, KIAA1199  -  kiaa1199, EED  -  embryonic ectoderm development, SLIT2  -  slit homolog 2 (drosophila), GPX1  -  glutathione peroxidase 1, PABPC1  -  poly(a) binding protein, cytoplasmic 1, PRNP  -  prion protein, CCNG1  -  cyclin g1, PLAT  -  plasminogen activator, tissue, FXR1  -  fragile x mental retardation, autosomal homolog 1, ISG15  -  isg15 ubiquitin-like modifier, JAK2  -  janus kinase 2, DLC1  -  deleted in liver cancer 1, NF2  -  neurofibromin 2 (merlin), RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, CLU  -  clusterin, MAP2K1  -  mitogen-activated protein kinase kinase 1, TPP1  -  tripeptidyl peptidase i, MAP2K3  -  mitogen-activated protein kinase kinase 3, MAPK10  -  mitogen-activated protein kinase 10, IGBP1  -  immunoglobulin (cd79a) binding protein 1, SFRP1  -  secreted frizzled-related protein 1, BDKRB2  -  bradykinin receptor b2, SERPINE2  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 2, IGF1R  -  insulin-like growth factor 1 receptor, IGF2  -  insulin-like growth factor 2 (somatomedin a), TGFB1  -  transforming growth factor, beta 1, UCHL1  -  ubiquitin carboxyl-terminal esterase l1 (ubiquitin thiolesterase), MVP  -  major vault protein, MAPK3  -  mitogen-activated protein kinase 3, TNFRSF14  -  tumor necrosis factor receptor superfamily, member 14, OGT  -  o-linked n-acetylglucosamine (glcnac) transferase, GNB2L1  -  guanine nucleotide binding protein (g protein), beta polypeptide 2-like 1, IGFBP1  -  insulin-like growth factor binding protein 1, PLCE1  -  phospholipase c, epsilon 1, TRIM21  -  tripartite motif containing 21, FADD  -  fas (tnfrsf6)-associated via death domain, TSPYL2  -  tspy-like 2, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), RPS6KA4  -  ribosomal protein s6 kinase, 90kda, polypeptide 4, DMD  -  dystrophin, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, PRKCG  -  protein kinase c, gamma, CCND2  -  cyclin d2, CSPG4  -  chondroitin sulfate proteoglycan 4, SMAD3  -  smad family member 3, PRKCA  -  protein kinase c, alpha, SMAD6  -  smad family member 6, GSK3B  -  glycogen synthase kinase 3 beta, CCND1  -  cyclin d1, CBS  -  cystathionine-beta-synthase, GAS6  -  growth arrest-specific 6, NUPR1  -  nuclear protein, transcriptional regulator, 1]"GO:0031589,cell-substrate adhesion,4.66E-04,4.72E-02,3.69,8230,93,312,13,"[TEK  -  tek tyrosine kinase, endothelial, ITGA7  -  integrin, alpha 7, DAG1  -  dystroglycan 1 (dystrophin-associated glycoprotein 1), ITGA3  -  integrin, alpha 3 (antigen cd49c, alpha 3 subunit of vla-3 receptor), FBLN5  -  fibulin 5, FZD7  -  frizzled family receptor 7, TYRO3  -  tyro3 protein tyrosine kinase, LAMA5  -  laminin, alpha 5, SMAD6  -  smad family member 6, NID2  -  nidogen 2 (osteonidogen), GAS6  -  growth arrest-specific 6, ITGA6  -  integrin, alpha 6, LAMB1  -  laminin, beta 1]"GO:0006096,glycolysis,4.75E-04,4.76E-02,3.45,8230,30,955,12,"[OGDH  -  oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide), LDHB  -  lactate dehydrogenase b, PFKL  -  phosphofructokinase, liver, PGK1  -  phosphoglycerate kinase 1, PFKP  -  phosphofructokinase, platelet, LDHA  -  lactate dehydrogenase a, GPI  -  glucose-6-phosphate isomerase, ENO2  -  enolase 2 (gamma, neuronal), PKM  -  pyruvate kinase, muscle, ENO1  -  enolase 1, (alpha), ALDOC  -  aldolase c, fructose-bisphosphate, BPGM  -  2,3-bisphosphoglycerate mutase]"GO:0046822,regulation of nucleocytoplasmic transport,5.25E-04,5.22E-02,2.48,8230,151,461,21,"[NCBP2  -  nuclear cap binding protein subunit 2, 20kda, RBPMS  -  rna binding protein with multiple splicing, MAPK7  -  mitogen-activated protein kinase 7, TGFB1  -  transforming growth factor, beta 1, SHH  -  sonic hedgehog, LITAF  -  lipopolysaccharide-induced tnf factor, NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, SOX4  -  sry (sex determining region y)-box 4, PPM1B  -  protein phosphatase, mg2+/mn2+ dependent, 1b, BAMBI  -  bmp and activin membrane-bound inhibitor, PARP1  -  poly (adp-ribose) polymerase 1, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), CAMK1  -  calcium/calmodulin-dependent protein kinase i, FLNA  -  filamin a, alpha, FZD7  -  frizzled family receptor 7, JAK2  -  janus kinase 2, NUP153  -  nucleoporin 153kda, MED1  -  mediator complex subunit 1, GSK3B  -  glycogen synthase kinase 3 beta, GAS6  -  growth arrest-specific 6, BMP4  -  bone morphogenetic protein 4]"GO:0070613,regulation of protein processing,5.28E-04,5.21E-02,5.69,8230,45,257,8,"[C9  -  complement component 9, C4A  -  complement component 4a (rodgers blood group), CFH  -  complement factor h, CFB  -  complement factor b, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, PROS1  -  protein s (alpha), SERPINF2  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 2]"GO:0050817,coagulation,5.56E-04,5.44E-02,1.85,8230,394,473,42,"[CAPZA2  -  capping protein (actin filament) muscle z-line, alpha 2, PDGFA  -  platelet-derived growth factor alpha polypeptide, TEK  -  tek tyrosine kinase, endothelial, ACTN1  -  actinin, alpha 1, ATP2B1  -  atpase, ca++ transporting, plasma membrane 1, PPIA  -  peptidylprolyl isomerase a (cyclophilin a), PDE5A  -  phosphodiesterase 5a, cgmp-specific, SHH  -  sonic hedgehog, SLC7A8  -  solute carrier family 7 (amino acid transporter light chain, l system), member 8, PROS1  -  protein s (alpha), ITGA3  -  integrin, alpha 3 (antigen cd49c, alpha 3 subunit of vla-3 receptor), SLC16A3  -  solute carrier family 16 (monocarboxylate transporter), member 3, RHOB  -  ras homolog family member b, PDPK1  -  3-phosphoinositide dependent protein kinase-1, PLAT  -  plasminogen activator, tissue, FLNA  -  filamin a, alpha, PTGIR  -  prostaglandin i2 (prostacyclin) receptor (ip), JAK2  -  janus kinase 2, PRCP  -  prolylcarboxypeptidase (angiotensinase c), CLU  -  clusterin, HRAS  -  harvey rat sarcoma viral oncogene homolog, KCNMB1  -  potassium large conductance calcium-activated channel, subfamily m, beta member 1, RHOG  -  ras homolog family member g, CAP1  -  cap, adenylate cyclase-associated protein 1 (yeast), TUBA4A  -  tubulin, alpha 4a, MGLL  -  monoglyceride lipase, IGF2  -  insulin-like growth factor 2 (somatomedin a), VEGFC  -  vascular endothelial growth factor c, WEE1  -  wee1 homolog (s. pombe), TGFB1  -  transforming growth factor, beta 1, PRKG1  -  protein kinase, cgmp-dependent, type i, PTPN1  -  protein tyrosine phosphatase, non-receptor type 1, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, YES1  -  v-yes-1 yamaguchi sarcoma viral oncogene homolog 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, APP  -  amyloid beta (a4) precursor protein, PRKCA  -  protein kinase c, alpha, GAS6  -  growth arrest-specific 6, HDAC1  -  histone deacetylase 1, ITGA6  -  integrin, alpha 6, SERPINF2  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 2]"GO:0007596,blood coagulation,5.56E-04,5.39E-02,1.85,8230,394,473,42,"[CAPZA2  -  capping protein (actin filament) muscle z-line, alpha 2, PDGFA  -  platelet-derived growth factor alpha polypeptide, TEK  -  tek tyrosine kinase, endothelial, ACTN1  -  actinin, alpha 1, ATP2B1  -  atpase, ca++ transporting, plasma membrane 1, PPIA  -  peptidylprolyl isomerase a (cyclophilin a), PDE5A  -  phosphodiesterase 5a, cgmp-specific, SHH  -  sonic hedgehog, SLC7A8  -  solute carrier family 7 (amino acid transporter light chain, l system), member 8, PROS1  -  protein s (alpha), ITGA3  -  integrin, alpha 3 (antigen cd49c, alpha 3 subunit of vla-3 receptor), SLC16A3  -  solute carrier family 16 (monocarboxylate transporter), member 3, RHOB  -  ras homolog family member b, PDPK1  -  3-phosphoinositide dependent protein kinase-1, PLAT  -  plasminogen activator, tissue, FLNA  -  filamin a, alpha, PTGIR  -  prostaglandin i2 (prostacyclin) receptor (ip), JAK2  -  janus kinase 2, PRCP  -  prolylcarboxypeptidase (angiotensinase c), CLU  -  clusterin, HRAS  -  harvey rat sarcoma viral oncogene homolog, KCNMB1  -  potassium large conductance calcium-activated channel, subfamily m, beta member 1, RHOG  -  ras homolog family member g, CAP1  -  cap, adenylate cyclase-associated protein 1 (yeast), TUBA4A  -  tubulin, alpha 4a, MGLL  -  monoglyceride lipase, IGF2  -  insulin-like growth factor 2 (somatomedin a), VEGFC  -  vascular endothelial growth factor c, WEE1  -  wee1 homolog (s. pombe), TGFB1  -  transforming growth factor, beta 1, PRKG1  -  protein kinase, cgmp-dependent, type i, PTPN1  -  protein tyrosine phosphatase, non-receptor type 1, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, YES1  -  v-yes-1 yamaguchi sarcoma viral oncogene homolog 1, APP  -  amyloid beta (a4) precursor protein, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, GAS6  -  growth arrest-specific 6, HDAC1  -  histone deacetylase 1, ITGA6  -  integrin, alpha 6, SERPINF2  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 2]"GO:1901135,carbohydrate derivative metabolic process,5.69E-04,5.46E-02,1.73,8230,448,553,52,"[FMOD  -  fibromodulin, AKR1C3  -  aldo-keto reductase family 1, member c3, NADK  -  nad kinase, PAICS  -  phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase, RFK  -  riboflavin kinase, PDE5A  -  phosphodiesterase 5a, cgmp-specific, TKT  -  transketolase, SEPT5  -  septin 5, NME4  -  nme/nm23 nucleoside diphosphate kinase 4, GPC1  -  glypican 1, RAB14  -  rab14, member ras oncogene family, GPI  -  glucose-6-phosphate isomerase, CTPS1  -  ctp synthase 1, HRAS  -  harvey rat sarcoma viral oncogene homolog, MSH6  -  muts homolog 6 (e. coli), AK2  -  adenylate kinase 2, RIT1  -  ras-like without caax 1, BGN  -  biglycan, FOXC1  -  forkhead box c1, RAB2A  -  rab2a, member ras oncogene family, SULT2B1  -  sulfotransferase family, cytosolic, 2b, member 1, ATP6V1B1  -  atpase, h+ transporting, lysosomal 56/58kda, v1 subunit b1, PLSCR1  -  phospholipid scramblase 1, TDG  -  thymine-dna glycosylase, PFKP  -  phosphofructokinase, platelet, RAB13  -  rab13, member ras oncogene family, MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), RAB33A  -  rab33a, member ras oncogene family, CTSA  -  cathepsin a, RAB9A  -  rab9a, member ras oncogene family, PRPS1  -  phosphoribosyl pyrophosphate synthetase 1, MYH10  -  myosin, heavy chain 10, non-muscle, TBPL1  -  tbp-like 1, ALDOC  -  aldolase c, fructose-bisphosphate, RHOB  -  ras homolog family member b, ST6GAL1  -  st6 beta-galactosamide alpha-2,6-sialyltranferase 1, LUM  -  lumican, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, ADA  -  adenosine deaminase, DDX17  -  dead (asp-glu-ala-asp) box helicase 17, RHOG  -  ras homolog family member g, CHST15  -  carbohydrate (n-acetylgalactosamine 4-sulfate 6-o) sulfotransferase 15, SMARCA5  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5, TGFB1  -  transforming growth factor, beta 1, SMARCA2  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, RBBP4  -  retinoblastoma binding protein 4, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, ADM  -  adrenomedullin, CSPG4  -  chondroitin sulfate proteoglycan 4, COL11A1  -  collagen, type xi, alpha 1, MPG  -  n-methylpurine-dna glycosylase, RAB7L1  -  rab7, member ras oncogene family-like 1]"GO:0010648,negative regulation of cell communication,5.73E-04,5.45E-02,1.57,8230,633,604,73,"[PAWR  -  prkc, apoptosis, wt1, regulator, STRN3  -  striatin, calmodulin binding protein 3, CDH2  -  cadherin 2, type 1, n-cadherin (neuronal), MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), CDC34  -  cell division cycle 34, GPC1  -  glypican 1, SPG20  -  spastic paraplegia 20 (troyer syndrome), FOXO1  -  forkhead box o1, RGS5  -  regulator of g-protein signaling 5, NBL1  -  neuroblastoma 1, dan family bmp antagonist, LPXN  -  leupaxin, HMGXB4  -  hmg box domain containing 4, NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, SOX9  -  sry (sex determining region y)-box 9, UBR2  -  ubiquitin protein ligase e3 component n-recognin 2, WNT5A  -  wingless-type mmtv integration site family, member 5a, RGS7  -  regulator of g-protein signaling 7, PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, APOE  -  apolipoprotein e, SOD2  -  superoxide dismutase 2, mitochondrial, RGS3  -  regulator of g-protein signaling 3, EZH2  -  enhancer of zeste homolog 2 (drosophila), SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, WWOX  -  ww domain containing oxidoreductase, IL6ST  -  interleukin 6 signal transducer (gp130, oncostatin m receptor), LMNA  -  lamin a/c, RGS16  -  regulator of g-protein signaling 16, BMP4  -  bone morphogenetic protein 4, DGKZ  -  diacylglycerol kinase, zeta, SHH  -  sonic hedgehog, ATXN1  -  ataxin 1, STAT1  -  signal transducer and activator of transcription 1, 91kda, ROR2  -  receptor tyrosine kinase-like orphan receptor 2, PPM1B  -  protein phosphatase, mg2+/mn2+ dependent, 1b, GPX1  -  glutathione peroxidase 1, NFE2L2  -  nuclear factor (erythroid-derived 2)-like 2, PDPK1  -  3-phosphoinositide dependent protein kinase-1, EGFR  -  epidermal growth factor receptor, PTGIR  -  prostaglandin i2 (prostacyclin) receptor (ip), ADA  -  adenosine deaminase, DLC1  -  deleted in liver cancer 1, TYRO3  -  tyro3 protein tyrosine kinase, CLU  -  clusterin, IGBP1  -  immunoglobulin (cd79a) binding protein 1, MGLL  -  monoglyceride lipase, BDKRB2  -  bradykinin receptor b2, IGF1R  -  insulin-like growth factor 1 receptor, MAPK7  -  mitogen-activated protein kinase 7, SERPINE2  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 2, CBLB  -  cbl proto-oncogene b, e3 ubiquitin protein ligase, TGFB1  -  transforming growth factor, beta 1, UCHL1  -  ubiquitin carboxyl-terminal esterase l1 (ubiquitin thiolesterase), TGFB1I1  -  transforming growth factor beta 1 induced transcript 1, DAG1  -  dystroglycan 1 (dystrophin-associated glycoprotein 1), CAV2  -  caveolin 2, TGIF1  -  tgfb-induced factor homeobox 1, CDKN2D  -  cyclin-dependent kinase inhibitor 2d (p19, inhibits cdk4), TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), DAPK1  -  death-associated protein kinase 1, BAMBI  -  bmp and activin membrane-bound inhibitor, TGFBR3  -  transforming growth factor, beta receptor iii, PTPN1  -  protein tyrosine phosphatase, non-receptor type 1, PHB2  -  prohibitin 2, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), STAM  -  signal transducing adaptor molecule (sh3 domain and itam motif) 1, PRKCA  -  protein kinase c, alpha, GSK3B  -  glycogen synthase kinase 3 beta, SMAD6  -  smad family member 6, HDAC1  -  histone deacetylase 1, GAS6  -  growth arrest-specific 6, ITGA6  -  integrin, alpha 6, GAS1  -  growth arrest-specific 1]"GO:0060445,branching involved in salivary gland morphogenesis,5.74E-04,5.42E-02,14.44,8230,12,190,4,"[FGFR1  -  fibroblast growth factor receptor 1, LAMA5  -  laminin, alpha 5, DAG1  -  dystroglycan 1 (dystrophin-associated glycoprotein 1), FGF7  -  fibroblast growth factor 7]"GO:0006958,"complement activation, classical pathway",5.97E-04,5.59E-02,10.83,8230,29,131,5,"[C9  -  complement component 9, C4A  -  complement component 4a (rodgers blood group), CLU  -  clusterin, C1R  -  complement component 1, r subcomponent, C1S  -  complement component 1, s subcomponent]"GO:0005975,carbohydrate metabolic process,5.97E-04,5.54E-02,1.6,8230,339,989,65,"[FMOD  -  fibromodulin, PGK1  -  phosphoglycerate kinase 1, PRKACB  -  protein kinase, camp-dependent, catalytic, beta, TRAK1  -  trafficking protein, kinesin binding 1, TKT  -  transketolase, PGD  -  phosphogluconate dehydrogenase, NUPL2  -  nucleoporin like 2, BPGM  -  2,3-bisphosphoglycerate mutase, LDHB  -  lactate dehydrogenase b, RPIA  -  ribose 5-phosphate isomerase a, GPC1  -  glypican 1, PC  -  pyruvate carboxylase, PRELP  -  proline/arginine-rich end leucine-rich repeat protein, LDHA  -  lactate dehydrogenase a, GPI  -  glucose-6-phosphate isomerase, ENO2  -  enolase 2 (gamma, neuronal), MAN2B1  -  mannosidase, alpha, class 2b, member 1, RPE  -  ribulose-5-phosphate-3-epimerase, ENO1  -  enolase 1, (alpha), ACAN  -  aggrecan, BGN  -  biglycan, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, SLC2A1  -  solute carrier family 2 (facilitated glucose transporter), member 1, OGDH  -  oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide), PFKL  -  phosphofructokinase, liver, CYB5A  -  cytochrome b5 type a (microsomal), B4GALT3  -  udp-gal:betaglcnac beta 1,4- galactosyltransferase, polypeptide 3, SORD  -  sorbitol dehydrogenase, SDC2  -  syndecan 2, GYS1  -  glycogen synthase 1 (muscle), SLC2A3  -  solute carrier family 2 (facilitated glucose transporter), member 3, POM121  -  pom121 transmembrane nucleoporin, PFKP  -  phosphofructokinase, platelet, B3GALT4  -  udp-gal:betaglcnac beta 1,3-galactosyltransferase, polypeptide 4, IL6ST  -  interleukin 6 signal transducer (gp130, oncostatin m receptor), ALDH2  -  aldehyde dehydrogenase 2 family (mitochondrial), GUSB  -  glucuronidase, beta, IDH2  -  isocitrate dehydrogenase 2 (nadp+), mitochondrial, PRPS1  -  phosphoribosyl pyrophosphate synthetase 1, CRYAB  -  crystallin, alpha b, ALDOC  -  aldolase c, fructose-bisphosphate, ST6GAL1  -  st6 beta-galactosamide alpha-2,6-sialyltranferase 1, MECP2  -  methyl cpg binding protein 2 (rett syndrome), EGFR  -  epidermal growth factor receptor, NUP98  -  nucleoporin 98kda, LUM  -  lumican, PDK3  -  pyruvate dehydrogenase kinase, isozyme 3, ST3GAL4  -  st3 beta-galactoside alpha-2,3-sialyltransferase 4, PKM  -  pyruvate kinase, muscle, CHST15  -  carbohydrate (n-acetylgalactosamine 4-sulfate 6-o) sulfotransferase 15, INPPL1  -  inositol polyphosphate phosphatase-like 1, IGF2  -  insulin-like growth factor 2 (somatomedin a), SLC23A2  -  solute carrier family 23 (ascorbic acid transporter), member 2, OGT  -  o-linked n-acetylglucosamine (glcnac) transferase, SLC35A2  -  solute carrier family 35 (udp-galactose transporter), member a2, GBE1  -  glucan (1,4-alpha-), branching enzyme 1, PARP1  -  poly (adp-ribose) polymerase 1, TIPARP  -  tcdd-inducible poly(adp-ribose) polymerase, UBE2G2  -  ubiquitin-conjugating enzyme e2g 2, HEXA  -  hexosaminidase a (alpha polypeptide), CSPG4  -  chondroitin sulfate proteoglycan 4, NUP153  -  nucleoporin 153kda, GSK3B  -  glycogen synthase kinase 3 beta, VCAN  -  versican, PARP4  -  poly (adp-ribose) polymerase family, member 4]"GO:0006952,defense response,6.14E-04,5.65E-02,1.54,8230,827,496,77,"[CAPZA2  -  capping protein (actin filament) muscle z-line, alpha 2, BNIP3  -  bcl2/adenovirus e1b 19kda interacting protein 3, IFIT1  -  interferon-induced protein with tetratricopeptide repeats 1, IFIT3  -  interferon-induced protein with tetratricopeptide repeats 3, NCK1  -  nck adaptor protein 1, PTX3  -  pentraxin 3, long, HNRNPA0  -  heterogeneous nuclear ribonucleoprotein a0, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), TICAM1  -  toll-like receptor adaptor molecule 1, GAB2  -  grb2-associated binding protein 2, LGALS3  -  lectin, galactoside-binding, soluble, 3, FOXO1  -  forkhead box o1, HRAS  -  harvey rat sarcoma viral oncogene homolog, TAB2  -  tgf-beta activated kinase 1/map3k7 binding protein 2, CTSK  -  cathepsin k, HDAC4  -  histone deacetylase 4, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, UBE2L6  -  ubiquitin-conjugating enzyme e2l 6, CFB  -  complement factor b, NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, PLSCR1  -  phospholipid scramblase 1, PDPN  -  podoplanin, GJA1  -  gap junction protein, alpha 1, 43kda, CFH  -  complement factor h, TNFAIP6  -  tumor necrosis factor, alpha-induced protein 6, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, APP  -  amyloid beta (a4) precursor protein, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, VDAC1  -  voltage-dependent anion channel 1, SERPINF2  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 2, IL32  -  interleukin 32, PDGFA  -  platelet-derived growth factor alpha polypeptide, C9  -  complement component 9, FGFR1  -  fibroblast growth factor receptor 1, RBPJ  -  recombination signal binding protein for immunoglobulin kappa j region, UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, MDK  -  midkine (neurite growth-promoting factor 2), JUN  -  jun proto-oncogene, STAT2  -  signal transducer and activator of transcription 2, 113kda, STAT1  -  signal transducer and activator of transcription 1, 91kda, PROS1  -  protein s (alpha), FGF7  -  fibroblast growth factor 7, MECP2  -  methyl cpg binding protein 2 (rett syndrome), ADAR  -  adenosine deaminase, rna-specific, PDPK1  -  3-phosphoinositide dependent protein kinase-1, FGF4  -  fibroblast growth factor 4, ISG15  -  isg15 ubiquitin-like modifier, CD14  -  cd14 molecule, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, CLU  -  clusterin, MAP2K1  -  mitogen-activated protein kinase kinase 1, PTGES  -  prostaglandin e synthase, MAP2K3  -  mitogen-activated protein kinase kinase 3, ARPC2  -  actin related protein 2/3 complex, subunit 2, 34kda, MGLL  -  monoglyceride lipase, BDKRB2  -  bradykinin receptor b2, MAPK7  -  mitogen-activated protein kinase 7, SRPK2  -  srsf protein kinase 2, TGFB1  -  transforming growth factor, beta 1, TNFRSF14  -  tumor necrosis factor receptor superfamily, member 14, TRIM21  -  tripartite motif containing 21, ASS1  -  argininosuccinate synthase 1, C1R  -  complement component 1, r subcomponent, GBP1  -  guanylate binding protein 1, interferon-inducible, C1S  -  complement component 1, s subcomponent, LY96  -  lymphocyte antigen 96, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, YES1  -  v-yes-1 yamaguchi sarcoma viral oncogene homolog 1, CXCL1  -  chemokine (c-x-c motif) ligand 1 (melanoma growth stimulating activity, alpha), C4A  -  complement component 4a (rodgers blood group), TRAF2  -  tnf receptor-associated factor 2, PRKCA  -  protein kinase c, alpha, GSK3B  -  glycogen synthase kinase 3 beta, CRCP  -  cgrp receptor component, PARP4  -  poly (adp-ribose) polymerase family, member 4]"GO:0050776,regulation of immune response,6.42E-04,5.86E-02,1.7,8230,582,448,54,"[MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), TICAM1  -  toll-like receptor adaptor molecule 1, GAB2  -  grb2-associated binding protein 2, HRAS  -  harvey rat sarcoma viral oncogene homolog, FOXO1  -  forkhead box o1, IFNGR1  -  interferon gamma receptor 1, PVRL2  -  poliovirus receptor-related 2 (herpesvirus entry mediator b), TAB2  -  tgf-beta activated kinase 1/map3k7 binding protein 2, CTSK  -  cathepsin k, CTSH  -  cathepsin h, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, CFB  -  complement factor b, NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, WNT5A  -  wingless-type mmtv integration site family, member 5a, PLSCR1  -  phospholipid scramblase 1, CFH  -  complement factor h, CFHR1  -  complement factor h-related 1, CD200  -  cd200 molecule, PDGFA  -  platelet-derived growth factor alpha polypeptide, C9  -  complement component 9, FGFR1  -  fibroblast growth factor receptor 1, STAT2  -  signal transducer and activator of transcription 2, 113kda, JUN  -  jun proto-oncogene, UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, STAT1  -  signal transducer and activator of transcription 1, 91kda, PROS1  -  protein s (alpha), FGF7  -  fibroblast growth factor 7, PDPK1  -  3-phosphoinositide dependent protein kinase-1, FGF4  -  fibroblast growth factor 4, CD14  -  cd14 molecule, JAK2  -  janus kinase 2, ADA  -  adenosine deaminase, TYRO3  -  tyro3 protein tyrosine kinase, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, CLU  -  clusterin, MED1  -  mediator complex subunit 1, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, CNR1  -  cannabinoid receptor 1 (brain), MAP2K1  -  mitogen-activated protein kinase kinase 1, MAP2K3  -  mitogen-activated protein kinase kinase 3, ARPC2  -  actin related protein 2/3 complex, subunit 2, 34kda, MAPK7  -  mitogen-activated protein kinase 7, TGFB1  -  transforming growth factor, beta 1, TNFRSF14  -  tumor necrosis factor receptor superfamily, member 14, C1R  -  complement component 1, r subcomponent, LY96  -  lymphocyte antigen 96, C1S  -  complement component 1, s subcomponent, PTPN1  -  protein tyrosine phosphatase, non-receptor type 1, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, YES1  -  v-yes-1 yamaguchi sarcoma viral oncogene homolog 1, C4A  -  complement component 4a (rodgers blood group), TRAF2  -  tnf receptor-associated factor 2, GSK3B  -  glycogen synthase kinase 3 beta, PIGR  -  polymeric immunoglobulin receptor]"GO:0006955,immune response,6.68E-04,6.05E-02,1.43,8230,742,832,107,"[SECTM1  -  secreted and transmembrane 1, NCK1  -  nck adaptor protein 1, TCF12  -  transcription factor 12, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), TICAM1  -  toll-like receptor adaptor molecule 1, GEM  -  gtp binding protein overexpressed in skeletal muscle, SPN  -  sialophorin, GAB2  -  grb2-associated binding protein 2, CD59  -  cd59 molecule, complement regulatory protein, LGALS3  -  lectin, galactoside-binding, soluble, 3, HRAS  -  harvey rat sarcoma viral oncogene homolog, FOXO1  -  forkhead box o1, CD97  -  cd97 molecule, MYO10  -  myosin x, IL4R  -  interleukin 4 receptor, UBE2L6  -  ubiquitin-conjugating enzyme e2l 6, CFB  -  complement factor b, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, IL1R1  -  interleukin 1 receptor, type i, APP  -  amyloid beta (a4) precursor protein, BMPR1A  -  bone morphogenetic protein receptor, type ia, CREB1  -  camp responsive element binding protein 1, IL32  -  interleukin 32, PDGFA  -  platelet-derived growth factor alpha polypeptide, C9  -  complement component 9, FGFR1  -  fibroblast growth factor receptor 1, FGF5  -  fibroblast growth factor 5, PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, FGF7  -  fibroblast growth factor 7, CFL1  -  cofilin 1 (non-muscle), ADAR  -  adenosine deaminase, rna-specific, SEMA3C  -  sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3c, MEF2A  -  myocyte enhancer factor 2a, PDPK1  -  3-phosphoinositide dependent protein kinase-1, FGF2  -  fibroblast growth factor 2 (basic), EGFR  -  epidermal growth factor receptor, FGF4  -  fibroblast growth factor 4, POLR1C  -  polymerase (rna) i polypeptide c, 30kda, CEBPB  -  ccaat/enhancer binding protein (c/ebp), beta, ARPC2  -  actin related protein 2/3 complex, subunit 2, 34kda, SERPING1  -  serpin peptidase inhibitor, clade g (c1 inhibitor), member 1, FCGRT  -  fc fragment of igg, receptor, transporter, alpha, C1R  -  complement component 1, r subcomponent, LY96  -  lymphocyte antigen 96, C1S  -  complement component 1, s subcomponent, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, C4A  -  complement component 4a (rodgers blood group), TRAF2  -  tnf receptor-associated factor 2, CRCP  -  cgrp receptor component, IRAK1  -  interleukin-1 receptor-associated kinase 1, CAPZA2  -  capping protein (actin filament) muscle z-line, alpha 2, CAPZA1  -  capping protein (actin filament) muscle z-line, alpha 1, IFI16  -  interferon, gamma-inducible protein 16, GPI  -  glucose-6-phosphate isomerase, FTH1  -  ferritin, heavy polypeptide 1, TANK  -  traf family member-associated nfkb activator, TAB2  -  tgf-beta activated kinase 1/map3k7 binding protein 2, CTSL  -  cathepsin l, CTSK  -  cathepsin k, CTSH  -  cathepsin h, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, CFH  -  complement factor h, CFHR1  -  complement factor h-related 1, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, CTSC  -  cathepsin c, CRIP1  -  cysteine-rich protein 1 (intestinal), MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), LTB  -  lymphotoxin beta (tnf superfamily, member 3), RBPJ  -  recombination signal binding protein for immunoglobulin kappa j region, JUN  -  jun proto-oncogene, UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, PROS1  -  protein s (alpha), ST6GAL1  -  st6 beta-galactosamide alpha-2,6-sialyltranferase 1, TNFSF4  -  tumor necrosis factor (ligand) superfamily, member 4, ISG15  -  isg15 ubiquitin-like modifier, CD14  -  cd14 molecule, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, CLU  -  clusterin, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, TNFSF9  -  tumor necrosis factor (ligand) superfamily, member 9, MAP2K1  -  mitogen-activated protein kinase kinase 1, IK  -  ik cytokine, down-regulator of hla ii, MAP2K3  -  mitogen-activated protein kinase kinase 3, MAPK10  -  mitogen-activated protein kinase 10, IGF1R  -  insulin-like growth factor 1 receptor, MAPK7  -  mitogen-activated protein kinase 7, CBLB  -  cbl proto-oncogene b, e3 ubiquitin protein ligase, SRPK2  -  srsf protein kinase 2, TGFB1  -  transforming growth factor, beta 1, SERPINB9  -  serpin peptidase inhibitor, clade b (ovalbumin), member 9, MAPK3  -  mitogen-activated protein kinase 3, TNFRSF14  -  tumor necrosis factor receptor superfamily, member 14, TRIM21  -  tripartite motif containing 21, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, FADD  -  fas (tnfrsf6)-associated via death domain, BCL6  -  b-cell cll/lymphoma 6, TGFBR3  -  transforming growth factor, beta receptor iii, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, FOS  -  fbj murine osteosarcoma viral oncogene homolog, YES1  -  v-yes-1 yamaguchi sarcoma viral oncogene homolog 1, CXCL1  -  chemokine (c-x-c motif) ligand 1 (melanoma growth stimulating activity, alpha), PRKCG  -  protein kinase c, gamma, SMAD3  -  smad family member 3, PRKCA  -  protein kinase c, alpha, GSK3B  -  glycogen synthase kinase 3 beta, SMAD6  -  smad family member 6]"GO:0016202,regulation of striated muscle tissue development,6.81E-04,6.12E-02,2.86,8230,88,555,17,"[HDAC4  -  histone deacetylase 4, TBX2  -  t-box 2, TGFB1  -  transforming growth factor, beta 1, FGFR1  -  fibroblast growth factor receptor 1, RBPJ  -  recombination signal binding protein for immunoglobulin kappa j region, SHH  -  sonic hedgehog, SOX9  -  sry (sex determining region y)-box 9, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), GPC1  -  glypican 1, GJA1  -  gap junction protein, alpha 1, 43kda, TSC22D3  -  tsc22 domain family, member 3, COL14A1  -  collagen, type xiv, alpha 1, DDX17  -  dead (asp-glu-ala-asp) box helicase 17, EFNB2  -  ephrin-b2, NR1D2  -  nuclear receptor subfamily 1, group d, member 2, BMP4  -  bone morphogenetic protein 4]"GO:0046185,aldehyde catabolic process,6.92E-04,6.17E-02,74.82,8230,4,55,2,"[GPI  -  glucose-6-phosphate isomerase, ADH5  -  alcohol dehydrogenase 5 (class iii), chi polypeptide]"GO:0042340,keratan sulfate catabolic process,7.14E-04,6.31E-02,6.95,8230,7,846,5,"[FMOD  -  fibromodulin, HEXA  -  hexosaminidase a (alpha polypeptide), LUM  -  lumican, PRELP  -  proline/arginine-rich end leucine-rich repeat protein, ACAN  -  aggrecan]"GO:0031666,positive regulation of lipopolysaccharide-mediated signaling pathway,7.14E-04,6.26E-02,18.1,8230,4,341,3,"[PRKCA  -  protein kinase c, alpha, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), LY96  -  lymphocyte antigen 96]"GO:0065007,biological regulation,7.17E-04,6.24E-02,1.1,8230,5683,613,466,"[SH3BP1  -  sh3-domain binding protein 1, HNRNPA0  -  heterogeneous nuclear ribonucleoprotein a0, ABCA1  -  atp-binding cassette, sub-family a (abc1), member 1, SEPT5  -  septin 5, GEM  -  gtp binding protein overexpressed in skeletal muscle, NCOR2  -  nuclear receptor corepressor 2, RNF14  -  ring finger protein 14, LGALS3  -  lectin, galactoside-binding, soluble, 3, TRAF4  -  tnf receptor-associated factor 4, ASIC2  -  acid-sensing (proton-gated) ion channel 2, CDC42EP4  -  cdc42 effector protein (rho gtpase binding) 4, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, SOX9  -  sry (sex determining region y)-box 9, ACR  -  acrosin, PLP2  -  proteolipid protein 2 (colonic epithelium-enriched), SOX4  -  sry (sex determining region y)-box 4, PLSCR1  -  phospholipid scramblase 1, GJA1  -  gap junction protein, alpha 1, 43kda, SOD2  -  superoxide dismutase 2, mitochondrial, LMNA  -  lamin a/c, SERPINF2  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 2, SNX1  -  sorting nexin 1, SNTA1  -  syntrophin, alpha 1, ACTN1  -  actinin, alpha 1, CTSA  -  cathepsin a, PPIA  -  peptidylprolyl isomerase a (cyclophilin a), CNN1  -  calponin 1, basic, smooth muscle, LITAF  -  lipopolysaccharide-induced tnf factor, PPM1B  -  protein phosphatase, mg2+/mn2+ dependent, 1b, TBPL1  -  tbp-like 1, ADAR  -  adenosine deaminase, rna-specific, FZD7  -  frizzled family receptor 7, SNAPC1  -  small nuclear rna activating complex, polypeptide 1, 43kda, ADA  -  adenosine deaminase, MED1  -  mediator complex subunit 1, CNR1  -  cannabinoid receptor 1 (brain), PTGES  -  prostaglandin e synthase, AMOTL2  -  angiomotin like 2, KRT18  -  keratin 18, SH3BP5  -  sh3-domain binding protein 5 (btk-associated), COL8A1  -  collagen, type viii, alpha 1, PLIN2  -  perilipin 2, HLTF  -  helicase-like transcription factor, ADD1  -  adducin 1 (alpha), EIF4E2  -  eukaryotic translation initiation factor 4e family member 2, ADH5  -  alcohol dehydrogenase 5 (class iii), chi polypeptide, SMARCA2  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, LY96  -  lymphocyte antigen 96, PARP1  -  poly (adp-ribose) polymerase 1, ADM  -  adrenomedullin, LAMA5  -  laminin, alpha 5, LAMA4  -  laminin, alpha 4, POLR2B  -  polymerase (rna) ii (dna directed) polypeptide b, 140kda, LAMB1  -  laminin, beta 1, QKI  -  qki, kh domain containing, rna binding, AP1G1  -  adaptor-related protein complex 1, gamma 1 subunit, ASCC2  -  activating signal cointegrator 1 complex subunit 2, SYT1  -  synaptotagmin i, NUPL2  -  nucleoporin like 2, HOMER3  -  homer homolog 3 (drosophila), PRCP  -  prolylcarboxypeptidase (angiotensinase c), AIMP2  -  aminoacyl trna synthetase complex-interacting multifunctional protein 2, PPP5C  -  protein phosphatase 5, catalytic subunit, KCNMB1  -  potassium large conductance calcium-activated channel, subfamily m, beta member 1, LPXN  -  leupaxin, CTSK  -  cathepsin k, CTSH  -  cathepsin h, PPP3CB  -  protein phosphatase 3, catalytic subunit, beta isozyme, WWP2  -  ww domain containing e3 ubiquitin protein ligase 2, AHR  -  aryl hydrocarbon receptor, PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, ARHGAP29  -  rho gtpase activating protein 29, ALDH2  -  aldehyde dehydrogenase 2 family (mitochondrial), CRIP2  -  cysteine-rich protein 2, CRIP1  -  cysteine-rich protein 1 (intestinal), RBPMS  -  rna binding protein with multiple splicing, ST13  -  suppression of tumorigenicity 13 (colon carcinoma) (hsp70 interacting protein), RAB33A  -  rab33a, member ras oncogene family, FOSL1  -  fos-like antigen 1, RAB9A  -  rab9a, member ras oncogene family, JUN  -  jun proto-oncogene, STAT2  -  signal transducer and activator of transcription 2, 113kda, STAT1  -  signal transducer and activator of transcription 1, 91kda, STAT4  -  signal transducer and activator of transcription 4, PROS1  -  protein s (alpha), CRYAB  -  crystallin, alpha b, ADRM1  -  adhesion regulating molecule 1, SSRP1  -  structure specific recognition protein 1, JAK2  -  janus kinase 2, MAP2K1  -  mitogen-activated protein kinase kinase 1, MAP2K3  -  mitogen-activated protein kinase kinase 3, MAPK7  -  mitogen-activated protein kinase 7, SRPK2  -  srsf protein kinase 2, RAB32  -  rab32, member ras oncogene family, PRKG1  -  protein kinase, cgmp-dependent, type i, TRIM21  -  tripartite motif containing 21, COPS2  -  cop9 signalosome subunit 2, NREP  -  neuronal regeneration related protein, GBP1  -  guanylate binding protein 1, interferon-inducible, BAMBI  -  bmp and activin membrane-bound inhibitor, STAM  -  signal transducing adaptor molecule (sh3 domain and itam motif) 1, CSPG4  -  chondroitin sulfate proteoglycan 4, SLC25A4  -  solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4, PRKCA  -  protein kinase c, alpha, GAS6  -  growth arrest-specific 6, GAS1  -  growth arrest-specific 1, APEX1  -  apex nuclease (multifunctional dna repair enzyme) 1, PAWR  -  prkc, apoptosis, wt1, regulator, GSN  -  gelsolin, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), MID1  -  midline 1 (opitz/bbb syndrome), PAX7  -  paired box 7, DDB1  -  damage-specific dna binding protein 1, 127kda, PBX1  -  pre-b-cell leukemia homeobox 1, ANXA6  -  annexin a6, DBP  -  d site of albumin promoter (albumin d-box) binding protein, AFF1  -  af4/fmr2 family, member 1, MSH6  -  muts homolog 6 (e. coli), KMT2A  -  lysine (k)-specific methyltransferase 2a, CRLF1  -  cytokine receptor-like factor 1, UBE2L6  -  ubiquitin-conjugating enzyme e2l 6, DFNA5  -  deafness, autosomal dominant 5, P4HB  -  prolyl 4-hydroxylase, beta polypeptide, PDLIM7  -  pdz and lim domain 7 (enigma), PDCD10  -  programmed cell death 10, RAB22A  -  rab22a, member ras oncogene family, MMP11  -  matrix metallopeptidase 11 (stromelysin 3), FURIN  -  furin (paired basic amino acid cleaving enzyme), ZNF473  -  zinc finger protein 473, APOE  -  apolipoprotein e, APP  -  amyloid beta (a4) precursor protein, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, CD200  -  cd200 molecule, WWOX  -  ww domain containing oxidoreductase, PDGFA  -  platelet-derived growth factor alpha polypeptide, MDK  -  midkine (neurite growth-promoting factor 2), ATXN1  -  ataxin 1, PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, RHOB  -  ras homolog family member b, MECP2  -  methyl cpg binding protein 2 (rett syndrome), PDPK1  -  3-phosphoinositide dependent protein kinase-1, PSIP1  -  pc4 and sfrs1 interacting protein 1, ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, ARHGAP1  -  rho gtpase activating protein 1, AMIGO2  -  adhesion molecule with ig-like domain 2, RHOG  -  ras homolog family member g, ZYX  -  zyxin, DAG1  -  dystroglycan 1 (dystrophin-associated glycoprotein 1), KAT8  -  k(lysine) acetyltransferase 8, ASPH  -  aspartate beta-hydroxylase, DAPK1  -  death-associated protein kinase 1, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, CDC37  -  cell division cycle 37, SAT1  -  spermidine/spermine n1-acetyltransferase 1, HDAC1  -  histone deacetylase 1, PKIG  -  protein kinase (camp-dependent, catalytic) inhibitor gamma, KAT7  -  k(lysine) acetyltransferase 7, SALL2  -  sal-like 2 (drosophila), ATP2B1  -  atpase, ca++ transporting, plasma membrane 1, RFK  -  riboflavin kinase, CDK14  -  cyclin-dependent kinase 14, SMC3  -  structural maintenance of chromosomes 3, SLC16A3  -  solute carrier family 16 (monocarboxylate transporter), member 3, ATP1B1  -  atpase, na+/k+ transporting, beta 1 polypeptide, ZHX2  -  zinc fingers and homeoboxes 2, GPC1  -  glypican 1, RAB14  -  rab14, member ras oncogene family, GPI  -  glucose-6-phosphate isomerase, DPYSL2  -  dihydropyrimidinase-like 2, MLXIP  -  mlx interacting protein, SLC12A2  -  solute carrier family 12 (sodium/potassium/chloride transporter), member 2, PEX6  -  peroxisomal biogenesis factor 6, WEE1  -  wee1 homolog (s. pombe), SLC2A1  -  solute carrier family 2 (facilitated glucose transporter), member 1, ATP6V1B1  -  atpase, h+ transporting, lysosomal 56/58kda, v1 subunit b1, WNT5A  -  wingless-type mmtv integration site family, member 5a, DVL3  -  dishevelled segment polarity protein 3, GULP1  -  gulp, engulfment adaptor ptb domain containing 1, TSC22D3  -  tsc22 domain family, member 3, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, PFDN1  -  prefoldin subunit 1, DLD  -  dihydrolipoamide dehydrogenase, BAG1  -  bcl2-associated athanogene, SHH  -  sonic hedgehog, GPX1  -  glutathione peroxidase 1, ATF5  -  activating transcription factor 5, PLAT  -  plasminogen activator, tissue, LUM  -  lumican, PLAGL1  -  pleiomorphic adenoma gene-like 1, UBA3  -  ubiquitin-like modifier activating enzyme 3, ATR  -  ataxia telangiectasia and rad3 related, BCAM  -  basal cell adhesion molecule (lutheran blood group), MPZL1  -  myelin protein zero-like 1, BDKRB2  -  bradykinin receptor b2, MGLL  -  monoglyceride lipase, SERPINE2  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 2, SERPINB9  -  serpin peptidase inhibitor, clade b (ovalbumin), member 9, TDP2  -  tyrosyl-dna phosphodiesterase 2, SERPINB6  -  serpin peptidase inhibitor, clade b (ovalbumin), member 6, PHB2  -  prohibitin 2, DMD  -  dystrophin, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, YES1  -  v-yes-1 yamaguchi sarcoma viral oncogene homolog 1, CXCL1  -  chemokine (c-x-c motif) ligand 1 (melanoma growth stimulating activity, alpha), DMPK  -  dystrophia myotonica-protein kinase, SCG5  -  secretogranin v (7b2 protein), SGK1  -  serum/glucocorticoid regulated kinase 1, GSK3B  -  glycogen synthase kinase 3 beta, SMAD6  -  smad family member 6, PIGR  -  polymeric immunoglobulin receptor, SH3BGR  -  sh3 domain binding glutamic acid-rich protein, ITSN1  -  intersectin 1 (sh3 domain protein), MAF  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog, YAF2  -  yy1 associated factor 2, NCBP2  -  nuclear cap binding protein subunit 2, 20kda, BNIP3  -  bcl2/adenovirus e1b 19kda interacting protein 3, HSF2  -  heat shock transcription factor 2, NDN  -  necdin, melanoma antigen (mage) family member, RFC2  -  replication factor c (activator 1) 2, 40kda, BNIP2  -  bcl2/adenovirus e1b 19kda interacting protein 2, NCK1  -  nck adaptor protein 1, ELF4  -  e74-like factor 4 (ets domain transcription factor), TRAK1  -  trafficking protein, kinesin binding 1, ELN  -  elastin, TSC22D4  -  tsc22 domain family, member 4, TICAM1  -  toll-like receptor adaptor molecule 1, IQGAP1  -  iq motif containing gtpase activating protein 1, ATF6  -  activating transcription factor 6, HRAS  -  harvey rat sarcoma viral oncogene homolog, NBN  -  nibrin, NBL1  -  neuroblastoma 1, dan family bmp antagonist, RIT1  -  ras-like without caax 1, EIF4A2  -  eukaryotic translation initiation factor 4a2, RRAGB  -  ras-related gtp binding b, TUBA4A  -  tubulin, alpha 4a, EIF4B  -  eukaryotic translation initiation factor 4b, CFB  -  complement factor b, PPP1R12B  -  protein phosphatase 1, regulatory subunit 12b, PIKFYVE  -  phosphoinositide kinase, fyve finger containing, NDEL1  -  nude neurodevelopment protein 1-like 1, BMP1  -  bone morphogenetic protein 1, RGS7  -  regulator of g-protein signaling 7, MYLK  -  myosin light chain kinase, RGS3  -  regulator of g-protein signaling 3, BMPR1A  -  bone morphogenetic protein receptor, type ia, ASAP2  -  arfgap with sh3 domain, ankyrin repeat and ph domain 2, EIF4G1  -  eukaryotic translation initiation factor 4 gamma, 1, BMP4  -  bone morphogenetic protein 4, RGS16  -  regulator of g-protein signaling 16, C9  -  complement component 9, TPM2  -  tropomyosin 2 (beta), STK38L  -  serine/threonine kinase 38 like, MYH10  -  myosin, heavy chain 10, non-muscle, EGFR  -  epidermal growth factor receptor, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, EFNB2  -  ephrin-b2, RNF2  -  ring finger protein 2, EFNB1  -  ephrin-b1, ROCK1  -  rho-associated, coiled-coil containing protein kinase 1, ARPC2  -  actin related protein 2/3 complex, subunit 2, 34kda, SERPING1  -  serpin peptidase inhibitor, clade g (c1 inhibitor), member 1, CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, C1R  -  complement component 1, r subcomponent, C1S  -  complement component 1, s subcomponent, C4A  -  complement component 4a (rodgers blood group), TRAF2  -  tnf receptor-associated factor 2, MBD2  -  methyl-cpg binding domain protein 2, ECE1  -  endothelin converting enzyme 1, EFS  -  embryonal fyn-associated substrate, RAB7L1  -  rab7, member ras oncogene family-like 1, OPTN  -  optineurin, TRAP1  -  tnf receptor-associated protein 1, ERC1  -  elks/rab6-interacting/cast family member 1, CAPZA2  -  capping protein (actin filament) muscle z-line, alpha 2, AKR1C3  -  aldo-keto reductase family 1, member c3, ACAA2  -  acetyl-coa acyltransferase 2, PDE5A  -  phosphodiesterase 5a, cgmp-specific, OSTF1  -  osteoclast stimulating factor 1, CAMK2G  -  calcium/calmodulin-dependent protein kinase ii gamma, SIK1  -  salt-inducible kinase 1, EIF3D  -  eukaryotic translation initiation factor 3, subunit d, SPG20  -  spastic paraplegia 20 (troyer syndrome), EIF4G3  -  eukaryotic translation initiation factor 4 gamma, 3, CASP4  -  caspase 4, apoptosis-related cysteine peptidase, COL14A1  -  collagen, type xiv, alpha 1, TANK  -  traf family member-associated nfkb activator, UNG  -  uracil-dna glycosylase, RPA3  -  replication protein a3, 14kda, TAB2  -  tgf-beta activated kinase 1/map3k7 binding protein 2, GPNMB  -  glycoprotein (transmembrane) nmb, HMGXB4  -  hmg box domain containing 4, CAP1  -  cap, adenylate cyclase-associated protein 1 (yeast), PLXND1  -  plexin d1, EIF3M  -  eukaryotic translation initiation factor 3, subunit m, VEGFC  -  vascular endothelial growth factor c, EZR  -  ezrin, EPB41L3  -  erythrocyte membrane protein band 4.1-like 3, DDR1  -  discoidin domain receptor tyrosine kinase 1, CREB3L1  -  camp responsive element binding protein 3-like 1, CFH  -  complement factor h, PTRF  -  polymerase i and transcript release factor, CFHR1  -  complement factor h-related 1, HSPB6  -  heat shock protein, alpha-crystallin-related, b6, EZH2  -  enhancer of zeste homolog 2 (drosophila), VCAM1  -  vascular cell adhesion molecule 1, HIVEP1  -  human immunodeficiency virus type i enhancer binding protein 1, ERF  -  ets2 repressor factor, MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), MYCBP  -  myc binding protein, UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, CTNNAL1  -  catenin (cadherin-associated protein), alpha-like 1, KIAA1199  -  kiaa1199, ARNT2  -  aryl-hydrocarbon receptor nuclear translocator 2, GBF1  -  golgi brefeldin a resistant guanine nucleotide exchange factor 1, CCNG1  -  cyclin g1, HNRNPU  -  heterogeneous nuclear ribonucleoprotein u (scaffold attachment factor a), CD14  -  cd14 molecule, OXSR1  -  oxidative stress responsive 1, DLC1  -  deleted in liver cancer 1, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, TYRO3  -  tyro3 protein tyrosine kinase, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, TNFSF9  -  tumor necrosis factor (ligand) superfamily, member 9, SACS  -  spastic ataxia of charlevoix-saguenay (sacsin), ZMIZ1  -  zinc finger, miz-type containing 1, TXNRD1  -  thioredoxin reductase 1, CBLB  -  cbl proto-oncogene b, e3 ubiquitin protein ligase, UCHL1  -  ubiquitin carboxyl-terminal esterase l1 (ubiquitin thiolesterase), TNFRSF14  -  tumor necrosis factor receptor superfamily, member 14, CAT  -  catalase, CAV2  -  caveolin 2, RUNX1T1  -  runt-related transcription factor 1; translocated to, 1 (cyclin d-related), KRIT1  -  krit1, ankyrin repeat containing, TBC1D1  -  tbc1 (tre-2/usp6, bub2, cdc16) domain family, member 1, RBM14  -  rna binding motif protein 14, CCND2  -  cyclin d2, NUP153  -  nucleoporin 153kda, RRAD  -  ras-related associated with diabetes, NR1D2  -  nuclear receptor subfamily 1, group d, member 2, RRAS  -  related ras viral (r-ras) oncogene homolog, PDLIM5  -  pdz and lim domain 5, SSH1  -  slingshot protein phosphatase 1, CDH2  -  cadherin 2, type 1, n-cadherin (neuronal), TCF12  -  transcription factor 12, CDC34  -  cell division cycle 34, GAB2  -  grb2-associated binding protein 2, FLNA  -  filamin a, alpha, FLNB  -  filamin b, beta, ARC  -  activity-regulated cytoskeleton-associated protein, FARP2  -  ferm, rhogef and pleckstrin domain protein 2, FOXO1  -  forkhead box o1, RGS5  -  regulator of g-protein signaling 5, CDC14B  -  cell division cycle 14b, SIN3B  -  sin3 transcription regulator family member b, FOXC1  -  forkhead box c1, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, DOK5  -  docking protein 5, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, LMO4  -  lim domain only 4, IL1R1  -  interleukin 1 receptor, type i, FOXF2  -  forkhead box f2, UBR2  -  ubiquitin protein ligase e3 component n-recognin 2, PDPN  -  podoplanin, CAMK1  -  calcium/calmodulin-dependent protein kinase i, TDG  -  thymine-dna glycosylase, NUAK1  -  nuak family, snf1-like kinase, 1, DYNLT3  -  dynein, light chain, tctex-type 3, SMG7  -  smg7 nonsense mediated mrna decay factor, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, IL6ST  -  interleukin 6 signal transducer (gp130, oncostatin m receptor), DGKZ  -  diacylglycerol kinase, zeta, TNFRSF11B  -  tumor necrosis factor receptor superfamily, member 11b, ITGA5  -  integrin, alpha 5 (fibronectin receptor, alpha polypeptide), PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), ITGA7  -  integrin, alpha 7, FGFR1  -  fibroblast growth factor receptor 1, ROR2  -  receptor tyrosine kinase-like orphan receptor 2, MAML1  -  mastermind-like 1 (drosophila), ITGA3  -  integrin, alpha 3 (antigen cd49c, alpha 3 subunit of vla-3 receptor), FGF7  -  fibroblast growth factor 7, PTGER1  -  prostaglandin e receptor 1 (subtype ep1), 42kda, ITGB5  -  integrin, beta 5, FGF4  -  fibroblast growth factor 4, FBLN5  -  fibulin 5, GTF2H5  -  general transcription factor iih, polypeptide 5, PTGIR  -  prostaglandin i2 (prostacyclin) receptor (ip), TRIM2  -  tripartite motif containing 2, DDX17  -  dead (asp-glu-ala-asp) box helicase 17, INPPL1  -  inositol polyphosphate phosphatase-like 1, TBX2  -  t-box 2, CDKN1C  -  cyclin-dependent kinase inhibitor 1c (p57, kip2), TBCD  -  tubulin folding cofactor d, SRGAP2  -  slit-robo rho gtpase activating protein 2, CDKN2D  -  cyclin-dependent kinase inhibitor 2d (p19, inhibits cdk4), PTPN1  -  protein tyrosine phosphatase, non-receptor type 1, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), ARL6IP5  -  adp-ribosylation-like factor 6 interacting protein 5, PPAP2B  -  phosphatidic acid phosphatase type 2b, EFEMP1  -  egf containing fibulin-like extracellular matrix protein 1, CDH13  -  cadherin 13, h-cadherin (heart), EIF3E  -  eukaryotic translation initiation factor 3, subunit e, ITGA6  -  integrin, alpha 6, FBLN2  -  fibulin 2, CRCP  -  cgrp receptor component, PTPRF  -  protein tyrosine phosphatase, receptor type, f, CHRND  -  cholinergic receptor, nicotinic, delta (muscle), IFIT1  -  interferon-induced protein with tetratricopeptide repeats 1, IFIT3  -  interferon-induced protein with tetratricopeptide repeats 3, TIMP3  -  timp metallopeptidase inhibitor 3, CHRNB1  -  cholinergic receptor, nicotinic, beta 1 (muscle), IFI27  -  interferon, alpha-inducible protein 27, IFI35  -  interferon-induced protein 35, PTX3  -  pentraxin 3, long, SLC7A8  -  solute carrier family 7 (amino acid transporter light chain, l system), member 8, STRN3  -  striatin, calmodulin binding protein 3, TKT  -  transketolase, TLE1  -  transducin-like enhancer of split 1 (e(sp1) homolog, drosophila), NOV  -  nephroblastoma overexpressed, IFNGR1  -  interferon gamma receptor 1, NOTCH3  -  notch 3, PVRL2  -  poliovirus receptor-related 2 (herpesvirus entry mediator b), ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, HDAC4  -  histone deacetylase 4, ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, NFX1  -  nuclear transcription factor, x-box binding 1, RAB2A  -  rab2a, member ras oncogene family, NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, NFIX  -  nuclear factor i/x (ccaat-binding transcription factor), RAD23B  -  rad23 homolog b (s. cerevisiae), TNFAIP6  -  tumor necrosis factor, alpha-induced protein 6, CGB  -  chorionic gonadotropin, beta polypeptide, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, RAB13  -  rab13, member ras oncogene family, RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), TEK  -  tek tyrosine kinase, endothelial, SUZ12  -  suz12 polycomb repressive complex 2 subunit, RECK  -  reversion-inducing-cysteine-rich protein with kazal motifs, RBPJ  -  recombination signal binding protein for immunoglobulin kappa j region, NFE2L2  -  nuclear factor (erythroid-derived 2)-like 2, ISG15  -  isg15 ubiquitin-like modifier, RARRES3  -  retinoic acid receptor responder (tazarotene induced) 3, FEZ1  -  fasciculation and elongation protein zeta 1 (zygin i), CLU  -  clusterin, RAP1GDS1  -  rap1, gtp-gdp dissociation stimulator 1, TPP1  -  tripeptidyl peptidase i, IGBP1  -  immunoglobulin (cd79a) binding protein 1, RBL2  -  retinoblastoma-like 2 (p130), SMARCA5  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5, IGF1R  -  insulin-like growth factor 1 receptor, IGF2  -  insulin-like growth factor 2 (somatomedin a), TGFB1  -  transforming growth factor, beta 1, OGT  -  o-linked n-acetylglucosamine (glcnac) transferase, TGFB1I1  -  transforming growth factor beta 1 induced transcript 1, TGIF1  -  tgfb-induced factor homeobox 1, TSPYL2  -  tspy-like 2, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), SND1  -  staphylococcal nuclease and tudor domain containing 1, TGFBR3  -  transforming growth factor, beta receptor iii, RBBP4  -  retinoblastoma binding protein 4, CUL4B  -  cullin 4b, CABIN1  -  calcineurin binding protein 1, FNTB  -  farnesyltransferase, caax box, beta, POLD3  -  polymerase (dna-directed), delta 3, accessory subunit, RBP1  -  retinol binding protein 1, cellular]"GO:0030029,actin filament-based process,7.26E-04,6.27E-02,1.83,8230,226,795,40,"[RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), CAPZA2  -  capping protein (actin filament) muscle z-line, alpha 2, PDGFA  -  platelet-derived growth factor alpha polypeptide, CAPZA1  -  capping protein (actin filament) muscle z-line, alpha 1, KRT19  -  keratin 19, TPM2  -  tropomyosin 2 (beta), SSH1  -  slingshot protein phosphatase 1, CNN1  -  calponin 1, basic, smooth muscle, DAAM1  -  dishevelled associated activator of morphogenesis 1, MYH10  -  myosin, heavy chain 10, non-muscle, GSN  -  gelsolin, PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, CFL1  -  cofilin 1 (non-muscle), FGF7  -  fibroblast growth factor 7, PDPK1  -  3-phosphoinositide dependent protein kinase-1, MEF2A  -  myocyte enhancer factor 2a, FLNA  -  filamin a, alpha, FLNB  -  filamin b, beta, DLC1  -  deleted in liver cancer 1, CNN3  -  calponin 3, acidic, NF2  -  neurofibromin 2 (merlin), FARP2  -  ferm, rhogef and pleckstrin domain protein 2, HRAS  -  harvey rat sarcoma viral oncogene homolog, RHOG  -  ras homolog family member g, MYO9B  -  myosin ixb, CAP1  -  cap, adenylate cyclase-associated protein 1 (yeast), ROCK1  -  rho-associated, coiled-coil containing protein kinase 1, ADD1  -  adducin 1 (alpha), EPB41L2  -  erythrocyte membrane protein band 4.1-like 2, PDLIM7  -  pdz and lim domain 7 (enigma), PRKG1  -  protein kinase, cgmp-dependent, type i, EPB41L3  -  erythrocyte membrane protein band 4.1-like 3, BCL6  -  b-cell cll/lymphoma 6, SRGAP2  -  slit-robo rho gtpase activating protein 2, PTPN1  -  protein tyrosine phosphatase, non-receptor type 1, DMD  -  dystrophin, CXCL1  -  chemokine (c-x-c motif) ligand 1 (melanoma growth stimulating activity, alpha), PFDN1  -  prefoldin subunit 1, TNNT3  -  troponin t type 3 (skeletal, fast), RAB13  -  rab13, member ras oncogene family]"GO:0065009,regulation of molecular function,7.40E-04,6.34E-02,1.26,8230,1630,892,222,"[BNIP2  -  bcl2/adenovirus e1b 19kda interacting protein 2, NCK1  -  nck adaptor protein 1, SERPINA3  -  serpin peptidase inhibitor, clade a (alpha-1 antiproteinase, antitrypsin), member 3, TICAM1  -  toll-like receptor adaptor molecule 1, IQGAP1  -  iq motif containing gtpase activating protein 1, HABP4  -  hyaluronan binding protein 4, ATF6  -  activating transcription factor 6, GCH1  -  gtp cyclohydrolase 1, HRAS  -  harvey rat sarcoma viral oncogene homolog, NBN  -  nibrin, TRAF4  -  tnf receptor-associated factor 4, PPP1R12B  -  protein phosphatase 1, regulatory subunit 12b, ACR  -  acrosin, TNK2  -  tyrosine kinase, non-receptor, 2, NDEL1  -  nude neurodevelopment protein 1-like 1, EIF2S1  -  eukaryotic translation initiation factor 2, subunit 1 alpha, 35kda, BID  -  bh3 interacting domain death agonist, PLSCR1  -  phospholipid scramblase 1, RGS7  -  regulator of g-protein signaling 7, PLCB2  -  phospholipase c, beta 2, SOD2  -  superoxide dismutase 2, mitochondrial, SOD1  -  superoxide dismutase 1, soluble, RGS3  -  regulator of g-protein signaling 3, ASAP2  -  arfgap with sh3 domain, ankyrin repeat and ph domain 2, CREB1  -  camp responsive element binding protein 1, SERPINF2  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 2, LMNA  -  lamin a/c, BMP4  -  bone morphogenetic protein 4, RGS16  -  regulator of g-protein signaling 16, ICAM1  -  intercellular adhesion molecule 1, TPM2  -  tropomyosin 2 (beta), CTSA  -  cathepsin a, GADD45B  -  growth arrest and dna-damage-inducible, beta, ADAR  -  adenosine deaminase, rna-specific, EGFR  -  epidermal growth factor receptor, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, MED1  -  mediator complex subunit 1, CNR1  -  cannabinoid receptor 1 (brain), EIF2B4  -  eukaryotic translation initiation factor 2b, subunit 4 delta, 67kda, ADD1  -  adducin 1 (alpha), SERPING1  -  serpin peptidase inhibitor, clade g (c1 inhibitor), member 1, MAPK8IP1  -  mitogen-activated protein kinase 8 interacting protein 1, PARP1  -  poly (adp-ribose) polymerase 1, RRP1B  -  ribosomal rna processing 1b, EDNRA  -  endothelin receptor type a, TAOK3  -  tao kinase 3, FZR1  -  fizzy/cell division cycle 20 related 1 (drosophila), TRAF2  -  tnf receptor-associated factor 2, ERC1  -  elks/rab6-interacting/cast family member 1, PDE5A  -  phosphodiesterase 5a, cgmp-specific, PPP4R1  -  protein phosphatase 4, regulatory subunit 1, SIK1  -  salt-inducible kinase 1, AGT  -  angiotensinogen (serpin peptidase inhibitor, clade a, member 8), CAST  -  calpastatin, TAB2  -  tgf-beta activated kinase 1/map3k7 binding protein 2, CTSH  -  cathepsin h, CAP1  -  cap, adenylate cyclase-associated protein 1 (yeast), PLXND1  -  plexin d1, WWP2  -  ww domain containing e3 ubiquitin protein ligase 2, STK3  -  serine/threonine kinase 3, PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, EZH2  -  enhancer of zeste homolog 2 (drosophila), ARHGAP29  -  rho gtpase activating protein 29, SNX13  -  sorting nexin 13, MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), CRKL  -  v-crk avian sarcoma virus ct10 oncogene homolog-like, TRADD  -  tnfrsf1a-associated via death domain, FOSL1  -  fos-like antigen 1, JUN  -  jun proto-oncogene, UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, KIAA1199  -  kiaa1199, SLIT2  -  slit homolog 2 (drosophila), PROS1  -  protein s (alpha), PRNP  -  prion protein, CRYAB  -  crystallin, alpha b, CCNG1  -  cyclin g1, GBF1  -  golgi brefeldin a resistant guanine nucleotide exchange factor 1, ADRM1  -  adhesion regulating molecule 1, TNFSF4  -  tumor necrosis factor (ligand) superfamily, member 4, JAK2  -  janus kinase 2, DLC1  -  deleted in liver cancer 1, RPS6KA3  -  ribosomal protein s6 kinase, 90kda, polypeptide 3, MAP2K1  -  mitogen-activated protein kinase kinase 1, MAP2K3  -  mitogen-activated protein kinase kinase 3, MAPK10  -  mitogen-activated protein kinase 10, MAPK7  -  mitogen-activated protein kinase 7, UCHL1  -  ubiquitin carboxyl-terminal esterase l1 (ubiquitin thiolesterase), MVP  -  major vault protein, MAPK3  -  mitogen-activated protein kinase 3, GNB2L1  -  guanine nucleotide binding protein (g protein), beta polypeptide 2-like 1, CAT  -  catalase, PLCE1  -  phospholipase c, epsilon 1, PRKG1  -  protein kinase, cgmp-dependent, type i, TRIM21  -  tripartite motif containing 21, FADD  -  fas (tnfrsf6)-associated via death domain, RUNX1T1  -  runt-related transcription factor 1; translocated to, 1 (cyclin d-related), BAMBI  -  bmp and activin membrane-bound inhibitor, KRIT1  -  krit1, ankyrin repeat containing, PRKCG  -  protein kinase c, gamma, CCND2  -  cyclin d2, CSPG4  -  chondroitin sulfate proteoglycan 4, PRKCA  -  protein kinase c, alpha, CBS  -  cystathionine-beta-synthase, GAS6  -  growth arrest-specific 6, GSTM2  -  glutathione s-transferase mu 2 (muscle), DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), HEXIM1  -  hexamethylene bis-acetamide inducible 1, PAX7  -  paired box 7, PBX1  -  pre-b-cell leukemia homeobox 1, HTRA2  -  htra serine peptidase 2, FLNA  -  filamin a, alpha, CYTH3  -  cytohesin 3, GTF2H1  -  general transcription factor iih, polypeptide 1, 62kda, PSMA1  -  proteasome (prosome, macropain) subunit, alpha type, 1, FARP2  -  ferm, rhogef and pleckstrin domain protein 2, RGS5  -  regulator of g-protein signaling 5, MSH6  -  muts homolog 6 (e. coli), KMT2A  -  lysine (k)-specific methyltransferase 2a, CDC14B  -  cell division cycle 14b, FOXC1  -  forkhead box c1, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, PSMB9  -  proteasome (prosome, macropain) subunit, beta type, 9, PDCD10  -  programmed cell death 10, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, FURIN  -  furin (paired basic amino acid cleaving enzyme), PSMB4  -  proteasome (prosome, macropain) subunit, beta type, 4, CAND1  -  cullin-associated and neddylation-dissociated 1, TDG  -  thymine-dna glycosylase, CAMK1  -  calcium/calmodulin-dependent protein kinase i, APOE  -  apolipoprotein e, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, APP  -  amyloid beta (a4) precursor protein, NUAK1  -  nuak family, snf1-like kinase, 1, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, AQP1  -  aquaporin 1 (colton blood group), PDGFA  -  platelet-derived growth factor alpha polypeptide, PSMD11  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 11, PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), FGFR1  -  fibroblast growth factor receptor 1, DDR2  -  discoidin domain receptor tyrosine kinase 2, PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, PDPK1  -  3-phosphoinositide dependent protein kinase-1, FGF2  -  fibroblast growth factor 2 (basic), PTGIR  -  prostaglandin i2 (prostacyclin) receptor (ip), ARHGDIA  -  rho gdp dissociation inhibitor (gdi) alpha, SERPINF1  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 1, RHOG  -  ras homolog family member g, PCOLCE  -  procollagen c-endopeptidase enhancer, PTN  -  pleiotrophin, NPR3  -  natriuretic peptide receptor c/guanylate cyclase c (atrionatriuretic peptide receptor c), CDKN1C  -  cyclin-dependent kinase inhibitor 1c (p57, kip2), TBCD  -  tubulin folding cofactor d, CDKN2D  -  cyclin-dependent kinase inhibitor 2d (p19, inhibits cdk4), ASPH  -  aspartate beta-hydroxylase, SRGAP2  -  slit-robo rho gtpase activating protein 2, DAPK1  -  death-associated protein kinase 1, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), ARL6IP5  -  adp-ribosylation-like factor 6 interacting protein 5, CDC37  -  cell division cycle 37, PPAP2B  -  phosphatidic acid phosphatase type 2b, PKIG  -  protein kinase (camp-dependent, catalytic) inhibitor gamma, IRAK1  -  interleukin-1 receptor-associated kinase 1, IFIT1  -  interferon-induced protein with tetratricopeptide repeats 1, TIMP3  -  timp metallopeptidase inhibitor 3, IFI16  -  interferon, gamma-inducible protein 16, IFI27  -  interferon, alpha-inducible protein 27, RFK  -  riboflavin kinase, AHCYL1  -  adenosylhomocysteinase-like 1, GPI  -  glucose-6-phosphate isomerase, ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, HDAC4  -  histone deacetylase 4, ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, NGF  -  nerve growth factor (beta polypeptide), NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, WNT5A  -  wingless-type mmtv integration site family, member 5a, DVL3  -  dishevelled segment polarity protein 3, TOR1AIP1  -  torsin a interacting protein 1, TNNT3  -  troponin t type 3 (skeletal, fast), TEK  -  tek tyrosine kinase, endothelial, RAN  -  ran, member ras oncogene family, RECK  -  reversion-inducing-cysteine-rich protein with kazal motifs, SHH  -  sonic hedgehog, GPX1  -  glutathione peroxidase 1, TERF1  -  telomeric repeat binding factor (nima-interacting) 1, PLAU  -  plasminogen activator, urokinase, NF2  -  neurofibromin 2 (merlin), CLU  -  clusterin, RAP1GDS1  -  rap1, gtp-gdp dissociation stimulator 1, ATR  -  ataxia telangiectasia and rad3 related, TPP1  -  tripeptidyl peptidase i, RBL2  -  retinoblastoma-like 2 (p130), IGBP1  -  immunoglobulin (cd79a) binding protein 1, SFRP1  -  secreted frizzled-related protein 1, SERPINE2  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 2, IGF1R  -  insulin-like growth factor 1 receptor, IGF2  -  insulin-like growth factor 2 (somatomedin a), SERPINB9  -  serpin peptidase inhibitor, clade b (ovalbumin), member 9, TGFB1  -  transforming growth factor, beta 1, SMAD2  -  smad family member 2, DNM2  -  dynamin 2, OGT  -  o-linked n-acetylglucosamine (glcnac) transferase, IGFBP1  -  insulin-like growth factor binding protein 1, SERPINB6  -  serpin peptidase inhibitor, clade b (ovalbumin), member 6, BCL6  -  b-cell cll/lymphoma 6, TSPYL2  -  tspy-like 2, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), TGFBR3  -  transforming growth factor, beta receptor iii, RPS6KA4  -  ribosomal protein s6 kinase, 90kda, polypeptide 4, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, DMD  -  dystrophin, FOS  -  fbj murine osteosarcoma viral oncogene homolog, CXCL1  -  chemokine (c-x-c motif) ligand 1 (melanoma growth stimulating activity, alpha), DMPK  -  dystrophia myotonica-protein kinase, CABIN1  -  calcineurin binding protein 1, SGK1  -  serum/glucocorticoid regulated kinase 1, SMAD3  -  smad family member 3, CCND1  -  cyclin d1, GSK3B  -  glycogen synthase kinase 3 beta, ITSN1  -  intersectin 1 (sh3 domain protein)]"GO:0055086,nucleobase-containing small molecule metabolic process,7.50E-04,6.38E-02,1.75,8230,357,634,48,"[MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), RAB33A  -  rab33a, member ras oncogene family, NADK  -  nad kinase, PAICS  -  phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase, RFK  -  riboflavin kinase, RAB9A  -  rab9a, member ras oncogene family, PRPS1  -  phosphoribosyl pyrophosphate synthetase 1, PDE5A  -  phosphodiesterase 5a, cgmp-specific, MYH10  -  myosin, heavy chain 10, non-muscle, GPX1  -  glutathione peroxidase 1, TKT  -  transketolase, PGD  -  phosphogluconate dehydrogenase, TBPL1  -  tbp-like 1, SEPT5  -  septin 5, NME4  -  nme/nm23 nucleoside diphosphate kinase 4, RHOB  -  ras homolog family member b, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, RAB14  -  rab14, member ras oncogene family, ADA  -  adenosine deaminase, GTF2H1  -  general transcription factor iih, polypeptide 1, 62kda, DDX17  -  dead (asp-glu-ala-asp) box helicase 17, CTPS1  -  ctp synthase 1, DPYSL2  -  dihydropyrimidinase-like 2, FDXR  -  ferredoxin reductase, HRAS  -  harvey rat sarcoma viral oncogene homolog, RPE  -  ribulose-5-phosphate-3-epimerase, MSH6  -  muts homolog 6 (e. coli), RHOG  -  ras homolog family member g, TXNRD1  -  thioredoxin reductase 1, PEX6  -  peroxisomal biogenesis factor 6, RIT1  -  ras-like without caax 1, AK2  -  adenylate kinase 2, SMARCA5  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5, TGFB1  -  transforming growth factor, beta 1, RAB2A  -  rab2a, member ras oncogene family, CAT  -  catalase, SULT2B1  -  sulfotransferase family, cytosolic, 2b, member 1, ATP6V1B1  -  atpase, h+ transporting, lysosomal 56/58kda, v1 subunit b1, SMARCA2  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, RBBP4  -  retinoblastoma binding protein 4, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, TDG  -  thymine-dna glycosylase, ADM  -  adrenomedullin, TNNT3  -  troponin t type 3 (skeletal, fast), MPG  -  n-methylpurine-dna glycosylase, IDH3B  -  isocitrate dehydrogenase 3 (nad+) beta, RAB7L1  -  rab7, member ras oncogene family-like 1, RAB13  -  rab13, member ras oncogene family]"GO:0032269,negative regulation of cellular protein metabolic process,7.55E-04,6.37E-02,1.55,8230,389,970,71,"[TRIM27  -  tripartite motif containing 27, FMR1  -  fragile x mental retardation 1, TIMP3  -  timp metallopeptidase inhibitor 3, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, NCK1  -  nck adaptor protein 1, HEXIM1  -  hexamethylene bis-acetamide inducible 1, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), PSEN2  -  presenilin 2 (alzheimer disease 4), PSMA1  -  proteasome (prosome, macropain) subunit, alpha type, 1, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, PSMB9  -  proteasome (prosome, macropain) subunit, beta type, 9, SOX4  -  sry (sex determining region y)-box 4, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, FURIN  -  furin (paired basic amino acid cleaving enzyme), PSMB4  -  proteasome (prosome, macropain) subunit, beta type, 4, PRMT3  -  protein arginine methyltransferase 3, PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, APOE  -  apolipoprotein e, RGS3  -  regulator of g-protein signaling 3, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, BMP4  -  bone morphogenetic protein 4, SNTA1  -  syntrophin, alpha 1, PSMD11  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 11, DDIT4  -  dna-damage-inducible transcript 4, PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), ST13  -  suppression of tumorigenicity 13 (colon carcinoma) (hsp70 interacting protein), GADD45B  -  growth arrest and dna-damage-inducible, beta, JUN  -  jun proto-oncogene, SHH  -  sonic hedgehog, UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, SLIT2  -  slit homolog 2 (drosophila), PRNP  -  prion protein, HMG20B  -  high mobility group 20b, MECP2  -  methyl cpg binding protein 2 (rett syndrome), ADAR  -  adenosine deaminase, rna-specific, PDPK1  -  3-phosphoinositide dependent protein kinase-1, PLAT  -  plasminogen activator, tissue, FXR1  -  fragile x mental retardation, autosomal homolog 1, SAMD4A  -  sterile alpha motif domain containing 4a, ISG15  -  isg15 ubiquitin-like modifier, NF2  -  neurofibromin 2 (merlin), EIF2B4  -  eukaryotic translation initiation factor 2b, subunit 4 delta, 67kda, IGBP1  -  immunoglobulin (cd79a) binding protein 1, SFRP1  -  secreted frizzled-related protein 1, BDKRB2  -  bradykinin receptor b2, IGF1R  -  insulin-like growth factor 1 receptor, SERPINE2  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 2, TGFB1  -  transforming growth factor, beta 1, UCHL1  -  ubiquitin carboxyl-terminal esterase l1 (ubiquitin thiolesterase), EIF4E2  -  eukaryotic translation initiation factor 4e family member 2, MVP  -  major vault protein, GNB2L1  -  guanine nucleotide binding protein (g protein), beta polypeptide 2-like 1, CDKN1C  -  cyclin-dependent kinase inhibitor 1c (p57, kip2), TRIM21  -  tripartite motif containing 21, CDKN2D  -  cyclin-dependent kinase inhibitor 2d (p19, inhibits cdk4), DAPK1  -  death-associated protein kinase 1, MAPK8IP1  -  mitogen-activated protein kinase 8 interacting protein 1, DMD  -  dystrophin, TAOK3  -  tao kinase 3, PRKCG  -  protein kinase c, gamma, FZR1  -  fizzy/cell division cycle 20 related 1 (drosophila), PPAP2B  -  phosphatidic acid phosphatase type 2b, PRKCA  -  protein kinase c, alpha, SMAD3  -  smad family member 3, EIF3E  -  eukaryotic translation initiation factor 3, subunit e, PRKAR1B  -  protein kinase, camp-dependent, regulatory, type i, beta, GSK3B  -  glycogen synthase kinase 3 beta, SMAD6  -  smad family member 6, PKIG  -  protein kinase (camp-dependent, catalytic) inhibitor gamma]"GO:0010035,response to inorganic substance,7.55E-04,6.32E-02,1.71,8230,274,861,49,"[APEX1  -  apex nuclease (multifunctional dna repair enzyme) 1, AKR1C3  -  aldo-keto reductase family 1, member c3, BNIP3  -  bcl2/adenovirus e1b 19kda interacting protein 3, GSN  -  gelsolin, SYT1  -  synaptotagmin i, CAMK2B  -  calcium/calmodulin-dependent protein kinase ii beta, IQGAP1  -  iq motif containing gtpase activating protein 1, FOXO1  -  forkhead box o1, KCNMB1  -  potassium large conductance calcium-activated channel, subfamily m, beta member 1, ID2  -  inhibitor of dna binding 2, dominant negative helix-loop-helix protein, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, NGF  -  nerve growth factor (beta polypeptide), WNT5A  -  wingless-type mmtv integration site family, member 5a, SOD2  -  superoxide dismutase 2, mitochondrial, SOD1  -  superoxide dismutase 1, soluble, VCAM1  -  vascular cell adhesion molecule 1, AQP1  -  aquaporin 1 (colton blood group), TNFRSF11B  -  tumor necrosis factor receptor superfamily, member 11b, PDGFA  -  platelet-derived growth factor alpha polypeptide, CRIP1  -  cysteine-rich protein 1 (intestinal), ICAM1  -  intercellular adhesion molecule 1, FOSL1  -  fos-like antigen 1, JUN  -  jun proto-oncogene, SHH  -  sonic hedgehog, STAT1  -  signal transducer and activator of transcription 1, 91kda, EEF1A2  -  eukaryotic translation elongation factor 1 alpha 2, GPX1  -  glutathione peroxidase 1, PRNP  -  prion protein, CRYAB  -  crystallin, alpha b, RHOB  -  ras homolog family member b, MEF2A  -  myocyte enhancer factor 2a, NFE2L2  -  nuclear factor (erythroid-derived 2)-like 2, EGFR  -  epidermal growth factor receptor, TNFSF4  -  tumor necrosis factor (ligand) superfamily, member 4, CD14  -  cd14 molecule, NDRG1  -  n-myc downstream regulated 1, ADA  -  adenosine deaminase, KRT14  -  keratin 14, PTGES  -  prostaglandin e synthase, MAPK7  -  mitogen-activated protein kinase 7, CAT  -  catalase, CACNA1H  -  calcium channel, voltage-dependent, t type, alpha 1h subunit, ASS1  -  argininosuccinate synthase 1, ASPH  -  aspartate beta-hydroxylase, FOS  -  fbj murine osteosarcoma viral oncogene homolog, FNTB  -  farnesyltransferase, caax box, beta, FSTL3  -  follistatin-like 3 (secreted glycoprotein), CCND1  -  cyclin d1, GSK3B  -  glycogen synthase kinase 3 beta]"GO:1901861,regulation of muscle tissue development,7.73E-04,6.43E-02,2.83,8230,89,555,17,"[HDAC4  -  histone deacetylase 4, TBX2  -  t-box 2, TGFB1  -  transforming growth factor, beta 1, RBPJ  -  recombination signal binding protein for immunoglobulin kappa j region, FGFR1  -  fibroblast growth factor receptor 1, SHH  -  sonic hedgehog, SOX9  -  sry (sex determining region y)-box 9, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), GPC1  -  glypican 1, GJA1  -  gap junction protein, alpha 1, 43kda, TSC22D3  -  tsc22 domain family, member 3, COL14A1  -  collagen, type xiv, alpha 1, DDX17  -  dead (asp-glu-ala-asp) box helicase 17, EFNB2  -  ephrin-b2, NR1D2  -  nuclear receptor subfamily 1, group d, member 2, BMP4  -  bone morphogenetic protein 4]"GO:2000121,regulation of removal of superoxide radicals,8.01E-04,6.61E-02,67.46,8230,4,61,2,"[NFE2L2  -  nuclear factor (erythroid-derived 2)-like 2, FBLN5  -  fibulin 5]"GO:0060391,positive regulation of SMAD protein import into nucleus,8.06E-04,6.60E-02,7.91,8230,10,520,5,"[PARP1  -  poly (adp-ribose) polymerase 1, RBPMS  -  rna binding protein with multiple splicing, TGFB1  -  transforming growth factor, beta 1, BMPR1A  -  bone morphogenetic protein receptor, type ia, BMP4  -  bone morphogenetic protein 4]"GO:0002053,positive regulation of mesenchymal cell proliferation,8.07E-04,6.56E-02,4.45,8230,32,520,9,"[PDGFA  -  platelet-derived growth factor alpha polypeptide, FGFR1  -  fibroblast growth factor receptor 1, BMPR1A  -  bone morphogenetic protein receptor, type ia, SHH  -  sonic hedgehog, SOX9  -  sry (sex determining region y)-box 9, STAT1  -  signal transducer and activator of transcription 1, 91kda, GAS1  -  growth arrest-specific 1, WNT5A  -  wingless-type mmtv integration site family, member 5a, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda)]"GO:0030168,platelet activation,8.37E-04,6.76E-02,2.17,8230,186,531,26,"[PDGFA  -  platelet-derived growth factor alpha polypeptide, ACTN1  -  actinin, alpha 1, PPIA  -  peptidylprolyl isomerase a (cyclophilin a), PROS1  -  protein s (alpha), RHOB  -  ras homolog family member b, PDPK1  -  3-phosphoinositide dependent protein kinase-1, FLNA  -  filamin a, alpha, TYRO3  -  tyro3 protein tyrosine kinase, CLU  -  clusterin, RHOG  -  ras homolog family member g, TUBA4A  -  tubulin, alpha 4a, CAP1  -  cap, adenylate cyclase-associated protein 1 (yeast), MGLL  -  monoglyceride lipase, VEGFC  -  vascular endothelial growth factor c, IGF2  -  insulin-like growth factor 2 (somatomedin a), TGFB1  -  transforming growth factor, beta 1, SERPING1  -  serpin peptidase inhibitor, clade g (c1 inhibitor), member 1, PLSCR1  -  phospholipid scramblase 1, PTPN1  -  protein tyrosine phosphatase, non-receptor type 1, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, APP  -  amyloid beta (a4) precursor protein, PRKCA  -  protein kinase c, alpha, GAS6  -  growth arrest-specific 6, SERPINF2  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 2, DGKZ  -  diacylglycerol kinase, zeta]"GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,8.38E-04,6.72E-02,3.33,8230,132,262,14,"[RBPMS  -  rna binding protein with multiple splicing, RBPJ  -  recombination signal binding protein for immunoglobulin kappa j region, TGFB1I1  -  transforming growth factor beta 1 induced transcript 1, CDKN1C  -  cyclin-dependent kinase inhibitor 1c (p57, kip2), TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), BAMBI  -  bmp and activin membrane-bound inhibitor, NREP  -  neuronal regeneration related protein, TGFBR3  -  transforming growth factor, beta receptor iii, PARP1  -  poly (adp-ribose) polymerase 1, PDPK1  -  3-phosphoinositide dependent protein kinase-1, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), SPG20  -  spastic paraplegia 20 (troyer syndrome), SMAD6  -  smad family member 6, BMP4  -  bone morphogenetic protein 4]"GO:0051222,positive regulation of protein transport,8.44E-04,6.71E-02,2.34,8230,170,455,22,"[RBPMS  -  rna binding protein with multiple splicing, VEGFC  -  vascular endothelial growth factor c, TGFB1  -  transforming growth factor, beta 1, PPIA  -  peptidylprolyl isomerase a (cyclophilin a), TNFRSF14  -  tumor necrosis factor receptor superfamily, member 14, SHH  -  sonic hedgehog, KIAA1199  -  kiaa1199, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), ASPH  -  aspartate beta-hydroxylase, WNT5A  -  wingless-type mmtv integration site family, member 5a, BAMBI  -  bmp and activin membrane-bound inhibitor, PARP1  -  poly (adp-ribose) polymerase 1, TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), CAMK1  -  calcium/calmodulin-dependent protein kinase i, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, CD14  -  cd14 molecule, FLNA  -  filamin a, alpha, JAK2  -  janus kinase 2, MED1  -  mediator complex subunit 1, GSK3B  -  glycogen synthase kinase 3 beta, GAS6  -  growth arrest-specific 6, BMP4  -  bone morphogenetic protein 4]"GO:0030036,actin cytoskeleton organization,8.59E-04,6.79E-02,1.87,8230,186,854,36,"[RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), PDGFA  -  platelet-derived growth factor alpha polypeptide, CAPZA2  -  capping protein (actin filament) muscle z-line, alpha 2, KRT19  -  keratin 19, CAPZA1  -  capping protein (actin filament) muscle z-line, alpha 1, SSH1  -  slingshot protein phosphatase 1, CNN1  -  calponin 1, basic, smooth muscle, MYH10  -  myosin, heavy chain 10, non-muscle, DAAM1  -  dishevelled associated activator of morphogenesis 1, PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, CFL1  -  cofilin 1 (non-muscle), FGF7  -  fibroblast growth factor 7, PDPK1  -  3-phosphoinositide dependent protein kinase-1, MEF2A  -  myocyte enhancer factor 2a, FLNA  -  filamin a, alpha, FLNB  -  filamin b, beta, DLC1  -  deleted in liver cancer 1, CNN3  -  calponin 3, acidic, NF2  -  neurofibromin 2 (merlin), FARP2  -  ferm, rhogef and pleckstrin domain protein 2, HRAS  -  harvey rat sarcoma viral oncogene homolog, RHOG  -  ras homolog family member g, TRIP10  -  thyroid hormone receptor interactor 10, ROCK1  -  rho-associated, coiled-coil containing protein kinase 1, CAP1  -  cap, adenylate cyclase-associated protein 1 (yeast), ADD1  -  adducin 1 (alpha), EPB41L2  -  erythrocyte membrane protein band 4.1-like 2, PDLIM7  -  pdz and lim domain 7 (enigma), PRKG1  -  protein kinase, cgmp-dependent, type i, EPB41L3  -  erythrocyte membrane protein band 4.1-like 3, BCL6  -  b-cell cll/lymphoma 6, PTPN1  -  protein tyrosine phosphatase, non-receptor type 1, CXCL1  -  chemokine (c-x-c motif) ligand 1 (melanoma growth stimulating activity, alpha), PFDN1  -  prefoldin subunit 1, AQP1  -  aquaporin 1 (colton blood group), RAB13  -  rab13, member ras oncogene family]"GO:0071560,cellular response to transforming growth factor beta stimulus,8.61E-04,6.75E-02,3.54,8230,138,219,13,"[PDGFA  -  platelet-derived growth factor alpha polypeptide, ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, MAPK7  -  mitogen-activated protein kinase 7, SOX9  -  sry (sex determining region y)-box 9, TGIF1  -  tgfb-induced factor homeobox 1, BAMBI  -  bmp and activin membrane-bound inhibitor, TGFBR3  -  transforming growth factor, beta receptor iii, PARP1  -  poly (adp-ribose) polymerase 1, NCOR2  -  nuclear receptor corepressor 2, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, SMAD6  -  smad family member 6, WWOX  -  ww domain containing oxidoreductase, HDAC1  -  histone deacetylase 1]"GO:0048870,cell motility,8.61E-04,6.71E-02,1.62,8230,518,598,61,"[NDN  -  necdin, melanoma antigen (mage) family member, NCK1  -  nck adaptor protein 1, SLC7A8  -  solute carrier family 7 (amino acid transporter light chain, l system), member 8, CDH2  -  cadherin 2, type 1, n-cadherin (neuronal), SLC16A3  -  solute carrier family 16 (monocarboxylate transporter), member 3, ATP1B1  -  atpase, na+/k+ transporting, beta 1 polypeptide, CD151  -  cd151 molecule (raph blood group), LGALS3  -  lectin, galactoside-binding, soluble, 3, ARC  -  activity-regulated cytoskeleton-associated protein, HRAS  -  harvey rat sarcoma viral oncogene homolog, CAP1  -  cap, adenylate cyclase-associated protein 1 (yeast), ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, FOXC1  -  forkhead box c1, PLXND1  -  plexin d1, VEGFC  -  vascular endothelial growth factor c, NDEL1  -  nude neurodevelopment protein 1-like 1, WNT5A  -  wingless-type mmtv integration site family, member 5a, DDR1  -  discoidin domain receptor tyrosine kinase 1, PLTP  -  phospholipid transfer protein, SORD  -  sorbitol dehydrogenase, GJA1  -  gap junction protein, alpha 1, 43kda, VCAM1  -  vascular cell adhesion molecule 1, RAB13  -  rab13, member ras oncogene family, DGKZ  -  diacylglycerol kinase, zeta, ITGA5  -  integrin, alpha 5 (fibronectin receptor, alpha polypeptide), TEK  -  tek tyrosine kinase, endothelial, ITGA7  -  integrin, alpha 7, PPIA  -  peptidylprolyl isomerase a (cyclophilin a), FGFR1  -  fibroblast growth factor receptor 1, SHH  -  sonic hedgehog, MDK  -  midkine (neurite growth-promoting factor 2), MYH10  -  myosin, heavy chain 10, non-muscle, GPX1  -  glutathione peroxidase 1, PROS1  -  protein s (alpha), ITGA3  -  integrin, alpha 3 (antigen cd49c, alpha 3 subunit of vla-3 receptor), PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, SEMA3C  -  sema domain, immunoglobulin domain (ig), short basic domain, secreted, (semaphorin) 3c, PLAT  -  plasminogen activator, tissue, EGFR  -  epidermal growth factor receptor, HTR2B  -  5-hydroxytryptamine (serotonin) receptor 2b, g protein-coupled, TYRO3  -  tyro3 protein tyrosine kinase, EFNB2  -  ephrin-b2, EFNB1  -  ephrin-b1, MAP2K1  -  mitogen-activated protein kinase kinase 1, RHOG  -  ras homolog family member g, ROCK1  -  rho-associated, coiled-coil containing protein kinase 1, TGFB1  -  transforming growth factor, beta 1, PRKG1  -  protein kinase, cgmp-dependent, type i, BAMBI  -  bmp and activin membrane-bound inhibitor, TGFBR3  -  transforming growth factor, beta receptor iii, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, YES1  -  v-yes-1 yamaguchi sarcoma viral oncogene homolog 1, CXCL1  -  chemokine (c-x-c motif) ligand 1 (melanoma growth stimulating activity, alpha), PPAP2B  -  phosphatidic acid phosphatase type 2b, CDH13  -  cadherin 13, h-cadherin (heart), LAMA5  -  laminin, alpha 5, CSPG4  -  chondroitin sulfate proteoglycan 4, PRKCA  -  protein kinase c, alpha, GSK3B  -  glycogen synthase kinase 3 beta, GAS6  -  growth arrest-specific 6, ITGA6  -  integrin, alpha 6]"GO:0051248,negative regulation of protein metabolic process,8.81E-04,6.81E-02,1.5,8230,446,970,79,"[TRIM27  -  tripartite motif containing 27, FMR1  -  fragile x mental retardation 1, TIMP3  -  timp metallopeptidase inhibitor 3, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, NCK1  -  nck adaptor protein 1, HEXIM1  -  hexamethylene bis-acetamide inducible 1, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), INHBA  -  inhibin, beta a, FLNA  -  filamin a, alpha, CD59  -  cd59 molecule, complement regulatory protein, PSEN2  -  presenilin 2 (alzheimer disease 4), PSMA1  -  proteasome (prosome, macropain) subunit, alpha type, 1, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, PSMB9  -  proteasome (prosome, macropain) subunit, beta type, 9, SOX4  -  sry (sex determining region y)-box 4, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, FURIN  -  furin (paired basic amino acid cleaving enzyme), PSMB4  -  proteasome (prosome, macropain) subunit, beta type, 4, PRMT3  -  protein arginine methyltransferase 3, PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, APOE  -  apolipoprotein e, RGS3  -  regulator of g-protein signaling 3, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, ATP2B4  -  atpase, ca++ transporting, plasma membrane 4, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, SERPINF2  -  serpin peptidase inhibitor, clade f (alpha-2 antiplasmin, pigment epithelium derived factor), member 2, BMP4  -  bone morphogenetic protein 4, SNTA1  -  syntrophin, alpha 1, PSMD11  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 11, DDIT4  -  dna-damage-inducible transcript 4, PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), ST13  -  suppression of tumorigenicity 13 (colon carcinoma) (hsp70 interacting protein), GADD45B  -  growth arrest and dna-damage-inducible, beta, JUN  -  jun proto-oncogene, SHH  -  sonic hedgehog, UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, SLIT2  -  slit homolog 2 (drosophila), PRNP  -  prion protein, HMG20B  -  high mobility group 20b, MECP2  -  methyl cpg binding protein 2 (rett syndrome), ADAR  -  adenosine deaminase, rna-specific, PDPK1  -  3-phosphoinositide dependent protein kinase-1, PLAT  -  plasminogen activator, tissue, EGFR  -  epidermal growth factor receptor, FXR1  -  fragile x mental retardation, autosomal homolog 1, SAMD4A  -  sterile alpha motif domain containing 4a, ISG15  -  isg15 ubiquitin-like modifier, NF2  -  neurofibromin 2 (merlin), EIF2B4  -  eukaryotic translation initiation factor 2b, subunit 4 delta, 67kda, IGBP1  -  immunoglobulin (cd79a) binding protein 1, SFRP1  -  secreted frizzled-related protein 1, BDKRB2  -  bradykinin receptor b2, IGF1R  -  insulin-like growth factor 1 receptor, SERPINE2  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 2, TGFB1  -  transforming growth factor, beta 1, UCHL1  -  ubiquitin carboxyl-terminal esterase l1 (ubiquitin thiolesterase), MVP  -  major vault protein, EIF4E2  -  eukaryotic translation initiation factor 4e family member 2, GNB2L1  -  guanine nucleotide binding protein (g protein), beta polypeptide 2-like 1, SERPING1  -  serpin peptidase inhibitor, clade g (c1 inhibitor), member 1, CDKN1C  -  cyclin-dependent kinase inhibitor 1c (p57, kip2), TRIM21  -  tripartite motif containing 21, CDKN2D  -  cyclin-dependent kinase inhibitor 2d (p19, inhibits cdk4), DAPK1  -  death-associated protein kinase 1, MAPK8IP1  -  mitogen-activated protein kinase 8 interacting protein 1, DMD  -  dystrophin, TAOK3  -  tao kinase 3, PRKCG  -  protein kinase c, gamma, FZR1  -  fizzy/cell division cycle 20 related 1 (drosophila), PPAP2B  -  phosphatidic acid phosphatase type 2b, PRKCA  -  protein kinase c, alpha, SMAD3  -  smad family member 3, EIF3E  -  eukaryotic translation initiation factor 3, subunit e, PRKAR1B  -  protein kinase, camp-dependent, regulatory, type i, beta, GSK3B  -  glycogen synthase kinase 3 beta, SMAD6  -  smad family member 6, GAS1  -  growth arrest-specific 1, PKIG  -  protein kinase (camp-dependent, catalytic) inhibitor gamma]"GO:0045087,innate immune response,8.81E-04,6.77E-02,1.96,8230,492,299,35,"[PDGFA  -  platelet-derived growth factor alpha polypeptide, C9  -  complement component 9, FGFR1  -  fibroblast growth factor receptor 1, UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, PROS1  -  protein s (alpha), TICAM1  -  toll-like receptor adaptor molecule 1, FGF7  -  fibroblast growth factor 7, ADAR  -  adenosine deaminase, rna-specific, PDPK1  -  3-phosphoinositide dependent protein kinase-1, FGF4  -  fibroblast growth factor 4, GAB2  -  grb2-associated binding protein 2, CD14  -  cd14 molecule, RPS6KA2  -  ribosomal protein s6 kinase, 90kda, polypeptide 2, CLU  -  clusterin, LGALS3  -  lectin, galactoside-binding, soluble, 3, HRAS  -  harvey rat sarcoma viral oncogene homolog, MAP2K1  -  mitogen-activated protein kinase kinase 1, TAB2  -  tgf-beta activated kinase 1/map3k7 binding protein 2, CTSK  -  cathepsin k, ARPC2  -  actin related protein 2/3 complex, subunit 2, 34kda, MAPK7  -  mitogen-activated protein kinase 7, SRPK2  -  srsf protein kinase 2, UBE2L6  -  ubiquitin-conjugating enzyme e2l 6, CFB  -  complement factor b, NFKBIA  -  nuclear factor of kappa light polypeptide gene enhancer in b-cells inhibitor, alpha, TRIM21  -  tripartite motif containing 21, C1R  -  complement component 1, r subcomponent, LY96  -  lymphocyte antigen 96, C1S  -  complement component 1, s subcomponent, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, YES1  -  v-yes-1 yamaguchi sarcoma viral oncogene homolog 1, C4A  -  complement component 4a (rodgers blood group), CFH  -  complement factor h, PRKCA  -  protein kinase c, alpha, GSK3B  -  glycogen synthase kinase 3 beta]"GO:0048634,regulation of muscle organ development,8.86E-04,6.76E-02,2.8,8230,90,555,17,"[HDAC4  -  histone deacetylase 4, TBX2  -  t-box 2, TGFB1  -  transforming growth factor, beta 1, RBPJ  -  recombination signal binding protein for immunoglobulin kappa j region, FGFR1  -  fibroblast growth factor receptor 1, SHH  -  sonic hedgehog, SOX9  -  sry (sex determining region y)-box 9, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), TCF7L2  -  transcription factor 7-like 2 (t-cell specific, hmg-box), GPC1  -  glypican 1, GJA1  -  gap junction protein, alpha 1, 43kda, TSC22D3  -  tsc22 domain family, member 3, COL14A1  -  collagen, type xiv, alpha 1, DDX17  -  dead (asp-glu-ala-asp) box helicase 17, EFNB2  -  ephrin-b2, NR1D2  -  nuclear receptor subfamily 1, group d, member 2, BMP4  -  bone morphogenetic protein 4]"GO:0071559,response to transforming growth factor beta,9.22E-04,6.99E-02,3.51,8230,139,219,13,"[PDGFA  -  platelet-derived growth factor alpha polypeptide, ID1  -  inhibitor of dna binding 1, dominant negative helix-loop-helix protein, MAPK7  -  mitogen-activated protein kinase 7, SOX9  -  sry (sex determining region y)-box 9, TGIF1  -  tgfb-induced factor homeobox 1, BAMBI  -  bmp and activin membrane-bound inhibitor, TGFBR3  -  transforming growth factor, beta receptor iii, PARP1  -  poly (adp-ribose) polymerase 1, NCOR2  -  nuclear receptor corepressor 2, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, SMAD6  -  smad family member 6, WWOX  -  ww domain containing oxidoreductase, HDAC1  -  histone deacetylase 1]"GO:0030638,polyketide metabolic process,9.56E-04,7.20E-02,"2,057.50",8230,2,2,1,"[AKR1C3  -  aldo-keto reductase family 1, member c3]"GO:2000224,regulation of testosterone biosynthetic process,9.56E-04,7.15E-02,"2,057.50",8230,2,2,1,"[AKR1C3  -  aldo-keto reductase family 1, member c3]"GO:0044598,doxorubicin metabolic process,9.56E-04,7.10E-02,"2,057.50",8230,2,2,1,"[AKR1C3  -  aldo-keto reductase family 1, member c3]"GO:0044597,daunorubicin metabolic process,9.56E-04,7.06E-02,"2,057.50",8230,2,2,1,"[AKR1C3  -  aldo-keto reductase family 1, member c3]"GO:0019747,regulation of isoprenoid metabolic process,9.56E-04,7.01E-02,"2,057.50",8230,2,2,1,"[AKR1C3  -  aldo-keto reductase family 1, member c3]"GO:0030334,regulation of cell migration,9.59E-04,6.98E-02,1.74,8230,370,600,47,"[ITGA5  -  integrin, alpha 5 (fibronectin receptor, alpha polypeptide), PDGFA  -  platelet-derived growth factor alpha polypeptide, APEX1  -  apex nuclease (multifunctional dna repair enzyme) 1, TEK  -  tek tyrosine kinase, endothelial, SHH  -  sonic hedgehog, KIAA1199  -  kiaa1199, ROR2  -  receptor tyrosine kinase-like orphan receptor 2, PDGFRA  -  platelet-derived growth factor receptor, alpha polypeptide, ITGA3  -  integrin, alpha 3 (antigen cd49c, alpha 3 subunit of vla-3 receptor), FGF7  -  fibroblast growth factor 7, PDPK1  -  3-phosphoinositide dependent protein kinase-1, EGFR  -  epidermal growth factor receptor, JAK2  -  janus kinase 2, ADA  -  adenosine deaminase, DLC1  -  deleted in liver cancer 1, LGALS3  -  lectin, galactoside-binding, soluble, 3, HRAS  -  harvey rat sarcoma viral oncogene homolog, MAP2K1  -  mitogen-activated protein kinase kinase 1, NBL1  -  neuroblastoma 1, dan family bmp antagonist, CTSH  -  cathepsin h, IGF1R  -  insulin-like growth factor 1 receptor, SERPINE2  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 2, PLXND1  -  plexin d1, VEGFC  -  vascular endothelial growth factor c, TGFB1  -  transforming growth factor, beta 1, TNFRSF14  -  tumor necrosis factor receptor superfamily, member 14, DAG1  -  dystroglycan 1 (dystrophin-associated glycoprotein 1), SOX9  -  sry (sex determining region y)-box 9, WNT5A  -  wingless-type mmtv integration site family, member 5a, SRGAP2  -  slit-robo rho gtpase activating protein 2, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), TGFBR3  -  transforming growth factor, beta receptor iii, PDPN  -  podoplanin, KRIT1  -  krit1, ankyrin repeat containing, MYLK  -  myosin light chain kinase, APOE  -  apolipoprotein e, SGK1  -  serum/glucocorticoid regulated kinase 1, CDH13  -  cadherin 13, h-cadherin (heart), SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, LAMA5  -  laminin, alpha 5, LAMA4  -  laminin, alpha 4, PRKCA  -  protein kinase c, alpha, RRAS  -  related ras viral (r-ras) oncogene homolog, GAS6  -  growth arrest-specific 6, LMNA  -  lamin a/c, BMP4  -  bone morphogenetic protein 4, LAMB1  -  laminin, beta 1]"GO:0070306,lens fiber cell differentiation,9.64E-04,6.97E-02,6.9,8230,8,745,5,"[FZR1  -  fizzy/cell division cycle 20 related 1 (drosophila), TGFB1  -  transforming growth factor, beta 1, SMAD3  -  smad family member 3, NF2  -  neurofibromin 2 (merlin), MAF  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog]"GO:0006081,cellular aldehyde metabolic process,9.75E-04,7.01E-02,26.41,8230,17,55,3,"[AKR1C3  -  aldo-keto reductase family 1, member c3, GPI  -  glucose-6-phosphate isomerase, ADH5  -  alcohol dehydrogenase 5 (class iii), chi polypeptide]"GO:0006082,organic acid metabolic process,9.84E-04,7.03E-02,1.55,8230,385,935,68,"[FMOD  -  fibromodulin, GSTM2  -  glutathione s-transferase mu 2 (muscle), AKR1C3  -  aldo-keto reductase family 1, member c3, GSTM1  -  glutathione s-transferase mu 1, QKI  -  qki, kh domain containing, rna binding, ACAA2  -  acetyl-coa acyltransferase 2, GSTM4  -  glutathione s-transferase mu 4, SLC7A8  -  solute carrier family 7 (amino acid transporter light chain, l system), member 8, BCKDK  -  branched chain ketoacid dehydrogenase kinase, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), PGD  -  phosphogluconate dehydrogenase, SLC16A3  -  solute carrier family 16 (monocarboxylate transporter), member 3, LDHB  -  lactate dehydrogenase b, GPC1  -  glypican 1, GCSH  -  glycine cleavage system protein h (aminomethyl carrier), PC  -  pyruvate carboxylase, PRELP  -  proline/arginine-rich end leucine-rich repeat protein, LDHA  -  lactate dehydrogenase a, CTPS1  -  ctp synthase 1, AIMP2  -  aminoacyl trna synthetase complex-interacting multifunctional protein 2, GCH1  -  gtp cyclohydrolase 1, ACAN  -  aggrecan, BGN  -  biglycan, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, P4HB  -  prolyl 4-hydroxylase, beta polypeptide, SULT2B1  -  sulfotransferase family, cytosolic, 2b, member 1, SLC2A1  -  solute carrier family 2 (facilitated glucose transporter), member 1, PLSCR1  -  phospholipid scramblase 1, OGDH  -  oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide), PDPN  -  podoplanin, B4GALT3  -  udp-gal:betaglcnac beta 1,4- galactosyltransferase, polypeptide 3, CYB5A  -  cytochrome b5 type a (microsomal), SLC7A5  -  solute carrier family 7 (amino acid transporter light chain, l system), member 5, GHR  -  growth hormone receptor, SDC2  -  syndecan 2, TST  -  thiosulfate sulfurtransferase (rhodanese), SLC2A3  -  solute carrier family 2 (facilitated glucose transporter), member 3, COASY  -  coa synthase, SOD2  -  superoxide dismutase 2, mitochondrial, SOD1  -  superoxide dismutase 1, soluble, IDH3B  -  isocitrate dehydrogenase 3 (nad+) beta, IDH2  -  isocitrate dehydrogenase 2 (nadp+), mitochondrial, DLD  -  dihydrolipoamide dehydrogenase, PRPS1  -  phosphoribosyl pyrophosphate synthetase 1, GPX1  -  glutathione peroxidase 1, PTGDS  -  prostaglandin d2 synthase 21kda (brain), MECP2  -  methyl cpg binding protein 2 (rett syndrome), ST6GAL1  -  st6 beta-galactosamide alpha-2,6-sialyltranferase 1, LUM  -  lumican, PDK3  -  pyruvate dehydrogenase kinase, isozyme 3, ST3GAL4  -  st3 beta-galactoside alpha-2,3-sialyltransferase 4, HADH  -  hydroxyacyl-coa dehydrogenase, MED1  -  mediator complex subunit 1, PTGES  -  prostaglandin e synthase, CHST15  -  carbohydrate (n-acetylgalactosamine 4-sulfate 6-o) sulfotransferase 15, MGLL  -  monoglyceride lipase, PLA2G15  -  phospholipase a2, group xv, SLC23A2  -  solute carrier family 23 (ascorbic acid transporter), member 2, ACOT7  -  acyl-coa thioesterase 7, ASS1  -  argininosuccinate synthase 1, PHYH  -  phytanoyl-coa 2-hydroxylase, HEXA  -  hexosaminidase a (alpha polypeptide), CSPG4  -  chondroitin sulfate proteoglycan 4, CKB  -  creatine kinase, brain, CBS  -  cystathionine-beta-synthase, VCAN  -  versican, P4HA2  -  prolyl 4-hydroxylase, alpha polypeptide ii, ECH1  -  enoyl coa hydratase 1, peroxisomal]"GO:0044248,cellular catabolic process,9.98E-04,7.08E-02,1.35,8230,844,999,138,"[FMOD  -  fibromodulin, APEX1  -  apex nuclease (multifunctional dna repair enzyme) 1, GSTM2  -  glutathione s-transferase mu 2 (muscle), GSTM1  -  glutathione s-transferase mu 1, NCBP2  -  nuclear cap binding protein subunit 2, 20kda, BNIP3  -  bcl2/adenovirus e1b 19kda interacting protein 3, DDX3X  -  dead (asp-glu-ala-asp) box helicase 3, x-linked, GSTM4  -  glutathione s-transferase mu 4, BCKDK  -  branched chain ketoacid dehydrogenase kinase, SEPT5  -  septin 5, CDC34  -  cell division cycle 34, DDB1  -  damage-specific dna binding protein 1, 127kda, MAP1LC3B  -  microtubule-associated protein 1 light chain 3 beta, GCSH  -  glycine cleavage system protein h (aminomethyl carrier), GTF2H1  -  general transcription factor iih, polypeptide 1, 62kda, PSMA1  -  proteasome (prosome, macropain) subunit, alpha type, 1, GCH1  -  gtp cyclohydrolase 1, HRAS  -  harvey rat sarcoma viral oncogene homolog, MSH6  -  muts homolog 6 (e. coli), RIT1  -  ras-like without caax 1, MYO10  -  myosin x, EIF4A2  -  eukaryotic translation initiation factor 4a2, BGN  -  biglycan, SMPD4  -  sphingomyelin phosphodiesterase 4, neutral membrane (neutral sphingomyelinase-3), EIF4B  -  eukaryotic translation initiation factor 4b, PSMA6  -  proteasome (prosome, macropain) subunit, alpha type, 6, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, NT5C2  -  5'-nucleotidase, cytosolic ii, UBE2L6  -  ubiquitin-conjugating enzyme e2l 6, PSMB10  -  proteasome (prosome, macropain) subunit, beta type, 10, PSMB9  -  proteasome (prosome, macropain) subunit, beta type, 9, PSMB8  -  proteasome (prosome, macropain) subunit, beta type, 8, PSMB7  -  proteasome (prosome, macropain) subunit, beta type, 7, UBR2  -  ubiquitin protein ligase e3 component n-recognin 2, ARF1  -  adp-ribosylation factor 1, LSM2  -  lsm2 homolog, u6 small nuclear rna associated (s. cerevisiae), PSMB4  -  proteasome (prosome, macropain) subunit, beta type, 4, OGDH  -  oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide), TDG  -  thymine-dna glycosylase, TST  -  thiosulfate sulfurtransferase (rhodanese), BLVRB  -  biliverdin reductase b (flavin reductase (nadph)), SOD1  -  superoxide dismutase 1, soluble, EIF4G1  -  eukaryotic translation initiation factor 4 gamma, 1, SMG7  -  smg7 nonsense mediated mrna decay factor, PSMD8  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 8, PSMD11  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 11, GLUL  -  glutamate-ammonia ligase, PSME1  -  proteasome (prosome, macropain) activator subunit 1 (pa28 alpha), MYH10  -  myosin, heavy chain 10, non-muscle, USP9Y  -  ubiquitin specific peptidase 9, y-linked, RHOB  -  ras homolog family member b, HADH  -  hydroxyacyl-coa dehydrogenase, ADA  -  adenosine deaminase, DDX17  -  dead (asp-glu-ala-asp) box helicase 17, RHOG  -  ras homolog family member g, PON2  -  paraoxonase 2, LAMP1  -  lysosomal-associated membrane protein 1, PLA2G15  -  phospholipase a2, group xv, GNB1  -  guanine nucleotide binding protein (g protein), beta polypeptide 1, ADH5  -  alcohol dehydrogenase 5 (class iii), chi polypeptide, SMARCA2  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, PDE1A  -  phosphodiesterase 1a, calmodulin-dependent, HEXA  -  hexosaminidase a (alpha polypeptide), RNF40  -  ring finger protein 40, e3 ubiquitin protein ligase, FZR1  -  fizzy/cell division cycle 20 related 1 (drosophila), EIF3E  -  eukaryotic translation initiation factor 3, subunit e, ECE1  -  endothelin converting enzyme 1, RAB7L1  -  rab7, member ras oncogene family-like 1, ECH1  -  enoyl coa hydratase 1, peroxisomal, AKR1C3  -  aldo-keto reductase family 1, member c3, RPL23A  -  ribosomal protein l23a, PRKACB  -  protein kinase, camp-dependent, catalytic, beta, MAGOH  -  mago-nashi homolog, proliferation-associated (drosophila), IFI16  -  interferon, gamma-inducible protein 16, PDE5A  -  phosphodiesterase 5a, cgmp-specific, RPL18A  -  ribosomal protein l18a, XPC  -  xeroderma pigmentosum, complementation group c, RPL15  -  ribosomal protein l15, RPL13  -  ribosomal protein l13, RPL12  -  ribosomal protein l12, ZHX2  -  zinc fingers and homeoboxes 2, SUPV3L1  -  suppressor of var1, 3-like 1 (s. cerevisiae), GPC1  -  glypican 1, RAB14  -  rab14, member ras oncogene family, RPL5  -  ribosomal protein l5, PRELP  -  proline/arginine-rich end leucine-rich repeat protein, GPI  -  glucose-6-phosphate isomerase, RPL4  -  ribosomal protein l4, DPYSL3  -  dihydropyrimidinase-like 3, DPYSL2  -  dihydropyrimidinase-like 2, RPA3  -  replication protein a3, 14kda, ACAN  -  aggrecan, RPA2  -  replication protein a2, 32kda, PEX6  -  peroxisomal biogenesis factor 6, CTSH  -  cathepsin h, RAB2A  -  rab2a, member ras oncogene family, WWP2  -  ww domain containing e3 ubiquitin protein ligase 2, RAD23B  -  rad23 homolog b (s. cerevisiae), PPP2CA  -  protein phosphatase 2, catalytic subunit, alpha isozyme, TNNT3  -  troponin t type 3 (skeletal, fast), RAB13  -  rab13, member ras oncogene family, DLD  -  dihydrolipoamide dehydrogenase, MSH2  -  muts homolog 2, colon cancer, nonpolyposis type 1 (e. coli), RAB33A  -  rab33a, member ras oncogene family, RAB9A  -  rab9a, member ras oncogene family, UBE2D1  -  ubiquitin-conjugating enzyme e2d 1, RPL14  -  ribosomal protein l14, UBE4A  -  ubiquitination factor e4a, GPX1  -  glutathione peroxidase 1, PABPC1  -  poly(a) binding protein, cytoplasmic 1, NFE2L2  -  nuclear factor (erythroid-derived 2)-like 2, LUM  -  lumican, ISG15  -  isg15 ubiquitin-like modifier, RPS13  -  ribosomal protein s13, CRYZ  -  crystallin, zeta (quinone reductase), TPP1  -  tripeptidyl peptidase i, MGLL  -  monoglyceride lipase, SMARCA5  -  swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5, PABPC4  -  poly(a) binding protein, cytoplasmic 4 (inducible form), TGFB1  -  transforming growth factor, beta 1, UCHL1  -  ubiquitin carboxyl-terminal esterase l1 (ubiquitin thiolesterase), TGFB1I1  -  transforming growth factor beta 1 induced transcript 1, DNM2  -  dynamin 2, ACOT7  -  acyl-coa thioesterase 7, CAT  -  catalase, PHYH  -  phytanoyl-coa 2-hydroxylase, RBBP4  -  retinoblastoma binding protein 4, PIK3CB  -  phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, CUL4B  -  cullin 4b, UBE2G2  -  ubiquitin-conjugating enzyme e2g 2, RPL23  -  ribosomal protein l23, CSPG4  -  chondroitin sulfate proteoglycan 4, NBAS  -  neuroblastoma amplified sequence, ARIH1  -  ariadne homolog, ubiquitin-conjugating enzyme e2 binding protein, 1 (drosophila), CBS  -  cystathionine-beta-synthase, VCAN  -  versican, MPG  -  n-methylpurine-dna glycosylase, FBXL2  -  f-box and leucine-rich repeat protein 2]"